"Drug Name and FDA Appl. #","Suppl. #","Active Ingredients","Company","Approval Type","Approval Date"
"ORTHO EVRA (NDA #021180)","044","ETHINYL ESTRADIOL; NORELGESTROMIN","JANSSEN PHARMS","Labeling Revision","07/01/2013"
"TRACLEER (NDA #021290)","025","BOSENTAN","ACTELION PHARMS LTD","Labeling Revision","07/01/2013"
"RIZATRIPTAN BENZOATE (ANDA #078739)","000","RIZATRIPTAN BENZOATE","SANDOZ","Approval","07/01/2013"
"FINASTERIDE (ANDA #090060)","000","FINASTERIDE","HETERO LABS LTD III","Approval","07/01/2013"
"FINASTERIDE (ANDA #090508)","000","FINASTERIDE","SUN PHARMA GLOBAL","Approval","07/01/2013"
"RASAGILINE MESYLATE (ANDA #201823)","000","RASAGILINE MESYLATE","WATSON LABS INC","Approval","07/01/2013"
"RIZATRIPTAN BENZOATE (ANDA #201914)","000","RIZATRIPTAN BENZOATE","GLENMARK GENERICS","Approval","07/01/2013"
"ARIPIPRAZOLE (ANDA #202102)","000","ARIPIPRAZOLE","ALEMBIC PHARMS LTD","Tentative Approval","07/01/2013"
"RIZATRIPTAN BENZOATE (ANDA #202477)","000","RIZATRIPTAN BENZOATE","APOTEX INC","Approval","07/01/2013"
"GATIFLOXACIN (ANDA #202653)","000","GATIFLOXACIN","LUPIN LTD","Tentative Approval","07/01/2013"
"RILUZOLE (ANDA #203042)","000","RILUZOLE","MYLAN PHARMS INC","Approval","07/01/2013"
"RIZATRIPTAN BENZOATE (ANDA #203062)","000","RIZATRIPTAN BENZOATE","AUROBINDO PHARMA LTD","Approval","07/01/2013"
"RIZATRIPTAN BENZOATE (ANDA #203478)","000","RIZATRIPTAN BENZOATE","NATCO PHARMA LTD","Approval","07/01/2013"
"RIZATRIPTAN BENZOATE (ANDA #204339)","000","RIZATRIPTAN BENZOATE","INVAGEN PHARMS","Approval","07/01/2013"
"EFUDEX (NDA #016831)","056","FLUOROURACIL","VALEANT PHARM INTL","Manufacturing Change or Addition","07/02/2013"
"NASACORT ALLERGY 24 HOUR (NDA #020468)","033","TRIAMCINOLONE ACETONIDE","SANOFI AVENTIS US","Efficacy Supplement with Clinical Data to Support","07/02/2013"
"NASACORT ALLERGY 24 HOUR (NDA #020468)","034","TRIAMCINOLONE ACETONIDE","SANOFI AVENTIS US","Efficacy Supplement with Clinical Data to Support","07/02/2013"
"SPRIX (NDA #022382)","007","KETOROLAC TROMETHAMINE","LUITPOLD","Manufacturing Change or Addition","07/02/2013"
"ZIANA (NDA #050802)","014","CLINDAMYCIN PHOSPHATE; TRETINOIN","MEDICIS","Manufacturing Change or Addition","07/02/2013"
"ROSUVASTATIN CALCIUM (ANDA #079161)","000","ROSUVASTATIN CALCIUM","MYLAN PHARMA","Tentative Approval","07/02/2013"
"PEGASYS (BLA #103964)","5245","PEGINTERFERON ALFA-2A","HOFFMAN-LA ROCHE","Labeling Revision","07/02/2013"
"ACTEMRA (BLA #125276)","075","TOCILIZUMAB","GENENTECH","Labeling Revision","07/02/2013"
"SUBLIMAZE PRESERVATIVE FREE (NDA #016619)","034","FENTANYL CITRATE","AKORN","Labeling Revision","07/03/2013"
"TENEX (NDA #019032)","021","GUANFACINE HYDROCHLORIDE","PROMIUS PHARMA","Labeling Revision","07/03/2013"
"PERIOCHIP (NDA #020774)","013","CHLORHEXIDINE GLUCONATE","DEXCEL PHARMA","Manufacturing Change or Addition","07/03/2013"
"GEODON (NDA #020825)","041","ZIPRASIDONE HYDROCHLORIDE","PFIZER","Labeling Revision","07/03/2013"
"GEODON (NDA #020919)","027","ZIPRASIDONE MESYLATE","PFIZER","Labeling Revision","07/03/2013"
"BENICAR (NDA #021286)","027","OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","07/03/2013"
"OXYTROL (NDA #021351)","007","OXYBUTYNIN","WATSON LABS (UTAH)","Manufacturing Change or Addition","07/03/2013"
"GEODON (NDA #021483)","007","ZIPRASIDONE HYDROCHLORIDE","PFIZER INC","Labeling Revision","07/03/2013"
"BENICAR HCT (NDA #021532)","022","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","07/03/2013"
"AZOR (NDA #022100)","022","AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","07/03/2013"
"CAPRELSA (NDA #022405)","004","VANDETANIB","IPR PHARMS INC","Labeling Revision","07/03/2013"
"GABAPENTIN (ANDA #076672)","000","GABAPENTIN","TARO","Approval","07/03/2013"
"PROLIA (BLA #125320)","113","DENOSUMAB","AMGEN","Labeling Revision","07/03/2013"
"XGEVA (BLA #125320)","113","DENOSUMAB","AMGEN","Labeling Revision","07/03/2013"
"TRIBENZOR (NDA #200175)","014","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Manufacturing Change or Addition","07/03/2013"
"TRIBENZOR (NDA #200175)","015","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","07/03/2013"
"ZELBORAF (NDA #202429)","002","VEMURAFENIB","HOFFMANN LA ROCHE","Labeling Revision","07/03/2013"
"ZELBORAF (NDA #202429)","003","VEMURAFENIB","HOFFMANN LA ROCHE","Labeling Revision","07/03/2013"
"ZOLEDRONIC ACID (NDA #204016)","000","ZOLEDRONIC ACID","HOSPIRA INC","Tentative Approval","07/03/2013"
"ZUBSOLV (NDA #204242)","000","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","OREXO AB","Approval","07/03/2013"
"DILAUDID (NDA #019892)","023","HYDROMORPHONE HYDROCHLORIDE","PURDUE PHARM PRODS","Manufacturing Change or Addition","07/05/2013"
"SARAFEM (NDA #021860)","006","FLUOXETINE HYDROCHLORIDE","WARNER CHILCOTT LLC","Labeling Revision","07/05/2013"
"SARAFEM (NDA #021860)","007","FLUOXETINE HYDROCHLORIDE","WARNER CHILCOTT LLC","Labeling Revision","07/05/2013"
"SARAFEM (NDA #021860)","008","FLUOXETINE HYDROCHLORIDE","WARNER CHILCOTT LLC","Labeling Revision","07/05/2013"
"SARAFEM (NDA #021860)","009","FLUOXETINE HYDROCHLORIDE","WARNER CHILCOTT LLC","Labeling Revision","07/05/2013"
"DONEPEZIL HYDROCHLORIDE (ANDA #202114)","000","DONEPEZIL HYDROCHLORIDE","CSPC OUYI PHARM CO","Approval","07/05/2013"
"TRUVADA (NDA #021752)","039","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","07/08/2013"
"INTELENCE (NDA #022187)","015","ETRAVIRINE","JANSSEN R AND D","Manufacturing Change or Addition","07/08/2013"
"CEVIMELINE HYDROCHLORIDE (ANDA #091591)","001","CEVIMELINE HYDROCHLORIDE","ROXANE","Approval","07/08/2013"
"DIPRIVAN (NDA #019627)","060","PROPOFOL","FRESENIUS KABI USA","Manufacturing Change or Addition","07/09/2013"
"CIPRO HC (NDA #020805)","010","CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE","ALCON PHARMS LTD","Manufacturing Change or Addition","07/09/2013"
"OVIDREL (NDA #021149)","017","CHORIOGONADOTROPIN ALFA","EMD SERONO","Manufacturing Change or Addition","07/09/2013"
"SUSTIVA (NDA #021360)","032","EFAVIRENZ","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","07/09/2013"
"SYNERA (NDA #021623)","022","LIDOCAINE; TETRACAINE","GALEN SPECIALTY","Manufacturing Change or Addition","07/09/2013"
"METHYLPHENIDATE HYDROCHLORIDE (ANDA #091695)","000","METHYLPHENIDATE HYDROCHLORIDE","KUDCO IRELAND","Approval","07/09/2013"
"DELZICOL (NDA #204412)","001","MESALAMINE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","07/09/2013"
"MONISTAT 7 (NDA #017450)","063","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT 7 (NDA #018520)","024","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT 3 (NDA #018888)","015","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"LUPRON DEPOT (NDA #019732)","040","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","07/10/2013"
"MONISTAT 7 COMBINATION PACK (NDA #020288)","017","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"LUPRON DEPOT (NDA #020517)","035","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","07/10/2013"
"MONISTAT-3 COMBINATION PACK (NDA #020670)","022","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT 3 (NDA #020827)","021","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT DUAL- PAK (NDA #020968)","003","MICONAZOLE NITRATE","PERSONAL PRODS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT 3 COMBINATION PACK (NDA #021261)","014","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT 3 COMBINATION PACK (PREFILLED) (NDA #021261)","014","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"MONISTAT 1 COMBINATION PACK (NDA #021308)","019","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","07/10/2013"
"OXYTROL (NDA #021351)","012","OXYBUTYNIN","WATSON LABS (UTAH)","Manufacturing Change or Addition","07/10/2013"
"LUVOX (NDA #021519)","006","FLUVOXAMINE MALEATE","ANI PHARMS","Manufacturing Change or Addition","07/10/2013"
"DURAPREP (NDA #021586)","004","IODINE POVACRYLEX; ISOPROPYL ALCOHOL","3M","Manufacturing Change or Addition","07/10/2013"
"EXPAREL (NDA #022496)","004","BUPIVACAINE","PACIRA PHARMS INC","Manufacturing Change or Addition","07/10/2013"
"MORPHINE SULFATE (NDA #201517)","005","MORPHINE SULFATE","LANNETT HOLDINGS INC","Manufacturing Change or Addition","07/10/2013"
"STENDRA (NDA #202276)","004","AVANAFIL","VIVUS","Manufacturing Change or Addition","07/10/2013"
"KHEDEZLA (NDA #204683)","000","DESVENLAFAXINE","OSMOTICA PHARM CORP","Approval","07/10/2013"
"FEMARA (NDA #020726)","025","LETROZOLE","NOVARTIS PHARMS","Manufacturing Change or Addition","07/11/2013"
"KETEK (NDA #021144)","016","TELITHROMYCIN","SANOFI AVENTIS US","Manufacturing Change or Addition","07/11/2013"
"TIROSINT (NDA #021924)","010","LEVOTHYROXINE SODIUM","INSTITUT BIOCHIMIQUE","Manufacturing Change or Addition","07/11/2013"
"NUCYNTA (NDA #022304)","007","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","07/11/2013"
"NUCYNTA (NDA #022304)","008","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","07/11/2013"
"NUCYNTA (NDA #022304)","009","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","07/11/2013"
"NUCYNTA (NDA #022304)","011","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","07/11/2013"
"NUCYNTA (NDA #022304)","012","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","07/11/2013"
"REPAGLINIDE (ANDA #077571)","000","REPAGLINIDE","CARACO","Approval","07/11/2013"
"OXYMORPHONE HYDROCHLORIDE (ANDA #079046)","000","OXYMORPHONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Approval","07/11/2013"
"OXYCODONE AND ACETAMINOPHEN (ANDA #090733)","000","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","VINTAGE PHARMS","Approval","07/11/2013"
"OXYCODONE AND ACETAMINOPHEN (ANDA #090734)","000","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","VINTAGE PHARMS","Approval","07/11/2013"
"SUPRENZA (NDA #202088)","006","PHENTERMINE HYDROCHLORIDE","CITIUS PHARMS","Labeling Revision","07/11/2013"
"DECITABINE (ANDA #203131)","000","DECITABINE","DR REDDYS LABS LTD","Approval","07/11/2013"
"MINASTRIN 24 FE (NDA #203667)","002","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Labeling Revision","07/11/2013"
"BACTRIM (NDA #017377)","068","SULFAMETHOXAZOLE; TRIMETHOPRIM","MUTUAL PHARM","Labeling Revision","07/12/2013"
"BACTRIM (NDA #017377)","073","SULFAMETHOXAZOLE; TRIMETHOPRIM","MUTUAL PHARM","Labeling Revision","07/12/2013"
"BACTRIM DS (NDA #017377)","068","SULFAMETHOXAZOLE; TRIMETHOPRIM","MUTUAL PHARM","Labeling Revision","07/12/2013"
"BACTRIM DS (NDA #017377)","073","SULFAMETHOXAZOLE; TRIMETHOPRIM","MUTUAL PHARM","Labeling Revision","07/12/2013"
"TRI-LUMA (NDA #021112)","007","FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN","GALDERMA LABS LP","Manufacturing Change or Addition","07/12/2013"
"FANAPT (NDA #022192)","010","ILOPERIDONE","NOVARTIS","Manufacturing Change or Addition","07/12/2013"
"RAPAFLO (NDA #022206)","012","SILODOSIN","WATSON LABS","Labeling Revision","07/12/2013"
"AZACTAM IN PLASTIC CONTAINER (NDA #050632)","016","AZTREONAM","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","07/12/2013"
"FOLIC ACID (ANDA #091145)","000","FOLIC ACID","BICON PHARM","Approval","07/12/2013"
"DESOGESTREL AND ETHINYL ESTRADIOL (ANDA #091234)","000","DESOGESTREL; ETHINYL ESTRADIOL","NOVAST LABS LTD","Approval","07/12/2013"
"MYCOPHENOLATE MOFETIL (ANDA #200197)","000","MYCOPHENOLATE MOFETIL","ALKEM LABS LTD","Approval","07/12/2013"
"LATUDA (NDA #200603)","015","LURASIDONE HYDROCHLORIDE","SUNOVION PHARMS INC","Manufacturing Change or Addition","07/12/2013"
"GILOTRIF (NDA #201292)","000","AFATINIB DIMALEATE","BOEHRINGER INGELHEIM","Approval","07/12/2013"
"OXYCODONE HYDROCHLORIDE (ANDA #203208)","000","OXYCODONE HYDROCHLORIDE","ROXANE","Approval","07/12/2013"
"GABAPENTIN (ANDA #203244)","000","GABAPENTIN","ACI HEALTHCARE LTD","Approval","07/12/2013"
"INFUVITE ADULT (NDA #021163)","026","ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K","SANDOZ","Manufacturing Change or Addition","07/13/2013"
"CORGARD (NDA #018063)","063","NADOLOL","KING PHARMS","Labeling Revision","07/15/2013"
"CORZIDE (NDA #018647)","025","BENDROFLUMETHIAZIDE; NADOLOL","KING PHARMS","Labeling Revision","07/15/2013"
"HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9% (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% (NDA #018916)","062","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","07/15/2013"
"FEMHRT (NDA #021065)","022","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","07/15/2013"
"MIRAPEX ER (NDA #022421)","008","PRAMIPEXOLE DIHYDROCHLORIDE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","07/15/2013"
"OXYMORPHONE HYDROCHLORIDE (ANDA #200822)","000","OXYMORPHONE HYDROCHLORIDE","ROXANE","Approval","07/15/2013"
"LAMOTRIGINE (ANDA #200828)","000","LAMOTRIGINE","WATSON LABS INC","Approval","07/15/2013"
"OXYCODONE AND ACETAMINOPHEN (ANDA #201972)","000","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","AUROLIFE PHARMA LLC","Approval","07/15/2013"
"OXYCODONE HYDROCHLORIDE (ANDA #204037)","000","OXYCODONE HYDROCHLORIDE","ROXANE","Approval","07/15/2013"
"ELOXATIN (NDA #021759)","016","OXALIPLATIN","SANOFI AVENTIS US","Labeling Revision","07/16/2013"
"ELSPAR (BLA #101063)","5169","ASPARAGINASE","MERCK","Labeling Revision","07/16/2013"
"ELIQUIS (NDA #202155)","001","APIXABAN","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","07/16/2013"
"ACAMPROSATE CALCIUM (ANDA #202229)","000","ACAMPROSATE CALCIUM","GLENMARK GENERICS","Approval","07/16/2013"
"AGRYLIN (NDA #020333)","020","ANAGRELIDE HYDROCHLORIDE","SHIRE LLC","Labeling Revision","07/17/2013"
"REPAGLINIDE (ANDA #201189)","000","REPAGLINIDE","PADDOCK LLC","Tentative Approval","07/17/2013"
"TRETINOIN (ANDA #202026)","000","TRETINOIN","SPEAR PHARMS INC","Approval","07/17/2013"
"TRETINOIN (ANDA #202567)","000","TRETINOIN","SPEAR PHARMS INC","Approval","07/17/2013"
"AZULFIDINE (NDA #007073)","126","SULFASALAZINE","PHARMACIA AND UPJOHN","Labeling Revision","07/18/2013"
"AZULFIDINE EN-TABS (NDA #007073)","126","SULFASALAZINE","PHARMACIA AND UPJOHN","Labeling Revision","07/18/2013"
"MEDROL (NDA #011153)","071","METHYLPREDNISOLONE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","07/18/2013"
"HEPARIN SODIUM (NDA #017651)","060","HEPARIN SODIUM","FRESENIUS KABI USA","Manufacturing Change or Addition","07/18/2013"
"CIS-MDP (NDA #018124)","021","TECHNETIUM TC-99M MEDRONATE KIT","PHARMALUCENCE","Manufacturing Change or Addition","07/18/2013"
"MICRO-K (NDA #018238)","041","POTASSIUM CHLORIDE","NESHER PHARMS","Manufacturing Change or Addition","07/18/2013"
"MICRO-K 10 (NDA #018238)","041","POTASSIUM CHLORIDE","NESHER PHARMS","Manufacturing Change or Addition","07/18/2013"
"NUTROPIN AQ (NDA #020522)","049","SOMATROPIN RECOMBINANT","GENENTECH","Manufacturing Change or Addition","07/18/2013"
"NUTROPIN AQ PEN (NDA #020522)","049","SOMATROPIN RECOMBINANT","GENENTECH","Manufacturing Change or Addition","07/18/2013"
"HUMALOG (NDA #020563)","141","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","07/18/2013"
"HUMALOG KWIKPEN (NDA #020563)","141","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","07/18/2013"
"HUMALOG PEN (NDA #020563)","141","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","07/18/2013"
"LANTUS (NDA #021081)","058","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","Manufacturing Change or Addition","07/18/2013"
"LANTUS SOLOSTAR (NDA #021081)","058","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","Manufacturing Change or Addition","07/18/2013"
"NEURONTIN (NDA #021129)","038","GABAPENTIN","PARKE DAVIS","Manufacturing Change or Addition","07/18/2013"
"RISPERDAL CONSTA (NDA #021346)","049","RISPERIDONE","JANSSEN PHARMS","Manufacturing Change or Addition","07/18/2013"
"FLOVENT HFA (NDA #021433)","022","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Manufacturing Change or Addition","07/18/2013"
"SIMPONI ARIA (BLA #125433)","000","GOLIMUMAB","JANSSEN BIOTECH","Approval","07/18/2013"
"FENOFIBRIC ACID (ANDA #201573)","000","CHOLINE FENOFIBRATE","ANCHEN PHARMS","Approval","07/18/2013"
"OSMITROL 10% IN WATER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 10% IN WATER IN PLASTIC CONTAINER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 15% IN WATER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 15% IN WATER IN PLASTIC CONTAINER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 20% IN WATER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 20% IN WATER IN PLASTIC CONTAINER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 5% IN WATER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"OSMITROL 5% IN WATER IN PLASTIC CONTAINER (NDA #013684)","097","MANNITOL","BAXTER HLTHCARE","Manufacturing Change or Addition","07/19/2013"
"CLOZARIL (NDA #019758)","069","CLOZAPINE","NOVARTIS","Labeling Revision","07/19/2013"
"CLOZARIL (NDA #019758)","071","CLOZAPINE","NOVARTIS","Labeling Revision","07/19/2013"
"NUVARING (NDA #021187)","023","ETHINYL ESTRADIOL; ETONOGESTREL","ORGANON USA INC","Manufacturing Change or Addition","07/19/2013"
"FAZACLO ODT (NDA #021590)","021","CLOZAPINE","JAZZ PHARMS III","Labeling Revision","07/19/2013"
"FANAPT (NDA #022192)","012","ILOPERIDONE","NOVARTIS","Manufacturing Change or Addition","07/19/2013"
"TIMENTIN (NDA #050590)","066","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Manufacturing Change or Addition","07/19/2013"
"METFORMIN HYDROCHLORIDE (ANDA #091664)","000","METFORMIN HYDROCHLORIDE","LUPIN LTD","Approval","07/19/2013"
"TBO-FILGRASTIM (BLA #125294)","007","TBO-FILGRASTIM","SICOR BIOTECH","Labeling Revision","07/19/2013"
"ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ANDA #202253)","000","ONDANSETRON HYDROCHLORIDE","BD RX","Approval","07/19/2013"
"JANUMET XR (NDA #202270)","004","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Manufacturing Change or Addition","07/19/2013"
"MYRBETRIQ (NDA #202611)","002","MIRABEGRON","APGDI","Manufacturing Change or Addition","07/19/2013"
"ASTAGRAF XL (NDA #204096)","000","TACROLIMUS","ASTELLAS","Approval","07/19/2013"
"XYLOCAINE (NDA #006488)","087","LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing Change or Addition","07/22/2013"
"XYLOCAINE W/ EPINEPHRINE (NDA #006488)","087","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing Change or Addition","07/22/2013"
"REGONOL (NDA #017398)","018","PYRIDOSTIGMINE BROMIDE","SANDOZ","Manufacturing Change or Addition","07/22/2013"
"ZEMPLAR (NDA #020819)","031","PARICALCITOL","ABBVIE","Manufacturing Change or Addition","07/22/2013"
"TARGRETIN (NDA #021056)","005","BEXAROTENE","VALEANT LUXEMBOURG","Manufacturing Change or Addition","07/22/2013"
"VANIQA (NDA #021145)","008","EFLORNITHINE HYDROCHLORIDE","SKINMEDICA","Manufacturing Change or Addition","07/22/2013"
"APIDRA (NDA #021629)","024","INSULIN GLULISINE RECOMBINANT","SANOFI AVENTIS US","Manufacturing Change or Addition","07/22/2013"
"APIDRA SOLOSTAR (NDA #021629)","024","INSULIN GLULISINE RECOMBINANT","SANOFI AVENTIS US","Manufacturing Change or Addition","07/22/2013"
"DUETACT (NDA #021925)","013","GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Manufacturing Change or Addition","07/22/2013"
"LUMIGAN (NDA #022184)","002","BIMATOPROST","ALLERGAN","Manufacturing Change or Addition","07/22/2013"
"CARBAGLU (NDA #022562)","001","CARGLUMIC ACID","ORPHAN EUROPE","Manufacturing Change or Addition","07/22/2013"
"INCIVEK (NDA #201917)","011","TELAPREVIR","VERTEX PHARMS","Manufacturing Change or Addition","07/22/2013"
"VICTRELIS (NDA #202258)","008","BOCEPREVIR","MERCK SHARP DOHME","Manufacturing Change or Addition","07/22/2013"
"CORDRAN (NDA #012806)","037","FLURANDRENOLIDE","AQUA PHARMS","Manufacturing Change or Addition","07/23/2013"
"CORDRAN SP (NDA #012806)","037","FLURANDRENOLIDE","AQUA PHARMS","Manufacturing Change or Addition","07/23/2013"
"CONRAY (NDA #013295)","063","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","07/23/2013"
"CONRAY 43 (NDA #013295)","063","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","07/23/2013"
"EPI E Z PEN JR (NDA #019430)","054","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","07/23/2013"
"EPIPEN (NDA #019430)","054","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","07/23/2013"
"EPIPEN E Z PEN (NDA #019430)","054","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","07/23/2013"
"EPIPEN JR. (NDA #019430)","054","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","07/23/2013"
"TERAZOL 7 (NDA #019579)","036","TERCONAZOLE","JANSSEN PHARMS","Manufacturing Change or Addition","07/23/2013"
"TERAZOL 3 (NDA #019641)","029","TERCONAZOLE","JANSSEN PHARMS","Manufacturing Change or Addition","07/23/2013"
"TERAZOL 3 (NDA #019964)","031","TERCONAZOLE","JANSSEN PHARMS","Manufacturing Change or Addition","07/23/2013"
"PENTASA (NDA #020049)","025","MESALAMINE","SHIRE","Labeling Revision","07/23/2013"
"CLARINEX (NDA #021165)","016","DESLORATADINE","MERCK SHARP DOHME","Manufacturing Change or Addition","07/23/2013"
"RECLAST (NDA #021817)","014","ZOLEDRONIC ACID","NOVARTIS","Manufacturing Change or Addition","07/23/2013"
"HYLENEX RECOMBINANT (NDA #021859)","018","HYALURONIDASE RECOMBINANT HUMAN","HALOZYME THERAP","Manufacturing Change or Addition","07/23/2013"
"GILOTRIF (NDA #201292)","001","AFATINIB DIMALEATE","BOEHRINGER INGELHEIM","Labeling Revision","07/23/2013"
"EDURANT (NDA #202022)","006","RILPIVIRINE HYDROCHLORIDE","JANSSEN PRODS","Manufacturing Change or Addition","07/23/2013"
"NORVASC (NDA #019787)","057","AMLODIPINE BESYLATE","PFIZER","Manufacturing Change or Addition","07/24/2013"
"PEDIATRIC ADVIL (NDA #020812)","019","IBUPROFEN","PFIZER","Manufacturing Change or Addition","07/24/2013"
"INVANZ (NDA #021337)","041","ERTAPENEM SODIUM","MERCK SHARP DOHME","Labeling Revision","07/24/2013"
"VIREAD (NDA #021356)","046","TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Efficacy Supplement with Clinical Data to Support","07/24/2013"
"ZINGO (NDA #022114)","002","LIDOCAINE HYDROCHLORIDE","POWDER PHARMS","Manufacturing Change or Addition","07/24/2013"
"VIREAD (NDA #022577)","003","TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Efficacy Supplement with Clinical Data to Support","07/24/2013"
"CELLCEPT (NDA #050759)","034","MYCOPHENOLATE MOFETIL","ROCHE PALO","Manufacturing Change or Addition","07/24/2013"
"DONEPEZIL HYDROCHLORIDE (ANDA #202542)","000","DONEPEZIL HYDROCHLORIDE","PAR PHARM","Approval","07/24/2013"
"DONEPEZIL HYDROCHLORIDE (ANDA #202631)","000","DONEPEZIL HYDROCHLORIDE","MACLEODS PHARMS LTD","Tentative Approval","07/24/2013"
"DONEPEZIL HYDROCHLORIDE (ANDA #202723)","000","DONEPEZIL HYDROCHLORIDE","DR REDDYS LABS LTD","Approval","07/24/2013"
"LO MINASTRIN FE (NDA #204654)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT","Approval","07/24/2013"
"PROCARDIA (NDA #018482)","051","NIFEDIPINE","PFIZER","Labeling Revision","07/25/2013"
"NIZORAL (NDA #018533)","040","KETOCONAZOLE","JANSSEN PHARMS","Labeling Revision","07/25/2013"
"PROCARDIA XL (NDA #019684)","026","NIFEDIPINE","PFIZER","Labeling Revision","07/25/2013"
"TOPAMAX (NDA #020505)","051","TOPIRAMATE","JANSSEN PHARMS","Manufacturing Change or Addition","07/25/2013"
"ZANTAC 75 (NDA #020520)","026","RANITIDINE HYDROCHLORIDE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","07/25/2013"
"KEPPRA (NDA #021035)","089","LEVETIRACETAM","UCB INC","Labeling Revision","07/25/2013"
"VFEND (NDA #021267)","042","VORICONAZOLE","PFIZER","Manufacturing Change or Addition","07/25/2013"
"BUTRANS (NDA #021306)","016","BUPRENORPHINE","PURDUE PHARMA LP","Manufacturing Change or Addition","07/25/2013"
"KEPPRA (NDA #021505)","030","LEVETIRACETAM","UCB INC","Labeling Revision","07/25/2013"
"KEPPRA (NDA #021872)","012","LEVETIRACETAM","UCB INC","Labeling Revision","07/25/2013"
"KEPPRA (NDA #021872)","013","LEVETIRACETAM","UCB INC","Labeling Revision","07/25/2013"
"KEPPRA XR (NDA #022285)","013","LEVETIRACETAM","UCB INC","Labeling Revision","07/25/2013"
"KEPPRA XR (NDA #022285)","015","LEVETIRACETAM","UCB INC","Labeling Revision","07/25/2013"
"ORACEA (NDA #050805)","008","DOXYCYCLINE","GALDERMA LABS LP","Labeling Revision","07/25/2013"
"CETIRIZINE HYDROCHLORIDE ALLERGY (ANDA #077318)","000","CETIRIZINE HYDROCHLORIDE","CIPLA LTD","Approval","07/25/2013"
"INJECTAFER (NDA #203565)","000","FERRIC CARBOXYMALTOSE","LUITPOLD","Approval","07/25/2013"
"FETZIMA (NDA #204168)","000","LEVOMILNACIPRAN HYDROCHLORIDE","FOREST LABS INC","Approval","07/25/2013"
"DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (NDA #018883)","050","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","07/26/2013"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","050","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","07/26/2013"
"DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (NDA #018883)","050","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","07/26/2013"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","050","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","07/26/2013"
"DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (NDA #018883)","050","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","07/26/2013"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","050","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","07/26/2013"
"PROZAC (NDA #018936)","100","FLUOXETINE HYDROCHLORIDE","ELI LILLY AND CO","Labeling Revision","07/26/2013"
"PROZAC (NDA #018936)","101","FLUOXETINE HYDROCHLORIDE","ELI LILLY AND CO","Efficacy Supplement with Clinical Data to Support","07/26/2013"
"SARAFEM (NDA #018936)","100","FLUOXETINE HYDROCHLORIDE","ELI LILLY AND CO","Labeling Revision","07/26/2013"
"SARAFEM (NDA #018936)","101","FLUOXETINE HYDROCHLORIDE","ELI LILLY AND CO","Efficacy Supplement with Clinical Data to Support","07/26/2013"
"DURAGESIC-100 (NDA #019813)","059","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","07/26/2013"
"DURAGESIC-12 (NDA #019813)","059","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","07/26/2013"
"DURAGESIC-25 (NDA #019813)","059","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","07/26/2013"
"DURAGESIC-50 (NDA #019813)","059","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","07/26/2013"
"DURAGESIC-75 (NDA #019813)","059","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","07/26/2013"
"ZYPREXA (NDA #020592)","063","OLANZAPINE","LILLY","Efficacy Supplement with Clinical Data to Support","07/26/2013"
"ZYPREXA ZYDIS (NDA #021086)","041","OLANZAPINE","LILLY","Efficacy Supplement with Clinical Data to Support","07/26/2013"
"PROZAC WEEKLY (NDA #021235)","021","FLUOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","07/26/2013"
"INSPRA (NDA #021437)","012","EPLERENONE","GD SEARLE LLC","Manufacturing Change or Addition","07/26/2013"
"SYMBYAX (NDA #021520)","037","FLUOXETINE HYDROCHLORIDE; OLANZAPINE","LILLY","Labeling Revision","07/26/2013"
"SYMBYAX (NDA #021520)","039","FLUOXETINE HYDROCHLORIDE; OLANZAPINE","LILLY","Efficacy Supplement with Clinical Data to Support","07/26/2013"
"ABSTRAL (NDA #022510)","010","FENTANYL CITRATE","GALENA BIOPHARMA","Labeling Revision","07/26/2013"
"MEFLOQUINE HYDROCHLORIDE (ANDA #076175)","030","MEFLOQUINE HYDROCHLORIDE","SANDOZ","Labeling Revision","07/26/2013"
"MEFLOQUINE HYDROCHLORIDE (ANDA #076392)","008","MEFLOQUINE HYDROCHLORIDE","BARR","Labeling Revision","07/26/2013"
"MEFLOQUINE HYDROCHLORIDE (ANDA #076523)","007","MEFLOQUINE HYDROCHLORIDE","ROXANE","Labeling Revision","07/26/2013"
"CYCLOBENZAPRINE HYDROCHLORIDE (ANDA #090864)","000","CYCLOBENZAPRINE HYDROCHLORIDE","PAR PHARM INC","Tentative Approval","07/26/2013"
"RAMELTEON (ANDA #091693)","000","RAMELTEON","TEVA PHARMS USA","Approval","07/26/2013"
"ARMODAFINIL (ANDA #200751)","000","ARMODAFINIL","LUPIN LTD","Tentative Approval","07/26/2013"
"DOXEPIN HYDROCHLORIDE (ANDA #201951)","000","DOXEPIN HYDROCHLORIDE","ACTAVIS ELIZABETH","Approval","07/26/2013"
"FENOFIBRATE (MICRONIZED) (ANDA #202252)","000","FENOFIBRATE","APOTEX INC","Approval","07/26/2013"
"LEVOCETIRIZINE DIHYDROCHLORIDE (ANDA #202673)","000","LEVOCETIRIZINE DIHYDROCHLORIDE","TARO PHARM INDS","Approval","07/26/2013"
"CHOLINE C-11 (NDA #203155)","001","CHOLINE C-11","MCPRF","Manufacturing Change or Addition","07/26/2013"
"ULTRAVIST 150 (NDA #020220)","040","IOPROMIDE","BAYER HLTHCARE","Manufacturing Change or Addition","07/29/2013"
"ULTRAVIST 240 (NDA #020220)","040","IOPROMIDE","BAYER HLTHCARE","Manufacturing Change or Addition","07/29/2013"
"ULTRAVIST 300 (NDA #020220)","040","IOPROMIDE","BAYER HLTHCARE","Manufacturing Change or Addition","07/29/2013"
"ULTRAVIST 300 IN PLASTIC CONTAINER (NDA #020220)","040","IOPROMIDE","BAYER HLTHCARE","Manufacturing Change or Addition","07/29/2013"
"ULTRAVIST 370 (NDA #020220)","040","IOPROMIDE","BAYER HLTHCARE","Manufacturing Change or Addition","07/29/2013"
"TEGRETOL-XR (NDA #020234)","041","CARBAMAZEPINE","NOVARTIS","Manufacturing Change or Addition","07/29/2013"
"CELEBREX (NDA #020998)","042","CELECOXIB","GD SEARLE","Manufacturing Change or Addition","07/29/2013"
"VIVITROL (NDA #021897)","020","NALTREXONE","ALKERMES","Labeling Revision","07/29/2013"
"VIVITROL (NDA #021897)","023","NALTREXONE","ALKERMES","Labeling Revision","07/29/2013"
"SPRIX (NDA #022382)","008","KETOROLAC TROMETHAMINE","LUITPOLD","Manufacturing Change or Addition","07/29/2013"
"DOXYCYCLINE (ANDA #091277)","000","DOXYCYCLINE","LUPIN LTD","Tentative Approval","07/29/2013"
"TEFLARO (NDA #200327)","010","CEFTAROLINE FOSAMIL","CEREXA","Manufacturing Change or Addition","07/29/2013"
"EDARBI (NDA #200796)","004","AZILSARTAN KAMEDOXOMIL","ARBOR PHARMS IRELAND","Manufacturing Change or Addition","07/29/2013"
"RANOLAZINE (ANDA #201046)","001","RANOLAZINE","LUPIN LTD","Approval","07/29/2013"
"ELETRIPTAN HYDROBROMIDE (ANDA #201536)","000","ELETRIPTAN HYDROBROMIDE","APOTEX INC","Tentative Approval","07/29/2013"
"MARCAINE HYDROCHLORIDE (NDA #016964)","071","BUPIVACAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/30/2013"
"MARCAINE HYDROCHLORIDE PRESERVATIVE FREE (NDA #016964)","071","BUPIVACAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/30/2013"
"MARCAINE HYDROCHLORIDE W/ EPINEPHRINE (NDA #016964)","071","BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","HOSPIRA","Manufacturing Change or Addition","07/30/2013"
"MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE (NDA #016964)","071","BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","HOSPIRA","Manufacturing Change or Addition","07/30/2013"
"ANGIOMAX (NDA #020873)","030","BIVALIRUDIN","MEDICINES CO","Manufacturing Change or Addition","07/30/2013"
"PEPCID COMPLETE (NDA #020958)","018","CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE","MCNEIL CONS","Labeling Revision","07/30/2013"
"CONCERTA (NDA #021121)","030","METHYLPHENIDATE HYDROCHLORIDE","JANSSEN PHARMS","Manufacturing Change or Addition","07/30/2013"
"MULTIHANCE (NDA #021357)","013","GADOBENATE DIMEGLUMINE","BRACCO","Labeling Revision","07/30/2013"
"MULTIHANCE MULTIPACK (NDA #021358)","012","GADOBENATE DIMEGLUMINE","BRACCO","Labeling Revision","07/30/2013"
"ABILIFY (NDA #021436)","037","ARIPIPRAZOLE","OTSUKA","Labeling Revision","07/30/2013"
"ABILIFY (NDA #021713)","029","ARIPIPRAZOLE","OTSUKA","Labeling Revision","07/30/2013"
"ABILIFY (NDA #021729)","021","ARIPIPRAZOLE","OTSUKA","Labeling Revision","07/30/2013"
"ABILIFY (NDA #021866)","022","ARIPIPRAZOLE","OTSUKA","Labeling Revision","07/30/2013"
"BUPIVACAINE HYDROCHLORIDE (NDA #022046)","005","BUPIVACAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/30/2013"
"BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE (NDA #022046)","005","BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","HOSPIRA","Manufacturing Change or Addition","07/30/2013"
"DULERA (NDA #022518)","011","FORMOTEROL FUMARATE; MOMETASONE FUROATE","MERCK SHARP DOHME","Labeling Revision","07/30/2013"
"CEFAZOLIN SODIUM (ANDA #065141)","003","CEFAZOLIN SODIUM","SAMSON MEDCL","Labeling Revision","07/30/2013"
"FLUTICASONE PROPIONATE (ANDA #091553)","000","FLUTICASONE PROPIONATE","PERRIGO ISRAEL","Approval","07/30/2013"
"SITAGLIPTIN; METFORMIN HYDROCHLORIDE (ANDA #202388)","000","SITAGLIPTIN; METFORMIN HYDROCHLORIDE","SANDOZ INC","Tentative Approval","07/30/2013"
"LISINOPRIL (ANDA #202554)","000","LISINOPRIL","ACCORD HLTHCARE","Approval","07/30/2013"
"AMINOSYN 10% (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 10% (PH6) (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 5% (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 7% (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 7% (PH6) (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 8.5% (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 8.5% (PH6) (NDA #017673)","089","AMINO ACIDS","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN 8.5% W/ ELECTROLYTES (NDA #017673)","089","AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"PARLODEL (NDA #017962)","071","BROMOCRIPTINE MESYLATE","US PHARMS HOLDINGS I","Manufacturing Change or Addition","07/31/2013"
"DEPAKENE (NDA #018081)","056","VALPROIC ACID","ABBVIE","Labeling Revision","07/31/2013"
"DEPAKENE (NDA #018082)","039","VALPROIC ACID","ABBVIE","Labeling Revision","07/31/2013"
"DEPAKOTE (NDA #018723)","048","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","07/31/2013"
"AMINOSYN II 10% W/ ELECTROLYTES (NDA #019437)","034","AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN II 3.5% M (NDA #019437)","034","AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN II 7% W/ ELECTROLYTES (NDA #019437)","034","AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"AMINOSYN II 8.5% W/ ELECTROLYTES (NDA #019437)","034","AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","07/31/2013"
"DEPAKOTE (NDA #019680)","035","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","07/31/2013"
"CEREZYME (NDA #020367)","088","IMIGLUCERASE","GENZYME","Manufacturing Change or Addition","07/31/2013"
"DEPACON (NDA #020593)","026","VALPROATE SODIUM","ABBVIE","Labeling Revision","07/31/2013"
"DEPAKOTE ER (NDA #021168)","024","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","07/31/2013"
"CADUET (NDA #021540)","029","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","PFIZER","Manufacturing Change or Addition","07/31/2013"
"ZIDOVUDINE (NDA #022294)","003","ZIDOVUDINE","AUROBINDO PHARMA","Manufacturing Change or Addition","07/31/2013"
"GRALISE (NDA #022544)","019","GABAPENTIN","DEPOMED INC","Manufacturing Change or Addition","07/31/2013"
"EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE (ANDA #091055)","000","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","STRIDES ARCOLAB LTD","Tentative Approval","07/31/2013"
"GADAVIST (NDA #201277)","002","GADOBUTROL","BAYER HLTHCARE","Manufacturing Change or Addition","07/31/2013"
"SUBSYS (NDA #202788)","005","FENTANYL","INSYS THERAP","Labeling Revision","07/31/2013"
"SUBSYS (NDA #202788)","006","FENTANYL","INSYS THERAP","Labeling Revision","07/31/2013"
"DEXTROAMPHETAMINE SULFATE (ANDA #202893)","000","DEXTROAMPHETAMINE SULFATE","AUROLIFE PHARMA LLC","Approval","07/31/2013"
"ORAP (NDA #017473)","047","PIMOZIDE","TEVA","Manufacturing Change or Addition","08/01/2013"
"K-TAB (NDA #018279)","031","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","08/01/2013"
"POTASSIUM CHLORIDE (NDA #018279)","031","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","08/01/2013"
"GALZIN (NDA #020458)","005","ZINC ACETATE","TEVA","Manufacturing Change or Addition","08/01/2013"
"AMARYL (NDA #020496)","026","GLIMEPIRIDE","SANOFI AVENTIS US","Labeling Revision","08/01/2013"
"DITROPAN XL (NDA #020897)","032","OXYBUTYNIN CHLORIDE","JANSSEN PHARMS","Labeling Revision","08/01/2013"
"ALTABAX (NDA #022055)","003","RETAPAMULIN","GLAXO GRP LTD","Manufacturing Change or Addition","08/01/2013"
"GLIMEPIRIDE (ANDA #078952)","000","GLIMEPIRIDE","HIKMA PHARMS","Approval","08/01/2013"
"PIMTREA (ANDA #091247)","000","DESOGESTREL; ETHINYL ESTRADIOL","NOVAST LABS LTD","Approval","08/01/2013"
"NORETHINDRONE (ANDA #202260)","000","NORETHINDRONE","HAUPT PHARMA","Approval","08/01/2013"
"BUPHENYL (NDA #020572)","020","SODIUM PHENYLBUTYRATE","HYPERION THERAPS INC","Manufacturing Change or Addition","08/02/2013"
"VALSTAR PRESERVATIVE FREE (NDA #020892)","016","VALRUBICIN","ENDO PHARM","Efficacy Supplement with Clinical Data to Support","08/02/2013"
"CANCIDAS (NDA #021227)","030","CASPOFUNGIN ACETATE","MERCK","Labeling Revision","08/02/2013"
"FORTEO (NDA #021318)","035","TERIPARATIDE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/02/2013"
"LEVITRA (NDA #021400)","016","VARDENAFIL HYDROCHLORIDE","BAYER HLTHCARE","Efficacy Supplement with Clinical Data to Support","08/02/2013"
"MUCINEX D (NDA #021585)","029","GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","08/02/2013"
"VELCADE (NDA #021602)","035","BORTEZOMIB","MILLENNIUM PHARMS","Manufacturing Change or Addition","08/02/2013"
"XENAZINE (NDA #021894)","009","TETRABENAZINE","VALEANT BERMUDA","Labeling Revision","08/02/2013"
"ZIANA (NDA #050802)","011","CLINDAMYCIN PHOSPHATE; TRETINOIN","MEDICIS","Manufacturing Change or Addition","08/02/2013"
"GABAPENTIN (ANDA #077261)","000","GABAPENTIN","TARO","Approval","08/02/2013"
"STAXYN (NDA #200179)","001","VARDENAFIL HYDROCHLORIDE","BAYER HLTHCARE","Efficacy Supplement with Clinical Data to Support","08/02/2013"
"CANDESARTAN CILEXETIL (ANDA #202079)","000","CANDESARTAN CILEXETIL","APOTEX INC","Tentative Approval","08/02/2013"
"BINOSTO (NDA #202344)","002","ALENDRONATE SODIUM","MISSION PHARMA","Manufacturing Change or Addition","08/02/2013"
"ZOLEDRONIC ACID (NDA #203231)","000","ZOLEDRONIC ACID","ACS DOBFAR INFO SA","Approval","08/02/2013"
"LOCOID (NDA #018514)","011","HYDROCORTISONE BUTYRATE","PRECISION DERMAT","Manufacturing Change or Addition","08/05/2013"
"CERETEC (NDA #019829)","026","TECHNETIUM TC-99M EXAMETAZIME KIT","GE HEALTHCARE","Labeling Revision","08/05/2013"
"BUPHENYL (NDA #020573)","019","SODIUM PHENYLBUTYRATE","HYPERION THERAPS INC","Manufacturing Change or Addition","08/05/2013"
"INVANZ (NDA #021337)","040","ERTAPENEM SODIUM","MERCK SHARP DOHME","Manufacturing Change or Addition","08/05/2013"
"STRATTERA (NDA #021411)","040","ATOMOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","08/05/2013"
"STRATTERA (NDA #021411)","042","ATOMOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","08/05/2013"
"VELCADE (NDA #021602)","036","BORTEZOMIB","MILLENNIUM PHARMS","Manufacturing Change or Addition","08/05/2013"
"ISENTRESS (NDA #022145)","029","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","08/05/2013"
"CARBAGLU (NDA #022562)","002","CARGLUMIC ACID","ORPHAN EUROPE","Labeling Revision","08/05/2013"
"PYLERA (NDA #050786)","008","BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE","FOREST LABS INC","Manufacturing Change or Addition","08/05/2013"
"NORETHINDRONE AND ETHINYL ESTRADIOL (ANDA #203006)","000","ETHINYL ESTRADIOL; NORETHINDRONE","FAMY CARE LTD","Approval","08/05/2013"
"ISENTRESS (NDA #203045)","007","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","08/05/2013"
"ANZEMET (NDA #020623)","011","DOLASETRON MESYLATE","SANOFI AVENTIS US","Manufacturing Change or Addition","08/06/2013"
"FEMCON FE (NDA #021490)","013","ETHINYL ESTRADIOL; NORETHINDRONE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","08/06/2013"
"ABELCET (NDA #050724)","016","AMPHOTERICIN B","SIGMA TAU","Manufacturing Change or Addition","08/06/2013"
"DILANTIN (ANDA #084349)","070","PHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","08/06/2013"
"DILANTIN (ANDA #084427)","028","PHENYTOIN","PFIZER PHARMS","Labeling Revision","08/06/2013"
"STENDRA (NDA #202276)","003","AVANAFIL","VIVUS","Manufacturing Change or Addition","08/06/2013"
"ESOMEPRAZOLE STRONTIUM (NDA #202342)","000","ESOMEPRAZOLE STRONTIUM","HANMI PHARM CO LTD","Approval","08/06/2013"
"AMMONUL (NDA #020645)","009","SODIUM BENZOATE; SODIUM PHENYLACETATE","UCYCLYD","Manufacturing Change or Addition","08/07/2013"
"MIRENA (NDA #021225)","032","LEVONORGESTREL","BAYER HLTHCARE","Labeling Revision","08/07/2013"
"COMMIT (NDA #021330)","015","NICOTINE POLACRILEX","GLAXOSMITHKLINE CONS","Labeling Revision","08/07/2013"
"CRESTOR (NDA #021366)","028","ROSUVASTATIN CALCIUM","IPR","Labeling Revision","08/07/2013"
"CRESTOR (NDA #021366)","029","ROSUVASTATIN CALCIUM","IPR","Labeling Revision","08/07/2013"
"SYMBYAX (NDA #021520)","040","FLUOXETINE HYDROCHLORIDE; OLANZAPINE","LILLY","Labeling Revision","08/07/2013"
"ABLAVAR (NDA #021711)","004","GADOFOSVESET TRISODIUM","LANTHEUS MEDCL","Labeling Revision","08/07/2013"
"COSYNTROPIN (NDA #022028)","004","COSYNTROPIN","SANDOZ","Manufacturing Change or Addition","08/07/2013"
"GRISEOFULVIN (ANDA #091592)","000","GRISEOFULVIN, MICROSIZE","SANDOZ","Approval","08/07/2013"
"EZETIMIBE (ANDA #201790)","000","EZETIMIBE","MYLAN PHARMS INC","Tentative Approval","08/07/2013"
"XARELTO (NDA #202439)","008","RIVAROXABAN","JANSSEN PHARMS","Labeling Revision","08/07/2013"
"LEVETIRACETAM IN SODIUM CHLORIDE (NDA #202543)","003","LEVETIRACETAM","HQ SPECIALITY PHARMA","Manufacturing Change or Addition","08/07/2013"
"SKYLA (NDA #203159)","001","LEVONORGESTREL","BAYER HLTHCARE","Labeling Revision","08/07/2013"
"DILANTIN-125 (NDA #008762)","048","PHENYTOIN","PARKE DAVIS","Manufacturing Change or Addition","08/08/2013"
"DILANTIN-30 (NDA #008762)","048","PHENYTOIN","PARKE DAVIS","Manufacturing Change or Addition","08/08/2013"
"BUPRENEX (NDA #018401)","019","BUPRENORPHINE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","08/08/2013"
"SUBUTEX (NDA #020732)","009","BUPRENORPHINE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","08/08/2013"
"SUBOXONE (NDA #020733)","011","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","08/08/2013"
"SUBOXONE (NDA #022410)","011","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","08/08/2013"
"LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER (ANDA #091397)","000","LEVOFLOXACIN","CLARIS LIFESCIENCES","Approval","08/08/2013"
"DISULFIRAM (ANDA #091681)","000","DISULFIRAM","ALVOGEN PINE BROOK","Approval","08/08/2013"
"LINZESS (NDA #202811)","003","LINACLOTIDE","FOREST LABS INC","Labeling Revision","08/08/2013"
"ALOPRIM (NDA #020298)","005","ALLOPURINOL SODIUM","MYLAN INSTITUTIONAL","Manufacturing Change or Addition","08/09/2013"
"DEPOCYT (NDA #021041)","026","CYTARABINE","PACIRA PHARMS INC","Manufacturing Change or Addition","08/09/2013"
"ENABLEX (NDA #021513)","012","DARIFENACIN HYDROBROMIDE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","08/09/2013"
"LIALDA (NDA #022000)","008","MESALAMINE","SHIRE","Labeling Revision","08/09/2013"
"LIALDA (NDA #022000)","010","MESALAMINE","SHIRE","Labeling Revision","08/09/2013"
"ZANOSAR (NDA #050577)","036","STREPTOZOCIN","TEVA PHARMS USA","Manufacturing Change or Addition","08/09/2013"
"QUILLIVANT XR (NDA #202100)","002","METHYLPHENIDATE HYDROCHLORIDE","NEXTWAVE PHARMS","Labeling Revision","08/09/2013"
"FLUVASTATIN (ANDA #202458)","000","FLUVASTATIN","MYLAN PHARMS INC","Tentative Approval","08/09/2013"
"FLUOCINOLONE ACETONIDE (ANDA #202847)","000","FLUOCINOLONE ACETONIDE","PERRIGO ISRAEL","Approval","08/09/2013"
"FLUOCINOLONE ACETONIDE (ANDA #202848)","000","FLUOCINOLONE ACETONIDE","PERRIGO ISRAEL","Approval","08/09/2013"
"GELNIQUE (NDA #022204)","007","OXYBUTYNIN CHLORIDE","WATSON LABS","Manufacturing Change or Addition","08/12/2013"
"NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NDA #022573)","004","ETHINYL ESTRADIOL; NORETHINDRONE","WARNER CHILCOTT","Manufacturing Change or Addition","08/12/2013"
"NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NDA #022573)","005","ETHINYL ESTRADIOL; NORETHINDRONE","WARNER CHILCOTT","Manufacturing Change or Addition","08/12/2013"
"ICLUSIG (NDA #203469)","003","PONATINIB HYDROCHLORIDE","ARIAD","Manufacturing Change or Addition","08/12/2013"
"TIVICAY (NDA #204790)","000","DOLUTEGRAVIR SODIUM","VIIV HLTHCARE","Approval","08/12/2013"
"MONISTAT 7 (NDA #017450)","064","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","08/13/2013"
"BREVIBLOC (NDA #019386)","041","ESMOLOL HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","08/13/2013"
"BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER (NDA #019386)","041","ESMOLOL HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","08/13/2013"
"BREVIBLOC IN PLASTIC CONTAINER (NDA #019386)","041","ESMOLOL HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","08/13/2013"
"PROHANCE (NDA #020131)","026","GADOTERIDOL","BRACCO","Labeling Revision","08/13/2013"
"GONAL-F (NDA #020378)","042","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","08/13/2013"
"GEODON (NDA #020825)","047","ZIPRASIDONE HYDROCHLORIDE","PFIZER","Labeling Revision","08/13/2013"
"GEODON (NDA #020919)","032","ZIPRASIDONE MESYLATE","PFIZER","Labeling Revision","08/13/2013"
"GEODON (NDA #021483)","010","ZIPRASIDONE HYDROCHLORIDE","PFIZER INC","Labeling Revision","08/13/2013"
"PROHANCE MULTIPACK (NDA #021489)","003","GADOTERIDOL","BRACCO","Labeling Revision","08/13/2013"
"CONZIP (NDA #022370)","009","TRAMADOL HYDROCHLORIDE","CIPHER PHARMS INC","Manufacturing Change or Addition","08/13/2013"
"DUEXIS (NDA #022519)","004","FAMOTIDINE; IBUPROFEN","HORIZON PHARMA","Manufacturing Change or Addition","08/13/2013"
"OFLOXACIN (ANDA #076182)","012","OFLOXACIN","TEVA","Labeling Revision","08/13/2013"
"BUPROPION HYDROBROMIDE (ANDA #200835)","000","BUPROPION HYDROBROMIDE","WATSON LABS INC","Tentative Approval","08/13/2013"
"OSPHENA (NDA #203505)","001","OSPEMIFENE","SHIONOGI INC","Manufacturing Change or Addition","08/13/2013"
"JUXTAPID (NDA #203858)","001","LOMITAPIDE MESYLATE","AEGERION","Labeling Revision","08/13/2013"
"EPANED KIT (NDA #204308)","000","ENALAPRIL MALEATE","SILVERGATE PHARMS","Approval","08/13/2013"
"CEENU (NDA #017588)","038","LOMUSTINE","CORDEN PHARMA","Manufacturing Change or Addition","08/14/2013"
"NOROXIN (NDA #019384)","066","NORFLOXACIN","MERCK","Labeling Revision","08/14/2013"
"CIPRO (NDA #019537)","082","CIPROFLOXACIN HYDROCHLORIDE","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"CIPRO (NDA #019847)","054","CIPROFLOXACIN","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019857)","062","CIPROFLOXACIN","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"MORPHINE SULFATE (NDA #019999)","019","MORPHINE SULFATE","MERIDIAN MEDCL TECHN","Manufacturing Change or Addition","08/14/2013"
"LEVAQUIN (NDA #020634)","065","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","08/14/2013"
"LEVAQUIN (NDA #020635)","071","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","08/14/2013"
"LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #020635)","071","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","08/14/2013"
"CIPRO (NDA #020780)","040","CIPROFLOXACIN","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"LANTUS (NDA #021081)","049","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","Manufacturing Change or Addition","08/14/2013"
"LANTUS SOLOSTAR (NDA #021081)","049","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","Manufacturing Change or Addition","08/14/2013"
"AVELOX (NDA #021085)","057","MOXIFLOXACIN HYDROCHLORIDE","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"FACTIVE (NDA #021158)","022","GEMIFLOXACIN MESYLATE","LG LIFE SCIENCES","Labeling Revision","08/14/2013"
"AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER (NDA #021277)","054","MOXIFLOXACIN HYDROCHLORIDE","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"CIPRO XR (NDA #021473)","035","CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE","BAYER HLTHCARE","Labeling Revision","08/14/2013"
"LEVAQUIN (NDA #021721)","032","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","08/14/2013"
"TASIGNA (NDA #022068)","015","NILOTINIB HYDROCHLORIDE MONOHYDRATE","NOVARTIS","Manufacturing Change or Addition","08/14/2013"
"VOTRIENT (NDA #022465)","014","PAZOPANIB HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","08/14/2013"
"VOTRIENT (NDA #022465)","015","PAZOPANIB HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","08/14/2013"
"VOTRIENT (NDA #022465)","016","PAZOPANIB HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","08/14/2013"
"ZINACEF (NDA #050558)","072","CEFUROXIME SODIUM","COVIS INJECTABLES","Manufacturing Change or Addition","08/14/2013"
"PYLERA (NDA #050786)","009","BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE","FOREST LABS INC","Manufacturing Change or Addition","08/14/2013"
"TOBRAMYCIN SULFATE (ANDA #065013)","012","TOBRAMYCIN SULFATE","X GEN PHARMS","Labeling Revision","08/14/2013"
"NITROFURANTOIN (ANDA #201355)","000","NITROFURANTOIN","CARACO","Approval","08/14/2013"
"MORPHINE SULFATE (NDA #202515)","003","MORPHINE SULFATE","HOSPIRA INC","Manufacturing Change or Addition","08/14/2013"
"CEENU (NDA #017588)","039","LOMUSTINE","CORDEN PHARMA","Labeling Revision","08/15/2013"
"HUMULIN R (NDA #018780)","145","INSULIN RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMULIN R PEN (NDA #018780)","145","INSULIN RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMULIN N (NDA #018781)","136","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/15/2013"
"DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (NDA #018883)","049","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","08/15/2013"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","049","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","08/15/2013"
"DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (NDA #018883)","049","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","08/15/2013"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","049","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","08/15/2013"
"DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (NDA #018883)","049","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","08/15/2013"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","049","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","08/15/2013"
"HUMULIN 70/30 (NDA #019717)","115","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMULIN 70/30 PEN (NDA #019717)","115","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/15/2013"
"TAXOTERE (NDA #020449)","070","DOCETAXEL","SANOFI AVENTIS US","Manufacturing Change or Addition","08/15/2013"
"HUMALOG (NDA #020563)","142","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG KWIKPEN (NDA #020563)","142","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG PEN (NDA #020563)","142","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG MIX 75/25 (NDA #021017)","094","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","094","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG MIX 75/25 PEN (NDA #021017)","094","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG MIX 50/50 (NDA #021018)","088","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG MIX 50/50 KWIKPEN (NDA #021018)","088","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"HUMALOG MIX 50/50 PEN (NDA #021018)","088","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/15/2013"
"GLUCOVANCE (NDA #021178)","014","GLYBURIDE; METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","08/15/2013"
"REYATAZ (NDA #021567)","032","ATAZANAVIR SULFATE","BRISTOL MYERS SQUIBB","Labeling Revision","08/15/2013"
"REYATAZ (NDA #021567)","033","ATAZANAVIR SULFATE","BRISTOL MYERS SQUIBB","Labeling Revision","08/15/2013"
"TRUVADA (NDA #021752)","037","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","08/15/2013"
"ACTOPLUS MET (NDA #021842)","018","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Manufacturing Change or Addition","08/15/2013"
"NESINA (NDA #022271)","003","ALOGLIPTIN BENZOATE","TAKEDA PHARMS USA","Manufacturing Change or Addition","08/15/2013"
"OSENI (NDA #022426)","001","ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Manufacturing Change or Addition","08/15/2013"
"ADVIL (NDA #201803)","001","IBUPROFEN SODIUM","PFIZER CONS HLTHCARE","Manufacturing Change or Addition","08/15/2013"
"SUCLEAR (NDA #203595)","001","MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE","BRAINTREE LABS","Manufacturing Change or Addition","08/15/2013"
"SUCLEAR (NDA #203595)","002","MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE","BRAINTREE LABS","Manufacturing Change or Addition","08/15/2013"
"FLAGYL (NDA #012623)","065","METRONIDAZOLE","GD SEARLE LLC","Labeling Revision","08/16/2013"
"DIABETA (NDA #017532)","035","GLYBURIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","08/16/2013"
"FLAGYL I.V. (NDA #018353)","026","METRONIDAZOLE HYDROCHLORIDE","PFIZER","Labeling Revision","08/16/2013"
"FLAGYL I.V. RTU IN PLASTIC CONTAINER (NDA #018353)","026","METRONIDAZOLE","PFIZER","Labeling Revision","08/16/2013"
"FLAGYL (NDA #020334)","008","METRONIDAZOLE","GD SEARLE LLC","Labeling Revision","08/16/2013"
"GLIADEL (NDA #020637)","026","CARMUSTINE","ARBOR PHARMS LLC","Labeling Revision","08/16/2013"
"FLAGYL ER (NDA #020868)","009","METRONIDAZOLE","GD SEARLE LLC","Labeling Revision","08/16/2013"
"OMEPRAZOLE (NDA #022032)","021","OMEPRAZOLE","DEXCEL PHARMA","Labeling Revision","08/16/2013"
"FIRMAGON (NDA #022201)","003","DEGARELIX ACETATE","FERRING","Labeling Revision","08/16/2013"
"BESIVANCE (NDA #022308)","005","BESIFLOXACIN HYDROCHLORIDE","BAUSCH AND LOMB","Manufacturing Change or Addition","08/16/2013"
"PROGRAF (NDA #050709)","035","TACROLIMUS","ASTELLAS","Manufacturing Change or Addition","08/16/2013"
"AMIODARONE HYDROCHLORIDE (ANDA #075955)","015","AMIODARONE HYDROCHLORIDE","HOSPIRA","Labeling Revision","08/16/2013"
"PROGESTERONE (ANDA #200900)","000","PROGESTERONE","BANNER PHARMACAPS","Approval","08/16/2013"
"TROKENDI XR (NDA #201635)","000","TOPIRAMATE","SUPERNUS PHARMS","Approval","08/16/2013"
"ZOLEDRONIC ACID (ANDA #202163)","000","ZOLEDRONIC ACID","PHARMACEUTICS","Approval","08/16/2013"
"OXYTROL FOR WOMEN (NDA #202211)","002","OXYBUTYNIN","MSD CONSUMER","Manufacturing Change or Addition","08/16/2013"
"VOGELXO (NDA #204399)","000","TESTOSTERONE","UPSHER SMITH","Tentative Approval","08/16/2013"
"LETAIRIS (NDA #022081)","019","AMBRISENTAN","GILEAD","Labeling Revision","08/17/2013"
"COLYTE (NDA #018983)","047","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","MEDA PHARMS","Labeling Revision","08/19/2013"
"COLYTE WITH FLAVOR PACKS (NDA #018983)","047","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","MEDA PHARMS","Labeling Revision","08/19/2013"
"COLYTE-FLAVORED (NDA #018983)","047","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","MEDA PHARMS","Labeling Revision","08/19/2013"
"URSO 250 (NDA #020675)","023","URSODIOL","FOREST LABS INC","Manufacturing Change or Addition","08/19/2013"
"URSO FORTE (NDA #020675)","023","URSODIOL","FOREST LABS INC","Manufacturing Change or Addition","08/19/2013"
"AMITIZA (NDA #021908)","012","LUBIPROSTONE","SUCAMPO PHARMS","Manufacturing Change or Addition","08/19/2013"
"JANUVIA (NDA #021995)","029","SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","08/19/2013"
"ERYTHROCIN (NDA #050609)","034","ERYTHROMYCIN LACTOBIONATE","HOSPIRA","Labeling Revision","08/19/2013"
"ADCETRIS (BLA #125388)","045","BRENTUXIMAB VEDOTIN","SEATTLE GENETICS","Labeling Revision","08/19/2013"
"KADCYLA (BLA #125427)","012","ADO-TRASTUZUMAB EMTANSINE","GENENTECH","Labeling Revision","08/19/2013"
"RISEDRONATE SODIUM (ANDA #200477)","000","RISEDRONATE SODIUM","MYLAN PHARMS INC","Tentative Approval","08/19/2013"
"JUVISYNC (NDA #202343)","010","SIMVASTATIN; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","08/19/2013"
"LANSOPRAZOLE (ANDA #202366)","000","LANSOPRAZOLE","ZYDUS HLTHCARE","Approval","08/19/2013"
"DEXILANT (NDA #022287)","017","DEXLANSOPRAZOLE","TAKEDA PHARMS USA","Labeling Revision","08/20/2013"
"ZOSYN (NDA #050684)","079","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Manufacturing Change or Addition","08/20/2013"
"ZIANA (NDA #050802)","013","CLINDAMYCIN PHOSPHATE; TRETINOIN","MEDICIS","Manufacturing Change or Addition","08/20/2013"
"OXYTROL FOR WOMEN (NDA #202211)","001","OXYBUTYNIN","MSD CONSUMER","Manufacturing Change or Addition","08/20/2013"
"TECFIDERA (NDA #204063)","002","DIMETHYL FUMARATE","BIOGEN IDEC INC","Manufacturing Change or Addition","08/20/2013"
"PROCALAMINE (NDA #018582)","047","AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","08/21/2013"
"HUMULIN N (NDA #018781)","132","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 140 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 180 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 210 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 240 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 300 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 350 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"OMNIPAQUE 70 (NDA #018956)","089","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","08/21/2013"
"HUMULIN 70/30 (NDA #019717)","111","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/21/2013"
"HUMULIN 70/30 PEN (NDA #019717)","111","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","08/21/2013"
"HUMALOG (NDA #020563)","139","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/21/2013"
"HUMALOG KWIKPEN (NDA #020563)","139","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/21/2013"
"HUMALOG PEN (NDA #020563)","139","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","08/21/2013"
"URSO 250 (NDA #020675)","024","URSODIOL","FOREST LABS INC","Manufacturing Change or Addition","08/21/2013"
"URSO FORTE (NDA #020675)","024","URSODIOL","FOREST LABS INC","Manufacturing Change or Addition","08/21/2013"
"CRINONE (NDA #020701)","026","PROGESTERONE","WATSON LABS","Manufacturing Change or Addition","08/21/2013"
"TRUVADA (NDA #021752)","038","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","08/21/2013"
"LYSTEDA (NDA #022430)","003","TRANEXAMIC ACID","FERRING PHARMS AS","Labeling Revision","08/21/2013"
"DULERA (NDA #022518)","013","FORMOTEROL FUMARATE; MOMETASONE FUROATE","MERCK SHARP DOHME","Labeling Revision","08/21/2013"
"CEFAZOLIN AND DEXTROSE (NDA #050779)","022","CEFAZOLIN SODIUM","B BRAUN","Manufacturing Change or Addition","08/21/2013"
"RIFAMPIN (ANDA #090034)","000","RIFAMPIN","LUPIN PHARMS","Approval","08/21/2013"
"HYDROXYZINE HYDROCHLORIDE (ANDA #201674)","000","HYDROXYZINE HYDROCHLORIDE","SILARX PHARMS INC","Approval","08/21/2013"
"OMNITROPE (NDA #021426)","027","SOMATROPIN RECOMBINANT","SANDOZ","Manufacturing Change or Addition","08/22/2013"
"NATAZIA (NDA #022252)","003","DIENOGEST; ESTRADIOL VALERATE","BAYER HLTHCARE","Labeling Revision","08/22/2013"
"OXYCODONE HYDROCHLORIDE (NDA #200535)","006","OXYCODONE HYDROCHLORIDE","LEHIGH VALLEY","Labeling Revision","08/22/2013"
"OXYCODONE HYDROCHLORIDE (NDA #200535)","008","OXYCODONE HYDROCHLORIDE","LEHIGH VALLEY","Manufacturing Change or Addition","08/22/2013"
"HALAVEN (NDA #201532)","006","ERIBULIN MESYLATE","EISAI INC","Labeling Revision","08/22/2013"
"VERSACLOZ (NDA #203479)","002","CLOZAPINE","JAZZ PHARMS III","Labeling Revision","08/22/2013"
"DESOXYN (NDA #005378)","027","METHAMPHETAMINE HYDROCHLORIDE","RECORDATI RARE","Labeling Revision","08/23/2013"
"NUVIGIL (NDA #021875)","019","ARMODAFINIL","CEPHALON","Manufacturing Change or Addition","08/23/2013"
"RELISTOR (NDA #021964)","011","METHYLNALTREXONE BROMIDE","SALIX PHARMS","Labeling Revision","08/23/2013"
"INTUNIV (NDA #022037)","009","GUANFACINE HYDROCHLORIDE","SHIRE","Labeling Revision","08/23/2013"
"NEXTERONE (NDA #022325)","007","AMIODARONE HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","08/23/2013"
"MIRAPEX ER (NDA #022421)","009","PRAMIPEXOLE DIHYDROCHLORIDE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","08/23/2013"
"DALIRESP (NDA #022522)","003","ROFLUMILAST","FOREST RES INST INC","Labeling Revision","08/23/2013"
"REPAGLINIDE (ANDA #090252)","000","REPAGLINIDE","MYLAN PHARMS INC","Approval","08/23/2013"
"LARIN FE 1.5/30 (ANDA #091453)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","NOVAST LABS LTD","Approval","08/23/2013"
"PROLIA (BLA #125320)","114","DENOSUMAB","AMGEN","Labeling Revision","08/23/2013"
"PROLIA (BLA #125320)","124","DENOSUMAB","AMGEN","Labeling Revision","08/23/2013"
"XGEVA (BLA #125320)","114","DENOSUMAB","AMGEN","Labeling Revision","08/23/2013"
"XGEVA (BLA #125320)","124","DENOSUMAB","AMGEN","Labeling Revision","08/23/2013"
"VALCHLOR (NDA #202317)","000","MECHLORETHAMINE HYDROCHLORIDE","ACTELION PHARMS LTD","Approval","08/23/2013"
"DACTINOMYCIN (ANDA #202562)","000","DACTINOMYCIN","LUITPOLD","Approval","08/23/2013"
"OXTELLAR XR (NDA #202810)","002","OXCARBAZEPINE","SUPERNUS PHARMS","Manufacturing Change or Addition","08/23/2013"
"MIRVASO (NDA #204708)","000","BRIMONIDINE TARTRATE","GALDERMA LABS LP","Approval","08/23/2013"
"BETADINE (NDA #018634)","013","POVIDONE-IODINE","ALCON PHARMS LTD","Manufacturing Change or Addition","08/26/2013"
"ETHYOL (NDA #020221)","028","AMIFOSTINE","MEDIMMUNE","Manufacturing Change or Addition","08/26/2013"
"OPTIMARK (NDA #020937)","022","GADOVERSETAMIDE","MALLINCKRODT","Labeling Revision","08/26/2013"
"OPTIMARK (NDA #020975)","023","GADOVERSETAMIDE","MALLINCKRODT","Labeling Revision","08/26/2013"
"OPTIMARK IN PLASTIC CONTAINER (NDA #020976)","024","GADOVERSETAMIDE","MALLINCKRODT","Labeling Revision","08/26/2013"
"INVEGA SUSTENNA (NDA #022264)","011","PALIPERIDONE PALMITATE","JANSSEN PHARMS","Manufacturing Change or Addition","08/26/2013"
"ERYTHROCIN (ANDA #062638)","029","ERYTHROMYCIN LACTOBIONATE","HOSPIRA","Labeling Revision","08/26/2013"
"LARIN FE 1/20 (ANDA #091454)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","NOVAST LABS LTD","Approval","08/26/2013"
"HEPARIN SODIUM (NDA #017037)","170","HEPARIN SODIUM","HIKMA MAPLE","Manufacturing Change or Addition","08/27/2013"
"OMNISCAN (NDA #020123)","039","GADODIAMIDE","GE HEALTHCARE","Labeling Revision","08/27/2013"
"ANTHELIOS SX (NDA #021502)","013","AVOBENZONE; ECAMSULE; OCTOCRYLENE","LOREAL USA","Manufacturing Change or Addition","08/27/2013"
"OMNISCAN (NDA #022066)","004","GADODIAMIDE","GE HEALTHCARE","Labeling Revision","08/27/2013"
"ZEBETA (NDA #019982)","017","BISOPROLOL FUMARATE","TEVA WOMENS","Manufacturing Change or Addition","08/28/2013"
"AEROSPAN HFA (NDA #021247)","008","FLUNISOLIDE","MEDA PHARMS INC","Efficacy Supplement with Clinical Data to Support","08/28/2013"
"LEXIVA (NDA #021548)","030","FOSAMPRENAVIR CALCIUM","VIIV HLTHCARE","Manufacturing Change or Addition","08/28/2013"
"LIALDA (NDA #022000)","009","MESALAMINE","SHIRE","Labeling Revision","08/28/2013"
"TREANDA (NDA #022249)","014","BENDAMUSTINE HYDROCHLORIDE","CEPHALON","Labeling Revision","08/28/2013"
"DUEXIS (NDA #022519)","007","FAMOTIDINE; IBUPROFEN","HORIZON PHARMA","Manufacturing Change or Addition","08/28/2013"
"ZIOPTAN (NDA #202514)","002","TAFLUPROST","OAK PHARMS INC","Manufacturing Change or Addition","08/28/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #202580)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","MYLAN PHARMS INC","Approval","08/28/2013"
"GATIFLOXACIN (ANDA #202653)","000","GATIFLOXACIN","LUPIN LTD","Approval","08/28/2013"
"SIRTURO (NDA #204384)","002","BEDAQUILINE FUMARATE","JANSSEN THERAP","Labeling Revision","08/28/2013"
"ACIPHEX SPRINKLE (NDA #204736)","001","RABEPRAZOLE SODIUM","EISAI INC","Manufacturing Change or Addition","08/28/2013"
"SINOGRAFIN (NDA #011324)","033","DIATRIZOATE MEGLUMINE; IODIPAMIDE MEGLUMINE","BRACCO","Manufacturing Change or Addition","08/29/2013"
"DIASTAT (NDA #020648)","009","DIAZEPAM","VALEANT","Labeling Revision","08/29/2013"
"DIASTAT ACUDIAL (NDA #020648)","009","DIAZEPAM","VALEANT","Labeling Revision","08/29/2013"
"NEORAL (NDA #050716)","035","CYCLOSPORINE","NOVARTIS","Manufacturing Change or Addition","08/29/2013"
"ADENOSINE (ANDA #077425)","000","ADENOSINE","TEVA PHARMS USA","Approval","08/29/2013"
"KADCYLA (BLA #125427)","014","ADO-TRASTUZUMAB EMTANSINE","GENENTECH","Labeling Revision","08/29/2013"
"ADEFOVIR DIPIVOXIL (ANDA #202051)","000","ADEFOVIR DIPIVOXIL","SIGMAPHARM LABS LLC","Approval","08/29/2013"
"TOPOTECAN HYDROCHLORIDE (ANDA #202203)","000","TOPOTECAN HYDROCHLORIDE","SUN PHARM INDS LTD","Approval","08/29/2013"
"QNASL (NDA #202813)","003","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Manufacturing Change or Addition","08/29/2013"
"SEPTRA (NDA #017376)","060","SULFAMETHOXAZOLE; TRIMETHOPRIM","MONARCH PHARMS","Labeling Revision","08/30/2013"
"SEPTRA DS (NDA #017376)","060","SULFAMETHOXAZOLE; TRIMETHOPRIM","MONARCH PHARMS","Labeling Revision","08/30/2013"
"HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019952)","031","HEPARIN SODIUM","B BRAUN","Labeling Revision","08/30/2013"
"HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019952)","031","HEPARIN SODIUM","B BRAUN","Labeling Revision","08/30/2013"
"HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019953)","030","HEPARIN SODIUM","B BRAUN","Labeling Revision","08/30/2013"
"CEREBYX (NDA #020450)","021","FOSPHENYTOIN SODIUM","PARKE DAVIS","Manufacturing Change or Addition","08/30/2013"
"ALORA (NDA #020655)","017","ESTRADIOL","WATSON LABS","Manufacturing Change or Addition","08/30/2013"
"VANIQA (NDA #021145)","009","EFLORNITHINE HYDROCHLORIDE","SKINMEDICA","Manufacturing Change or Addition","08/30/2013"
"FORTEO (NDA #021318)","036","TERIPARATIDE RECOMBINANT HUMAN","LILLY","Supplement","08/30/2013"
"TESTIM (NDA #021454)","016","TESTOSTERONE","AUXILIUM PHARMS","Labeling Revision","08/30/2013"
"CHLORHEXIDINE GLUCONATE (NDA #021669)","017","CHLORHEXIDINE GLUCONATE","SAGE PRODS","Manufacturing Change or Addition","08/30/2013"
"SUTENT (NDA #021938)","024","SUNITINIB MALATE","CPPI CV","Labeling Revision","08/30/2013"
"SUTENT (NDA #021938)","025","SUNITINIB MALATE","CPPI CV","Labeling Revision","08/30/2013"
"FIRAZYR (NDA #022150)","004","ICATIBANT ACETATE","SHIRE ORPHAN THERAP","Labeling Revision","08/30/2013"
"ASTEPRO (NDA #022203)","008","AZELASTINE HYDROCHLORIDE","MEDA PHARMS","Efficacy Supplement with Clinical Data to Support","08/30/2013"
"DOXIL (LIPOSOMAL) (NDA #050718)","045","DOXORUBICIN HYDROCHLORIDE","JANSSEN RES AND DEV","Labeling Revision","08/30/2013"
"DOXERCALCIFEROL (ANDA #091101)","000","DOXERCALCIFEROL","HIKMA PHARMS LLC","Approval","08/30/2013"
"ZEVALIN (BLA #125019)","210","IBRITUMOMAB TIUXETAN","SPECTRUM PHARMS","Labeling Revision","08/30/2013"
"ZEVALIN (BLA #125019)","213","IBRITUMOMAB TIUXETAN","SPECTRUM PHARMS","Labeling Revision","08/30/2013"
"LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (ANDA #200218)","000","AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE","TEVA PHARMS USA","Approval","08/30/2013"
"LOSARTAN POTASSIUM (ANDA #200290)","000","LOSARTAN POTASSIUM","IPCA LABS LTD","Approval","08/30/2013"
"DESOGESTREL AND ETHINYL ESTRADIOL (ANDA #202296)","000","DESOGESTREL; ETHINYL ESTRADIOL","FAMY CARE LTD","Approval","08/30/2013"
"FYCOMPA (NDA #202834)","002","PERAMPANEL","EISAI INC","Manufacturing Change or Addition","09/02/2013"
"LATUDA (NDA #200603)","016","LURASIDONE HYDROCHLORIDE","SUNOVION PHARMS INC","Labeling Revision","09/03/2013"
"INFUVITE ADULT (NDA #021163)","025","ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K","SANDOZ","Manufacturing Change or Addition","09/04/2013"
"MINIRIN (NDA #021333)","009","DESMOPRESSIN ACETATE","FERRING","Manufacturing Change or Addition","09/04/2013"
"VIBRAMYCIN (NDA #050006)","085","DOXYCYCLINE","PFIZER","Labeling Revision","09/04/2013"
"VIBRAMYCIN (NDA #050007)","026","DOXYCYCLINE HYCLATE","PFIZER","Labeling Revision","09/04/2013"
"VIBRAMYCIN (NDA #050480)","051","DOXYCYCLINE CALCIUM","PFIZER","Labeling Revision","09/04/2013"
"VIBRA-TABS (NDA #050533)","041","DOXYCYCLINE HYCLATE","PFIZER","Labeling Revision","09/04/2013"
"PROGRAF (NDA #050708)","043","TACROLIMUS","ASTELLAS","Labeling Revision","09/04/2013"
"PROGRAF (NDA #050709)","036","TACROLIMUS","ASTELLAS","Labeling Revision","09/04/2013"
"ZUBSOLV (NDA #204242)","002","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","OREXO AB","Supplement","09/04/2013"
"METOPIRONE (NDA #012911)","033","METYRAPONE","HRA PHARMA","Manufacturing Change or Addition","09/05/2013"
"DEXTROSE 5% IN PLASTIC CONTAINER (NDA #016367)","218","DEXTROSE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"NORMOSOL-R IN PLASTIC CONTAINER (NDA #017586)","127","MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #017606)","141","DEXTROSE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER (NDA #017609)","127","DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #017799)","130","DEXTROSE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"STERILE WATER FOR INJECTION IN PLASTIC CONTAINER (NDA #018233)","080","STERILE WATER FOR INJECTION","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #018365)","091","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #018365)","091","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #018365)","091","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #018365)","091","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #018365)","091","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER (NDA #018365)","091","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #018876)","045","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"ETHAMOLIN (NDA #019357)","020","ETHANOLAMINE OLEATE","QOL MEDCL","Manufacturing Change or Addition","09/05/2013"
"IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019513)","045","DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019515)","033","DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS","HOSPIRA","Manufacturing Change or Addition","09/05/2013"
"LIORESAL (NDA #020075)","027","BACLOFEN","MEDTRONIC NEURO","Manufacturing Change or Addition","09/05/2013"
"NIZORAL A-D (NDA #020310)","020","KETOCONAZOLE","MCNEIL CONS","Manufacturing Change or Addition","09/05/2013"
"COPAXONE (NDA #020622)","083","GLATIRAMER ACETATE","TEVA PHARMS USA","Manufacturing Change or Addition","09/05/2013"
"COPAXONE (NDA #020622)","085","GLATIRAMER ACETATE","TEVA PHARMS USA","Manufacturing Change or Addition","09/05/2013"
"GEMCITABINE HYDROCHLORIDE (NDA #200795)","004","GEMCITABINE HYDROCHLORIDE","HOSPIRA INC","Labeling Revision","09/05/2013"
"JENTADUETO (NDA #201281)","004","LINAGLIPTIN; METFORMIN HYDROCHLORIDE","BOEHRINGER INGELHEIM","Efficacy Supplement with Clinical Data to Support","09/05/2013"
"RASAGILINE MESYLATE (ANDA #201971)","000","RASAGILINE MESYLATE","MYLAN PHARMA","Tentative Approval","09/05/2013"
"DILANTIN-125 (NDA #008762)","049","PHENYTOIN","PARKE DAVIS","Manufacturing Change or Addition","09/06/2013"
"DILANTIN-30 (NDA #008762)","049","PHENYTOIN","PARKE DAVIS","Manufacturing Change or Addition","09/06/2013"
"MACRODANTIN (NDA #016620)","072","NITROFURANTOIN, MACROCRYSTALLINE","ALVOGEN INC","Labeling Revision","09/06/2013"
"MAGNEVIST (NDA #019596)","055","GADOPENTETATE DIMEGLUMINE","BAYER HLTHCARE","Manufacturing Change or Addition","09/06/2013"
"MACROBID (NDA #020064)","021","NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE","ALVOGEN INC","Labeling Revision","09/06/2013"
"LOVENOX (NDA #020164)","098","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","09/06/2013"
"LOVENOX (PRESERVATIVE FREE) (NDA #020164)","098","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","09/06/2013"
"HUMALOG (NDA #020563)","133","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","09/06/2013"
"HUMALOG KWIKPEN (NDA #020563)","133","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","09/06/2013"
"HUMALOG PEN (NDA #020563)","133","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","09/06/2013"
"ARICEPT (NDA #020690)","037","DONEPEZIL HYDROCHLORIDE","EISAI INC","Labeling Revision","09/06/2013"
"ADRENACLICK (NDA #020800)","023","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","09/06/2013"
"TWINJECT 0.15 (NDA #020800)","023","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","09/06/2013"
"TWINJECT 0.3 (NDA #020800)","023","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","09/06/2013"
"PRILOSEC OTC (NDA #021229)","025","OMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","09/06/2013"
"APIDRA (NDA #021629)","028","INSULIN GLULISINE RECOMBINANT","SANOFI AVENTIS US","Labeling Revision","09/06/2013"
"APIDRA SOLOSTAR (NDA #021629)","028","INSULIN GLULISINE RECOMBINANT","SANOFI AVENTIS US","Labeling Revision","09/06/2013"
"NASCOBAL (NDA #021642)","021","CYANOCOBALAMIN","PAR PHARM","Manufacturing Change or Addition","09/06/2013"
"ABRAXANE (NDA #021660)","037","PACLITAXEL","ABRAXIS BIOSCIENCE","New or Modified Indication","09/06/2013"
"ARICEPT ODT (NDA #021720)","010","DONEPEZIL HYDROCHLORIDE","EISAI INC","Labeling Revision","09/06/2013"
"POTIGA (NDA #022345)","006","EZOGABINE","GLAXOSMITHKLINE","Labeling Revision","09/06/2013"
"ARICEPT (NDA #022568)","007","DONEPEZIL HYDROCHLORIDE","EISAI INC","Labeling Revision","09/06/2013"
"ZOSYN (NDA #050684)","063","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Labeling Revision","09/06/2013"
"ZOSYN (NDA #050684)","074","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Labeling Revision","09/06/2013"
"ZOSYN (NDA #050684)","080","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Labeling Revision","09/06/2013"
"ZOSYN IN PLASTIC CONTAINER (NDA #050750)","021","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Labeling Revision","09/06/2013"
"ZOSYN IN PLASTIC CONTAINER (NDA #050750)","026","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Labeling Revision","09/06/2013"
"ZOSYN IN PLASTIC CONTAINER (NDA #050750)","030","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Labeling Revision","09/06/2013"
"RYTHMOL SR (NDA #021416)","012","PROPAFENONE HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Manufacturing Change or Addition","09/09/2013"
"FORTESTA (NDA #021463)","009","TESTOSTERONE","ENDO PHARMS","Manufacturing Change or Addition","09/09/2013"
"ORAVERSE (NDA #022159)","006","PHENTOLAMINE MESYLATE","SEPTODONT HOLDING","Manufacturing Change or Addition","09/09/2013"
"GRALISE (NDA #022544)","021","GABAPENTIN","DEPOMED INC","Manufacturing Change or Addition","09/09/2013"
"BIAXIN (NDA #050662)","052","CLARITHROMYCIN","ABBVIE","Labeling Revision","09/09/2013"
"BIAXIN (NDA #050662)","053","CLARITHROMYCIN","ABBVIE","Labeling Revision","09/09/2013"
"BIAXIN (NDA #050698)","031","CLARITHROMYCIN","ABBVIE","Labeling Revision","09/09/2013"
"BIAXIN (NDA #050698)","032","CLARITHROMYCIN","ABBVIE","Labeling Revision","09/09/2013"
"BIAXIN XL (NDA #050775)","020","CLARITHROMYCIN","ABBVIE","Labeling Revision","09/09/2013"
"BIAXIN XL (NDA #050775)","021","CLARITHROMYCIN","ABBVIE","Labeling Revision","09/09/2013"
"LEVETIRACETAM (ANDA #203059)","000","LEVETIRACETAM","SUN PHARMA GLOBAL","Approval","09/09/2013"
"CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY (ANDA #204226)","000","CETIRIZINE HYDROCHLORIDE","PERRIGO R AND D","Approval","09/09/2013"
"DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #016678)","105","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #016683)","100","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER (NDA #016687)","102","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER (NDA #016689)","105","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #016696)","097","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #016697)","096","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018008)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) (NDA #018037)","070","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019308)","027","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019308)","027","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019308)","027","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019308)","027","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019308)","027","DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/10/2013"
"PREPIDIL (NDA #019617)","016","DINOPROSTONE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","09/10/2013"
"LAMISIL (NDA #020980)","010","TERBINAFINE HYDROCHLORIDE","NOVARTIS","Manufacturing Change or Addition","09/10/2013"
"AVODART (NDA #021319)","030","DUTASTERIDE","GLAXOSMITHKLINE","Manufacturing Change or Addition","09/10/2013"
"FORTESTA (NDA #021463)","010","TESTOSTERONE","ENDO PHARMS","Supplement","09/10/2013"
"XOPENEX HFA (NDA #021730)","033","LEVALBUTEROL TARTRATE","SUNOVION","Labeling Revision","09/10/2013"
"CHILDREN'S CLARITIN (NDA #021891)","017","LORATADINE","SCHERING PLOUGH","Manufacturing Change or Addition","09/10/2013"
"ZOLPIDEM TARTRATE (ANDA #200266)","000","ZOLPIDEM TARTRATE","APOTEX INC","Approval","09/10/2013"
"VARENICLINE (ANDA #201920)","000","VARENICLINE","TEVA PHARMS USA","Tentative Approval","09/10/2013"
"SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #016677)","147","SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/11/2013"
"RINGER'S IN PLASTIC CONTAINER (NDA #016693)","096","CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/11/2013"
"PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER (NDA #017378)","068","MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","BAXTER HLTHCARE","Labeling Revision","09/11/2013"
"PLASMA-LYTE A IN PLASTIC CONTAINER (NDA #017378)","068","MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","BAXTER HLTHCARE","Labeling Revision","09/11/2013"
"PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER (NDA #017385)","059","DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/11/2013"
"SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018016)","061","SODIUM CHLORIDE","BAXTER HLTHCARE","Labeling Revision","09/11/2013"
"DENAVIR (NDA #020629)","016","PENCICLOVIR SODIUM","DENCO ASSET","Labeling Revision","09/11/2013"
"URSO 250 (NDA #020675)","025","URSODIOL","FOREST LABS INC","Manufacturing Change or Addition","09/11/2013"
"URSO FORTE (NDA #020675)","025","URSODIOL","FOREST LABS INC","Manufacturing Change or Addition","09/11/2013"
"PEPCID AC (NDA #020801)","017","FAMOTIDINE","MCNEIL CONS","Manufacturing Change or Addition","09/11/2013"
"ZIAGEN (NDA #020977)","026","ABACAVIR SULFATE","VIIV HLTHCARE","Labeling Revision","09/11/2013"
"ZIAGEN (NDA #020978)","030","ABACAVIR SULFATE","VIIV HLTHCARE","Labeling Revision","09/11/2013"
"LOVAZA (NDA #021654)","039","OMEGA-3-ACID ETHYL ESTERS","SMITHKLINE BEECHAM","Manufacturing Change or Addition","09/11/2013"
"JANUMET (NDA #022044)","029","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","09/11/2013"
"VIBRAMYCIN (NDA #050442)","016","DOXYCYCLINE HYCLATE","PFIZER","Labeling Revision","09/11/2013"
"TOPIRAMATE (ANDA #078410)","000","TOPIRAMATE","LUPIN","Approval","09/11/2013"
"ZOLPIDEM TARTRATE (ANDA #078970)","000","ZOLPIDEM TARTRATE","LUPIN LTD","Approval","09/11/2013"
"BOTOX (BLA #103000)","5260","OnabotulinumtoxinA","ALLERGAN","Efficacy Supplement with Clinical Data to Support","09/11/2013"
"BOTOX COSMETIC (BLA #103000)","5260","OnabotulinumtoxinA","ALLERGAN","Efficacy Supplement with Clinical Data to Support","09/11/2013"
"JEVTANA KIT (NDA #201023)","009","CABAZITAXEL","SANOFI AVENTIS US","Manufacturing Change or Addition","09/11/2013"
"METFORMIN HYDROCHLORIDE (ANDA #203769)","000","METFORMIN HYDROCHLORIDE","SCIEGEN PHARMS INC","Approval","09/11/2013"
"UNISOM (NDA #018066)","020","DOXYLAMINE SUCCINATE","CHATTEM","Labeling Revision","09/12/2013"
"NORVASC (NDA #019787)","056","AMLODIPINE BESYLATE","PFIZER","Manufacturing Change or Addition","09/12/2013"
"ESTROSTEP 21 (NDA #020130)","012","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","09/12/2013"
"ESTROSTEP FE (NDA #020130)","012","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","09/12/2013"
"VISIPAQUE 270 (NDA #020351)","040","IODIXANOL","GE HEALTHCARE","Manufacturing Change or Addition","09/12/2013"
"VISIPAQUE 320 (NDA #020351)","040","IODIXANOL","GE HEALTHCARE","Manufacturing Change or Addition","09/12/2013"
"CASODEX (NDA #020498)","024","BICALUTAMIDE","ASTRAZENECA","Manufacturing Change or Addition","09/12/2013"
"PATANOL (NDA #020688)","025","OLOPATADINE HYDROCHLORIDE","ALCON","Manufacturing Change or Addition","09/12/2013"
"PLAVIX (NDA #020839)","057","CLOPIDOGREL BISULFATE","SANOFI AVENTIS US","Labeling Revision","09/12/2013"
"PHOSLO (NDA #021160)","026","CALCIUM ACETATE","FRESENIUS MEDCL","Manufacturing Change or Addition","09/12/2013"
"PHOSLO GELCAPS (NDA #021160)","026","CALCIUM ACETATE","FRESENIUS MEDCL","Manufacturing Change or Addition","09/12/2013"
"ARIXTRA (NDA #021345)","030","FONDAPARINUX SODIUM","AGI","Labeling Revision","09/12/2013"
"ALIMTA (NDA #021462)","045","PEMETREXED DISODIUM","LILLY","Labeling Revision","09/12/2013"
"MOVIPREP (NDA #021881)","015","ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE","SALIX PHARMS","Labeling Revision","09/12/2013"
"RASAGILINE MESYLATE (ANDA #201950)","000","RASAGILINE MESYLATE","APOTEX INC","Approval","09/12/2013"
"VINORELBINE TARTRATE (ANDA #202017)","000","VINORELBINE TARTRATE","DR REDDYS LABS LTD","Approval","09/12/2013"
"ZYTIGA (NDA #202379)","007","ABIRATERONE ACETATE","JANSSEN BIOTECH","Labeling Revision","09/12/2013"
"DIFLUCAN (NDA #019949)","057","FLUCONAZOLE","PFIZER","Labeling Revision","09/13/2013"
"DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019950)","061","FLUCONAZOLE","PFIZER","Labeling Revision","09/13/2013"
"DIFLUCAN IN SODIUM CHLORIDE 0.9% (NDA #019950)","061","FLUCONAZOLE","PFIZER","Labeling Revision","09/13/2013"
"DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019950)","061","FLUCONAZOLE","PFIZER","Labeling Revision","09/13/2013"
"DIFLUCAN (NDA #020090)","040","FLUCONAZOLE","PFIZER","Labeling Revision","09/13/2013"
"FEMHRT (NDA #021065)","021","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","09/13/2013"
"KEPPRA (NDA #021505)","032","LEVETIRACETAM","UCB INC","Manufacturing Change or Addition","09/13/2013"
"OMEPRAZOLE (NDA #022032)","022","OMEPRAZOLE","DEXCEL PHARMA","Manufacturing Change or Addition","09/13/2013"
"TREANDA (NDA #022249)","015","BENDAMUSTINE HYDROCHLORIDE","CEPHALON","Manufacturing Change or Addition","09/13/2013"
"ISTODAX (NDA #022393)","012","ROMIDEPSIN","CELGENE","Manufacturing Change or Addition","09/13/2013"
"LANSOPRAZOLE (ANDA #091509)","000","LANSOPRAZOLE","SUN PHARMA GLOBAL","Approval","09/13/2013"
"ABACAVIR SULFATE (ANDA #091560)","000","ABACAVIR SULFATE","HETERO LABS LTD III","Approval","09/13/2013"
"NEUPOGEN (BLA #103353)","5157","FILGRASTIM","AMGEN","Labeling Revision","09/13/2013"
"NORETHINDRONE (ANDA #200961)","000","NORETHINDRONE","NOVAST LABS","Approval","09/13/2013"
"NORETHINDRONE (ANDA #202014)","000","NORETHINDRONE","NOVAST LABS LTD","Approval","09/13/2013"
"XALKORI (NDA #202570)","008","CRIZOTINIB","PF PRISM CV","Manufacturing Change or Addition","09/13/2013"
"LANSOPRAZOLE (ANDA #202637)","000","LANSOPRAZOLE","SUN PHARMA GLOBAL","Approval","09/13/2013"
"STIVARGA (NDA #203085)","003","REGORAFENIB","BAYER HLTHCARE","Manufacturing Change or Addition","09/13/2013"
"SKYLA (NDA #203159)","002","LEVONORGESTREL","BAYER HLTHCARE","Labeling Revision","09/13/2013"
"EPI E Z PEN JR (NDA #019430)","055","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","09/16/2013"
"EPIPEN (NDA #019430)","055","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","09/16/2013"
"EPIPEN E Z PEN (NDA #019430)","055","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","09/16/2013"
"EPIPEN JR. (NDA #019430)","055","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","09/16/2013"
"ANZEMET (NDA #020623)","010","DOLASETRON MESYLATE","SANOFI AVENTIS US","Labeling Revision","09/16/2013"
"ANZEMET (NDA #020624)","023","DOLASETRON MESYLATE","SANOFI AVENTIS US","Labeling Revision","09/16/2013"
"AVANDIA (NDA #021071)","045","ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","09/16/2013"
"AVANDAMET (NDA #021410)","034","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","09/16/2013"
"ZOMIG (NDA #021450)","007","ZOLMITRIPTAN","ASTRAZENECA","Efficacy Supplement with Clinical Data to Support","09/16/2013"
"RIOMET (NDA #021591)","006","METFORMIN HYDROCHLORIDE","RANBAXY","Manufacturing Change or Addition","09/16/2013"
"AVANDARYL (NDA #021700)","016","GLIMEPIRIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","09/16/2013"
"MAKENA (NDA #021945)","005","HYDROXYPROGESTERONE CAPROATE","LUMARA HEALTH INC","Labeling Revision","09/16/2013"
"CAPECITABINE (ANDA #091649)","000","CAPECITABINE","TEVA PHARMS USA","Approval","09/16/2013"
"AZACITIDINE (ANDA #201537)","000","AZACITIDINE","DR REDDYS LABS LTD","Approval","09/16/2013"
"INLYTA (NDA #202324)","001","AXITINIB","PFIZER","Approval","09/16/2013"
"CYCLOPHOSPHAMIDE (NDA #203856)","000","CYCLOPHOSPHAMIDE","ROXANE","Approval","09/16/2013"
"NUTROPIN AQ (NDA #020522)","050","SOMATROPIN RECOMBINANT","GENENTECH","Manufacturing Change or Addition","09/17/2013"
"NUTROPIN AQ PEN (NDA #020522)","050","SOMATROPIN RECOMBINANT","GENENTECH","Manufacturing Change or Addition","09/17/2013"
"OPANA (NDA #021611)","008","OXYMORPHONE HYDROCHLORIDE","ENDO PHARMS","Manufacturing Change or Addition","09/17/2013"
"RECLAST (NDA #021817)","017","ZOLEDRONIC ACID","NOVARTIS","Manufacturing Change or Addition","09/17/2013"
"LEVOCETIRIZINE DIHYDROCHLORIDE (ANDA #202046)","000","LEVOCETIRIZINE DIHYDROCHLORIDE","MICRO LABS LTD INDIA","Approval","09/17/2013"
"BICNU (NDA #017422)","045","CARMUSTINE","EMCURE PHARMS LTD","Manufacturing Change or Addition","09/18/2013"
"VICTRELIS (NDA #202258)","009","BOCEPREVIR","MERCK SHARP DOHME","Labeling Revision","09/18/2013"
"GANCICLOVIR (ANDA #202624)","000","GANCICLOVIR SODIUM","LUITPOLD","Approval","09/18/2013"
"SUPRAX (NDA #203195)","002","CEFIXIME","LUPIN LTD","Manufacturing Change or Addition","09/18/2013"
"METHADONE HYDROCHLORIDE (NDA #017058)","021","METHADONE HYDROCHLORIDE","ROXANE","Labeling Revision","09/19/2013"
"COMBIPATCH (NDA #020870)","017","ESTRADIOL; NORETHINDRONE ACETATE","NOVARTIS","Labeling Revision","09/19/2013"
"HUMIRA (BLA #125057)","327","ADALIMUMAB","ABBVIE INC","Labeling Revision","09/19/2013"
"8-MOP (NDA #009048)","046","METHOXSALEN","VALEANT PHARM INTL","Labeling Revision","09/20/2013"
"OXSORALEN (NDA #009048)","046","METHOXSALEN","VALEANT PHARM INTL","Labeling Revision","09/20/2013"
"METOPIRONE (NDA #012911)","032","METYRAPONE","HRA PHARMA","Manufacturing Change or Addition","09/20/2013"
"GONAL-F (NDA #020378)","062","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","09/20/2013"
"ANZEMET (NDA #020623)","011","DOLASETRON MESYLATE","SANOFI AVENTIS US","Manufacturing Change or Addition","09/20/2013"
"XOPENEX (NDA #020837)","038","LEVALBUTEROL HYDROCHLORIDE","SUNOVION","Labeling Revision","09/20/2013"
"CAMPRAL (NDA #021431)","016","ACAMPROSATE CALCIUM","FOREST LABS","Manufacturing Change or Addition","09/20/2013"
"ENABLEX (NDA #021513)","013","DARIFENACIN HYDROBROMIDE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","09/20/2013"
"BYSTOLIC (NDA #021742)","017","NEBIVOLOL HYDROCHLORIDE","FOREST LABS","Manufacturing Change or Addition","09/20/2013"
"GLIPIZIDE (ANDA #076159)","000","GLIPIZIDE","PAR PHARM","Approval","09/20/2013"
"NITROGLYCERIN (ANDA #091496)","000","NITROGLYCERIN","PERRIGO ISRAEL","Approval","09/20/2013"
"STELARA (BLA #125261)","103","USTEKINUMAB","CENTOCOR ORTHO BIOTECH INC","Efficacy Supplement with Clinical Data to Support","09/20/2013"
"DESOXIMETASONE (ANDA #202838)","000","DESOXIMETASONE","GLENMARK GENERICS","Approval","09/20/2013"
"GOLYTELY (NDA #019011)","025","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","BRAINTREE","Labeling Revision","09/23/2013"
"NULYTELY (NDA #019797)","022","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","BRAINTREE","Labeling Revision","09/23/2013"
"NULYTELY-FLAVORED (NDA #019797)","022","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","BRAINTREE","Labeling Revision","09/23/2013"
"DURAGESIC-100 (NDA #019813)","060","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","09/23/2013"
"DURAGESIC-12 (NDA #019813)","060","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","09/23/2013"
"DURAGESIC-25 (NDA #019813)","060","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","09/23/2013"
"DURAGESIC-50 (NDA #019813)","060","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","09/23/2013"
"DURAGESIC-75 (NDA #019813)","060","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","09/23/2013"
"ACCUPRIL (NDA #019885)","038","QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","09/23/2013"
"ALTACE (NDA #019901)","060","RAMIPRIL","KING PHARMS","Labeling Revision","09/23/2013"
"SUPRANE (NDA #020118)","018","DESFLURANE","BAXTER HLTHCARE","Labeling Revision","09/23/2013"
"ACCURETIC (NDA #020125)","015","HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","09/23/2013"
"HECTOROL (NDA #021027)","027","DOXERCALCIFEROL","GENZYME CORP","Manufacturing Change or Addition","09/23/2013"
"BIVALIRUDIN (ANDA #090811)","000","BIVALIRUDIN","HOSPIRA INC","Tentative Approval","09/23/2013"
"METHYLPHENIDATE HYDROCHLORIDE (ANDA #091695)","001","METHYLPHENIDATE HYDROCHLORIDE","KUDCO IRELAND","Approval","09/23/2013"
"PERCODAN (NDA #007337)","047","ASPIRIN; OXYCODONE HYDROCHLORIDE","ENDO PHARMS","Manufacturing Change or Addition","09/24/2013"
"PERCODAN (NDA #007337)","047","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","ENDO PHARMS","Manufacturing Change or Addition","09/24/2013"
"PERCODAN-DEMI (NDA #007337)","047","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","ENDO PHARMS","Manufacturing Change or Addition","09/24/2013"
"XYLOCAINE (NDA #008816)","037","LIDOCAINE HYDROCHLORIDE","OAK PHARMS","Manufacturing Change or Addition","09/24/2013"
"HEPARIN SODIUM (NDA #017029)","136","HEPARIN SODIUM","FRESENIUS KABI USA","Manufacturing Change or Addition","09/24/2013"
"HEPARIN SODIUM IN PLASTIC CONTAINER (NDA #017029)","136","HEPARIN SODIUM","FRESENIUS KABI USA","Manufacturing Change or Addition","09/24/2013"
"HEPARIN SODIUM PRESERVATIVE FREE (NDA #017029)","136","HEPARIN SODIUM","FRESENIUS KABI USA","Manufacturing Change or Addition","09/24/2013"
"REMODULIN (NDA #021272)","020","TREPROSTINIL","UNITED THERAP","Labeling Revision","09/24/2013"
"QSYMIA (NDA #022580)","008","PHENTERMINE HYDROCHLORIDE; TOPIRAMATE","VIVUS","Manufacturing Change or Addition","09/24/2013"
"RITUXAN (BLA #103705)","5414","RITUXIMAB","GENENTECH","Labeling Revision","09/24/2013"
"ARZERRA (BLA #125326)","059","OFATUMUMAB","GLAXO GRP LTD","Labeling Revision","09/24/2013"
"SIROLIMUS (ANDA #201676)","000","SIROLIMUS","ZYDUS PHARMS USA INC","Tentative Approval","09/24/2013"
"SODIUM CHLORIDE 0.9% (ANDA #201833)","000","SODIUM CHLORIDE","HIKMA MAPLE","Approval","09/24/2013"
"REBETOL (NDA #021546)","005","RIBAVIRIN","SCHERING","Manufacturing Change or Addition","09/25/2013"
"VIMPAT (NDA #022253)","014","LACOSAMIDE","UCB INC","Labeling Revision","09/25/2013"
"VIMPAT (NDA #022253)","016","LACOSAMIDE","UCB INC","Labeling Revision","09/25/2013"
"VIMPAT (NDA #022254)","008","LACOSAMIDE","UCB INC","Labeling Revision","09/25/2013"
"VIMPAT (NDA #022254)","009","LACOSAMIDE","UCB INC","Labeling Revision","09/25/2013"
"VIMPAT (NDA #022255)","003","LACOSAMIDE","UCB INC","Labeling Revision","09/25/2013"
"VIMPAT (NDA #022255)","005","LACOSAMIDE","UCB INC","Labeling Revision","09/25/2013"
"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ANDA #040422)","030","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","BARR","Labeling Revision","09/25/2013"
"MESTINON (NDA #015193)","024","PYRIDOSTIGMINE BROMIDE","VALEANT PHARM INTL","Manufacturing Change or Addition","09/26/2013"
"TERAZOL 7 (NDA #019579)","035","TERCONAZOLE","JANSSEN PHARMS","Labeling Revision","09/26/2013"
"TERAZOL 3 (NDA #019641)","028","TERCONAZOLE","JANSSEN PHARMS","Labeling Revision","09/26/2013"
"ZOLOFT (NDA #019839)","082","SERTRALINE HYDROCHLORIDE","PFIZER","Manufacturing Change or Addition","09/26/2013"
"TERAZOL 3 (NDA #019964)","030","TERCONAZOLE","JANSSEN PHARMS","Labeling Revision","09/26/2013"
"SOMAVERT (NDA #021106)","042","PEGVISOMANT","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","09/26/2013"
"REMODULIN (NDA #021272)","020","TREPROSTINIL","UNITED THERAP","Labeling Revision","09/26/2013"
"TYGACIL (NDA #021821)","026","TIGECYCLINE","PF PRISM CV","Labeling Revision","09/26/2013"
"TYGACIL (NDA #021821)","031","TIGECYCLINE","PF PRISM CV","Labeling Revision","09/26/2013"
"PUR-WASH (NDA #022305)","001","PURIFIED WATER","NIAGARA PHARMS","Manufacturing Change or Addition","09/26/2013"
"TOBI (NDA #050753)","011","TOBRAMYCIN","NOVARTIS PHARMS","Labeling Revision","09/26/2013"
"VYFEMLA (ANDA #201886)","000","ETHINYL ESTRADIOL; NORETHINDRONE","LUPIN LTD","Approval","09/26/2013"
"SOLU-CORTEF (NDA #009866)","097","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","09/27/2013"
"MAXIDEX (NDA #013422)","040","DEXAMETHASONE","ALCON","Manufacturing Change or Addition","09/27/2013"
"CARDENE (NDA #019734)","021","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","09/27/2013"
"CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #019734)","021","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","09/27/2013"
"CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #019734)","021","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","09/27/2013"
"CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NDA #019734)","021","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","09/27/2013"
"CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER (NDA #019734)","021","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","09/27/2013"
"SUPRANE (NDA #020118)","019","DESFLURANE","BAXTER HLTHCARE","Manufacturing Change or Addition","09/27/2013"
"LOVENOX (NDA #020164)","103","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","09/27/2013"
"LOVENOX (PRESERVATIVE FREE) (NDA #020164)","103","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","09/27/2013"
"FRAGMIN (NDA #020287)","059","DALTEPARIN SODIUM","EISAI INC","Manufacturing Change or Addition","09/27/2013"
"IMODIUM A-D EZ CHEWS (NDA #020448)","007","LOPERAMIDE HYDROCHLORIDE","MCNEIL","Manufacturing Change or Addition","09/27/2013"
"GLUCAGON (NDA #020928)","047","GLUCAGON RECOMBINANT","LILLY","Manufacturing Change or Addition","09/27/2013"
"FROVA (NDA #021006)","020","FROVATRIPTAN SUCCINATE","ENDO PHARMS","Manufacturing Change or Addition","09/27/2013"
"ZOMETA (NDA #021223)","027","ZOLEDRONIC ACID","NOVARTIS","Labeling Revision","09/27/2013"
"IMPLANON (NDA #021529)","010","ETONOGESTREL","ORGANON USA INC","Labeling Revision","09/27/2013"
"NEXPLANON (NDA #021529)","010","ETONOGESTREL","ORGANON USA INC","Labeling Revision","09/27/2013"
"ACTOPLUS MET XR (NDA #022024)","010","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Manufacturing Change or Addition","09/27/2013"
"TASIGNA (NDA #022068)","018","NILOTINIB HYDROCHLORIDE MONOHYDRATE","NOVARTIS","Labeling Revision","09/27/2013"
"SAMSCA (NDA #022275)","010","TOLVAPTAN","OTSUKA AMERICA PHARM","Manufacturing Change or Addition","09/27/2013"
"TIMENTIN (NDA #050590)","067","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Labeling Revision","09/27/2013"
"TIMENTIN IN PLASTIC CONTAINER (NDA #050658)","029","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050722)","030","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050722)","031","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050723)","029","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050723)","030","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050758)","028","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050758)","029","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050759)","036","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling Revision","09/27/2013"
"CELLCEPT (NDA #050759)","037","MYCOPHENOLATE MOFETIL","ROCHE PALO","Labeling Revision","09/27/2013"
"MYFORTIC (NDA #050791)","018","MYCOPHENOLIC ACID","NOVARTIS","Labeling Revision","09/27/2013"
"MYFORTIC (NDA #050791)","019","MYCOPHENOLIC ACID","NOVARTIS","Labeling Revision","09/27/2013"
"PARICALCITOL (ANDA #090829)","000","PARICALCITOL","TEVA PHARMS USA","Approval","09/27/2013"
"CIMZIA (BLA #125160)","213","CERTOLIZUMAB PEGOL","UCB INC","Efficacy Supplement with Clinical Data to Support","09/27/2013"
"HALAVEN (NDA #201532)","007","ERIBULIN MESYLATE","EISAI INC","Manufacturing Change or Addition","09/27/2013"
"BUDESONIDE (ANDA #201966)","000","BUDESONIDE","SANDOZ","Approval","09/27/2013"
"HYDROCORTISONE BUTYRATE (ANDA #202145)","000","HYDROCORTISONE BUTYRATE","GLENMARK GENERICS","Approval","09/27/2013"
"NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (ANDA #202461)","000","ESOMEPRAZOLE MAGNESIUM; NAPROXEN","DR REDDYS LABS LTD","Approval","09/27/2013"
"OSPHENA (NDA #203505)","002","OSPEMIFENE","SHIONOGI INC","Manufacturing Change or Addition","09/27/2013"
"PRECEDEX (NDA #021038)","023","DEXMEDETOMIDINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","09/28/2013"
"ACCUNEB (NDA #020949)","025","ALBUTEROL SULFATE","MYLAN SPECLT","Manufacturing Change or Addition","09/30/2013"
"ACCUNEB (NDA #020949)","026","ALBUTEROL SULFATE","MYLAN SPECLT","Manufacturing Change or Addition","09/30/2013"
"AEROSPAN HFA (NDA #021247)","009","FLUNISOLIDE","MEDA PHARMS INC","Manufacturing Change or Addition","09/30/2013"
"DICLEGIS (NDA #021876)","002","DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE","DUCHESNAY","Manufacturing Change or Addition","09/30/2013"
"PERJETA (BLA #125409)","051","PERTUZUMAB","GENENTECH","New or Modified Indication","09/30/2013"
"CLONIDINE HYDROCHLORIDE (ANDA #202984)","000","CLONIDINE HYDROCHLORIDE","ANCHEN PHARMS","Approval","09/30/2013"
"BOSULIF (NDA #203341)","001","BOSUTINIB MONOHYDRATE","WYETH PHARMS INC","Labeling Revision","09/30/2013"
"BRINTELLIX (NDA #204447)","000","VORTIOXETINE HYDROBROMIDE","TAKEDA PHARMS USA","Approval","09/30/2013"
"EXELON (NDA #020823)","009","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"EXELON (NDA #020823)","027","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"EXELON (NDA #020823)","028","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"EXELON (NDA #020823)","029","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"EXELON (NDA #021025)","018","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"EXELON (NDA #021025)","019","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"EXELON (NDA #021025)","020","RIVASTIGMINE TARTRATE","NOVARTIS","Labeling Revision","10/01/2013"
"KHEDEZLA (NDA #204683)","001","DESVENLAFAXINE","OSMOTICA PHARM CORP","Labeling Revision","10/01/2013"
"MODICON 28 (NDA #017735)","104","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"MODICON 28 (NDA #017735)","108","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"MODICON 28 (NDA #017735)","110","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"MODICON 28 (NDA #017735)","114","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 1/35-28 (NDA #017919)","086","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 1/35-28 (NDA #017919)","090","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 1/35-28 (NDA #017919)","092","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 1/35-28 (NDA #017919)","096","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-21 (NDA #018985)","050","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-21 (NDA #018985)","054","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-21 (NDA #018985)","056","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-21 (NDA #018985)","060","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-28 (NDA #018985)","050","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-28 (NDA #018985)","054","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-28 (NDA #018985)","056","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-NOVUM 7/7/7-28 (NDA #018985)","060","ETHINYL ESTRADIOL; NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-21 (NDA #019653)","046","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-21 (NDA #019653)","049","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-21 (NDA #019653)","051","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-21 (NDA #019653)","054","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-28 (NDA #019653)","046","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-28 (NDA #019653)","049","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-28 (NDA #019653)","051","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO CYCLEN-28 (NDA #019653)","054","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO TRI-CYCLEN (NDA #019697)","042","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO TRI-CYCLEN (NDA #019697)","045","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO TRI-CYCLEN (NDA #019697)","047","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO TRI-CYCLEN (NDA #019697)","050","ETHINYL ESTRADIOL; NORGESTIMATE","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-CEPT (NDA #020301)","025","DESOGESTREL; ETHINYL ESTRADIOL","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-CEPT (NDA #020301)","028","DESOGESTREL; ETHINYL ESTRADIOL","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-CEPT (NDA #020301)","030","DESOGESTREL; ETHINYL ESTRADIOL","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"ORTHO-CEPT (NDA #020301)","034","DESOGESTREL; ETHINYL ESTRADIOL","JANSSEN PHARMS","Labeling Revision","10/02/2013"
"VIMPAT (NDA #022254)","017","LACOSAMIDE","UCB INC","Manufacturing Change or Addition","10/02/2013"
"ABSTRAL (NDA #022510)","011","FENTANYL CITRATE","GALENA BIOPHARMA","Manufacturing Change or Addition","10/02/2013"
"VPRIV (NDA #022575)","013","VELAGLUCERASE ALFA","SHIRE HUMAN GENETIC","Labeling Revision","10/02/2013"
"STRIBILD (NDA #203100)","004","COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Efficacy Supplement with Clinical Data to Support","10/02/2013"
"REVIA (NDA #018932)","017","NALTREXONE HYDROCHLORIDE","TEVA WOMENS","Labeling Revision","10/03/2013"
"ZINECARD (NDA #020212)","016","DEXRAZOXANE HYDROCHLORIDE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/03/2013"
"RELPAX (NDA #021016)","021","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Labeling Revision","10/03/2013"
"RELPAX (NDA #021016)","023","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Labeling Revision","10/03/2013"
"RELPAX (NDA #021016)","024","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Labeling Revision","10/03/2013"
"RELPAX (NDA #021016)","027","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Labeling Revision","10/03/2013"
"SURFAXIN (NDA #021746)","003","LUCINACTANT","DISCOVERY LABS","Manufacturing Change or Addition","10/03/2013"
"ACZONE (NDA #021794)","011","DAPSONE","ALLERGAN","Manufacturing Change or Addition","10/03/2013"
"DUAVEE (NDA #022247)","000","BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","WYETH PHARMS PFIZER","Approval","10/03/2013"
"DUAVEE (NDA #022247)","001","BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","WYETH PHARMS PFIZER","Approval","10/03/2013"
"LYSTEDA (NDA #022430)","004","TRANEXAMIC ACID","FERRING PHARMS AS","Labeling Revision","10/03/2013"
"TOPOTECAN HYDROCHLORIDE (NDA #022453)","001","TOPOTECAN HYDROCHLORIDE","TEVA PHARMS USA","Manufacturing Change or Addition","10/03/2013"
"KORLYM (NDA #202107)","002","MIFEPRISTONE","CORCEPT THERAP","Manufacturing Change or Addition","10/03/2013"
"POMALYST (NDA #204026)","001","POMALIDOMIDE","CELGENE","Manufacturing Change or Addition","10/03/2013"
"CLINOLIPID 20% (NDA #204508)","000","OLIVE OIL; SOYBEAN OIL","BAXTER HLTHCARE","Approval","10/03/2013"
"NEXIUM (NDA #021153)","047","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Manufacturing Change or Addition","10/04/2013"
"NUVARING (NDA #021187)","021","ETHINYL ESTRADIOL; ETONOGESTREL","ORGANON USA INC","Efficacy Supplement with Clinical Data to Support","10/04/2013"
"NUVARING (NDA #021187)","022","ETHINYL ESTRADIOL; ETONOGESTREL","ORGANON USA INC","Labeling Revision","10/04/2013"
"HEPSERA (NDA #021449)","021","ADEFOVIR DIPIVOXIL","GILEAD","Manufacturing Change or Addition","10/04/2013"
"LEVETIRACETAM IN SODIUM CHLORIDE (NDA #202543)","004","LEVETIRACETAM","HQ SPECIALITY PHARMA","Manufacturing Change or Addition","10/04/2013"
"BC (NDA #204553)","000","SODIUM SULFATE; POTASSIUM SULFATE; MAGNESIUM SULFATE","GATOR PHARMA INC","Tentative Approval","10/04/2013"
"DEPO-MEDROL (NDA #011757)","097","METHYLPREDNISOLONE ACETATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/07/2013"
"ADAGEN (NDA #019818)","047","PEGADEMASE BOVINE","SIGMA TAU","Manufacturing Change or Addition","10/07/2013"
"ALVESCO (NDA #021658)","007","CICLESONIDE","TAKEDA GMBH","Manufacturing Change or Addition","10/07/2013"
"XALKORI (NDA #202570)","007","CRIZOTINIB","PF PRISM CV","Labeling Revision","10/07/2013"
"XALKORI (NDA #202570)","009","CRIZOTINIB","PF PRISM CV","Labeling Revision","10/07/2013"
"PEDIAPRED (NDA #019157)","020","PREDNISOLONE SODIUM PHOSPHATE","SETON PHARM","Labeling Revision","10/08/2013"
"PAREMYD (NDA #019261)","012","HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE","AKORN","Manufacturing Change or Addition","10/08/2013"
"ACTIVELLA (NDA #020907)","013","ESTRADIOL; NORETHINDRONE ACETATE","AMNEAL PHARMS LLC","Labeling Revision","10/08/2013"
"VISUDYNE (NDA #021119)","025","VERTEPORFIN","VALEANT PHARMS INC","Manufacturing Change or Addition","10/08/2013"
"FASLODEX (NDA #021344)","021","FULVESTRANT","ASTRAZENECA","Manufacturing Change or Addition","10/08/2013"
"FASLODEX (NDA #021344)","022","FULVESTRANT","ASTRAZENECA","Manufacturing Change or Addition","10/08/2013"
"OXYCODONE HYDROCHLORIDE (NDA #200535)","007","OXYCODONE HYDROCHLORIDE","LEHIGH VALLEY","Manufacturing Change or Addition","10/08/2013"
"PROCYSBI (NDA #203389)","001","CYSTEAMINE BITARTRATE","RAPTOR PHARMS","Manufacturing Change or Addition","10/08/2013"
"PHENYLEPHRINE HYDROCHLORIDE (NDA #203510)","001","PHENYLEPHRINE HYDROCHLORIDE","PARAGON BIOTECK","Manufacturing Change or Addition","10/08/2013"
"ADEMPAS (NDA #204819)","000","RIOCIGUAT","BAYER HLTHCARE","Approval","10/08/2013"
"MORPHINE SULFATE (NDA #019999)","020","MORPHINE SULFATE","MERIDIAN MEDCL TECHN","Manufacturing Change or Addition","10/09/2013"
"CLIMARA (NDA #020375)","027","ESTRADIOL","BAYER HLTHCARE","Labeling Revision","10/09/2013"
"LOTEMAX (NDA #020583)","027","LOTEPREDNOL ETABONATE","BAUSCH AND LOMB","Manufacturing Change or Addition","10/09/2013"
"ALREX (NDA #020803)","025","LOTEPREDNOL ETABONATE","BAUSCH AND LOMB","Manufacturing Change or Addition","10/09/2013"
"ZYVOX (NDA #021132)","030","LINEZOLID","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/09/2013"
"CLIMARA PRO (NDA #021258)","006","ESTRADIOL; LEVONORGESTREL","BAYER HLTHCARE","Labeling Revision","10/09/2013"
"VESICARE (NDA #021518)","016","SOLIFENACIN SUCCINATE","ASTELLAS","Labeling Revision","10/09/2013"
"CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #050639)","026","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/09/2013"
"ZYLET (NDA #050804)","020","LOTEPREDNOL ETABONATE; TOBRAMYCIN","BAUSCH AND LOMB","Manufacturing Change or Addition","10/09/2013"
"LEVONORGESTREL AND ETHINYL ESTRADIOL (ANDA #200245)","000","ETHINYL ESTRADIOL; LEVONORGESTREL","FAMY CARE LTD","Approval","10/09/2013"
"VANCOMYCIN HYDROCHLORIDE (ANDA #202464)","000","VANCOMYCIN HYDROCHLORIDE","EMCURE PHARMS LTD","Approval","10/09/2013"
"TINIDAZOLE (ANDA #202489)","000","TINIDAZOLE","UNIQUE PHARM LABS","Labeling Revision","10/09/2013"
"CLIMARA (NDA #020375)","028","ESTRADIOL","BAYER HLTHCARE","Labeling Revision","10/10/2013"
"AVAPRO (NDA #020757)","063","IRBESARTAN","SANOFI AVENTIS US","Manufacturing Change or Addition","10/10/2013"
"CHLORAPREP ONE-STEP (NDA #020832)","031","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","10/10/2013"
"CHLORAPREP ONE-STEP FREPP (NDA #020832)","031","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","10/10/2013"
"CHLORAPREP WITH TINT (NDA #020832)","031","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","10/10/2013"
"AGGRASTAT (NDA #020912)","019","TIROFIBAN HYDROCHLORIDE","MEDICURE","Efficacy Supplement with Clinical Data to Support","10/10/2013"
"AGGRASTAT (NDA #020912)","020","TIROFIBAN HYDROCHLORIDE","MEDICURE","Labeling Revision","10/10/2013"
"TEMODAR (NDA #021029)","025","TEMOZOLOMIDE","MERCK SHARP DOHME","Manufacturing Change or Addition","10/10/2013"
"RISPERDAL CONSTA (NDA #021346)","047","RISPERIDONE","JANSSEN PHARMS","Manufacturing Change or Addition","10/10/2013"
"CIALIS (NDA #021368)","022","TADALAFIL","LILLY","Efficacy Supplement with Clinical Data to Support","10/10/2013"
"CHLORAPREP ONE-STEP SEPP (NDA #021555)","018","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","10/10/2013"
"CHLORAPREP SINGLE SWABSTICK (NDA #021555)","018","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","10/10/2013"
"CHLORAPREP TRIPLE SWABSTICK (NDA #021555)","018","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","10/10/2013"
"ADRIAMYCIN RDF (NDA #050467)","074","DOXORUBICIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/10/2013"
"ADRIAMYCIN PFS (NDA #050629)","023","DOXORUBICIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/10/2013"
"TOBRAMYCIN (ANDA #091589)","000","TOBRAMYCIN","TEVA PHARMS USA","Approval","10/10/2013"
"KRYSTEXXA (BLA #125293)","060","PEGLOTICASE","SAVIENT PHARMS","Labeling Revision","10/10/2013"
"ZIPRASIDONE HYDROCHLORIDE (ANDA #202395)","000","ZIPRASIDONE HYDROCHLORIDE","MYLAN PHARMS INC","Approval","10/10/2013"
"DEPO-MEDROL (NDA #011757)","098","METHYLPREDNISOLONE ACETATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/11/2013"
"NICORETTE (NDA #018612)","069","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","10/11/2013"
"NICORETTE (MINT) (NDA #018612)","069","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","10/11/2013"
"NASACORT ALLERGY 24 HOUR (NDA #020468)","035","TRIAMCINOLONE ACETONIDE","SANOFI AVENTIS US","OTC Labeling","10/11/2013"
"ZONEGRAN (NDA #020789)","032","ZONISAMIDE","EISAI INC","Manufacturing Change or Addition","10/11/2013"
"COMTAN (NDA #020796)","022","ENTACAPONE","ORION PHARMA","Manufacturing Change or Addition","10/11/2013"
"FROVA (NDA #021006)","019","FROVATRIPTAN SUCCINATE","ENDO PHARMS","Labeling Revision","10/11/2013"
"SOMAVERT (NDA #021106)","043","PEGVISOMANT","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/11/2013"
"VIMPAT (NDA #022253)","025","LACOSAMIDE","UCB INC","Manufacturing Change or Addition","10/11/2013"
"MONODOX (NDA #050641)","027","DOXYCYCLINE","AQUA PHARMS","Labeling Revision","10/11/2013"
"ZMAX (NDA #050797)","013","AZITHROMYCIN","PF PRISM CV","Labeling Revision","10/11/2013"
"PENICILLIN V POTASSIUM (ANDA #090549)","000","PENICILLIN V POTASSIUM","HIKMA PHARMS","Approval","10/11/2013"
"ENTECAVIR (ANDA #202122)","000","ENTECAVIR","TEVA PHARMS USA","Tentative Approval","10/11/2013"
"BUPROPION HYDROCHLORIDE (ANDA #202774)","000","BUPROPION HYDROCHLORIDE","JUBILANT LIFE","Approval","10/11/2013"
"BUPROPION HYDROCHLORIDE (ANDA #202775)","000","BUPROPION HYDROCHLORIDE","JUBILANT LIFE","Approval","10/11/2013"
"ACYCLOVIR SODIUM (ANDA #203701)","000","ACYCLOVIR SODIUM","AUROBINDO PHARMA LTD","Approval","10/11/2013"
"OTREXUP (NDA #204824)","000","METHOTREXATE","ANTARES PHARMA INC","Approval","10/11/2013"
"DESVENLAFAXINE (NDA #205208)","000","DESVENLAFAXINE FUMARATE","TEVA PHARMS USA","Approval","10/11/2013"
"CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019857)","061","CIPROFLOXACIN","BAYER HLTHCARE","Manufacturing Change or Addition","10/14/2013"
"NORDITROPIN (NDA #021148)","039","SOMATROPIN RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/14/2013"
"NORDITROPIN FLEXPRO (NDA #021148)","039","SOMATROPIN RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/14/2013"
"NORDITROPIN NORDIFLEX (NDA #021148)","039","SOMATROPIN RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/14/2013"
"MICRONASE (NDA #017498)","031","GLYBURIDE","PHARMACIA AND UPJOHN","Labeling Revision","10/15/2013"
"DIABETA (NDA #017532)","034","GLYBURIDE","SANOFI AVENTIS US","Labeling Revision","10/15/2013"
"GLUCOTROL (NDA #017783)","025","GLIPIZIDE","PFIZER","Labeling Revision","10/15/2013"
"ADAGEN (NDA #019818)","048","PEGADEMASE BOVINE","SIGMA TAU","Manufacturing Change or Addition","10/15/2013"
"GLYNASE (NDA #020051)","020","GLYBURIDE","PHARMACIA AND UPJOHN","Labeling Revision","10/15/2013"
"FRAGMIN (NDA #020287)","060","DALTEPARIN SODIUM","EISAI INC","Labeling Revision","10/15/2013"
"GLUCOTROL XL (NDA #020329)","028","GLIPIZIDE","PFIZER","Labeling Revision","10/15/2013"
"AMARYL (NDA #020496)","027","GLIMEPIRIDE","SANOFI AVENTIS US","Labeling Revision","10/15/2013"
"ZOLOFT (NDA #020990)","042","SERTRALINE HYDROCHLORIDE","PFIZER","Manufacturing Change or Addition","10/15/2013"
"GLUCOVANCE (NDA #021178)","015","GLYBURIDE; METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Labeling Revision","10/15/2013"
"METAGLIP (NDA #021460)","010","GLIPIZIDE; METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Labeling Revision","10/15/2013"
"PROCHLORPERAZINE EDISYLATE (ANDA #204147)","000","PROCHLORPERAZINE EDISYLATE","EMCURE PHARMS LTD","Approval","10/15/2013"
"AMERGE (NDA #020763)","001","NARATRIPTAN HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Labeling Revision","10/16/2013"
"AMERGE (NDA #020763)","002","NARATRIPTAN HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Labeling Revision","10/16/2013"
"AMERGE (NDA #020763)","010","NARATRIPTAN HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Labeling Revision","10/16/2013"
"XENICAL (NDA #020766)","033","ORLISTAT","HOFFMANN LA ROCHE","Labeling Revision","10/16/2013"
"SYNERA (NDA #021623)","021","LIDOCAINE; TETRACAINE","GALEN SPECIALTY","Manufacturing Change or Addition","10/16/2013"
"GONAL-F RFF REDI-JECT (NDA #021684)","036","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","10/16/2013"
"EOVIST (NDA #022090)","008","GADOXETATE DISODIUM","BAYER HLTHCARE","Labeling Revision","10/16/2013"
"EFFIENT (NDA #022307)","008","PRASUGREL HYDROCHLORIDE","ELI LILLY AND CO","Efficacy Supplement with Clinical Data to Support","10/16/2013"
"LIVALO (NDA #022363)","012","PITAVASTATIN CALCIUM","KOWA CO","Labeling Revision","10/16/2013"
"STRIBILD (NDA #203100)","007","COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Manufacturing Change or Addition","10/16/2013"
"MAGNEVIST (NDA #019596)","056","GADOPENTETATE DIMEGLUMINE","BAYER HLTHCARE","Labeling Revision","10/17/2013"
"GENOTROPIN (NDA #020280)","075","SOMATROPIN RECOMBINANT","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/17/2013"
"GENOTROPIN PRESERVATIVE FREE (NDA #020280)","075","SOMATROPIN RECOMBINANT","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/17/2013"
"LANOXIN (NDA #020405)","007","DIGOXIN","COVIS PHARMA","Labeling Revision","10/17/2013"
"MAGNEVIST (NDA #021037)","029","GADOPENTETATE DIMEGLUMINE","BAYER HLTHCARE","Labeling Revision","10/17/2013"
"ZEMPLAR (NDA #021606)","013","PARICALCITOL","ABBVIE","Manufacturing Change or Addition","10/17/2013"
"JANUVIA (NDA #021995)","028","SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Manufacturing Change or Addition","10/17/2013"
"PRANDIMET (NDA #022386)","009","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Manufacturing Change or Addition","10/17/2013"
"PRANDIMET (NDA #022386)","011","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Manufacturing Change or Addition","10/17/2013"
"QSYMIA (NDA #022580)","007","PHENTERMINE HYDROCHLORIDE; TOPIRAMATE","VIVUS","Manufacturing Change or Addition","10/17/2013"
"ACARBOSE (ANDA #091343)","000","ACARBOSE","VIRTUS PHARM","Approval","10/17/2013"
"CIMZIA (BLA #125160)","215","CERTOLIZUMAB PEGOL","UCB INC","Efficacy Supplement with Clinical Data to Support","10/17/2013"
"LAMOTRIGINE (ANDA #200672)","000","LAMOTRIGINE","ACTAVIS ELIZABETH","Approval","10/17/2013"
"GADAVIST (NDA #201277)","003","GADOBUTROL","BAYER HLTHCARE","Labeling Revision","10/17/2013"
"JANUMET XR (NDA #202270)","005","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Manufacturing Change or Addition","10/17/2013"
"KAZANO (NDA #203414)","001","ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE","TAKEDA PHARMS USA","Manufacturing Change or Addition","10/17/2013"
"BICNU (NDA #017422)","046","CARMUSTINE","EMCURE PHARMS LTD","Labeling Revision","10/18/2013"
"ASACOL (NDA #019651)","024","MESALAMINE","WARNER CHILCOTT LLC","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"CLARITIN-D (NDA #019670)","031","LORATADINE; PSEUDOEPHEDRINE SULFATE","SCHERING PLOUGH","Manufacturing Change or Addition","10/18/2013"
"FIORICET W/ CODEINE (NDA #020232)","036","ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE","WATSON LABS INC","Labeling Revision","10/18/2013"
"INFASURF PRESERVATIVE FREE (NDA #020521)","026","CALFACTANT","ONY","Manufacturing Change or Addition","10/18/2013"
"DUONEB (NDA #020950)","038","ALBUTEROL SULFATE; IPRATROPIUM BROMIDE","MYLAN SPECLT","Manufacturing Change or Addition","10/18/2013"
"LANTUS (NDA #021081)","057","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"LANTUS SOLOSTAR (NDA #021081)","057","INSULIN GLARGINE RECOMBINANT","SANOFI AVENTIS US","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"TRI-LUMA (NDA #021112)","008","FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN","GALDERMA LABS LP","Manufacturing Change or Addition","10/18/2013"
"ULTRACET (NDA #021123)","008","ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","10/18/2013"
"DIOVAN (NDA #021283)","040","VALSARTAN","NOVARTIS","Manufacturing Change or Addition","10/18/2013"
"ANTARA (MICRONIZED) (NDA #021695)","009","FENOFIBRATE","LUPIN ATLANTIS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 2/0 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 4/0 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BK 0/0 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER (NDA #021703)","011","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","10/18/2013"
"ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (NDA #021704)","015","FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","10/18/2013"
"ENTEREG (NDA #021775)","010","ALVIMOPAN","CUBIST PHARMS","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"ASACOL HD (NDA #021830)","006","MESALAMINE","WARNER CHILCOTT LLC","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"TYKERB (NDA #022059)","016","LAPATINIB DITOSYLATE","SMITHKLINE BEECHAM","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"TYKERB (NDA #022059)","017","LAPATINIB DITOSYLATE","SMITHKLINE BEECHAM","Efficacy Supplement with Clinical Data to Support","10/18/2013"
"OFIRMEV (NDA #022450)","005","ACETAMINOPHEN","CADENCE PHARMS","Labeling Revision","10/18/2013"
"OFIRMEV (NDA #022450)","006","ACETAMINOPHEN","CADENCE PHARMS","Labeling Revision","10/18/2013"
"PRADAXA (NDA #022512)","019","DABIGATRAN ETEXILATE MESYLATE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","10/18/2013"
"PROCYSBI (NDA #203389)","002","CYSTEAMINE BITARTRATE","RAPTOR PHARMS","Manufacturing Change or Addition","10/18/2013"
"OPSUMIT (NDA #204410)","000","MACITENTAN","ACTELION PHARMS LTD","Approval","10/18/2013"
"LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE (NDA #204505)","000","LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE","AUROBINDO PHARMA LTD","Tentative Approval","10/18/2013"
"ZORVOLEX (NDA #204592)","000","DICLOFENAC","IROKO PHARMS LLC","Approval","10/18/2013"
"ZYPREXA (NDA #020592)","065","OLANZAPINE","LILLY","Manufacturing Change or Addition","10/21/2013"
"PENNSAID (NDA #020947)","008","DICLOFENAC SODIUM","MALLINCKRODT","Labeling Revision","10/21/2013"
"EXJADE (NDA #021882)","019","DEFERASIROX","NOVARTIS","Labeling Revision","10/21/2013"
"SOLODYN (NDA #050808)","023","MINOCYCLINE HYDROCHLORIDE","MEDICIS","Labeling Revision","10/21/2013"
"ACTEMRA (BLA #125276)","092","TOCILIZUMAB","GENENTECH","Labeling Revision","10/21/2013"
"ACTEMRA (BLA #125472)","000","TOCILIZUMAB","GENENTECH","Approval","10/21/2013"
"RALOXIFENE HYDROCHLORIDE (ANDA #200825)","000","RALOXIFENE HYDROCHLORIDE","WATSON LABS INC","Tentative Approval","10/21/2013"
"DARUNAVIR (ANDA #202136)","000","DARUNAVIR","MYLAN PHARMS INC","Tentative Approval","10/21/2013"
"AMLODIPINE BESYLATE (ANDA #203245)","000","AMLODIPINE BESYLATE","UNICHEM LABS LTD","Approval","10/21/2013"
"VALIUM (NDA #013263)","092","DIAZEPAM","ROCHE","Labeling Revision","10/22/2013"
"FRAGMIN (NDA #020287)","061","DALTEPARIN SODIUM","EISAI INC","Manufacturing Change or Addition","10/22/2013"
"CEREBYX (NDA #020450)","024","FOSPHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","10/22/2013"
"RISPERDAL CONSTA (NDA #021346)","050","RISPERIDONE","JANSSEN PHARMS","Manufacturing Change or Addition","10/22/2013"
"MIRALAX (NDA #022015)","017","POLYETHYLENE GLYCOL 3350","SCHERING PLOUGH","Manufacturing Change or Addition","10/22/2013"
"DELZICOL (NDA #204412)","002","MESALAMINE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","10/22/2013"
"LOVENOX (NDA #020164)","102","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Labeling Revision","10/23/2013"
"LOVENOX (PRESERVATIVE FREE) (NDA #020164)","102","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Labeling Revision","10/23/2013"
"LAMISIL (NDA #020539)","024","TERBINAFINE HYDROCHLORIDE","NOVARTIS","Labeling Revision","10/23/2013"
"SUBOXONE (NDA #020733)","012","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","10/23/2013"
"ZYRTEC-D 12 HOUR (NDA #021150)","010","CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","MCNEIL","Manufacturing Change or Addition","10/23/2013"
"VIREAD (NDA #021356)","048","TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling Revision","10/23/2013"
"TRUVADA (NDA #021752)","042","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Labeling Revision","10/23/2013"
"ATRIPLA (NDA #021937)","031","EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Labeling Revision","10/23/2013"
"LAMISIL (NDA #022071)","010","TERBINAFINE HYDROCHLORIDE","NOVARTIS","Labeling Revision","10/23/2013"
"VIREAD (NDA #022577)","006","TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling Revision","10/23/2013"
"ADRIAMYCIN PFS (NDA #050629)","024","DOXORUBICIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","10/23/2013"
"KINERET (BLA #103950)","5150","ANAKINRA","BIOVITRUM AB","Labeling Revision","10/23/2013"
"COMPLERA (NDA #202123)","015","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling Revision","10/23/2013"
"STRIBILD (NDA #203100)","009","COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling Revision","10/23/2013"
"AMINOHIPPURATE SODIUM (NDA #005619)","024","AMINOHIPPURATE SODIUM","MERCK","Manufacturing Change or Addition","10/24/2013"
"XYLOCAINE (NDA #008816)","038","LIDOCAINE HYDROCHLORIDE","OAK PHARMS","Manufacturing Change or Addition","10/24/2013"
"FLAGYL I.V. RTU IN PLASTIC CONTAINER (NDA #018657)","032","METRONIDAZOLE","BAXTER HLTHCARE","Labeling Revision","10/24/2013"
"INNOPRAN XL (NDA #021438)","017","PROPRANOLOL HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Manufacturing Change or Addition","10/24/2013"
"NAMENDA (NDA #021487)","010","MEMANTINE HYDROCHLORIDE","FOREST LABS","Labeling Revision","10/24/2013"
"NAMENDA (NDA #021487)","012","MEMANTINE HYDROCHLORIDE","FOREST LABS","Labeling Revision","10/24/2013"
"NAMENDA (NDA #021487)","014","MEMANTINE HYDROCHLORIDE","FOREST LABS","Labeling Revision","10/24/2013"
"NAMENDA (NDA #021627)","008","MEMANTINE HYDROCHLORIDE","FOREST LABS","Labeling Revision","10/24/2013"
"ISENTRESS (NDA #022145)","030","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","10/24/2013"
"BIAXIN (NDA #050698)","034","CLARITHROMYCIN","ABBVIE","Manufacturing Change or Addition","10/24/2013"
"TOBI (NDA #050753)","015","TOBRAMYCIN","NOVARTIS PHARMS","Manufacturing Change or Addition","10/24/2013"
"HALAVEN (NDA #201532)","008","ERIBULIN MESYLATE","EISAI INC","Manufacturing Change or Addition","10/24/2013"
"ISENTRESS (NDA #203045)","008","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","10/24/2013"
"ECOZA (NDA #205175)","000","ECONAZOLE NITRATE","VELDANA MEDICAL SA","Approval","10/24/2013"
"RITALIN (NDA #010187)","075","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Manufacturing Change or Addition","10/25/2013"
"RITALIN-SR (NDA #018029)","045","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Manufacturing Change or Addition","10/25/2013"
"CALAN (NDA #018817)","031","VERAPAMIL HYDROCHLORIDE","GD SEARLE LLC","Labeling Revision","10/25/2013"
"ZOCOR (NDA #019766)","090","SIMVASTATIN","MERCK","Labeling Revision","10/25/2013"
"ACCUPRIL (NDA #019885)","039","QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","10/25/2013"
"ALTACE (NDA #019901)","063","RAMIPRIL","KING PHARMS","Labeling Revision","10/25/2013"
"ACCURETIC (NDA #020125)","017","HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","10/25/2013"
"ZYPREXA (NDA #020592)","066","OLANZAPINE","LILLY","Manufacturing Change or Addition","10/25/2013"
"RITALIN LA (NDA #021284)","021","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Manufacturing Change or Addition","10/25/2013"
"VYTORIN (NDA #021687)","048","EZETIMIBE; SIMVASTATIN","MSD INTL","Labeling Revision","10/25/2013"
"APRISO (NDA #022301)","004","MESALAMINE","SALIX PHARMS","Manufacturing Change or Addition","10/25/2013"
"ZALTRAP (BLA #125418)","020","ZIV-AFLIBERCEPT","SANOFI AVENTIS US","Labeling Revision","10/25/2013"
"AMYVID (NDA #202008)","018","FLORBETAPIR F-18","AVID RADIOPHARMS INC","Manufacturing Change or Addition","10/25/2013"
"RAYOS (NDA #202020)","004","PREDNISONE","HORIZON PHARMA","Manufacturing Change or Addition","10/25/2013"
"JUVISYNC (NDA #202343)","008","SIMVASTATIN; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","10/25/2013"
"ZOHYDRO ER (NDA #202880)","000","HYDROCODONE BITARTRATE","ZOGENIX INC","Approval","10/25/2013"
"VIZAMYL (NDA #203137)","000","FLUTEMETAMOL F-18","GE HEALTHCARE","Approval","10/25/2013"
"SABRIL (NDA #020427)","010","VIGABATRIN","LUNDBECK LLC","Labeling Revision","10/26/2013"
"SABRIL (NDA #020427)","011","VIGABATRIN","LUNDBECK LLC","Efficacy Supplement with Clinical Data to Support","10/26/2013"
"SABRIL (NDA #020427)","012","VIGABATRIN","LUNDBECK LLC","Labeling Revision","10/26/2013"
"SABRIL (NDA #022006)","011","VIGABATRIN","LUNDBECK LLC","Labeling Revision","10/26/2013"
"SABRIL (NDA #022006)","012","VIGABATRIN","LUNDBECK LLC","Efficacy Supplement with Clinical Data to Support","10/26/2013"
"SABRIL (NDA #022006)","013","VIGABATRIN","LUNDBECK LLC","Efficacy Supplement with Clinical Data to Support","10/26/2013"
"CALAN SR (NDA #019152)","038","VERAPAMIL HYDROCHLORIDE","PFIZER","Labeling Revision","10/28/2013"
"COMMIT (NDA #021330)","016","NICOTINE POLACRILEX","GLAXOSMITHKLINE CONS","Labeling Revision","10/28/2013"
"NICORETTE (NDA #022360)","007","NICOTINE POLACRILEX","GLAXOSMITHKLINE CONS","Labeling Revision","10/28/2013"
"DICLOFENAC SODIUM (ANDA #200936)","000","DICLOFENAC SODIUM","TOLMAR","Approval","10/28/2013"
"INCIVEK (NDA #201917)","010","TELAPREVIR","VERTEX PHARMS","Efficacy Supplement with Clinical Data to Support","10/28/2013"
"INCIVEK (NDA #201917)","012","TELAPREVIR","VERTEX PHARMS","Labeling Revision","10/28/2013"
"XYLOCAINE (NDA #006488)","079","LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing Change or Addition","10/29/2013"
"XYLOCAINE W/ EPINEPHRINE (NDA #006488)","079","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing Change or Addition","10/29/2013"
"NIZORAL (NDA #019927)","032","KETOCONAZOLE","JANSSEN PHARMS","Labeling Revision","10/29/2013"
"SEROQUEL (NDA #020639)","061","QUETIAPINE FUMARATE","ASTRAZENECA","Labeling Revision","10/29/2013"
"DIOVAN (NDA #020665)","033","VALSARTAN","NOVARTIS","Labeling Revision","10/29/2013"
"LEXIVA (NDA #021548)","033","FOSAMPRENAVIR CALCIUM","VIIV HLTHCARE","Manufacturing Change or Addition","10/29/2013"
"SEROQUEL XR (NDA #022047)","034","QUETIAPINE FUMARATE","ASTRAZENECA","Labeling Revision","10/29/2013"
"HORIZANT (NDA #022399)","009","GABAPENTIN ENACARBIL","XENOPORT INC","Manufacturing Change or Addition","10/29/2013"
"CLONIDINE HYDROCHLORIDE (ANDA #203167)","000","CLONIDINE HYDROCHLORIDE","EXELA PHARMA SCS LLC","Approval","10/29/2013"
"LISINOPRIL (ANDA #203508)","000","LISINOPRIL","INVAGEN PHARMS","Approval","10/29/2013"
"ACYCLOVIR (ANDA #203834)","000","ACYCLOVIR","HETERO LABS LTD V","Approval","10/29/2013"
"EURAX (NDA #006927)","033","CROTAMITON","RANBAXY","Manufacturing Change or Addition","10/30/2013"
"NORINYL 1+50 28-DAY (NDA #016659)","137","MESTRANOL; NORETHINDRONE","WATSON LABS","Manufacturing Change or Addition","10/30/2013"
"NICORETTE (NDA #018612)","068","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","10/30/2013"
"NICORETTE (MINT) (NDA #018612)","068","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","10/30/2013"
"LUPRON (NDA #019943)","034","LEUPROLIDE ACETATE","ABBOTT LABS","Labeling Revision","10/30/2013"
"LUPRON DEPOT (NDA #020011)","041","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","10/30/2013"
"NICORETTE (NDA #020066)","049","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","10/30/2013"
"NICORETTE (MINT) (NDA #020066)","049","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","10/30/2013"
"CEREZYME (NDA #020367)","089","IMIGLUCERASE","GENZYME","Manufacturing Change or Addition","10/30/2013"
"LUPRON DEPOT (NDA #020708)","034","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","10/30/2013"
"GLEEVEC (NDA #021588)","039","IMATINIB MESYLATE","NOVARTIS","Labeling Revision","10/30/2013"
"ABRAXANE (NDA #021660)","038","PACLITAXEL","ABRAXIS BIOSCIENCE","Labeling Revision","10/30/2013"
"NEXAVAR (NDA #021923)","015","SORAFENIB TOSYLATE","BAYER HLTHCARE","Labeling Revision","10/30/2013"
"SAVELLA (NDA #022256)","014","MILNACIPRAN HYDROCHLORIDE","CYPRESS BIOSCIENCE","Labeling Revision","10/30/2013"
"SAVELLA (NDA #022256)","015","MILNACIPRAN HYDROCHLORIDE","CYPRESS BIOSCIENCE","Labeling Revision","10/30/2013"
"BRILINTA (NDA #022433)","009","TICAGRELOR","ASTRAZENECA LP","Efficacy Supplement with Clinical Data to Support","10/30/2013"
"ZUPLENZ (NDA #022524)","002","ONDANSETRON","VESTIQ PHARMS","Labeling Revision","10/30/2013"
"CHOLINE C-11 (NDA #203155)","002","CHOLINE C-11","MCPRF","Manufacturing Change or Addition","10/30/2013"
"LUPANETA PACK (NDA #203696)","001","LEUPROLIDE ACETATE; NORETHINDRONE ACETATE","ABBVIE ENDOCRINE","Labeling Revision","10/30/2013"
"MORPHINE SULFATE (NDA #204223)","000","MORPHINE SULFATE","BD RX","Approval","10/30/2013"
"DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #016683)","101","DEXTROSE; SODIUM CHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","10/31/2013"
"KLONOPIN (NDA #017533)","053","CLONAZEPAM","ROCHE","Labeling Revision","10/31/2013"
"LOPID (NDA #018422)","053","GEMFIBROZIL","PFIZER PHARMS","Labeling Revision","10/31/2013"
"NICODERM CQ (NDA #020165)","031","NICOTINE","SANOFI AVENTIS US","Labeling Revision","10/31/2013"
"KLONOPIN RAPIDLY DISINTEGRATING (NDA #020813)","009","CLONAZEPAM","ROCHE","Labeling Revision","10/31/2013"
"UVADEX (NDA #020969)","006","METHOXSALEN","THERAKOS","Labeling Revision","10/31/2013"
"NOVOLOG (NDA #020986)","061","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"NOVOLOG FLEXPEN (NDA #020986)","061","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"NOVOLOG FLEXTOUCH (NDA #020986)","061","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"NOVOLOG INNOLET (NDA #020986)","061","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"NOVOLOG PENFILL (NDA #020986)","061","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"FUZEON (NDA #021481)","027","ENFUVIRTIDE","ROCHE","Labeling Revision","10/31/2013"
"LEVEMIR (NDA #021536)","033","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"LEVEMIR FLEXPEN (NDA #021536)","033","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"LEVEMIR FLEXTOUCH (NDA #021536)","033","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"LEVEMIR INNOLET (NDA #021536)","033","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"LEVEMIR PENFILL (NDA #021536)","033","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","10/31/2013"
"ACZONE (NDA #021794)","010","DAPSONE","ALLERGAN","Manufacturing Change or Addition","10/31/2013"
"PREZISTA (NDA #021976)","032","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Manufacturing Change or Addition","10/31/2013"
"NUCYNTA (NDA #022304)","014","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","10/31/2013"
"NUCYNTA (NDA #022304)","015","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","10/31/2013"
"DUEXIS (NDA #022519)","006","FAMOTIDINE; IBUPROFEN","HORIZON PHARMA","Labeling Revision","10/31/2013"
"ADRIAMYCIN RDF (NDA #050467)","073","DOXORUBICIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","10/31/2013"
"ADRIAMYCIN PFS (NDA #050629)","022","DOXORUBICIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","10/31/2013"
"E.E.S. 200 (ANDA #061639)","032","ERYTHROMYCIN ETHYLSUCCINATE","ARBOR PHARMS INC","Labeling Revision","10/31/2013"
"E.E.S. 400 (ANDA #061639)","032","ERYTHROMYCIN ETHYLSUCCINATE","ARBOR PHARMS INC","Labeling Revision","10/31/2013"
"E.E.S. 400 (ANDA #061905)","049","ERYTHROMYCIN ETHYLSUCCINATE","ARBOR PHARMS INC","Labeling Revision","10/31/2013"
"TOLTERODINE TARTRATE (ANDA #201486)","000","TOLTERODINE TARTRATE","MYLAN PHARMS INC","Approval","10/31/2013"
"ELIQUIS (NDA #202155)","004","APIXABAN","BRISTOL MYERS SQUIBB","Labeling Revision","10/31/2013"
"VANCOMYCIN HYDROCHLORIDE (ANDA #202274)","000","VANCOMYCIN HYDROCHLORIDE","EMCURE PHARMS LTD","Approval","10/31/2013"
"VANCOMYCIN HYDROCHLORIDE (ANDA #202275)","000","VANCOMYCIN HYDROCHLORIDE","EMCURE PHARMS LTD","Approval","10/31/2013"
"EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE (ANDA #203053)","000","EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","HETERO LABS LTD V","Tentative Approval","10/31/2013"
"PROCYSBI (NDA #203389)","003","CYSTEAMINE BITARTRATE","RAPTOR PHARMS","Manufacturing Change or Addition","10/31/2013"
"EVOXAC (NDA #020989)","012","CEVIMELINE HYDROCHLORIDE","DAIICHI SANKYO","Manufacturing Change or Addition","11/01/2013"
"EXJADE (NDA #021882)","018","DEFERASIROX","NOVARTIS","Manufacturing Change or Addition","11/01/2013"
"EMBEDA (NDA #022321)","013","MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE","ALPHARMA PHARMS","Manufacturing Change or Addition","11/01/2013"
"LATISSE (NDA #022369)","009","BIMATOPROST","ALLERGAN","Manufacturing Change or Addition","11/01/2013"
"BELVIQ (NDA #022529)","002","LORCASERIN HYDROCHLORIDE","EISAI INC","Manufacturing Change or Addition","11/01/2013"
"GAZYVA (BLA #125486)","000","OBINUTUZUMAB","GENENTECH","Approval","11/01/2013"
"FURADANTIN (NDA #009175)","036","NITROFURANTOIN","SHIONOGI INC","Labeling Revision","11/04/2013"
"MINIPRESS (NDA #017442)","041","PRAZOSIN HYDROCHLORIDE","PFIZER","Labeling Revision","11/04/2013"
"ALTACE (NDA #019901)","062","RAMIPRIL","KING PHARMS","Labeling Revision","11/04/2013"
"REVLIMID (NDA #021880)","038","LENALIDOMIDE","CELGENE","Labeling Revision","11/04/2013"
"TEKTURNA (NDA #021985)","025","ALISKIREN HEMIFUMARATE","NOVARTIS","Labeling Revision","11/04/2013"
"TEKTURNA HCT (NDA #022107)","023","ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE","NOVARTIS","Labeling Revision","11/04/2013"
"TEKAMLO (NDA #022545)","014","ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE","NOVARTIS","Labeling Revision","11/04/2013"
"AMTURNIDE (NDA #200045)","014","ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE","NOVARTIS","Labeling Revision","11/04/2013"
"DOCETAXEL (NDA #203551)","001","DOCETAXEL","ACTAVIS INC","Labeling Revision","11/04/2013"
"PAREMYD (NDA #019261)","013","HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE","AKORN","Manufacturing Change or Addition","11/05/2013"
"ZESTRIL (NDA #019777)","063","LISINOPRIL","ASTRAZENECA","Labeling Revision","11/05/2013"
"ZESTORETIC (NDA #019888)","055","HYDROCHLOROTHIAZIDE; LISINOPRIL","ASTRAZENECA","Labeling Revision","11/05/2013"
"FINASTERIDE (ANDA #076905)","000","FINASTERIDE","TEVA","Approval","11/05/2013"
"FINASTERIDE (ANDA #078161)","000","FINASTERIDE","MYLAN PHARMS INC","Approval","11/05/2013"
"FINASTERIDE (ANDA #078371)","000","FINASTERIDE","ACTAVIS TOTOWA","Approval","11/05/2013"
"PARICALCITOL (ANDA #091583)","000","PARICALCITOL","TEVA PHARMS USA","Tentative Approval","11/05/2013"
"FINASTERIDE (ANDA #091643)","000","FINASTERIDE","ACCORD HLTHCARE INC","Approval","11/05/2013"
"FINASTERIDE (ANDA #203687)","000","FINASTERIDE","AUROBINDO PHARMA LTD","Approval","11/05/2013"
"BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE (ANDA #203895)","000","BUPIVACAINE HYDROCHLORIDE","AUROBINDO PHARMA LTD","Approval","11/05/2013"
"ARALEN (NDA #006002)","043","CHLOROQUINE PHOSPHATE","SANOFI AVENTIS US","Labeling Revision","11/06/2013"
"ARALEN HYDROCHLORIDE (NDA #006002)","043","CHLOROQUINE HYDROCHLORIDE","SANOFI AVENTIS US","Labeling Revision","11/06/2013"
"LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (NDA #016679)","106","CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","BAXTER HLTHCARE","Manufacturing Change or Addition","11/06/2013"
"CARDURA (NDA #019668)","026","DOXAZOSIN MESYLATE","PFIZER","Labeling Revision","11/06/2013"
"REPRONEX (NDA #021047)","013","MENOTROPINS (FSH;LH)","FERRING","Manufacturing Change or Addition","11/06/2013"
"RAPAMUNE (NDA #021110)","069","SIROLIMUS","PF PRISM CV","Manufacturing Change or Addition","11/06/2013"
"AFINITOR (NDA #022334)","022","EVEROLIMUS","NOVARTIS","Efficacy Supplement with Clinical Data to Support","11/06/2013"
"PREVPAC (NDA #050757)","017","AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE","TAKEDA PHARMS USA","Labeling Revision","11/06/2013"
"REMICADE (BLA #103772)","5359","INFLIXIMAB","CENTOCOR INC","Labeling Revision","11/06/2013"
"DOCETAXEL (NDA #201195)","005","DOCETAXEL","ACCORD HLTHCARE","Manufacturing Change or Addition","11/06/2013"
"FULYZAQ (NDA #202292)","001","CROFELEMER","SALIX PHARMS","Manufacturing Change or Addition","11/06/2013"
"SILDENAFIL CITRATE (ANDA #202659)","000","SILDENAFIL CITRATE","HETERO LABS LTD V","Tentative Approval","11/06/2013"
"NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (ANDA #202771)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","FAMY CARE LTD","Approval","11/06/2013"
"METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (ANDA #202870)","000","HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE","ALEMBIC PHARMS LTD","Approval","11/06/2013"
"AFINITOR DISPERZ (NDA #203985)","003","EVEROLIMUS","NOVARTIS PHARM","Efficacy Supplement with Clinical Data to Support","11/06/2013"
"HUMULIN N (NDA #018781)","118","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","11/07/2013"
"HUMULIN N (NDA #018781)","122","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","11/07/2013"
"HUMULIN 70/30 (NDA #019717)","098","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","11/07/2013"
"HUMULIN 70/30 (NDA #019717)","101","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","11/07/2013"
"HUMULIN 70/30 PEN (NDA #019717)","098","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","11/07/2013"
"HUMULIN 70/30 PEN (NDA #019717)","101","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","11/07/2013"
"MAGNESIUM SULFATE IN PLASTIC CONTAINER (NDA #020309)","020","MAGNESIUM SULFATE","HOSPIRA","Manufacturing Change or Addition","11/07/2013"
"ZANAFLEX (NDA #020397)","026","TIZANIDINE HYDROCHLORIDE","ACORDA","Labeling Revision","11/07/2013"
"NORVIR (NDA #020659)","058","RITONAVIR","ABBVIE","Labeling Revision","11/07/2013"
"ACTIQ (NDA #020747)","037","FENTANYL CITRATE","CEPHALON","Labeling Revision","11/07/2013"
"NORVIR (NDA #020945)","036","RITONAVIR","ABBVIE","Labeling Revision","11/07/2013"
"RELPAX (NDA #021016)","025","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Manufacturing Change or Addition","11/07/2013"
"KALETRA (NDA #021226)","038","LOPINAVIR; RITONAVIR","ABBVIE","Labeling Revision","11/07/2013"
"KALETRA (NDA #021251)","046","LOPINAVIR; RITONAVIR","ABBVIE","Labeling Revision","11/07/2013"
"ZANAFLEX (NDA #021447)","011","TIZANIDINE HYDROCHLORIDE","ACORDA","Labeling Revision","11/07/2013"
"CADUET (NDA #021540)","030","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","PFIZER","Labeling Revision","11/07/2013"
"CADUET (NDA #021540)","031","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","PFIZER","Labeling Revision","11/07/2013"
"PLIAGLIS (NDA #021717)","005","LIDOCAINE; TETRACAINE","GALDERMA LABS LP","Labeling Revision","11/07/2013"
"FOSAMAX PLUS D (NDA #021762)","018","ALENDRONATE SODIUM; CHOLECALCIFEROL","MERCK","Labeling Revision","11/07/2013"
"KALETRA (NDA #021906)","039","LOPINAVIR; RITONAVIR","ABBVIE","Labeling Revision","11/07/2013"
"FENTORA (NDA #021947)","017","FENTANYL CITRATE","CEPHALON","Efficacy Supplement with Clinical Data to Support","11/07/2013"
"PREZISTA (NDA #021976)","033","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Labeling Revision","11/07/2013"
"XYZAL (NDA #022064)","028","LEVOCETIRIZINE DIHYDROCHLORIDE","UCB INC","Labeling Revision","11/07/2013"
"XYZAL (NDA #022157)","012","LEVOCETIRIZINE DIHYDROCHLORIDE","UCB INC","Labeling Revision","11/07/2013"
"TACLONEX (NDA #022185)","015","BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE","LEO PHARMA AS","Manufacturing Change or Addition","11/07/2013"
"TACLONEX (NDA #022185)","016","BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE","LEO PHARMA AS","Labeling Revision","11/07/2013"
"ONSOLIS (NDA #022266)","012","FENTANYL CITRATE","MEDA PHARMS","Labeling Revision","11/07/2013"
"NORVIR (NDA #022417)","010","RITONAVIR","ABBVIE","Labeling Revision","11/07/2013"
"ABSTRAL (NDA #022510)","007","FENTANYL CITRATE","GALENA BIOPHARMA","Efficacy Supplement with Clinical Data to Support","11/07/2013"
"LAZANDA (NDA #022569)","012","FENTANYL CITRATE","DEPOMED INC","Manufacturing Change or Addition","11/07/2013"
"LAZANDA (NDA #022569)","015","FENTANYL CITRATE","DEPOMED INC","Efficacy Supplement with Clinical Data to Support","11/07/2013"
"LAZANDA (NDA #022569)","017","FENTANYL CITRATE","DEPOMED INC","Package Change","11/07/2013"
"JAKAFI (NDA #202192)","004","RUXOLITINIB PHOSPHATE","INCYTE CORP","Manufacturing Change or Addition","11/07/2013"
"SUBSYS (NDA #202788)","010","FENTANYL","INSYS THERAP","Efficacy Supplement with Clinical Data to Support","11/07/2013"
"PREZISTA (NDA #202895)","010","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Labeling Revision","11/07/2013"
"SOLU-CORTEF (NDA #009866)","096","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","11/08/2013"
"THAM (NDA #013025)","055","TROMETHAMINE","HOSPIRA","Manufacturing Change or Addition","11/08/2013"
"THAM-E (NDA #013025)","055","POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE","HOSPIRA","Manufacturing Change or Addition","11/08/2013"
"TEGRETOL (NDA #016608)","108","CARBAMAZEPINE","NOVARTIS","Manufacturing Change or Addition","11/08/2013"
"FREAMINE 8.5% (NDA #016822)","081","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"FREAMINE HBC 6.9% (NDA #016822)","081","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"FREAMINE II 8.5% (NDA #016822)","081","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"FREAMINE III 10% (NDA #016822)","081","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"FREAMINE III 3% W/ ELECTROLYTES (NDA #016822)","081","AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"FREAMINE III 8.5% (NDA #016822)","081","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"FREAMINE III 8.5% W/ ELECTROLYTES (NDA #016822)","081","AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"DEMSER (NDA #017871)","018","METYROSINE","ATON PHARMA VPNA","Manufacturing Change or Addition","11/08/2013"
"TEGRETOL (NDA #018281)","056","CARBAMAZEPINE","NOVARTIS","Manufacturing Change or Addition","11/08/2013"
"TEGRETOL (NDA #018927)","049","CARBAMAZEPINE","NOVARTIS","Manufacturing Change or Addition","11/08/2013"
"TROPHAMINE (NDA #019018)","031","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"TROPHAMINE 10% (NDA #019018)","031","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","11/08/2013"
"INDIUM IN-111 OXYQUINOLINE (NDA #019044)","022","INDIUM IN-111 OXYQUINOLINE","GE HEALTHCARE","Manufacturing Change or Addition","11/08/2013"
"EPI E Z PEN JR (NDA #019430)","056","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","11/08/2013"
"EPIPEN (NDA #019430)","056","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","11/08/2013"
"EPIPEN E Z PEN (NDA #019430)","056","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","11/08/2013"
"EPIPEN JR. (NDA #019430)","056","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","11/08/2013"
"LUPRON DEPOT (NDA #020517)","034","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Manufacturing Change or Addition","11/08/2013"
"MINIRIN (NDA #021333)","007","DESMOPRESSIN ACETATE","FERRING","Labeling Revision","11/08/2013"
"EMTRIVA (NDA #021500)","024","EMTRICITABINE","GILEAD","Manufacturing Change or Addition","11/08/2013"
"TRUVADA (NDA #021752)","040","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","11/08/2013"
"ACZONE (NDA #021794)","012","DAPSONE","ALLERGAN","Labeling Revision","11/08/2013"
"EMTRIVA (NDA #021896)","020","EMTRICITABINE","GILEAD","Manufacturing Change or Addition","11/08/2013"
"ATRIPLA (NDA #021937)","030","EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","11/08/2013"
"CLEVIPREX (NDA #022156)","004","CLEVIDIPINE","MEDICINES CO","Manufacturing Change or Addition","11/08/2013"
"RAPAFLO (NDA #022206)","013","SILODOSIN","WATSON LABS","Manufacturing Change or Addition","11/08/2013"
"NEXTERONE (NDA #022325)","005","AMIODARONE HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","11/08/2013"
"APTIOM (NDA #022416)","000","ESLICARBAZEPINE ACETATE","SUNOVION PHARMS INC","Approval","11/08/2013"
"RABEPRAZOLE SODIUM (ANDA #076822)","000","RABEPRAZOLE SODIUM","TEVA PHARMS USA","Approval","11/08/2013"
"RABEPRAZOLE SODIUM (ANDA #076824)","000","RABEPRAZOLE SODIUM","DR REDDYS LABS LTD","Approval","11/08/2013"
"RABEPRAZOLE SODIUM (ANDA #076885)","000","RABEPRAZOLE SODIUM","MYLAN PHARMS INC","Approval","11/08/2013"
"RABEPRAZOLE SODIUM (ANDA #078964)","000","RABEPRAZOLE SODIUM","LUPIN LTD","Approval","11/08/2013"
"RABEPRAZOLE SODIUM (ANDA #090678)","000","RABEPRAZOLE SODIUM","KREMERS URBAN DEV","Approval","11/08/2013"
"TERBUTALINE SULFATE (ANDA #200122)","000","TERBUTALINE SULFATE","UNITED BIOMEDCL","Approval","11/08/2013"
"ZIDOVUDINE (NDA #200732)","001","ZIDOVUDINE","MATRIX LABS LTD","Manufacturing Change or Addition","11/08/2013"
"FELODIPINE (ANDA #201964)","000","FELODIPINE","HERITAGE PHARMS INC","Approval","11/08/2013"
"AMYVID (NDA #202008)","019","FLORBETAPIR F-18","AVID RADIOPHARMS INC","Manufacturing Change or Addition","11/08/2013"
"COMPLERA (NDA #202123)","014","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Manufacturing Change or Addition","11/08/2013"
"JUVISYNC (NDA #202343)","009","SIMVASTATIN; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Manufacturing Change or Addition","11/08/2013"
"RABEPRAZOLE SODIUM (ANDA #202376)","000","RABEPRAZOLE SODIUM","TORRENT PHARMS LTD","Approval","11/08/2013"
"LINZESS (NDA #202811)","002","LINACLOTIDE","FOREST LABS INC","Manufacturing Change or Addition","11/08/2013"
"STRIBILD (NDA #203100)","008","COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Manufacturing Change or Addition","11/08/2013"
"XELJANZ (NDA #203214)","006","TOFACITINIB CITRATE","PF PRISM CV","Supplement","11/08/2013"
"VALSTAR PRESERVATIVE FREE (NDA #020892)","017","VALRUBICIN","ENDO PHARM","Manufacturing Change or Addition","11/12/2013"
"ACTOS (NDA #021073)","046","PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling Revision","11/12/2013"
"RANEXA (NDA #021526)","025","RANOLAZINE","GILEAD","Labeling Revision","11/12/2013"
"DUETACT (NDA #021925)","006","GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling Revision","11/12/2013"
"DUETACT (NDA #021925)","014","GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling Revision","11/12/2013"
"ACTOPLUS MET XR (NDA #022024)","001","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","Labeling Revision","11/12/2013"
"MOZOBIL (NDA #022311)","014","PLERIXAFOR","GENZYME","Manufacturing Change or Addition","11/12/2013"
"OCTREOTIDE ACETATE (PRESERVATIVE FREE) (ANDA #090834)","000","OCTREOTIDE ACETATE","SAGENT PHARMS","Approval","11/12/2013"
"OCTREOTIDE ACETATE (ANDA #091041)","000","OCTREOTIDE ACETATE","SAGENT PHARMS","Approval","11/12/2013"
"METHYLPHENIDATE HYDROCHLORIDE (ANDA #201466)","000","METHYLPHENIDATE HYDROCHLORIDE","CARACO","Approval","11/12/2013"
"DDAVP (NDA #018938)","030","DESMOPRESSIN ACETATE","SANOFI AVENTIS US","Manufacturing Change or Addition","11/13/2013"
"SAIZEN (NDA #019764)","059","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","11/13/2013"
"GLUCOPHAGE (NDA #020357)","036","METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","11/13/2013"
"VISTIDE (NDA #020638)","011","CIDOFOVIR","GILEAD SCIENCES INC","Manufacturing Change or Addition","11/13/2013"
"LAMISIL AT (NDA #021124)","013","TERBINAFINE HYDROCHLORIDE","NOVARTIS","Labeling Revision","11/13/2013"
"SIMPONI (BLA #125289)","094","GOLIMUMAB","CENTOCOR ORTHO BIOTECH INC","Labeling Revision","11/13/2013"
"LAMOTRIGINE (ANDA #203733)","000","LAMOTRIGINE","ACTAVIS ELIZABETH","Approval","11/13/2013"
"IMBRUVICA (NDA #205552)","000","IBRUTINIB","PHARMACYCLICS INC","Approval","11/13/2013"
"ATROPEN (NDA #017106)","045","ATROPINE","MERIDIAN MEDCL TECHN","Manufacturing Change or Addition","11/14/2013"
"DILAUDID (NDA #019891)","016","HYDROMORPHONE HYDROCHLORIDE","PURDUE PHARM PRODS","Manufacturing Change or Addition","11/14/2013"
"LEVULAN (NDA #020965)","013","AMINOLEVULINIC ACID HYDROCHLORIDE","DUSA","Manufacturing Change or Addition","11/14/2013"
"NAMENDA (NDA #021487)","018","MEMANTINE HYDROCHLORIDE","FOREST LABS","Manufacturing Change or Addition","11/14/2013"
"ZORTRESS (NDA #021560)","013","EVEROLIMUS","NOVARTIS","Manufacturing Change or Addition","11/14/2013"
"BESIVANCE (NDA #022308)","007","BESIFLOXACIN HYDROCHLORIDE","BAUSCH AND LOMB","Manufacturing Change or Addition","11/14/2013"
"NAMENDA XR (NDA #022525)","003","MEMANTINE HYDROCHLORIDE","FOREST LABS","Manufacturing Change or Addition","11/14/2013"
"NITHIODOTE (NDA #201444)","011","SODIUM NITRITE; SODIUM THIOSULFATE","HOPE PHARMS","Manufacturing Change or Addition","11/14/2013"
"NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (ANDA #202772)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","FAMY CARE LTD","Approval","11/14/2013"
"LUZU (NDA #204153)","000","LULICONAZOLE","MEDICIS","Approval","11/14/2013"
"KENALOG (NDA #012104)","035","TRIAMCINOLONE ACETONIDE","RANBAXY","Manufacturing Change or Addition","11/15/2013"
"LYSODREN (NDA #016885)","025","MITOTANE","BRISTOL MYERS SQUIBB","Labeling Revision","11/15/2013"
"ACCOLATE (NDA #020547)","033","ZAFIRLUKAST","ASTRAZENECA","Labeling Revision","11/15/2013"
"THALOMID (NDA #020785)","050","THALIDOMIDE","CELGENE","Supplement","11/15/2013"
"OPTISON (NDA #020899)","016","ALBUMIN HUMAN","GE HEALTHCARE","Manufacturing Change or Addition","11/15/2013"
"REBETOL (NDA #020903)","052","RIBAVIRIN","MERCK SHARP DOHME","Labeling Revision","11/15/2013"
"ARIXTRA (NDA #021345)","031","FONDAPARINUX SODIUM","AGI","Manufacturing Change or Addition","11/15/2013"
"REBETOL (NDA #021546)","008","RIBAVIRIN","SCHERING","Labeling Revision","11/15/2013"
"LOVAZA (NDA #021654)","038","OMEGA-3-ACID ETHYL ESTERS","SMITHKLINE BEECHAM","Manufacturing Change or Addition","11/15/2013"
"ELOXATIN (NDA #021759)","017","OXALIPLATIN","SANOFI AVENTIS US","Manufacturing Change or Addition","11/15/2013"
"REVLIMID (NDA #021880)","035","LENALIDOMIDE","CELGENE","Supplement","11/15/2013"
"ZEGERID OTC (NDA #022281)","007","OMEPRAZOLE; SODIUM BICARBONATE","MSD CONSUMER","Manufacturing Change or Addition","11/15/2013"
"SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM (ANDA #090872)","000","SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM","MYLAN PHARMS INC","Tentative Approval","11/15/2013"
"INTRON A (BLA #103132)","5178","INTERFERON ALFA-2B","SCHERING","Labeling Revision","11/15/2013"
"ENBREL (BLA #103795)","5531","ETANERCEPT","IMMUNEX","Labeling Revision","11/15/2013"
"PEGINTRON (BLA #103949)","5273","PEGINTERFERON ALFA-2B","SCHERING","Labeling Revision","11/15/2013"
"SYLATRON (BLA #103949)","5273","PEGINTERFERON ALFA-2B","SCHERING","Labeling Revision","11/15/2013"
"ACYCLOVIR (ANDA #202168)","000","ACYCLOVIR","CADILA PHARMS LTD","Approval","11/15/2013"
"POMALYST (NDA #204026)","002","POMALIDOMIDE","CELGENE","Efficacy Supplement with Clinical Data to Support","11/15/2013"
"ULTRA-TECHNEKOW FM (NDA #017243)","041","TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR","MALLINCKRODT","Manufacturing Change or Addition","11/18/2013"
"SAIZEN (NDA #019764)","071","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","11/18/2013"
"COARTEM (NDA #022268)","007","ARTEMETHER; LUMEFANTRINE","NOVARTIS","Manufacturing Change or Addition","11/18/2013"
"EFFIENT (NDA #022307)","010","PRASUGREL HYDROCHLORIDE","ELI LILLY AND CO","Labeling Revision","11/18/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #078992)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","INTELLIPHARMACEUTICS","Approval","11/18/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #078992)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","INTELLIPHARMACEUTICS","Tentative Approval","11/18/2013"
"FLUVOXAMINE MALEATE (ANDA #091482)","000","FLUVOXAMINE MALEATE","ACTAVIS ELIZABETH","Approval","11/18/2013"
"ACAMPROSATE CALCIUM (ANDA #200143)","000","ACAMPROSATE CALCIUM","BARR LABS DIV TEVA","Approval","11/18/2013"
"DIFICID (NDA #201699)","007","FIDAXOMICIN","OPTIMER PHARMS","Manufacturing Change or Addition","11/18/2013"
"MOXIFLOXACIN (ANDA #202916)","000","MOXIFLOXACIN","AKORN INC","Tentative Approval","11/18/2013"
"XELJANZ (NDA #203214)","002","TOFACITINIB CITRATE","PF PRISM CV","Efficacy Supplement with Clinical Data to Support","11/18/2013"
"LIORESAL (NDA #020075)","028","BACLOFEN","MEDTRONIC NEURO","Labeling Revision","11/19/2013"
"FOLLISTIM AQ (NDA #021273)","009","FOLLITROPIN ALFA/BETA","ORGANON USA INC","Manufacturing Change or Addition","11/19/2013"
"INNOPRAN XL (NDA #021438)","016","PROPRANOLOL HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Labeling Revision","11/19/2013"
"LOCOID (NDA #022076)","004","HYDROCORTISONE BUTYRATE","PRECISION DERMAT","Manufacturing Change or Addition","11/19/2013"
"SANCUSO (NDA #022198)","010","GRANISETRON","PROSTRAKAN INC","Manufacturing Change or Addition","11/19/2013"
"TRAZODONE HYDROCHLORIDE (ANDA #071196)","063","TRAZODONE HYDROCHLORIDE","APOTEX INC","Labeling Revision","11/19/2013"
"TRAZODONE HYDROCHLORIDE (ANDA #071258)","040","TRAZODONE HYDROCHLORIDE","APOTEX","Labeling Revision","11/19/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #078908)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","TEVA PHARMS USA","Approval","11/19/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #078908)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","TEVA PHARMS USA","Tentative Approval","11/19/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #202731)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","TEVA PHARMS USA","Approval","11/19/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #202731)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","TEVA PHARMS USA","Tentative Approval","11/19/2013"
"MINASTRIN 24 FE (NDA #203667)","001","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","11/19/2013"
"OMNIPAQUE 140 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"OMNIPAQUE 180 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"OMNIPAQUE 210 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"OMNIPAQUE 240 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"OMNIPAQUE 300 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"OMNIPAQUE 350 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"OMNIPAQUE 70 (NDA #018956)","092","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"VISIPAQUE 270 (NDA #020351)","041","IODIXANOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"VISIPAQUE 320 (NDA #020351)","041","IODIXANOL","GE HEALTHCARE","Manufacturing Change or Addition","11/20/2013"
"ADCIRCA (NDA #022332)","005","TADALAFIL","ELI LILLY CO","Labeling Revision","11/20/2013"
"HERCEPTIN (BLA #103792)","5187","TRASTUZUMAB","GENENTECH","Approval","11/20/2013"
"HERCEPTIN (BLA #103792)","5189","TRASTUZUMAB","GENENTECH","Approval","11/20/2013"
"HERCEPTIN (BLA #103792)","5305","TRASTUZUMAB","GENENTECH","Labeling Revision","11/20/2013"
"XALKORI (NDA #202570)","006","CRIZOTINIB","PF PRISM CV","Efficacy Supplement with Clinical Data to Support","11/20/2013"
"LUPANETA PACK (NDA #203696)","002","LEUPROLIDE ACETATE; NORETHINDRONE ACETATE","ABBVIE ENDOCRINE","Manufacturing Change or Addition","11/20/2013"
"PROGLYCEM (NDA #017453)","016","DIAZOXIDE","TEVA BRANDED PHARM","Manufacturing Change or Addition","11/21/2013"
"DOVONEX (NDA #020554)","011","CALCIPOTRIENE","LEO PHARMA AS","Manufacturing Change or Addition","11/21/2013"
"CYANOKIT (NDA #022041)","013","HYDROXOCOBALAMIN","MERCK SANTE SAS","Manufacturing Change or Addition","11/21/2013"
"VPRIV (NDA #022575)","012","VELAGLUCERASE ALFA","SHIRE HUMAN GENETIC","Efficacy Supplement with Clinical Data to Support","11/21/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #079108)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","WATSON LABS INC","Approval","11/21/2013"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #079108)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","WATSON LABS INC","Tentative Approval","11/21/2013"
"GILOTRIF (NDA #201292)","002","AFATINIB DIMALEATE","BOEHRINGER INGELHEIM","Labeling Revision","11/21/2013"
"ONFI (NDA #202067)","002","CLOBAZAM","LUNDBECK LLC","Labeling Revision","11/21/2013"
"ONFI (NDA #203993)","002","CLOBAZAM","LUNDBECK LLC","Labeling Revision","11/21/2013"
"ZAROXOLYN (NDA #017386)","039","METOLAZONE","UCB INC","Manufacturing Change or Addition","11/22/2013"
"MPI DMSA KIDNEY REAGENT (NDA #017944)","023","TECHNETIUM TC-99M SUCCIMER KIT","GE HEALTHCARE","Manufacturing Change or Addition","11/22/2013"
"DEMADEX (NDA #020136)","026","TORSEMIDE","MEDA PHARMS","Manufacturing Change or Addition","11/22/2013"
"LANOXIN (NDA #020405)","010","DIGOXIN","COVIS PHARMA","Manufacturing Change or Addition","11/22/2013"
"PANRETIN (NDA #020886)","006","ALITRETINOIN","EISAI INC","Manufacturing Change or Addition","11/22/2013"
"CUBICIN (NDA #021572)","043","DAPTOMYCIN","CUBIST","Labeling Revision","11/22/2013"
"CUBICIN (NDA #021572)","044","DAPTOMYCIN","CUBIST","Labeling Revision","11/22/2013"
"CHLORHEXIDINE GLUCONATE (NDA #021669)","018","CHLORHEXIDINE GLUCONATE","SAGE PRODS","Manufacturing Change or Addition","11/22/2013"
"VENTAVIS (NDA #021779)","014","ILOPROST","ACTELION PHARMS LTD","Labeling Revision","11/22/2013"
"NEXAVAR (NDA #021923)","016","SORAFENIB TOSYLATE","BAYER HLTHCARE","Efficacy Supplement with Clinical Data to Support","11/22/2013"
"KUVAN (NDA #022181)","012","SAPROPTERIN DIHYDROCHLORIDE","BIOMARIN PHARM","Manufacturing Change or Addition","11/22/2013"
"SUBOXONE (NDA #022410)","015","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Labeling Revision","11/22/2013"
"REPAGLINIDE (ANDA #078555)","000","REPAGLINIDE","SANDOZ","Approval","11/22/2013"
"REPAGLINIDE (ANDA #078555)","000","REPAGLINIDE","SANDOZ","Tentative Approval","11/22/2013"
"LEVOFLOXACIN (ANDA #201484)","000","LEVOFLOXACIN","WATSON LABS INC","Approval","11/22/2013"
"SUPRAX (NDA #203195)","003","CEFIXIME","LUPIN LTD","Manufacturing Change or Addition","11/22/2013"
"SYNRIBO (NDA #203585)","002","OMACETAXINE MEPESUCCINATE","IVAX INTL","Manufacturing Change or Addition","11/22/2013"
"OLYSIO (NDA #205123)","000","SIMEPREVIR SODIUM","JANSSEN PRODS","Approval","11/22/2013"
"TECHNESCAN PYP KIT (NDA #017538)","018","TECHNETIUM TC-99M PYROPHOSPHATE KIT","MALLINCKRODT","Manufacturing Change or Addition","11/25/2013"
"K-TAB (NDA #018279)","033","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","11/25/2013"
"POTASSIUM CHLORIDE (NDA #018279)","033","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","11/25/2013"
"IMITREX (NDA #020132)","028","SUMATRIPTAN SUCCINATE","GLAXOSMITHKLINE","Labeling Revision","11/25/2013"
"IMITREX (NDA #020626)","025","SUMATRIPTAN","GLAXOSMITHKLINE","Labeling Revision","11/25/2013"
"XOPENEX HFA (NDA #021730)","034","LEVALBUTEROL TARTRATE","SUNOVION","Manufacturing Change or Addition","11/25/2013"
"OXALIPLATIN (NDA #022160)","008","OXALIPLATIN","TEVA PHARMS","Labeling Revision","11/25/2013"
"OXALIPLATIN (NDA #022160)","009","OXALIPLATIN","TEVA PHARMS","Labeling Revision","11/25/2013"
"SAVELLA (NDA #022256)","017","MILNACIPRAN HYDROCHLORIDE","CYPRESS BIOSCIENCE","Manufacturing Change or Addition","11/25/2013"
"COLCRYS (NDA #022352)","021","COLCHICINE","TAKEDA PHARMS USA","Manufacturing Change or Addition","11/25/2013"
"DORYX (NDA #050795)","015","DOXYCYCLINE HYCLATE","MAYNE PHARMA","Manufacturing Change or Addition","11/25/2013"
"TOPIRAMATE (ANDA #091185)","000","TOPIRAMATE","HIKMA PHARMS","Approval","11/25/2013"
"REOPRO (BLA #103575)","5126","ABCIXIMAB","CENTOCOR INC","Labeling Revision","11/25/2013"
"VASCEPA (NDA #202057)","009","ICOSAPENT ETHYL","AMARIN PHARMS","Labeling Revision","11/25/2013"
"JAKAFI (NDA #202192)","005","RUXOLITINIB PHOSPHATE","INCYTE CORP","Labeling Revision","11/25/2013"
"AMIODARONE HYDROCHLORIDE (ANDA #203884)","000","AMIODARONE HYDROCHLORIDE","HOSPIRA INC","Approval","11/25/2013"
"AMIODARONE HYDROCHLORIDE (ANDA #203885)","000","AMIODARONE HYDROCHLORIDE","HOSPIRA INC","Approval","11/25/2013"
"NOXAFIL (NDA #205053)","000","POSACONAZOLE","MERCK SHARP DOHME","Approval","11/25/2013"
"VARITHENA (NDA #205098)","000","POLIDOCANOL","PROVENSIS","Approval","11/25/2013"
"EXELDERM (NDA #018737)","007","SULCONAZOLE NITRATE","RANBAXY","Manufacturing Change or Addition","11/26/2013"
"FORTESTA (NDA #021463)","011","TESTOSTERONE","ENDO PHARMS","Manufacturing Change or Addition","11/26/2013"
"SUMAVEL DOSEPRO (NDA #022239)","005","SUMATRIPTAN SUCCINATE","ZOGENIX INC","Efficacy Supplement with Clinical Data to Support","11/26/2013"
"LEVOTHYROXINE SODIUM (NDA #202231)","005","LEVOTHYROXINE SODIUM","FRESENIUS KABI USA","Manufacturing Change or Addition","11/26/2013"
"QUETIAPINE FUMARATE (ANDA #203150)","000","QUETIAPINE FUMARATE","JUBILANT LIFE","Approval","11/26/2013"
"INVOKANA (NDA #204042)","001","CANAGLIFLOZIN","JANSSEN PHARMS","Manufacturing Change or Addition","11/26/2013"
"RIZATRIPTAN BENZOATE (ANDA #204090)","000","RIZATRIPTAN BENZOATE","EMCURE PHARMS LTD","Approval","11/26/2013"
"ZIDOVUDINE (ANDA #204538)","000","ZIDOVUDINE","LIAONING CHENGDA","Approval","11/26/2013"
"RELPAX (NDA #021016)","016","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Manufacturing Change or Addition","11/27/2013"
"TRUVADA (NDA #021752)","033","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","11/27/2013"
"SOMATULINE DEPOT (NDA #022074)","006","LANREOTIDE ACETATE","IPSEN PHARMA","Labeling Revision","11/27/2013"
"CAPRELSA (NDA #022405)","005","VANDETANIB","IPR PHARMS INC","Labeling Revision","11/27/2013"
"VOTRIENT (NDA #022465)","017","PAZOPANIB HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","11/27/2013"
"AUGMENTIN XR (NDA #050785)","014","AMOXICILLIN; CLAVULANATE POTASSIUM","DR REDDYS LABS INC","Labeling Revision","11/27/2013"
"KETOROLAC TROMETHAMINE (ANDA #091065)","000","KETOROLAC TROMETHAMINE","SAGENT PHARMS","Approval","11/27/2013"
"GEMCITABINE HYDROCHLORIDE (NDA #200795)","003","GEMCITABINE HYDROCHLORIDE","HOSPIRA INC","Manufacturing Change or Addition","11/27/2013"
"TRAZODONE HYDROCHLORIDE (ANDA #202180)","000","TRAZODONE HYDROCHLORIDE","TORRENT PHARMS LTD","Approval","11/27/2013"
"DUTASTERIDE (ANDA #202421)","000","DUTASTERIDE","ENDO PHARMS","Tentative Approval","11/27/2013"
"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ANDA #202424)","000","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","AUROLIFE PHARMA LLC","Approval","11/27/2013"
"VELPHORO (NDA #205109)","000","SUCROFERRIC OXYHYDROXIDE","VIFOR FRESENIUS","Approval","11/27/2013"
"KLOR-CON (NDA #019123)","034","POTASSIUM CHLORIDE","UPSHER-SMITH LABS","Manufacturing Change or Addition","11/29/2013"
"SUMATRIPTAN; NAPROXEN SODIUM (ANDA #090753)","000","SUMATRIPTAN; NAPROXEN SODIUM","PAR PHARM","Tentative Approval","11/29/2013"
"AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM (ANDA #200465)","000","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","MYLAN PHARMS INC","Approval","11/29/2013"
"DUTASTERIDE (ANDA #202204)","000","DUTASTERIDE","ROXANE","Tentative Approval","11/29/2013"
"AMOXICILLIN AND CLAVULANATE POTASSIUM (ANDA #065420)","000","AMOXICILLIN; CLAVULANATE POTASSIUM","WOCKHARDT EU OPERATN","Approval","12/02/2013"
"LINEZOLID (ANDA #200068)","000","LINEZOLID","ROXANE","Tentative Approval","12/02/2013"
"CABERGOLINE (ANDA #202947)","000","CABERGOLINE","MYLAN PHARMS INC","Approval","12/02/2013"
"DESOXYN (NDA #005378)","028","METHAMPHETAMINE HYDROCHLORIDE","RECORDATI RARE","Labeling Revision","12/03/2013"
"NORINYL 1+50 28-DAY (NDA #016659)","136","MESTRANOL; NORETHINDRONE","WATSON LABS","Manufacturing Change or Addition","12/03/2013"
"RELPAX (NDA #021016)","026","ELETRIPTAN HYDROBROMIDE","PFIZER IRELAND","Manufacturing Change or Addition","12/03/2013"
"INFUVITE ADULT (NDA #021163)","028","ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K","SANDOZ","Manufacturing Change or Addition","12/03/2013"
"ADDERALL XR 10 (NDA #021303)","026","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","12/03/2013"
"ADDERALL XR 15 (NDA #021303)","026","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","12/03/2013"
"ADDERALL XR 20 (NDA #021303)","026","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","12/03/2013"
"ADDERALL XR 25 (NDA #021303)","026","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","12/03/2013"
"ADDERALL XR 30 (NDA #021303)","026","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","12/03/2013"
"ADDERALL XR 5 (NDA #021303)","026","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","12/03/2013"
"NEOPROFEN (NDA #021903)","008","IBUPROFEN LYSINE","RECORDATI RARE","Labeling Revision","12/03/2013"
"BRINTELLIX (NDA #204447)","001","VORTIOXETINE HYDROBROMIDE","TAKEDA PHARMS USA","Manufacturing Change or Addition","12/03/2013"
"AN-SULFUR COLLOID (NDA #017858)","038","TECHNETIUM TC-99M SULFUR COLLOID KIT","PHARMALUCENCE","Manufacturing Change or Addition","12/04/2013"
"STRATTERA (NDA #021411)","045","ATOMOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","12/04/2013"
"XANAX XR (NDA #021434)","013","ALPRAZOLAM","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","12/04/2013"
"ERYTHROCIN STEARATE (ANDA #060359)","028","ERYTHROMYCIN STEARATE","ARBOR PHARMS INC","Supplement","12/04/2013"
"ERYTHROMYCIN (ANDA #061621)","039","ERYTHROMYCIN","ARBOR PHARMS INC","Labeling Revision","12/04/2013"
"ERYTHROMYCIN ETHYLSUCCINATE (ANDA #061904)","021","ERYTHROMYCIN ETHYLSUCCINATE","ARBOR PHARMS INC","Labeling Revision","12/04/2013"
"ERY-TAB (ANDA #062298)","068","ERYTHROMYCIN","ARBOR PHARMS LLC","Labeling Revision","12/04/2013"
"DORZOLAMIDE HYDROCHLORIDE (ANDA #091034)","000","DORZOLAMIDE HYDROCHLORIDE","ZACH SYSTEMS","Approval","12/04/2013"
"DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (ANDA #091180)","000","DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE","ZACH SYSTEMS","Approval","12/04/2013"
"LARIN 1/20 (ANDA #202995)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","NOVAST LABS LTD","Approval","12/04/2013"
"ENABLEX (NDA #021513)","009","DARIFENACIN HYDROBROMIDE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","12/05/2013"
"ZORTRESS (NDA #021560)","012","EVEROLIMUS","NOVARTIS","Manufacturing Change or Addition","12/05/2013"
"RESTASIS (NDA #050790)","023","CYCLOSPORINE","ALLERGAN","Manufacturing Change or Addition","12/05/2013"
"YERVOY (BLA #125377)","055","IPILIMUMAB","BRISTOL MYERS SQUIBB","Labeling Revision","12/05/2013"
"OPANA ER (NDA #201655)","010","OXYMORPHONE HYDROCHLORIDE","ENDO PHARMS","Labeling Revision","12/05/2013"
"ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE (ANDA #202912)","000","ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE","LUPIN LTD","Approval","12/05/2013"
"VERSACLOZ (NDA #203479)","001","CLOZAPINE","JAZZ PHARMS III","Labeling Revision","12/05/2013"
"OLYSIO (NDA #205123)","001","SIMEPREVIR SODIUM","JANSSEN PRODS","Labeling Revision","12/05/2013"
"DEXEDRINE (NDA #017078)","047","DEXTROAMPHETAMINE SULFATE","AMEDRA PHARMS","Labeling Revision","12/06/2013"
"OPTIRAY 160 (NDA #019710)","051","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/06/2013"
"OPTIRAY 240 (NDA #019710)","051","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/06/2013"
"OPTIRAY 300 (NDA #019710)","051","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/06/2013"
"OPTIRAY 320 (NDA #019710)","051","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/06/2013"
"OPTIRAY 350 (NDA #019710)","051","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/06/2013"
"COPAXONE (NDA #020622)","091","GLATIRAMER ACETATE","TEVA PHARMS USA","Manufacturing Change or Addition","12/06/2013"
"PEDIATRIC ADVIL (NDA #020812)","020","IBUPROFEN","PFIZER","Manufacturing Change or Addition","12/06/2013"
"TIKOSYN (NDA #020931)","007","DOFETILIDE","PFIZER","Labeling Revision","12/06/2013"
"VYVANSE (NDA #021977)","030","LISDEXAMFETAMINE DIMESYLATE","SHIRE DEVELOPMENT","Labeling Revision","12/06/2013"
"TYZEKA (NDA #022011)","016","TELBIVUDINE","NOVARTIS","Manufacturing Change or Addition","12/06/2013"
"TYZEKA (NDA #022154)","013","TELBIVUDINE","NOVARTIS","Manufacturing Change or Addition","12/06/2013"
"COLY-MYCIN S (NDA #050356)","055","COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE","PAR STERILE PRODUCTS","Manufacturing Change or Addition","12/06/2013"
"DORYX (NDA #050795)","016","DOXYCYCLINE HYCLATE","MAYNE PHARMA","Manufacturing Change or Addition","12/06/2013"
"DORYX (NDA #050795)","017","DOXYCYCLINE HYCLATE","MAYNE PHARMA","Manufacturing Change or Addition","12/06/2013"
"PERPHENAZINE (ANDA #089683)","024","PERPHENAZINE","SANDOZ","Labeling Revision","12/06/2013"
"PERPHENAZINE (ANDA #089684)","024","PERPHENAZINE","SANDOZ","Labeling Revision","12/06/2013"
"PERPHENAZINE (ANDA #089685)","024","PERPHENAZINE","SANDOZ","Labeling Revision","12/06/2013"
"XIAFLEX (BLA #125338)","0061","COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","AUXILIUM PHARMS","Efficacy Supplement with Clinical Data to Support","12/06/2013"
"SOVALDI (NDA #204671)","000","SOFOSBUVIR","GILEAD SCIENCES INC","Approval","12/06/2013"
"NASACORT ALLERGY 24 HOUR (NDA #020468)","020","TRIAMCINOLONE ACETONIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","12/07/2013"
"NASACORT ALLERGY 24 HOUR (NDA #020468)","037","TRIAMCINOLONE ACETONIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","12/07/2013"
"PEPCID COMPLETE (NDA #020958)","020","CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE","MCNEIL CONS","Manufacturing Change or Addition","12/07/2013"
"HUMULIN N (NDA #018781)","144","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","12/09/2013"
"HUMULIN 70/30 (NDA #019717)","123","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","12/09/2013"
"HUMULIN 70/30 PEN (NDA #019717)","123","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","12/09/2013"
"ADENOSCAN (NDA #020059)","015","ADENOSINE","ASTELLAS","Manufacturing Change or Addition","12/09/2013"
"AEROSPAN HFA (NDA #021247)","010","FLUNISOLIDE","MEDA PHARMS INC","Manufacturing Change or Addition","12/09/2013"
"CHILDREN'S ALLEGRA ALLERGY (NDA #021909)","009","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","12/09/2013"
"CHILDREN'S ALLEGRA HIVES (NDA #021909)","009","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","12/09/2013"
"ZENPEP (NDA #022210)","015","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","FOREST LABS INC","Manufacturing Change or Addition","12/09/2013"
"ADASUVE (NDA #022549)","002","LOXAPINE","TEVA PHARMS USA INC","Labeling Revision","12/09/2013"
"GUANFACINE HYDROCHLORIDE (ANDA #202568)","000","GUANFACINE HYDROCHLORIDE","SANDOZ INC","Tentative Approval","12/09/2013"
"INDOMETHACIN (ANDA #202572)","000","INDOMETHACIN","WATSON LABS INC","Approval","12/09/2013"
"ILEVRO (NDA #203491)","005","NEPAFENAC","ALCON RES LTD","Manufacturing Change or Addition","12/09/2013"
"AMMONIA N 13 (ANDA #203938)","000","AMMONIA N-13","KREITCHMAN PET CTR","Approval","12/09/2013"
"ZOFRAN (NDA #020007)","044","ONDANSETRON HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/10/2013"
"ZOFRAN PRESERVATIVE FREE (NDA #020007)","044","ONDANSETRON HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/10/2013"
"ZOFRAN (NDA #020103)","031","ONDANSETRON HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/10/2013"
"ZOFRAN (NDA #020605)","015","ONDANSETRON HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/10/2013"
"ZOFRAN ODT (NDA #020781)","015","ONDANSETRON","GLAXOSMITHKLINE","Labeling Revision","12/10/2013"
"XELODA (NDA #020896)","032","CAPECITABINE","HOFFMANN LA ROCHE","Efficacy Supplement with Clinical Data to Support","12/10/2013"
"PROTONIX (NDA #020987)","048","PANTOPRAZOLE SODIUM","WYETH PHARMS INC","Labeling Revision","12/10/2013"
"SOMAVERT (NDA #021106)","036","PEGVISOMANT","PHARMACIA AND UPJOHN","Efficacy Supplement with Clinical Data to Support","12/10/2013"
"PRISTIQ (NDA #021992)","031","DESVENLAFAXINE SUCCINATE","WYETH PHARMS INC","Labeling Revision","12/10/2013"
"PROTONIX (NDA #022020)","010","PANTOPRAZOLE SODIUM","WYETH PHARMS INC","Labeling Revision","12/10/2013"
"PRADAXA (NDA #022512)","021","DABIGATRAN ETEXILATE MESYLATE","BOEHRINGER INGELHEIM","Labeling Revision","12/10/2013"
"HEMABATE (NDA #017989)","019","CARBOPROST TROMETHAMINE","PHARMACIA AND UPJOHN","Labeling Revision","12/11/2013"
"GONAL-F (NDA #020378)","063","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","12/11/2013"
"SEROSTIM (NDA #020604)","075","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/11/2013"
"SEROSTIM LQ (NDA #020604)","075","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/11/2013"
"OVIDREL (NDA #021149)","036","CHORIOGONADOTROPIN ALFA","EMD SERONO","Manufacturing Change or Addition","12/11/2013"
"GONAL-F (NDA #021765)","032","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","12/11/2013"
"GONAL-F RFF (NDA #021765)","032","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","12/11/2013"
"NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NDA #022573)","001","ETHINYL ESTRADIOL; NORETHINDRONE","WARNER CHILCOTT","Manufacturing Change or Addition","12/11/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090694)","000","DULOXETINE HYDROCHLORIDE","LUPIN LTD","Approval","12/11/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090723)","000","DULOXETINE HYDROCHLORIDE","DR REDDYS LABS LTD","Approval","12/11/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090745)","000","DULOXETINE HYDROCHLORIDE","SUN PHARMA GLOBAL","Approval","12/11/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090774)","000","DULOXETINE HYDROCHLORIDE","TORRENT PHARMS LTD","Approval","12/11/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090778)","000","DULOXETINE HYDROCHLORIDE","AUROBINDO PHARMA LTD","Approval","12/11/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090783)","000","DULOXETINE HYDROCHLORIDE","TEVA PHARMS USA","Approval","12/11/2013"
"EFUDEX (NDA #016831)","055","FLUOROURACIL","VALEANT PHARM INTL","Manufacturing Change or Addition","12/12/2013"
"HUMULIN N (NDA #018781)","137","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","12/12/2013"
"HUMULIN 70/30 (NDA #019717)","116","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","12/12/2013"
"HUMULIN 70/30 PEN (NDA #019717)","116","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","12/12/2013"
"SAIZEN (NDA #019764)","070","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/12/2013"
"ZIAC (NDA #020186)","030","BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE","TEVA WOMENS","Manufacturing Change or Addition","12/12/2013"
"SEROSTIM (NDA #020604)","076","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/12/2013"
"SEROSTIM LQ (NDA #020604)","076","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/12/2013"
"PLAVIX (NDA #020839)","058","CLOPIDOGREL BISULFATE","SANOFI AVENTIS US","Labeling Revision","12/12/2013"
"PROTONIX IV (NDA #020988)","048","PANTOPRAZOLE SODIUM","WYETH PHARMS INC","Labeling Revision","12/12/2013"
"HUMALOG MIX 75/25 (NDA #021017)","095","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","12/12/2013"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","095","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","12/12/2013"
"HUMALOG MIX 75/25 PEN (NDA #021017)","095","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","12/12/2013"
"CONCERTA (NDA #021121)","032","METHYLPHENIDATE HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","12/12/2013"
"FOCALIN (NDA #021278)","017","DEXMETHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Labeling Revision","12/12/2013"
"METHYLIN (NDA #021419)","007","METHYLPHENIDATE HYDROCHLORIDE","MALLINCKRODT","Labeling Revision","12/12/2013"
"METHYLIN (NDA #021475)","007","METHYLPHENIDATE HYDROCHLORIDE","MALLINCKRODT","Labeling Revision","12/12/2013"
"DAYTRANA (NDA #021514)","017","METHYLPHENIDATE","NOVEN PHARMS INC","Labeling Revision","12/12/2013"
"FOCALIN XR (NDA #021802)","026","DEXMETHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Labeling Revision","12/12/2013"
"ULORIC (NDA #021856)","007","FEBUXOSTAT","TAKEDA PHARMS USA","Manufacturing Change or Addition","12/12/2013"
"VIBATIV (NDA #022110)","008","TELAVANCIN HYDROCHLORIDE","THERAVANCE BIOPHARMA","Manufacturing Change or Addition","12/12/2013"
"DOXIL (LIPOSOMAL) (NDA #050718)","031","DOXORUBICIN HYDROCHLORIDE","JANSSEN RES AND DEV","Manufacturing Change or Addition","12/12/2013"
"CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER (NDA #050780)","018","CEFUROXIME SODIUM","B BRAUN","Manufacturing Change or Addition","12/12/2013"
"AMYVID (NDA #202008)","020","FLORBETAPIR F-18","AVID RADIOPHARMS INC","Labeling Revision","12/12/2013"
"QUILLIVANT XR (NDA #202100)","003","METHYLPHENIDATE HYDROCHLORIDE","NEXTWAVE PHARMS","Labeling Revision","12/12/2013"
"AMIKACIN SULFATE (ANDA #204040)","000","AMIKACIN SULFATE","EMCURE PHARMS LTD","Approval","12/12/2013"
"RITALIN (NDA #010187)","077","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Labeling Revision","12/13/2013"
"TECHNETIUM TC 99M GENERATOR (NDA #017693)","025","TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR","GE HEALTHCARE","Manufacturing Change or Addition","12/13/2013"
"RITALIN-SR (NDA #018029)","047","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Labeling Revision","12/13/2013"
"EPI E Z PEN JR (NDA #019430)","057","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","12/13/2013"
"EPIPEN (NDA #019430)","057","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","12/13/2013"
"EPIPEN E Z PEN (NDA #019430)","057","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","12/13/2013"
"EPIPEN JR. (NDA #019430)","057","EPINEPHRINE","MYLAN SPECLT","Manufacturing Change or Addition","12/13/2013"
"ADENOCARD (NDA #019937)","028","ADENOSINE","ASTELLAS","Manufacturing Change or Addition","12/13/2013"
"TAXOTERE (NDA #020449)","071","DOCETAXEL","SANOFI AVENTIS US","Labeling Revision","12/13/2013"
"ANTIZOL (NDA #020696)","005","FOMEPIZOLE","PALADIN LABS","Manufacturing Change or Addition","12/13/2013"
"FORADIL (NDA #020831)","033","FORMOTEROL FUMARATE","NOVARTIS","Manufacturing Change or Addition","12/13/2013"
"AVAGE (NDA #021184)","007","TAZAROTENE","ALLERGAN","Labeling Revision","12/13/2013"
"TAZORAC (NDA #021184)","007","TAZAROTENE","ALLERGAN","Labeling Revision","12/13/2013"
"METADATE CD (NDA #021259)","027","METHYLPHENIDATE HYDROCHLORIDE","UCB INC","Labeling Revision","12/13/2013"
"RITALIN LA (NDA #021284)","023","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Labeling Revision","12/13/2013"
"PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 2/0 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 4/0 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BK 0/0 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER (NDA #021703)","012","CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","GAMBRO RENAL PRODS","Manufacturing Change or Addition","12/13/2013"
"MEN'S ROGAINE (NDA #021812)","010","MINOXIDIL","JOHNSON AND JOHNSON","Labeling Revision","12/13/2013"
"WOMEN'S ROGAINE (NDA #021812)","010","MINOXIDIL","JOHNSON AND JOHNSON","Labeling Revision","12/13/2013"
"BRILINTA (NDA #022433)","010","TICAGRELOR","ASTRAZENECA LP","Labeling Revision","12/13/2013"
"LEVALBUTEROL HYDROCHLORIDE (ANDA #078171)","000","LEVALBUTEROL HYDROCHLORIDE","CIPLA LTD","Approval","12/13/2013"
"FELODIPINE (ANDA #091200)","000","FELODIPINE","RANBAXY LABS LTD","Approval","12/13/2013"
"BENLYSTA (BLA #125370)","047","BELIMUMAB","HUMAN GENOME SCIENCES INC.","Labeling Revision","12/13/2013"
"DESMOPRESSIN ACETATE (ANDA #201831)","000","DESMOPRESSIN ACETATE","GLENMARK GENERICS","Tentative Approval","12/13/2013"
"COMPLERA (NDA #202123)","012","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Efficacy Supplement with Clinical Data to Support","12/13/2013"
"KALYDECO (NDA #203188)","003","IVACAFTOR","VERTEX PHARMS","Manufacturing Change or Addition","12/13/2013"
"TYSABRI (BLA #125104)","840","NATALIZUMAB","BIOGEN IDEC","Efficacy Supplement with Clinical Data to Support","12/15/2013"
"TYSABRI (BLA #125104)","847","NATALIZUMAB","BIOGEN IDEC","Labeling Revision","12/15/2013"
"TYSABRI (BLA #125104)","889","NATALIZUMAB","BIOGEN IDEC","Labeling Revision","12/15/2013"
"DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018826)","044","DOPAMINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","12/16/2013"
"PENTASA (NDA #020049)","026","MESALAMINE","SHIRE","Labeling Revision","12/16/2013"
"LOTEMAX (NDA #020583)","028","LOTEPREDNOL ETABONATE","BAUSCH AND LOMB","Manufacturing Change or Addition","12/16/2013"
"ALREX (NDA #020803)","026","LOTEPREDNOL ETABONATE","BAUSCH AND LOMB","Manufacturing Change or Addition","12/16/2013"
"TRUVADA (NDA #021752)","043","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Labeling Revision","12/16/2013"
"LIALDA (NDA #022000)","011","MESALAMINE","SHIRE","Labeling Revision","12/16/2013"
"GIAZO (NDA #022205)","001","BALSALAZIDE DISODIUM","SALIX PHARMS","Labeling Revision","12/16/2013"
"MERREM (NDA #050706)","032","MEROPENEM","ASTRAZENECA","Labeling Revision","12/16/2013"
"MERREM (NDA #050706)","034","MEROPENEM","ASTRAZENECA","Labeling Revision","12/16/2013"
"AVASTIN (BLA #125085)","285","BEVACIZUMAB","GENENTECH","Labeling Revision","12/16/2013"
"TEFLARO (NDA #200327)","011","CEFTAROLINE FOSAMIL","CEREXA","Labeling Revision","12/16/2013"
"ADAGEN (NDA #019818)","051","PEGADEMASE BOVINE","SIGMA TAU","Manufacturing Change or Addition","12/17/2013"
"SEROSTIM (NDA #020604)","071","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/17/2013"
"SEROSTIM LQ (NDA #020604)","071","SOMATROPIN RECOMBINANT","EMD SERONO","Manufacturing Change or Addition","12/17/2013"
"GEODON (NDA #020825)","049","ZIPRASIDONE HYDROCHLORIDE","PFIZER","Labeling Revision","12/17/2013"
"GEODON (NDA #020919)","035","ZIPRASIDONE MESYLATE","PFIZER","Labeling Revision","12/17/2013"
"CANASA (NDA #021252)","020","MESALAMINE","FOREST LABS INC","Labeling Revision","12/17/2013"
"MOVIPREP (NDA #021881)","016","ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE","SALIX PHARMS","Labeling Revision","12/17/2013"
"VIIBRYD (NDA #022567)","009","VILAZODONE HYDROCHLORIDE","FOREST LABS INC","Labeling Revision","12/17/2013"
"DULOXETINE HYDROCHLORIDE (ANDA #090776)","000","DULOXETINE HYDROCHLORIDE","ACTAVIS ELIZABETH","Approval","12/17/2013"
"Sildenafil Citrate (ANDA #202255)","000","Sildenafil Citrate","MACLEODS PHARMA","Tentative Approval","12/17/2013"
"SILDENAFIL CITRATE (ANDA #203814)","001","SILDENAFIL CITRATE","MACLEODS PHARMS LTD","Approval","12/17/2013"
"JUXTAPID (NDA #203858)","004","LOMITAPIDE MESYLATE","AEGERION","Manufacturing Change or Addition","12/17/2013"
"STIMATE (NDA #020355)","019","DESMOPRESSIN ACETATE","CSL BEHRING","Manufacturing Change or Addition","12/18/2013"
"STIMATE (NEEDS NO REFRIGERATION) (NDA #020355)","019","DESMOPRESSIN ACETATE","CSL BEHRING","Manufacturing Change or Addition","12/18/2013"
"CANCIDAS (NDA #021227)","032","CASPOFUNGIN ACETATE","MERCK","Manufacturing Change or Addition","12/18/2013"
"BARACLUDE (NDA #021798)","018","ENTECAVIR","BRISTOL MYERS SQUIBB","Labeling Revision","12/18/2013"
"CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER (ANDA #065430)","006","CEFOTETAN DISODIUM","B BRAUN","Manufacturing Change or Addition","12/18/2013"
"PEGINTRON (BLA #103949)","5259","PEGINTERFERON ALFA-2B","SCHERING","Efficacy Supplement with Clinical Data to Support","12/18/2013"
"SYLATRON (BLA #103949)","5259","PEGINTERFERON ALFA-2B","SCHERING","Efficacy Supplement with Clinical Data to Support","12/18/2013"
"GADAVIST (NDA #201277)","004","GADOBUTROL","BAYER HLTHCARE","Manufacturing Change or Addition","12/18/2013"
"JENTADUETO (NDA #201281)","005","LINAGLIPTIN; METFORMIN HYDROCHLORIDE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","12/18/2013"
"ANORO ELLIPTA (NDA #203975)","000","UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE","GLAXOSMITHKLINE","Approval","12/18/2013"
"ADRENALIN (NDA #204640)","000","EPINEPHRINE","PAR STERILE PRODUCTS","Approval","12/18/2013"
"PROPYLTHIOURACIL (NDA #006188)","023","PROPYLTHIOURACIL","DAVA PHARMS INC","Manufacturing Change or Addition","12/19/2013"
"DARANIDE (NDA #011366)","029","DICHLORPHENAMIDE","TARO","Manufacturing Change or Addition","12/19/2013"
"TENUATE DOSPAN (NDA #012546)","033","DIETHYLPROPION HYDROCHLORIDE","WATSON PHARMS","Manufacturing Change or Addition","12/19/2013"
"CONRAY (NDA #013295)","064","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"CONRAY 43 (NDA #013295)","064","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"CONRAY 30 (NDA #016983)","032","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"CYSTO-CONRAY (NDA #017057)","031","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"CYSTO-CONRAY II (NDA #017057)","031","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"HALDOL (NDA #018701)","069","HALOPERIDOL DECANOATE","JANSSEN PHARMS","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 160 (NDA #019710)","050","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 240 (NDA #019710)","050","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 300 (NDA #019710)","050","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 320 (NDA #019710)","050","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 350 (NDA #019710)","050","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"RETROVIR (NDA #019951)","031","ZIDOVUDINE","VIIV HLTHCARE","Manufacturing Change or Addition","12/19/2013"
"GONAL-F (NDA #020378)","064","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 240 (NDA #020923)","016","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 300 (NDA #020923)","016","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 320 (NDA #020923)","016","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OPTIRAY 350 (NDA #020923)","016","IOVERSOL","MALLINCKRODT","Manufacturing Change or Addition","12/19/2013"
"OVIDREL (NDA #021149)","037","CHORIOGONADOTROPIN ALFA","EMD SERONO","Manufacturing Change or Addition","12/19/2013"
"CAVERJECT IMPULSE (NDA #021212)","007","ALPROSTADIL","PHARMACIA AND UPJOHN","Labeling Revision","12/19/2013"
"RANEXA (NDA #021526)","026","RANOLAZINE","GILEAD","Labeling Revision","12/19/2013"
"GONAL-F (NDA #021765)","034","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","12/19/2013"
"GONAL-F RFF (NDA #021765)","034","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","12/19/2013"
"BARACLUDE (NDA #021797)","017","ENTECAVIR","BRISTOL MYERS SQUIBB","Labeling Revision","12/19/2013"
"REVLIMID (NDA #021880)","036","LENALIDOMIDE","CELGENE","Manufacturing Change or Addition","12/19/2013"
"KUVAN (NDA #022181)","009","SAPROPTERIN DIHYDROCHLORIDE","BIOMARIN PHARM","Manufacturing Change or Addition","12/19/2013"
"KUVAN (NDA #022181)","010","SAPROPTERIN DIHYDROCHLORIDE","BIOMARIN PHARM","Efficacy Supplement with Clinical Data to Support","12/19/2013"
"ERYC (NDA #050536)","023","ERYTHROMYCIN","MAYNE PHARMA","Manufacturing Change or Addition","12/19/2013"
"ERYC (NDA #050536)","024","ERYTHROMYCIN","MAYNE PHARMA","Manufacturing Change or Addition","12/19/2013"
"ERIVEDGE (NDA #203388)","003","VISMODEGIB","GENENTECH","Manufacturing Change or Addition","12/19/2013"
"GABAPENTIN (ANDA #203611)","000","GABAPENTIN","ACTAVIS ELIZABETH","Tentative Approval","12/19/2013"
"BRISDELLE (NDA #204516)","001","PAROXETINE MESYLATE","NOVEN THERAP","Manufacturing Change or Addition","12/19/2013"
"KUVAN (NDA #205065)","000","SAPROPTERIN DIHYDROCHLORIDE","BIOMARIN PHARM","Approval","12/19/2013"
"ULTRA-TECHNEKOW FM (NDA #017243)","044","TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR","MALLINCKRODT","Labeling Revision","12/20/2013"
"TYLENOL (NDA #019872)","039","ACETAMINOPHEN","MCNEIL CONS","Labeling Revision","12/20/2013"
"METASTRON (NDA #020134)","012","STRONTIUM CHLORIDE SR-89","GE HEALTHCARE","Labeling Revision","12/20/2013"
"LAMICTAL (NDA #020241)","039","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","12/20/2013"
"CHILDREN'S ADVIL (NDA #020589)","029","IBUPROFEN","PFIZER","Manufacturing Change or Addition","12/20/2013"
"CHILDREN'S ADVIL-FLAVORED (NDA #020589)","029","IBUPROFEN","PFIZER","Manufacturing Change or Addition","12/20/2013"
"LAMICTAL CD (NDA #020764)","032","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","12/20/2013"
"EPIVIR-HBV (NDA #021003)","015","LAMIVUDINE","GLAXOSMITHKLINE","Labeling Revision","12/20/2013"
"EPIVIR-HBV (NDA #021004)","015","LAMIVUDINE","GLAXOSMITHKLINE","Labeling Revision","12/20/2013"
"TAMIFLU (NDA #021087)","063","OSELTAMIVIR PHOSPHATE","ROCHE","Manufacturing Change or Addition","12/20/2013"
"XYREM (NDA #021196)","018","SODIUM OXYBATE","JAZZ PHARMS","Manufacturing Change or Addition","12/20/2013"
"ZEGERID (NDA #021636)","014","OMEPRAZOLE; SODIUM BICARBONATE","SANTARUS INC","Manufacturing Change or Addition","12/20/2013"
"RELISTOR (NDA #021964)","014","METHYLNALTREXONE BROMIDE","SALIX PHARMS","Manufacturing Change or Addition","12/20/2013"
"TORISEL (NDA #022088)","015","TEMSIROLIMUS","PF PRISM CV","Manufacturing Change or Addition","12/20/2013"
"LAMICTAL XR (NDA #022115)","003","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","12/20/2013"
"ISENTRESS (NDA #022145)","031","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Efficacy Supplement with Clinical Data to Support","12/20/2013"
"LAMICTAL ODT (NDA #022251)","001","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","12/20/2013"
"ORENCIA (BLA #125118)","171","ABATACEPT","BRISTOL MYERS SQUIBB","Efficacy Supplement with Clinical Data to Support","12/20/2013"
"AMPICILLIN SODIUM (ANDA #201404)","000","AMPICILLIN SODIUM","ISTITUTO BIO ITA SPA","Approval","12/20/2013"
"ISENTRESS (NDA #203045)","009","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Efficacy Supplement with Clinical Data to Support","12/20/2013"
"ICLUSIG (NDA #203469)","007","PONATINIB HYDROCHLORIDE","ARIAD","Labeling Revision","12/20/2013"
"ICLUSIG (NDA #203469)","008","PONATINIB HYDROCHLORIDE","ARIAD","Labeling Revision","12/20/2013"
"ORENITRAM (NDA #203496)","000","TREPROSTINIL DIOLAMINE","UNITED THERAP","Approval","12/20/2013"
"METOCLOPRAMIDE (ANDA #204756)","000","METOCLOPRAMIDE HYDROCHLORIDE","EMCURE PHARMS LTD","Approval","12/20/2013"
"ISENTRESS (NDA #205786)","000","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Efficacy Supplement with Clinical Data to Support","12/20/2013"
"SURMONTIL (NDA #016792)","035","TRIMIPRAMINE MALEATE","ODYSSEY PHARMS","Manufacturing Change or Addition","12/23/2013"
"WELLBUTRIN (NDA #018644)","046","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/23/2013"
"WELLBUTRIN (NDA #018644)","047","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/23/2013"
"WELLBUTRIN SR (NDA #020358)","053","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/23/2013"
"WELLBUTRIN SR (NDA #020358)","054","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","12/23/2013"
"INFASURF PRESERVATIVE FREE (NDA #020521)","025","CALFACTANT","ONY","Manufacturing Change or Addition","12/23/2013"
"FOSAMAX (NDA #020560)","066","ALENDRONATE SODIUM","MERCK AND CO INC","Labeling Revision","12/23/2013"
"LYRICA (NDA #021446)","029","PREGABALIN","PF PRISM","Labeling Revision","12/23/2013"
"FOSAMAX (NDA #021575)","023","ALENDRONATE SODIUM","MERCK","Labeling Revision","12/23/2013"
"PRISTIQ (NDA #021992)","037","DESVENLAFAXINE SUCCINATE","WYETH PHARMS INC","Labeling Revision","12/23/2013"
"FERAHEME (NDA #022180)","010","FERUMOXYTOL","AMAG PHARMS INC","Manufacturing Change or Addition","12/23/2013"
"LYRICA (NDA #022488)","008","PREGABALIN","PF PRISM","Manufacturing Change or Addition","12/23/2013"
"ABELCET (NDA #050724)","017","AMPHOTERICIN B","SIGMA TAU","Manufacturing Change or Addition","12/23/2013"
"DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) (ANDA #078271)","000","DESMOPRESSIN ACETATE","SUN PHARMA GLOBAL","Approval","12/23/2013"
"DARUNAVIR ETHANOLATE (ANDA #202118)","000","DARUNAVIR ETHANOLATE","TEVA PHARMS USA","Tentative Approval","12/23/2013"
"BINOSTO (NDA #202344)","006","ALENDRONATE SODIUM","MISSION PHARMA","Manufacturing Change or Addition","12/23/2013"
"SODIUM FLUORIDE F-18 (ANDA #203247)","000","SODIUM FLUORIDE F-18","UNIV TX MD ANDERSON","Approval","12/23/2013"
"LAMOTRIGINE (ANDA #203370)","000","LAMOTRIGINE","TORRENT PHARMS LTD","Approval","12/23/2013"
"FLUDEOXYGLUCOSE F18 (ANDA #203709)","000","FLUDEOXYGLUCOSE F-18","WI MEDCL CYCLOTRON","Approval","12/23/2013"
"HECTOROL (NDA #021027)","028","DOXERCALCIFEROL","GENZYME CORP","Manufacturing Change or Addition","12/24/2013"
"CANASA (NDA #021252)","018","MESALAMINE","FOREST LABS INC","Manufacturing Change or Addition","12/24/2013"
"XYLOCAINE (NDA #006488)","088","LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing Change or Addition","12/26/2013"
"XYLOCAINE W/ EPINEPHRINE (NDA #006488)","088","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","FRESENIUS KABI USA","Manufacturing Change or Addition","12/26/2013"
"OXYCODONE AND ACETAMINOPHEN (ANDA #090535)","000","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","CARACO","Approval","12/26/2013"
"ETHINYL ESTRADIOL; NORETHINDRONE ACETATE (ANDA #090938)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","BARR LABS INC","Tentative Approval","12/26/2013"
"FERROUS FUMARATE (ANDA #090938)","000","FERROUS FUMARATE","BARR LABS INC","Tentative Approval","12/26/2013"
"DEXLANSOPRAZOLE (ANDA #202294)","000","DEXLANSOPRAZOLE","PAR PHARM INC","Tentative Approval","12/26/2013"
"DICLOFENAC SODIUM (ANDA #202393)","000","DICLOFENAC SODIUM","PADDOCK LLC","Tentative Approval","12/26/2013"
"TAFINLAR (NDA #202806)","001","DABRAFENIB MESYLATE","GLAXOSMITHKLINE","Labeling Revision","12/26/2013"
"POTASSIUM CHLORIDE (ANDA #202886)","000","POTASSIUM CHLORIDE","ANCHEN PHARMS","Approval","12/26/2013"
"DUAC (NDA #050741)","021","BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","STIEFEL","Labeling Revision","12/27/2013"
"SIMPONI (BLA #125289)","103","GOLIMUMAB","CENTOCOR ORTHO BIOTECH INC","Labeling Revision","12/27/2013"
"SINGULAIR (NDA #020829)","066","MONTELUKAST SODIUM","MERCK","Labeling Revision","12/30/2013"
"SINGULAIR (NDA #020830)","068","MONTELUKAST SODIUM","MERCK","Labeling Revision","12/30/2013"
"SINGULAIR (NDA #021409)","043","MONTELUKAST SODIUM","MERCK","Labeling Revision","12/30/2013"
"KEFLEX (NDA #050405)","104","CEPHALEXIN","SHIONOGI INC","Manufacturing Change or Addition","12/30/2013"
"NIACIN (ANDA #090446)","000","NIACIN","LUPIN LTD","Tentative Approval","12/30/2013"
"NIACIN (ANDA #090860)","000","NIACIN","LUPIN LTD","Tentative Approval","12/30/2013"
"NIACIN (ANDA #090892)","000","NIACIN","LUPIN LTD","Tentative Approval","12/30/2013"
"AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (ANDA #091431)","000","AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE","APOTEX INC","Approval","12/30/2013"
"EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE (NDA #204568)","000","EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE","CIPLA","Tentative Approval","12/30/2013"
"PRALIDOXIME CHLORIDE (NDA #018986)","043","PRALIDOXIME CHLORIDE","MERIDIAN MEDCL TECHN","Manufacturing Change or Addition","12/31/2013"
"NITROGLYCERIN IN DEXTROSE 5% (NDA #019970)","014","NITROGLYCERIN","BAXTER HLTHCARE","Manufacturing Change or Addition","12/31/2013"
"EPOGEN/PROCRIT (BLA #103234)","5323","EPOETIN ALFA","AMGEN","Labeling Revision","12/31/2013"
"ARANESP (BLA #103951)","5325","DARBEPOETIN ALFA","AMGEN","Labeling Revision","12/31/2013"
"ARANESP (BLA #103951)","5349","DARBEPOETIN ALFA","AMGEN","Labeling Revision","12/31/2013"
"MONISTAT-DERM (NDA #017494)","037","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","01/02/2014"
"HECTOROL (NDA #020862)","032","DOXERCALCIFEROL","GENZYME CORP","Manufacturing Change or Addition","01/02/2014"
"CANASA (NDA #021252)","019","MESALAMINE","FOREST LABS INC","Manufacturing Change or Addition","01/02/2014"
"TESTIM (NDA #021454)","019","TESTOSTERONE","AUXILIUM PHARMS","Manufacturing Change or Addition","01/02/2014"
"LAMIVUDINE (ANDA #202941)","000","LAMIVUDINE","APOTEX INC","Approval","01/02/2014"
"LAMIVUDINE (ANDA #203260)","000","LAMIVUDINE","HETERO LABS LTD V","Approval","01/02/2014"
"MESTINON (NDA #011665)","019","PYRIDOSTIGMINE BROMIDE","VALEANT PHARMS LLC","Manufacturing Change or Addition","01/03/2014"
"ADENOSCAN (NDA #020059)","016","ADENOSINE","ASTELLAS","Labeling Revision","01/03/2014"
"NIZORAL A-D (NDA #020310)","021","KETOCONAZOLE","MCNEIL CONS","Manufacturing Change or Addition","01/03/2014"
"PYRIDOSTIGMINE BROMIDE (NDA #020414)","002","PYRIDOSTIGMINE BROMIDE","US ARMY","Manufacturing Change or Addition","01/03/2014"
"CEREBYX (NDA #020450)","023","FOSPHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","01/03/2014"
"CLARITIN-D 24 HOUR (NDA #020470)","043","LORATADINE; PSEUDOEPHEDRINE SULFATE","SCHERING PLOUGH","Manufacturing Change or Addition","01/03/2014"
"VENTOLIN HFA (NDA #020983)","030","ALBUTEROL SULFATE","GLAXO GRP LTD","Manufacturing Change or Addition","01/03/2014"
"REMODULIN (NDA #021272)","021","TREPROSTINIL","UNITED THERAP","Manufacturing Change or Addition","01/03/2014"
"LEXISCAN (NDA #022161)","011","REGADENOSON","ASTELLAS","Labeling Revision","01/03/2014"
"ADVIL (NDA #201803)","003","IBUPROFEN SODIUM","PFIZER CONS HLTHCARE","Manufacturing Change or Addition","01/03/2014"
"ASPIRIN (NDA #203697)","001","ASPIRIN","PLX PHARMA","Manufacturing Change or Addition","01/03/2014"
"ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (NDA #021704)","014","FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","01/06/2014"
"FIBRICOR (NDA #022418)","011","FENOFIBRIC ACID","MUTUAL PHARM CO INC","Labeling Revision","01/06/2014"
"VIOKACE (NDA #022542)","001","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","FOREST LABS INC","Manufacturing Change or Addition","01/06/2014"
"LAMIVUDINE (ANDA #203277)","000","LAMIVUDINE","HETERO LABS LTD V","Approval","01/06/2014"
"MACROBID (NDA #020064)","022","NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE","ALVOGEN INC","Manufacturing Change or Addition","01/07/2014"
"DIFLUCAN (NDA #020090)","041","FLUCONAZOLE","PFIZER","Manufacturing Change or Addition","01/07/2014"
"VIVITROL (NDA #021897)","025","NALTREXONE","ALKERMES","Manufacturing Change or Addition","01/07/2014"
"NOXAFIL (NDA #022003)","013","POSACONAZOLE","SCHERING","Manufacturing Change or Addition","01/07/2014"
"XARELTO (NDA #022406)","007","RIVAROXABAN","JANSSEN PHARMS","Labeling Revision","01/07/2014"
"TOBI PODHALER (NDA #201688)","001","TOBRAMYCIN","NOVARTIS","Manufacturing Change or Addition","01/07/2014"
"ANCOBON (NDA #017001)","030","FLUCYTOSINE","VALEANT","Manufacturing Change or Addition","01/08/2014"
"LOCOID (NDA #018514)","012","HYDROCORTISONE BUTYRATE","PRECISION DERMAT","Manufacturing Change or Addition","01/08/2014"
"PENTAM (NDA #019264)","032","PENTAMIDINE ISETHIONATE","FRESENIUS KABI USA","Manufacturing Change or Addition","01/08/2014"
"NIZORAL (NDA #019927)","034","KETOCONAZOLE","JANSSEN PHARMS","Manufacturing Change or Addition","01/08/2014"
"FEMHRT (NDA #021065)","020","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Labeling Revision","01/08/2014"
"PROAIR HFA (NDA #021457)","030","ALBUTEROL SULFATE","TEVA BRANDED PHARM","Manufacturing Change or Addition","01/08/2014"
"TELMISARTAN (ANDA #078710)","000","TELMISARTAN","WATSON LABS","Approval","01/08/2014"
"DULOXETINE HYDROCHLORIDE (ANDA #090728)","000","DULOXETINE HYDROCHLORIDE","ZYDUS PHARMS USA INC","Approval","01/08/2014"
"DULOXETINE HYDROCHLORIDE (ANDA #090739)","000","DULOXETINE HYDROCHLORIDE","ZYDUS PHARMS USA INC","Approval","01/08/2014"
"MYCOPHENOLIC ACID (ANDA #091248)","000","MYCOPHENOLIC ACID","MYLAN PHARMS INC","Approval","01/08/2014"
"TELMISARTAN AND AMLODIPINE (ANDA #201586)","000","AMLODIPINE BESYLATE; TELMISARTAN","LUPIN LTD","Approval","01/08/2014"
"SIROLIMUS (ANDA #201676)","000","SIROLIMUS","ZYDUS PHARMS USA INC","Approval","01/08/2014"
"SIROLIMUS (ANDA #201676)","000","SIROLIMUS","ZYDUS PHARMS USA INC","Tentative Approval","01/08/2014"
"FARXIGA (NDA #202293)","000","DAPAGLIFLOZIN","ASTRAZENECA AB","Approval","01/08/2014"
"TELMISARTAN AND AMLODIPINE (ANDA #202517)","000","AMLODIPINE BESYLATE; TELMISARTAN","TORRENT PHARMS LTD","Approval","01/08/2014"
"OSPHENA (NDA #203505)","003","OSPEMIFENE","SHIONOGI INC","Manufacturing Change or Addition","01/08/2014"
"MEKINIST (NDA #204114)","001","TRAMETINIB DIMETHYL SULFOXIDE","GLAXOSMITHKLINE LLC","New or Modified Indication","01/08/2014"
"MESTINON (NDA #009829)","016","PYRIDOSTIGMINE BROMIDE","VALEANT PHARMS LLC","Manufacturing Change or Addition","01/09/2014"
"HEPARIN SODIUM (NDA #017037)","171","HEPARIN SODIUM","HIKMA MAPLE","Manufacturing Change or Addition","01/09/2014"
"HEXALEN (NDA #019926)","024","ALTRETAMINE","EISAI INC","Manufacturing Change or Addition","01/09/2014"
"VANTAS (NDA #021732)","015","HISTRELIN ACETATE","ENDO PHARM","Manufacturing Change or Addition","01/09/2014"
"TYGACIL (NDA #021821)","036","TIGECYCLINE","PF PRISM CV","Manufacturing Change or Addition","01/09/2014"
"ORAVERSE (NDA #022159)","005","PHENTOLAMINE MESYLATE","SEPTODONT HOLDING","Manufacturing Change or Addition","01/09/2014"
"LEXISCAN (NDA #022161)","011","REGADENOSON","ASTELLAS","Labeling Revision","01/09/2014"
"MORPHINE SULFATE (NDA #022195)","009","MORPHINE SULFATE","ROXANE","Labeling Revision","01/09/2014"
"SIROLIMUS (ANDA #201578)","000","SIROLIMUS","DR REDDYS LABS LTD","Tentative Approval","01/09/2014"
"GRISEOFULVIN, ULTRAMICROSIZE (ANDA #204371)","000","GRISEOFULVIN, ULTRAMICROSIZE","RICONPHARMA LLC","Approval","01/09/2014"
"ADAGEN (NDA #019818)","050","PEGADEMASE BOVINE","SIGMA TAU","Manufacturing Change or Addition","01/10/2014"
"ZOLOFT (NDA #019839)","085","SERTRALINE HYDROCHLORIDE","PFIZER","Manufacturing Change or Addition","01/10/2014"
"SYNERA (NDA #021623)","023","LIDOCAINE; TETRACAINE","GALEN SPECIALTY","Manufacturing Change or Addition","01/10/2014"
"VIDAZA (NDA #050794)","026","AZACITIDINE","CELGENE","Labeling Revision","01/10/2014"
"PIOGLITAZONE HYDROCHLORIDE (ANDA #077210)","000","PIOGLITAZONE HYDROCHLORIDE","TEVA PHARMS USA","Approval","01/10/2014"
"PREGABALIN (ANDA #091025)","000","PREGABALIN","ACTAVIS ELIZABETH","Tentative Approval","01/10/2014"
"CANDESARTAN CILEXETIL (ANDA #202079)","000","CANDESARTAN CILEXETIL","APOTEX INC","Approval","01/10/2014"
"TAFINLAR (NDA #202806)","002","DABRAFENIB MESYLATE","GLAXOSMITHKLINE","New or Modified Indication","01/10/2014"
"KAYEXALATE (NDA #011287)","024","SODIUM POLYSTYRENE SULFONATE","COVIS PHARMA SARL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (NDA #018883)","052","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","052","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (NDA #018883)","052","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","052","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (NDA #018883)","052","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","052","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","034","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","034","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","034","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/13/2014"
"ASACOL HD (NDA #021830)","007","MESALAMINE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","01/13/2014"
"ELELYSO (NDA #022458)","001","TALIGLUCERASE ALFA","PFIZER","Manufacturing Change or Addition","01/13/2014"
"FLUDEOXYGLUCOSE F18 (ANDA #203246)","000","FLUDEOXYGLUCOSE F-18","UNIV TX MD ANDERSON","Approval","01/13/2014"
"THYROLAR-0.25 (NDA #016807)","033","LIOTRIX (T4;T3)","FOREST LABS","Manufacturing Change or Addition","01/14/2014"
"THYROLAR-0.5 (NDA #016807)","033","LIOTRIX (T4;T3)","FOREST LABS","Manufacturing Change or Addition","01/14/2014"
"THYROLAR-1 (NDA #016807)","033","LIOTRIX (T4;T3)","FOREST LABS","Manufacturing Change or Addition","01/14/2014"
"THYROLAR-2 (NDA #016807)","033","LIOTRIX (T4;T3)","FOREST LABS","Manufacturing Change or Addition","01/14/2014"
"THYROLAR-3 (NDA #016807)","033","LIOTRIX (T4;T3)","FOREST LABS","Manufacturing Change or Addition","01/14/2014"
"THYROLAR-5 (NDA #016807)","033","LIOTRIX (T4;T3)","FOREST LABS","Manufacturing Change or Addition","01/14/2014"
"DOVONEX (NDA #020554)","010","CALCIPOTRIENE","LEO PHARMA AS","Manufacturing Change or Addition","01/14/2014"
"XOPENEX (NDA #020837)","040","LEVALBUTEROL HYDROCHLORIDE","SUNOVION","Labeling Revision","01/14/2014"
"CALDOLOR (NDA #022348)","002","IBUPROFEN","CUMBERLAND PHARMS","Manufacturing Change or Addition","01/14/2014"
"FLUOCINONIDE (ANDA #090256)","000","FLUOCINONIDE","PERRIGO ISRAEL","Approval","01/14/2014"
"DOXERCALCIFEROL (ANDA #091433)","000","DOXERCALCIFEROL","ROXANE","Approval","01/14/2014"
"ZUBSOLV (NDA #204242)","001","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","OREXO AB","Manufacturing Change or Addition","01/14/2014"
"PROTOPAM CHLORIDE (NDA #014134)","035","PRALIDOXIME CHLORIDE","BAXTER HLTHCARE CORP","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM (NDA #017037)","172","HEPARIN SODIUM","HIKMA MAPLE","Manufacturing Change or Addition","01/15/2014"
"LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","084","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Labeling Revision","01/15/2014"
"LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","084","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Labeling Revision","01/15/2014"
"LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","084","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Labeling Revision","01/15/2014"
"HUMULIN N (NDA #018781)","145","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","01/15/2014"
"HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9% (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9% (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% (NDA #018916)","064","HEPARIN SODIUM","HOSPIRA","Manufacturing Change or Addition","01/15/2014"
"HUMULIN 70/30 (NDA #019717)","124","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","01/15/2014"
"HUMULIN 70/30 PEN (NDA #019717)","124","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Labeling Revision","01/15/2014"
"FEMARA (NDA #020726)","027","LETROZOLE","NOVARTIS PHARMS","Labeling Revision","01/15/2014"
"XOPENEX (NDA #020837)","040","LEVALBUTEROL HYDROCHLORIDE","SUNOVION","Labeling Revision","01/15/2014"
"SUSTIVA (NDA #020972)","044","EFAVIRENZ","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","01/15/2014"
"DACOGEN (NDA #021790)","017","DECITABINE","EISAI INC","Manufacturing Change or Addition","01/15/2014"
"SYMBICORT (NDA #021929)","035","BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE","ASTRAZENECA","Manufacturing Change or Addition","01/15/2014"
"AXIRON (NDA #022504)","007","TESTOSTERONE","ELI LILLY AND CO","Manufacturing Change or Addition","01/15/2014"
"POLYMYXIN B SULFATE (ANDA #202766)","000","POLYMYXIN B SULFATE","XELLIA PHARMS APS","Approval","01/15/2014"
"TEGRETOL (NDA #016608)","103","CARBAMAZEPINE","NOVARTIS","Labeling Revision","01/16/2014"
"TEGRETOL (NDA #018281)","051","CARBAMAZEPINE","NOVARTIS","Labeling Revision","01/16/2014"
"ACETAMINOPHEN (NDA #018337)","032","ACETAMINOPHEN","TARO PHARMS NORTH","Labeling Revision","01/16/2014"
"INFANTS' FEVERALL (NDA #018337)","032","ACETAMINOPHEN","TARO PHARMS NORTH","Labeling Revision","01/16/2014"
"TEGRETOL (NDA #018927)","044","CARBAMAZEPINE","NOVARTIS","Labeling Revision","01/16/2014"
"TEGRETOL-XR (NDA #020234)","035","CARBAMAZEPINE","NOVARTIS","Labeling Revision","01/16/2014"
"ANDRODERM (NDA #020489)","030","TESTOSTERONE","WATSON LABS","Manufacturing Change or Addition","01/16/2014"
"COMTAN (NDA #020796)","021","ENTACAPONE","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"PRECEDEX (NDA #021038)","025","DEXMEDETOMIDINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","01/16/2014"
"STALEVO 100 (NDA #021485)","030","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"STALEVO 125 (NDA #021485)","030","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"STALEVO 150 (NDA #021485)","030","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"STALEVO 200 (NDA #021485)","030","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"STALEVO 50 (NDA #021485)","030","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"STALEVO 75 (NDA #021485)","030","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","01/16/2014"
"EOVIST (NDA #022090)","010","GADOXETATE DISODIUM","BAYER HLTHCARE","Manufacturing Change or Addition","01/16/2014"
"VIMPAT (NDA #022253)","023","LACOSAMIDE","UCB INC","Labeling Revision","01/16/2014"
"VIMPAT (NDA #022254)","015","LACOSAMIDE","UCB INC","Labeling Revision","01/16/2014"
"VIMPAT (NDA #022255)","009","LACOSAMIDE","UCB INC","Labeling Revision","01/16/2014"
"NUCYNTA (NDA #022304)","013","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Manufacturing Change or Addition","01/16/2014"
"ARGATROBAN IN SODIUM CHLORIDE (NDA #022434)","005","ARGATROBAN","EAGLE PHARMS","Manufacturing Change or Addition","01/16/2014"
"RESTASIS (NDA #050790)","022","CYCLOSPORINE","ALLERGAN","Manufacturing Change or Addition","01/16/2014"
"ZARONTIN (ANDA #080258)","029","ETHOSUXIMIDE","PARKE DAVIS","Labeling Revision","01/16/2014"
"ZARONTIN (ANDA #080258)","031","ETHOSUXIMIDE","PARKE DAVIS","Labeling Revision","01/16/2014"
"NUCYNTA ER (NDA #200533)","007","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Manufacturing Change or Addition","01/16/2014"
"OXECTA (NDA #202080)","002","OXYCODONE HYDROCHLORIDE","ACURA PHARMS INC","Labeling Revision","01/16/2014"
"SUPRAX (NDA #202091)","001","CEFIXIME","LUPIN LTD","Manufacturing Change or Addition","01/16/2014"
"DOXEPIN HYDROCHLORIDE (ANDA #202337)","000","DOXEPIN HYDROCHLORIDE","MYLAN PHARMS INC","Tentative Approval","01/16/2014"
"NUCYNTA (NDA #203794)","001","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Manufacturing Change or Addition","01/16/2014"
"ONFI (NDA #203993)","001","CLOBAZAM","LUNDBECK LLC","Manufacturing Change or Addition","01/16/2014"
"PENNSAID (NDA #204623)","000","DICLOFENAC SODIUM","MALLINCKRODT INC","Approval","01/16/2014"
"ALEVE PM (NDA #205352)","000","DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM","BAYER HLTHCARE","Approval","01/16/2014"
"H.P. ACTHAR GEL (NDA #008372)","047","CORTICOTROPIN","QUESTCOR PHARMS","Manufacturing Change or Addition","01/17/2014"
"ALDACTAZIDE (NDA #012616)","074","HYDROCHLOROTHIAZIDE; SPIRONOLACTONE","GD SEARLE LLC","Labeling Revision","01/17/2014"
"CORDARONE (NDA #018972)","049","AMIODARONE HYDROCHLORIDE","WYETH PHARMS INC","Manufacturing Change or Addition","01/17/2014"
"TROPHAMINE (NDA #019018)","032","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","01/17/2014"
"TROPHAMINE 10% (NDA #019018)","032","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","01/17/2014"
"CONDYLOX (NDA #019795)","012","PODOFILOX","WATSON PHARMS","Manufacturing Change or Addition","01/17/2014"
"ACCURETIC (NDA #020125)","016","HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","01/17/2014"
"COZAAR (NDA #020386)","060","LOSARTAN POTASSIUM","MERCK SHARP DOHME","Labeling Revision","01/17/2014"
"HYZAAR (NDA #020387)","059","HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM","MERCK SHARP DOHME","Labeling Revision","01/17/2014"
"VALSTAR PRESERVATIVE FREE (NDA #020892)","018","VALRUBICIN","ENDO PHARM","Manufacturing Change or Addition","01/17/2014"
"RANEXA (NDA #021526)","027","RANOLAZINE","GILEAD","Manufacturing Change or Addition","01/17/2014"
"DORIBAX (NDA #022106)","012","DORIPENEM","SHIONOGI INC","Labeling Revision","01/17/2014"
"VIMPAT (NDA #022255)","011","LACOSAMIDE","UCB INC","Manufacturing Change or Addition","01/17/2014"
"PHOSLYRA (NDA #022581)","004","CALCIUM ACETATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/17/2014"
"BUPROPION HYDROCHLORIDE (ANDA #201567)","000","BUPROPION HYDROCHLORIDE","ZYDUS PHARMS USA INC","Approval","01/17/2014"
"VICTRELIS (NDA #202258)","012","BOCEPREVIR","MERCK SHARP DOHME","Labeling Revision","01/17/2014"
"ZECUITY (NDA #202278)","004","SUMATRIPTAN SUCCINATE","TEVA BRANDED PHARM","Manufacturing Change or Addition","01/17/2014"
"PERCODAN (NDA #007337)","048","ASPIRIN; OXYCODONE HYDROCHLORIDE","ENDO PHARMS","Manufacturing Change or Addition","01/21/2014"
"PERCODAN (NDA #007337)","048","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","ENDO PHARMS","Manufacturing Change or Addition","01/21/2014"
"PERCODAN-DEMI (NDA #007337)","048","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","ENDO PHARMS","Manufacturing Change or Addition","01/21/2014"
"HALCION (NDA #017892)","045","TRIAZOLAM","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","01/21/2014"
"VENTOLIN HFA (NDA #020983)","029","ALBUTEROL SULFATE","GLAXO GRP LTD","Manufacturing Change or Addition","01/21/2014"
"DYMISTA (NDA #202236)","004","AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE","MEDA PHARMS","Manufacturing Change or Addition","01/21/2014"
"CORDARONE (NDA #018972)","048","AMIODARONE HYDROCHLORIDE","WYETH PHARMS INC","Labeling Revision","01/22/2014"
"SUSTIVA (NDA #020972)","045","EFAVIRENZ","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","01/22/2014"
"WELCHOL (NDA #021176)","037","COLESEVELAM HYDROCHLORIDE","DAIICHI SANKYO","Efficacy Supplement with Clinical Data to Support","01/22/2014"
"SUSTIVA (NDA #021360)","034","EFAVIRENZ","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","01/22/2014"
"ERTACZO (NDA #021385)","005","SERTACONAZOLE NITRATE","VALEANT LUXEMBOURG","Labeling Revision","01/22/2014"
"ALPHAGAN P (NDA #021770)","009","BRIMONIDINE TARTRATE","ALLERGAN","Manufacturing Change or Addition","01/22/2014"
"TASIGNA (NDA #022068)","017","NILOTINIB HYDROCHLORIDE MONOHYDRATE","NOVARTIS","Efficacy Supplement with Clinical Data to Support","01/22/2014"
"EMBEDA (NDA #022321)","015","MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE","ALPHARMA PHARMS","Manufacturing Change or Addition","01/22/2014"
"WELCHOL (NDA #022362)","020","COLESEVELAM HYDROCHLORIDE","DAIICHI SANKYO","Labeling Revision","01/22/2014"
"XERESE (NDA #022436)","004","ACYCLOVIR; HYDROCORTISONE","VALEANT BERMUDA","Efficacy Supplement with Clinical Data to Support","01/22/2014"
"SANDIMMUNE (NDA #050574)","049","CYCLOSPORINE","NOVARTIS","Manufacturing Change or Addition","01/22/2014"
"REPAGLINIDE (ANDA #078555)","000","REPAGLINIDE","SANDOZ","Approval","01/22/2014"
"REPAGLINIDE (ANDA #090008)","000","REPAGLINIDE","ACTAVIS TOTOWA","Approval","01/22/2014"
"REPAGLINIDE (ANDA #090252)","000","REPAGLINIDE","MYLAN PHARMS INC","Approval","01/22/2014"
"REPAGLINIDE (ANDA #201189)","000","REPAGLINIDE","PADDOCK LLC","Approval","01/22/2014"
"DONEPEZIL HYDROCHLORIDE (ANDA #202631)","000","DONEPEZIL HYDROCHLORIDE","MACLEODS PHARMS LTD","Approval","01/22/2014"
"BROMFENAC SODIUM (ANDA #203395)","000","BROMFENAC SODIUM","HI-TECH PHARMACAL","Approval","01/22/2014"
"METRONIDAZOLE (ANDA #203458)","000","METRONIDAZOLE","UNICHEM LABS LTD","Approval","01/22/2014"
"REPAGLINIDE (ANDA #203820)","000","REPAGLINIDE","AUROBINDO PHARMA LTD","Approval","01/22/2014"
"LIPIODOL (NDA #009190)","022","ETHIODIZED OIL","GUERBET","Manufacturing Change or Addition","01/23/2014"
"BREVITAL SODIUM (NDA #011559)","045","METHOHEXITAL SODIUM","PAR STERILE PRODUCTS","Labeling Revision","01/23/2014"
"INFUVITE ADULT (NDA #021559)","020","ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K","SANDOZ","Manufacturing Change or Addition","01/23/2014"
"PERTZYE (NDA #022175)","001","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","DIGESTIVE CARE INC","Manufacturing Change or Addition","01/23/2014"
"DOCETAXEL (NDA #022234)","002","DOCETAXEL","HOSPIRA INC","Manufacturing Change or Addition","01/23/2014"
"ONGLYZA (NDA #022350)","013","SAXAGLIPTIN HYDROCHLORIDE","ASTRAZENECA AB","Manufacturing Change or Addition","01/23/2014"
"CARBAGLU (NDA #022562)","003","CARGLUMIC ACID","ORPHAN EUROPE","Manufacturing Change or Addition","01/23/2014"
"CELLCEPT (NDA #050722)","032","MYCOPHENOLATE MOFETIL","ROCHE PALO","Manufacturing Change or Addition","01/23/2014"
"CELLCEPT (NDA #050723)","031","MYCOPHENOLATE MOFETIL","ROCHE PALO","Manufacturing Change or Addition","01/23/2014"
"ETODOLAC (ANDA #091134)","000","ETODOLAC","ZYDUS PHARMS USA INC","Approval","01/23/2014"
"ONDANSETRON HYDROCHLORIDE (ANDA #203761)","000","ONDANSETRON HYDROCHLORIDE","IPCA LABS LTD","Approval","01/23/2014"
"DECITABINE (NDA #205582)","000","DECITABINE","SUN PHARMA GLOBAL","Approval","01/23/2014"
"DILANTIN-125 (NDA #008762)","050","PHENYTOIN","PARKE DAVIS","Labeling Revision","01/24/2014"
"DILANTIN-30 (NDA #008762)","050","PHENYTOIN","PARKE DAVIS","Labeling Revision","01/24/2014"
"DILANTIN (NDA #010151)","038","PHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","01/24/2014"
"HUMULIN N (NDA #018781)","141","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (NDA #018883)","053","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","053","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (NDA #018883)","053","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","053","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (NDA #018883)","053","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","053","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019631)","034","DEXTROSE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","01/24/2014"
"HUMATROPE (NDA #019640)","093","SOMATROPIN RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMULIN 70/30 (NDA #019717)","120","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMULIN 70/30 PEN (NDA #019717)","120","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","035","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","035","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","035","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","01/24/2014"
"HUMALOG (NDA #020563)","146","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG KWIKPEN (NDA #020563)","146","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG PEN (NDA #020563)","146","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG MIX 75/25 (NDA #021017)","099","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","099","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG MIX 75/25 PEN (NDA #021017)","099","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG MIX 50/50 (NDA #021018)","091","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG MIX 50/50 KWIKPEN (NDA #021018)","091","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"HUMALOG MIX 50/50 PEN (NDA #021018)","091","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/24/2014"
"ZYVOX (NDA #021130)","032","LINEZOLID","PHARMACIA AND UPJOHN","Labeling Revision","01/24/2014"
"ZYVOX (NDA #021131)","026","LINEZOLID","PHARMACIA AND UPJOHN","Labeling Revision","01/24/2014"
"ZYVOX (NDA #021132)","031","LINEZOLID","PHARMACIA AND UPJOHN","Labeling Revision","01/24/2014"
"FORTEO (NDA #021318)","038","TERIPARATIDE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","01/24/2014"
"SIMPONI (BLA #125289)","105","GOLIMUMAB","CENTOCOR ORTHO BIOTECH INC","Labeling Revision","01/24/2014"
"SKELAXIN (NDA #013217)","055","METAXALONE","KING PHARMS","Manufacturing Change or Addition","01/27/2014"
"MONISTAT-DERM (NDA #017494)","039","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","01/27/2014"
"VIRAMUNE (NDA #020636)","044","NEVIRAPINE","BOEHRINGER INGELHEIM","Labeling Revision","01/27/2014"
"VIRAMUNE (NDA #020933)","035","NEVIRAPINE","BOEHRINGER INGELHEIM","Labeling Revision","01/27/2014"
"BROMDAY (NDA #021664)","014","BROMFENAC SODIUM","BAUSCH AND LOMB INC","Labeling Revision","01/27/2014"
"BROMDAY (NDA #021664)","019","BROMFENAC SODIUM","BAUSCH AND LOMB INC","Labeling Revision","01/27/2014"
"XIBROM (NDA #021664)","014","BROMFENAC SODIUM","BAUSCH AND LOMB INC","Labeling Revision","01/27/2014"
"XIBROM (NDA #021664)","019","BROMFENAC SODIUM","BAUSCH AND LOMB INC","Labeling Revision","01/27/2014"
"TETRACYCLINE HYDROCHLORIDE (ANDA #060704)","035","TETRACYCLINE HYDROCHLORIDE","IVAX SUB TEVA PHARMS","Labeling Revision","01/27/2014"
"EYLEA (BLA #125387)","023","AFLIBERCEPT","REGENERON PHARMACEUTICALS","Labeling Revision","01/27/2014"
"ISOPTO CARPINE (NDA #200890)","005","PILOCARPINE HYDROCHLORIDE","ALCON RES","Manufacturing Change or Addition","01/27/2014"
"VIRAMUNE XR (NDA #201152)","007","NEVIRAPINE","BOEHRINGER INGELHEIM","Labeling Revision","01/27/2014"
"TRANEXAMIC ACID (ANDA #202286)","000","TRANEXAMIC ACID","APOTEX INC","Approval","01/27/2014"
"FOLIC ACID (ANDA #202437)","000","FOLIC ACID","CADILA PHARMS LTD","Approval","01/27/2014"
"FUROSEMIDE (ANDA #202747)","000","FUROSEMIDE","CLARIS LIFESCIENCES","Approval","01/27/2014"
"CARISOPRODOL (ANDA #203374)","000","CARISOPRODOL","SCIEGEN PHARMS INC","Approval","01/27/2014"
"RETIN-A MICRO (NDA #020475)","021","TRETINOIN","VALEANT INTL","Manufacturing Change or Addition","01/28/2014"
"RETIN-A-MICRO (NDA #020475)","021","TRETINOIN","VALEANT INTL","Manufacturing Change or Addition","01/28/2014"
"COPAXONE (NDA #020622)","089","GLATIRAMER ACETATE","TEVA PHARMS USA","Efficacy Supplement with Clinical Data to Support","01/28/2014"
"SINGULAIR (NDA #020829)","067","MONTELUKAST SODIUM","MERCK","Manufacturing Change or Addition","01/28/2014"
"RESTASIS (NDA #050790)","022","CYCLOSPORINE","ALLERGAN","Manufacturing Change or Addition","01/28/2014"
"DOXY 100 (ANDA #062475)","038","DOXYCYCLINE HYCLATE","FRESENIUS KABI USA","Labeling Revision","01/28/2014"
"DOXY 200 (ANDA #062475)","038","DOXYCYCLINE HYCLATE","FRESENIUS KABI USA","Labeling Revision","01/28/2014"
"BETASERON (BLA #103471)","5185","INTERFERON BETA-1B","BAYER HEALTHCARE PHARMS","Labeling Revision","01/28/2014"
"DESVENLAFAXINE (NDA #205583)","000","DESVENLAFAXINE FUMARATE","SUN PHARMA GLOBAL","Approval","01/28/2014"
"CHORIONIC GONADOTROPIN (NDA #017067)","060","GONADOTROPIN, CHORIONIC","FRESENIUS KABI USA","Manufacturing Change or Addition","01/29/2014"
"RETIN-A MICRO (NDA #020475)","023","TRETINOIN","VALEANT INTL","Manufacturing Change or Addition","01/29/2014"
"RETIN-A-MICRO (NDA #020475)","023","TRETINOIN","VALEANT INTL","Manufacturing Change or Addition","01/29/2014"
"TOPAMAX (NDA #020505)","053","TOPIRAMATE","JANSSEN PHARMS","Labeling Revision","01/29/2014"
"TOPAMAX (NDA #020844)","044","TOPIRAMATE","JANSSEN PHARMS","Labeling Revision","01/29/2014"
"TOPAMAX SPRINKLE (NDA #020844)","044","TOPIRAMATE","JANSSEN PHARMS","Labeling Revision","01/29/2014"
"RAPAMUNE (NDA #021110)","070","SIROLIMUS","PF PRISM CV","Manufacturing Change or Addition","01/29/2014"
"VANDAZOLE (NDA #021806)","004","METRONIDAZOLE","TEVA PHARMS","Manufacturing Change or Addition","01/29/2014"
"DICLEGIS (NDA #021876)","001","DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE","DUCHESNAY","Manufacturing Change or Addition","01/29/2014"
"TOBRAMYCIN SULFATE (ANDA #065122)","008","TOBRAMYCIN SULFATE","FRESENIUS KABI USA","Labeling Revision","01/29/2014"
"SUMATRIPTAN SUCCINATE (ANDA #090495)","000","SUMATRIPTAN SUCCINATE","DR REDDYS LABS INC","Approval","01/29/2014"
"SORIATANE (NDA #019821)","023","ACITRETIN","STIEFEL LABS INC","Labeling Revision","01/30/2014"
"GONAL-F (NDA #020378)","061","FOLLITROPIN ALFA/BETA","EMD SERONO","Manufacturing Change or Addition","01/30/2014"
"SANDOSTATIN LAR (NDA #021008)","029","OCTREOTIDE ACETATE","NOVARTIS","Manufacturing Change or Addition","01/30/2014"
"ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (NDA #021704)","016","FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","01/30/2014"
"BYETTA (NDA #021773)","034","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Manufacturing Change or Addition","01/30/2014"
"TYZEKA (NDA #022154)","014","TELBIVUDINE","NOVARTIS","Manufacturing Change or Addition","01/30/2014"
"MULTAQ (NDA #022425)","023","DRONEDARONE HYDROCHLORIDE","SANOFI AVENTIS US","Labeling Revision","01/30/2014"
"SUNITINIB MALATE (ANDA #201275)","000","SUNITINIB MALATE","MYLAN PHARMS INC","Approval","01/30/2014"
"ELIQUIS (NDA #202155)","002","APIXABAN","BRISTOL MYERS SQUIBB","Labeling Revision","01/30/2014"
"PROCYSBI (NDA #203389)","004","CYSTEAMINE BITARTRATE","RAPTOR PHARMS","Manufacturing Change or Addition","01/30/2014"
"ICLUSIG (NDA #203469)","004","PONATINIB HYDROCHLORIDE","ARIAD","Manufacturing Change or Addition","01/30/2014"
"ACTHREL (NDA #020162)","009","CORTICORELIN OVINE TRIFLUTATE","FERRING","Manufacturing Change or Addition","01/31/2014"
"HUMALOG (NDA #020563)","143","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/31/2014"
"HUMALOG KWIKPEN (NDA #020563)","143","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/31/2014"
"HUMALOG PEN (NDA #020563)","143","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","01/31/2014"
"PYTEST (NDA #020617)","004","UREA, C-14","AVENT","Manufacturing Change or Addition","01/31/2014"
"PYTEST KIT (NDA #020617)","004","UREA, C-14","AVENT","Manufacturing Change or Addition","01/31/2014"
"PROPECIA (NDA #020788)","024","FINASTERIDE","MERCK","Labeling Revision","01/31/2014"
"SEPTOCAINE (NDA #020971)","030","ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","DEPROCO","Manufacturing Change or Addition","01/31/2014"
"GLUCOPHAGE XR (NDA #021202)","019","METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","01/31/2014"
"REVATIO (NDA #021845)","012","SILDENAFIL CITRATE","PFIZER","Efficacy Supplement with Clinical Data to Support","01/31/2014"
"REVATIO (NDA #021845)","013","SILDENAFIL CITRATE","PFIZER","Labeling Revision","01/31/2014"
"CHILDREN'S ALLEGRA ALLERGY (NDA #021909)","008","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","01/31/2014"
"CHILDREN'S ALLEGRA HIVES (NDA #021909)","008","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","01/31/2014"
"SALONPAS (NDA #022029)","014","MENTHOL; METHYL SALICYLATE","HISAMITSU PHARM CO","Manufacturing Change or Addition","01/31/2014"
"LETAIRIS (NDA #022081)","030","AMBRISENTAN","GILEAD","Labeling Revision","01/31/2014"
"OXYCONTIN (NDA #022272)","020","OXYCODONE HYDROCHLORIDE","PURDUE PHARMA LP","Manufacturing Change or Addition","01/31/2014"
"REVATIO (NDA #022473)","005","SILDENAFIL CITRATE","PFIZER","Labeling Revision","01/31/2014"
"REVATIO (NDA #022473)","006","SILDENAFIL CITRATE","PFIZER","Efficacy Supplement with Clinical Data to Support","01/31/2014"
"CEFTRIAXONE (ANDA #065168)","019","CEFTRIAXONE SODIUM","SANDOZ","Labeling Revision","01/31/2014"
"ZETONNA (NDA #202129)","002","CICLESONIDE","TAKEDA GMBH","Manufacturing Change or Addition","01/31/2014"
"KYPROLIS (NDA #202714)","003","CARFILZOMIB","ONYX PHARMS","Manufacturing Change or Addition","01/31/2014"
"REVATIO (NDA #203109)","003","SILDENAFIL CITRATE","PFIZER","Labeling Revision","01/31/2014"
"REVATIO (NDA #203109)","004","SILDENAFIL CITRATE","PFIZER","Efficacy Supplement with Clinical Data to Support","01/31/2014"
"ATAZANAVIR SULFATE (ANDA #204806)","000","ATAZANAVIR SULFATE","AUROBINDO PHARMA LTD","Tentative Approval","01/31/2014"
"HETLIOZ (NDA #205677)","000","TASIMELTEON","VANDA PHARMS INC","Approval","01/31/2014"
"PEPCID (NDA #019462)","038","FAMOTIDINE","MARATHON PHARMS","Labeling Revision","02/03/2014"
"TRUSOPT (NDA #020408)","050","DORZOLAMIDE HYDROCHLORIDE","MERCK","Labeling Revision","02/03/2014"
"ELIGARD (NDA #021379)","027","LEUPROLIDE ACETATE","TOLMAR THERAP","Manufacturing Change or Addition","02/03/2014"
"LUNESTA (NDA #021476)","028","ESZOPICLONE","SUNOVION PHARMS INC","Labeling Revision","02/03/2014"
"MODAFINIL (ANDA #077667)","000","MODAFINIL","APOTEX INC","Approval","02/03/2014"
"BIVALIRUDIN (ANDA #090816)","000","BIVALIRUDIN","HOSPIRA INC","Tentative Approval","02/03/2014"
"GLYCOPYRROLATE (ANDA #091182)","000","GLYCOPYRROLATE","STASON PHARMS","Approval","02/03/2014"
"SELFEMRA (ANDA #200151)","000","FLUOXETINE HYDROCHLORIDE","TEVA PHARMS USA","Approval","02/03/2014"
"LAMIVUDINE AND ZIDOVUDINE (ANDA #203259)","000","LAMIVUDINE; ZIDOVUDINE","HETERO LABS LTD V","Approval","02/03/2014"
"PRIMAQUINE PHOSPHATE (ANDA #203924)","000","PRIMAQUINE PHOSPHATE","ALVOGEN INC","Approval","02/03/2014"
"EPANED KIT (NDA #204308)","001","ENALAPRIL MALEATE","SILVERGATE PHARMS","Manufacturing Change or Addition","02/03/2014"
"SANDOSTATIN (NDA #019667)","059","OCTREOTIDE ACETATE","NOVARTIS","Manufacturing Change or Addition","02/04/2014"
"EXTRANEAL (NDA #021321)","030","ICODEXTRIN","BAXTER HLTHCARE","Manufacturing Change or Addition","02/04/2014"
"OXYCONTIN (NDA #022272)","015","OXYCODONE HYDROCHLORIDE","PURDUE PHARMA LP","Manufacturing Change or Addition","02/04/2014"
"SIMPONI ARIA (BLA #125433)","002","GOLIMUMAB","JANSSEN BIOTECH","Labeling Revision","02/04/2014"
"LAMIVUDINE; ZIDOVUDINE (NDA #204914)","000","LAMIVUDINE; ZIDOVUDINE","MYLAN LABS","Tentative Approval","02/04/2014"
"PYLERA (NDA #050786)","011","BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE","FOREST LABS INC","Manufacturing Change or Addition","02/05/2014"
"CEFTRIAXONE (ANDA #065169)","022","CEFTRIAXONE SODIUM","SANDOZ","Labeling Revision","02/05/2014"
"CEFPODOXIME PROXETIL (ANDA #065462)","005","CEFPODOXIME PROXETIL","SANDOZ","Labeling Revision","02/05/2014"
"DOXERCALCIFEROL (ANDA #200926)","000","DOXERCALCIFEROL","SANDOZ","Approval","02/05/2014"
"MORPHINE SULFATE (ANDA #201011)","000","MORPHINE SULFATE","CARACO","Approval","02/05/2014"
"LEVONORGESTREL AND ETHINYL ESTRADIOL (ANDA #201108)","000","ETHINYL ESTRADIOL; LEVONORGESTREL","HAUPT PHARMA","Approval","02/05/2014"
"DISULFIRAM (ANDA #202652)","000","DISULFIRAM","ROXANE","Approval","02/05/2014"
"PHENTERMINE HYDROCHLORIDE (ANDA #202846)","000","PHENTERMINE HYDROCHLORIDE","INVAGEN PHARMS","Approval","02/05/2014"
"PHENTERMINE HYDROCHLORIDE (ANDA #202942)","000","PHENTERMINE HYDROCHLORIDE","INVAGEN PHARMS","Approval","02/05/2014"
"ILEVRO (NDA #203491)","003","NEPAFENAC","ALCON RES LTD","Manufacturing Change or Addition","02/05/2014"
"FLUDEOXYGLUCOSE F18 (ANDA #203935)","000","FLUDEOXYGLUCOSE F-18","WUSM CYCLOTRON","Approval","02/05/2014"
"FLUDEOXYGLUCOSE F18 (ANDA #203946)","000","FLUDEOXYGLUCOSE F-18","ESSENTIAL ISOTOPES","Approval","02/05/2014"
"IMURAN (NDA #016324)","037","AZATHIOPRINE","PROMETHEUS LABS","Labeling Revision","02/06/2014"
"ANADROL-50 (NDA #016848)","023","OXYMETHOLONE","MEDA PHARMS","Manufacturing Change or Addition","02/06/2014"
"IMURAN (NDA #017391)","016","AZATHIOPRINE SODIUM","PROMETHEUS LABS","Labeling Revision","02/06/2014"
"CISPLATIN (NDA #018057)","082","CISPLATIN","HQ SPCLT PHARMA","Manufacturing Change or Addition","02/06/2014"
"PLATINOL (NDA #018057)","082","CISPLATIN","HQ SPCLT PHARMA","Manufacturing Change or Addition","02/06/2014"
"PLATINOL-AQ (NDA #018057)","082","CISPLATIN","HQ SPCLT PHARMA","Manufacturing Change or Addition","02/06/2014"
"BUPRENEX (NDA #018401)","018","BUPRENORPHINE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","02/06/2014"
"ALOXI (NDA #021372)","017","PALONOSETRON HYDROCHLORIDE","HELSINN HLTHCARE","Labeling Revision","02/06/2014"
"ARIPIPRAZOLE (ANDA #078583)","000","ARIPIPRAZOLE","APOTEX INC","Tentative Approval","02/06/2014"
"PRAMIPEXOLE DIHYDROCHLORIDE (ANDA #202206)","000","PRAMIPEXOLE DIHYDROCHLORIDE","ANCHEN PHARMS","Approval","02/06/2014"
"ZELBORAF (NDA #202429)","005","VEMURAFENIB","HOFFMANN LA ROCHE","Labeling Revision","02/06/2014"
"RITALIN (NDA #010187)","076","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Manufacturing Change or Addition","02/07/2014"
"ETHAMOLIN (NDA #019357)","018","ETHANOLAMINE OLEATE","QOL MEDCL","Manufacturing Change or Addition","02/07/2014"
"AGRYLIN (NDA #020333)","021","ANAGRELIDE HYDROCHLORIDE","SHIRE LLC","Labeling Revision","02/07/2014"
"VIBATIV (NDA #022110)","007","TELAVANCIN HYDROCHLORIDE","THERAVANCE BIOPHARMA","Labeling Revision","02/07/2014"
"OZURDEX (NDA #022315)","008","DEXAMETHASONE","ALLERGAN","Labeling Revision","02/07/2014"
"CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER (NDA #050796)","018","CEFTRIAXONE SODIUM","B BRAUN","Manufacturing Change or Addition","02/07/2014"
"BUSPIRONE HYDROCHLORIDE (ANDA #078888)","000","BUSPIRONE HYDROCHLORIDE","ZYDUS PHARMS USA INC","Approval","02/07/2014"
"VICTRELIS (NDA #202258)","013","BOCEPREVIR","MERCK SHARP DOHME","Labeling Revision","02/07/2014"
"ZYTIGA (NDA #202379)","008","ABIRATERONE ACETATE","JANSSEN BIOTECH","Manufacturing Change or Addition","02/07/2014"
"ZOLEDRONIC ACID (NDA #203231)","001","ZOLEDRONIC ACID","ACS DOBFAR INFO SA","Manufacturing Change or Addition","02/07/2014"
"AMMONIA N 13 (ANDA #204506)","000","AMMONIA N-13","WA UNIV SCH MED","Approval","02/07/2014"
"VIVITROL (NDA #021897)","024","NALTREXONE","ALKERMES","Manufacturing Change or Addition","02/09/2014"
"OMNIPAQUE 140 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"OMNIPAQUE 180 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"OMNIPAQUE 210 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"OMNIPAQUE 240 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"OMNIPAQUE 300 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"OMNIPAQUE 350 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"OMNIPAQUE 70 (NDA #018956)","091","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","02/10/2014"
"ZAVESCA (NDA #021348)","010","MIGLUSTAT","ACTELION PHARMS LTD","Labeling Revision","02/10/2014"
"PROMACTA (NDA #022291)","010","ELTROMBOPAG OLAMINE","GLAXOSMITHKLINE","Labeling Revision","02/10/2014"
"NPLATE (BLA #125268)","141","ROMIPLOSTIM","AMGEN","Labeling Revision","02/10/2014"
"RAYOS (NDA #202020)","006","PREDNISONE","HORIZON PHARMA","Manufacturing Change or Addition","02/10/2014"
"CLOPIDOGREL BISULFATE (ANDA #202928)","000","CLOPIDOGREL BISULFATE","MACLEODS PHARMS LTD","Approval","02/10/2014"
"KETOROLAC TROMETHAMINE (ANDA #203376)","000","KETOROLAC TROMETHAMINE","AKORN","Approval","02/10/2014"
"SYNRIBO (NDA #203585)","001","OMACETAXINE MEPESUCCINATE","IVAX INTL","Efficacy Supplement with Clinical Data to Support","02/10/2014"
"ASTAGRAF XL (NDA #204096)","001","TACROLIMUS","ASTELLAS","Labeling Revision","02/10/2014"
"MONISTAT-DERM (NDA #017494)","040","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT-DERM (NDA #017494)","065","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT 3 (NDA #018888)","017","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"EDEX (NDA #020649)","021","ALPROSTADIL","AUXILIUM PHARMS LLC","Manufacturing Change or Addition","02/11/2014"
"MONISTAT-3 COMBINATION PACK (NDA #020670)","024","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT 3 (NDA #020827)","023","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT DUAL- PAK (NDA #020968)","005","MICONAZOLE NITRATE","PERSONAL PRODS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT 3 COMBINATION PACK (NDA #021261)","016","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT 3 COMBINATION PACK (PREFILLED) (NDA #021261)","016","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"MONISTAT 1 COMBINATION PACK (NDA #021308)","021","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/11/2014"
"VITRASE (NDA #021640)","022","HYALURONIDASE","BAUSCH AND LOMB","Manufacturing Change or Addition","02/11/2014"
"VPRIV (NDA #022575)","008","VELAGLUCERASE ALFA","SHIRE HUMAN GENETIC","Manufacturing Change or Addition","02/11/2014"
"TRANEXAMIC ACID (ANDA #202436)","000","TRANEXAMIC ACID","ACIC FINE CHEMS","Approval","02/11/2014"
"RIZATRIPTAN BENZOATE (ANDA #203147)","000","RIZATRIPTAN BENZOATE","MACLEODS PHARMS LTD","Approval","02/11/2014"
"ACETYLCYSTEINE (ANDA #204674)","000","ACETYLCYSTEINE","INNOPHARMA LICENSING","Approval","02/11/2014"
"TECHNELITE (NDA #017771)","035","TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR","LANTHEUS MEDCL","Labeling Revision","02/12/2014"
"BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018800)","026","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","02/12/2014"
"SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018803)","027","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","02/12/2014"
"SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #018897)","027","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","02/12/2014"
"RENACIDIN (NDA #019481)","011","CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE","UNITED GUARDIAN","Manufacturing Change or Addition","02/12/2014"
"CUROSURF (NDA #020744)","027","PORACTANT ALFA","CHIESI USA INC","Manufacturing Change or Addition","02/12/2014"
"CHLORAPREP ONE-STEP (NDA #020832)","033","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Manufacturing Change or Addition","02/12/2014"
"CHLORAPREP ONE-STEP FREPP (NDA #020832)","033","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Manufacturing Change or Addition","02/12/2014"
"CHLORAPREP WITH TINT (NDA #020832)","033","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Manufacturing Change or Addition","02/12/2014"
"ZYRTEC-D 12 HOUR (NDA #021150)","011","CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","MCNEIL","Manufacturing Change or Addition","02/12/2014"
"FLUORESCITE (NDA #021980)","005","FLUORESCEIN SODIUM","ALCON PHARMS LTD","Manufacturing Change or Addition","02/12/2014"
"TIMENTIN (NDA #050590)","068","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Manufacturing Change or Addition","02/12/2014"
"SIMPONI ARIA (BLA #125433)","005","GOLIMUMAB","JANSSEN BIOTECH","Labeling Revision","02/12/2014"
"ISOPTO CARPINE (NDA #200890)","006","PILOCARPINE HYDROCHLORIDE","ALCON RES","Manufacturing Change or Addition","02/12/2014"
"TEMOZOLOMIDE (ANDA #201742)","000","TEMOZOLOMIDE","SUN PHARMA GLOBAL","Approval","02/12/2014"
"JANUMET XR (NDA #202270)","006","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","02/12/2014"
"XARELTO (NDA #202439)","005","RIVAROXABAN","JANSSEN PHARMS","Labeling Revision","02/12/2014"
"XARELTO (NDA #202439)","012","RIVAROXABAN","JANSSEN PHARMS","Labeling Revision","02/12/2014"
"IMBRUVICA (NDA #205552)","000","IBRUTINIB","PHARMACYCLICS INC","Approval","02/12/2014"
"CHILDREN'S ADVIL (NDA #020944)","010","IBUPROFEN","PFIZER","Manufacturing Change or Addition","02/13/2014"
"JUNIOR STRENGTH ADVIL (NDA #020944)","010","IBUPROFEN","PFIZER","Manufacturing Change or Addition","02/13/2014"
"XARELTO (NDA #022406)","010","RIVAROXABAN","JANSSEN PHARMS","Labeling Revision","02/13/2014"
"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ANDA #040422)","033","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","BARR","Labeling Revision","02/13/2014"
"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ANDA #040422)","034","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","BARR","Labeling Revision","02/13/2014"
"LIPTRUZET (NDA #200153)","002","ATORVASTATIN CALCIUM; EZETIMIBE","MERCK SHARP DOHME","Manufacturing Change or Addition","02/13/2014"
"VASCEPA (NDA #202057)","006","ICOSAPENT ETHYL","AMARIN PHARMS","Manufacturing Change or Addition","02/13/2014"
"ILEVRO (NDA #203491)","004","NEPAFENAC","ALCON RES LTD","Manufacturing Change or Addition","02/13/2014"
"SEPTOCAINE (NDA #020971)","029","ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","DEPROCO","Manufacturing Change or Addition","02/14/2014"
"NEXIUM (NDA #021153)","048","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Manufacturing Change or Addition","02/14/2014"
"AEROSPAN HFA (NDA #021247)","011","FLUNISOLIDE","MEDA PHARMS INC","Manufacturing Change or Addition","02/14/2014"
"STALEVO 100 (NDA #021485)","032","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","02/14/2014"
"STALEVO 125 (NDA #021485)","032","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","02/14/2014"
"STALEVO 150 (NDA #021485)","032","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","02/14/2014"
"STALEVO 200 (NDA #021485)","032","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","02/14/2014"
"STALEVO 50 (NDA #021485)","032","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","02/14/2014"
"STALEVO 75 (NDA #021485)","032","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Manufacturing Change or Addition","02/14/2014"
"XYZAL (NDA #022064)","027","LEVOCETIRIZINE DIHYDROCHLORIDE","UCB INC","Manufacturing Change or Addition","02/14/2014"
"XYZAL (NDA #022157)","011","LEVOCETIRIZINE DIHYDROCHLORIDE","UCB INC","Manufacturing Change or Addition","02/14/2014"
"NICORETTE (NDA #022360)","008","NICOTINE POLACRILEX","GLAXOSMITHKLINE CONS","Manufacturing Change or Addition","02/14/2014"
"IBANDRONATE SODIUM (ANDA #090853)","000","IBANDRONATE SODIUM","SUN PHARM INDS LTD","Approval","02/14/2014"
"VIMIZIM (BLA #125460)","000","ELOSULFASE ALFA","BIOMARIN PHARM","Approval","02/14/2014"
"XALKORI (NDA #202570)","010","CRIZOTINIB","PF PRISM CV","Manufacturing Change or Addition","02/14/2014"
"FYCOMPA (NDA #202834)","004","PERAMPANEL","EISAI INC","Labeling Revision","02/14/2014"
"PHENTERMINE HYDROCHLORIDE (ANDA #202858)","000","PHENTERMINE HYDROCHLORIDE","INVAGEN PHARMS","Approval","02/14/2014"
"ULTRA-TECHNEKOW FM (NDA #017243)","043","TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR","MALLINCKRODT","Labeling Revision","02/18/2014"
"SORIATANE (NDA #019821)","022","ACITRETIN","STIEFEL LABS INC","Labeling Revision","02/18/2014"
"ZYPREXA RELPREVV (NDA #022173)","020","OLANZAPINE PAMOATE","ELI LILLY CO","Manufacturing Change or Addition","02/18/2014"
"MOXIFLOXACIN HYDROCHLORIDE (ANDA #077437)","000","MOXIFLOXACIN HYDROCHLORIDE","TEVA PHARMS USA","Approval","02/18/2014"
"SUPRENZA (NDA #202088)","007","PHENTERMINE HYDROCHLORIDE","CITIUS PHARMS","Manufacturing Change or Addition","02/18/2014"
"SITAGLIPTIN PHOSPHATE (ANDA #202425)","000","SITAGLIPTIN PHOSPHATE","APOTEX INC","Tentative Approval","02/18/2014"
"NORTHERA (NDA #203202)","000","DROXIDOPA","LUNDBECK NA LTD","Approval","02/18/2014"
"JUXTAPID (NDA #203858)","006","LOMITAPIDE MESYLATE","AEGERION","Labeling Revision","02/18/2014"
"BRAVELLE (NDA #021289)","019","UROFOLLITROPIN","FERRING","Efficacy Supplement with Clinical Data to Support","02/19/2014"
"MENOPUR (NDA #021663)","014","MENOTROPINS (FSH;LH)","FERRING","Efficacy Supplement with Clinical Data to Support","02/19/2014"
"BACTOCILL IN PLASTIC CONTAINER (NDA #050640)","009","OXACILLIN SODIUM","BAXTER HLTHCARE","Manufacturing Change or Addition","02/19/2014"
"COLISTIMETHATE SODIUM (ANDA #201365)","000","COLISTIMETHATE SODIUM","SAGENT PHARMS","Approval","02/19/2014"
"PARAGARD T 380A (NDA #018680)","068","COPPER","TEVA WOMENS","Manufacturing Change or Addition","02/20/2014"
"NICODERM CQ (NDA #020165)","026","NICOTINE","SANOFI AVENTIS US","Manufacturing Change or Addition","02/20/2014"
"COZAAR (NDA #020386)","059","LOSARTAN POTASSIUM","MERCK SHARP DOHME","Manufacturing Change or Addition","02/20/2014"
"STRATTERA (NDA #021411)","044","ATOMOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","02/20/2014"
"HEPSERA (NDA #021449)","022","ADEFOVIR DIPIVOXIL","GILEAD","Manufacturing Change or Addition","02/20/2014"
"EMTRIVA (NDA #021896)","021","EMTRICITABINE","GILEAD","Manufacturing Change or Addition","02/20/2014"
"AFINITOR (NDA #022334)","021","EVEROLIMUS","NOVARTIS","Labeling Revision","02/20/2014"
"AFINITOR (NDA #022334)","023","EVEROLIMUS","NOVARTIS","Labeling Revision","02/20/2014"
"AFINITOR (NDA #022334)","024","EVEROLIMUS","NOVARTIS","Labeling Revision","02/20/2014"
"CLONIDINE HYDROCHLORIDE (ANDA #202601)","000","CLONIDINE HYDROCHLORIDE","ZYDUS PHARMS USA INC","Approval","02/20/2014"
"AFINITOR DISPERZ (NDA #203985)","002","EVEROLIMUS","NOVARTIS PHARM","Labeling Revision","02/20/2014"
"AFINITOR DISPERZ (NDA #203985)","004","EVEROLIMUS","NOVARTIS PHARM","Labeling Revision","02/20/2014"
"AFINITOR DISPERZ (NDA #203985)","005","EVEROLIMUS","NOVARTIS PHARM","Labeling Revision","02/20/2014"
"LODOSYN (NDA #017830)","014","CARBIDOPA","ATON","Labeling Revision","02/21/2014"
"LODOSYN (NDA #017830)","016","CARBIDOPA","ATON","Labeling Revision","02/21/2014"
"LODOSYN (NDA #017830)","017","CARBIDOPA","ATON","Labeling Revision","02/21/2014"
"LODOSYN (NDA #017830)","018","CARBIDOPA","ATON","Labeling Revision","02/21/2014"
"LODOSYN (NDA #017830)","019","CARBIDOPA","ATON","Labeling Revision","02/21/2014"
"LODOSYN (NDA #017830)","030","CARBIDOPA","ATON","Labeling Revision","02/21/2014"
"MDP-BRACCO (NDA #018107)","012","TECHNETIUM TC-99M MEDRONATE KIT","BRACCO","Manufacturing Change or Addition","02/21/2014"
"CIS-MDP (NDA #018124)","023","TECHNETIUM TC-99M MEDRONATE KIT","PHARMALUCENCE","Manufacturing Change or Addition","02/21/2014"
"NICORETTE (NDA #018612)","071","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","02/21/2014"
"NICORETTE (MINT) (NDA #018612)","071","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","02/21/2014"
"STRATTERA (NDA #021411)","043","ATOMOXETINE HYDROCHLORIDE","LILLY","Manufacturing Change or Addition","02/21/2014"
"ANTHELIOS 20 (NDA #021471)","008","AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE","LOREAL USA","Manufacturing Change or Addition","02/21/2014"
"CAPITAL SOLEIL 15 (NDA #021501)","009","AVOBENZONE; ECAMSULE; OCTOCRYLENE","LOREAL USA","Manufacturing Change or Addition","02/21/2014"
"ANTHELIOS SX (NDA #021502)","014","AVOBENZONE; ECAMSULE; OCTOCRYLENE","LOREAL USA","Manufacturing Change or Addition","02/21/2014"
"ANTHELIOS 40 (NDA #022009)","007","AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE","LOREAL USA","Manufacturing Change or Addition","02/21/2014"
"SOMATULINE DEPOT (NDA #022074)","007","LANREOTIDE ACETATE","IPSEN PHARMA","Manufacturing Change or Addition","02/21/2014"
"ZYRTEC ALLERGY (NDA #022578)","004","CETIRIZINE HYDROCHLORIDE","MCNEIL CONSUMER","Manufacturing Change or Addition","02/21/2014"
"CLAFORAN (NDA #050547)","070","CEFOTAXIME SODIUM","SANOFI AVENTIS US","Labeling Revision","02/21/2014"
"CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #050596)","040","CEFOTAXIME SODIUM","SANOFI AVENTIS US","Labeling Revision","02/21/2014"
"CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #050596)","040","CEFOTAXIME SODIUM","SANOFI AVENTIS US","Labeling Revision","02/21/2014"
"BRIMONIDINE TARTRATE; TIMOLOL MALEATE (ANDA #091087)","000","BRIMONIDINE TARTRATE; TIMOLOL MALEATE","SANDOZ","Tentative Approval","02/21/2014"
"PREGABALIN (ANDA #203022)","000","PREGABALIN","APOTEX INC","Tentative Approval","02/21/2014"
"KALYDECO (NDA #203188)","004","IVACAFTOR","VERTEX PHARMS","Efficacy Supplement with Clinical Data to Support","02/21/2014"
"XELJANZ (NDA #203214)","004","TOFACITINIB CITRATE","PF PRISM CV","Efficacy Supplement with Clinical Data to Support","02/21/2014"
"OPANA ER (NDA #021610)","017","OXYMORPHONE HYDROCHLORIDE","ENDO PHARMS","Manufacturing Change or Addition","02/23/2014"
"ZYRTEC ALLERGY (NDA #022578)","003","CETIRIZINE HYDROCHLORIDE","MCNEIL CONSUMER","Manufacturing Change or Addition","02/24/2014"
"RIFABUTIN (ANDA #090033)","000","RIFABUTIN","LUPIN LTD","Approval","02/24/2014"
"MYALEPT (BLA #125390)","000","METRELEPTIN","AMYLIN PHARMS LLC","Approval","02/24/2014"
"VICTRELIS (NDA #202258)","014","BOCEPREVIR","MERCK SHARP DOHME","Labeling Revision","02/24/2014"
"AZITHROMYCIN (ANDA #202308)","000","AZITHROMYCIN","SANDOZ INC","Tentative Approval","02/24/2014"
"JUVISYNC (NDA #202343)","011","SIMVASTATIN; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","02/24/2014"
"FYCOMPA (NDA #202834)","003","PERAMPANEL","EISAI INC","Labeling Revision","02/24/2014"
"TIVORBEX (NDA #204768)","000","INDOMETHACIN","IROKO PHARMS LLC","Approval","02/24/2014"
"CONRAY (NDA #013295)","065","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","02/25/2014"
"CONRAY 43 (NDA #013295)","065","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Manufacturing Change or Addition","02/25/2014"
"NIZORAL (NDA #018533)","041","KETOCONAZOLE","JANSSEN PHARMS","Labeling Revision","02/25/2014"
"BILTRICIDE (NDA #018714)","013","PRAZIQUANTEL","BAYER HLTHCARE","Labeling Revision","02/25/2014"
"PRILOSEC (NDA #019810)","099","OMEPRAZOLE","ASTRAZENECA","Labeling Revision","02/25/2014"
"NOVOLOG (NDA #020986)","075","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"NOVOLOG FLEXPEN (NDA #020986)","075","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"NOVOLOG FLEXTOUCH (NDA #020986)","075","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"NOVOLOG INNOLET (NDA #020986)","075","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"NOVOLOG PENFILL (NDA #020986)","075","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"NEXIUM (NDA #021153)","049","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","02/25/2014"
"EXTRANEAL (NDA #021321)","029","ICODEXTRIN","BAXTER HLTHCARE","Labeling Revision","02/25/2014"
"LEVEMIR (NDA #021536)","048","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"LEVEMIR FLEXPEN (NDA #021536)","048","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"LEVEMIR FLEXTOUCH (NDA #021536)","048","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"LEVEMIR INNOLET (NDA #021536)","048","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"LEVEMIR PENFILL (NDA #021536)","048","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Labeling Revision","02/25/2014"
"ZEGERID (NDA #021636)","015","OMEPRAZOLE; SODIUM BICARBONATE","SANTARUS INC","Labeling Revision","02/25/2014"
"NEXIUM IV (NDA #021689)","028","ESOMEPRAZOLE SODIUM","ASTRAZENECA","Labeling Revision","02/25/2014"
"ZEGERID (NDA #021849)","009","OMEPRAZOLE; SODIUM BICARBONATE","SANTARUS INC","Labeling Revision","02/25/2014"
"NEXIUM (NDA #021957)","016","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","02/25/2014"
"PRILOSEC (NDA #022056)","015","OMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","02/25/2014"
"NEXIUM (NDA #022101)","013","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","02/25/2014"
"VIMOVO (NDA #022511)","012","ESOMEPRAZOLE MAGNESIUM; NAPROXEN","HORIZON PHARMA","Labeling Revision","02/25/2014"
"ZOSYN (NDA #050684)","081","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Manufacturing Change or Addition","02/25/2014"
"TELMISARTAN AND HYDROCHLOROTHIAZIDE (ANDA #091648)","000","HYDROCHLOROTHIAZIDE; TELMISARTAN","MYLAN PHARMS INC","Approval","02/25/2014"
"TELMISARTAN AND HYDROCHLOROTHIAZIDE (ANDA #201192)","000","HYDROCHLOROTHIAZIDE; TELMISARTAN","TORRENT PHARMS LTD","Approval","02/25/2014"
"TELMISARTAN AND HYDROCHLOROTHIAZIDE (ANDA #203010)","000","HYDROCHLOROTHIAZIDE; TELMISARTAN","ALEMBIC PHARMS LTD","Approval","02/25/2014"
"PRIMAQUINE PHOSPHATE (ANDA #204476)","000","PRIMAQUINE PHOSPHATE","BAYSHORE PHARMS LLC","Approval","02/25/2014"
"KETEK (NDA #021144)","017","TELITHROMYCIN","SANOFI AVENTIS US","Manufacturing Change or Addition","02/26/2014"
"REYATAZ (NDA #021567)","034","ATAZANAVIR SULFATE","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","02/26/2014"
"TACLONEX (NDA #022185)","017","BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE","LEO PHARMA AS","Manufacturing Change or Addition","02/26/2014"
"ZIRGAN (NDA #022211)","004","GANCICLOVIR","BAUSCH AND LOMB","Manufacturing Change or Addition","02/26/2014"
"EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE (ANDA #090958)","000","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","CIPLA LTD","Tentative Approval","02/26/2014"
"HUMIRA (BLA #125057)","355","ADALIMUMAB","ABBVIE INC","Labeling Revision","02/26/2014"
"VASCEPA (NDA #202057)","008","ICOSAPENT ETHYL","AMARIN PHARMS","Manufacturing Change or Addition","02/26/2014"
"DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (ANDA #202509)","000","DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE","ANCHEN PHARMS","Approval","02/26/2014"
"MONISTAT 7 (NDA #017450)","066","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/27/2014"
"PARLODEL (NDA #017962)","072","BROMOCRIPTINE MESYLATE","US PHARMS HOLDINGS I","Manufacturing Change or Addition","02/27/2014"
"MONISTAT 3 (NDA #018888)","018","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/27/2014"
"MEVACOR (NDA #019643)","088","LOVASTATIN","MERCK","Labeling Revision","02/27/2014"
"ZOCOR (NDA #019766)","091","SIMVASTATIN","MERCK","Labeling Revision","02/27/2014"
"MIACALCIN (NDA #020313)","035","CALCITONIN SALMON","NOVARTIS","Manufacturing Change or Addition","02/27/2014"
"CEREZYME (NDA #020367)","090","IMIGLUCERASE","GENZYME","Manufacturing Change or Addition","02/27/2014"
"MONISTAT 3 (NDA #020827)","024","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/27/2014"
"ANDROGEL (NDA #021015)","037","TESTOSTERONE","ABBVIE","Manufacturing Change or Addition","02/27/2014"
"MONISTAT 3 COMBINATION PACK (NDA #021261)","017","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/27/2014"
"MONISTAT 3 COMBINATION PACK (PREFILLED) (NDA #021261)","017","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","02/27/2014"
"VYTORIN (NDA #021687)","050","EZETIMIBE; SIMVASTATIN","MSD INTL","Labeling Revision","02/27/2014"
"ELESTRIN (NDA #021813)","004","ESTRADIOL","MEDA PHARMS","Manufacturing Change or Addition","02/27/2014"
"BROVANA (NDA #021912)","023","ARFORMOTEROL TARTRATE","SUNOVION","Efficacy Supplement with Clinical Data to Support","02/27/2014"
"SYMBICORT (NDA #021929)","036","BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE","ASTRAZENECA","Manufacturing Change or Addition","02/27/2014"
"AXIRON (NDA #022504)","009","TESTOSTERONE","ELI LILLY AND CO","Manufacturing Change or Addition","02/27/2014"
"DILANTIN (ANDA #084349)","062","PHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","02/27/2014"
"DILANTIN (ANDA #084349)","072","PHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","02/27/2014"
"DILANTIN (ANDA #084427)","017","PHENYTOIN","PFIZER PHARMS","Labeling Revision","02/27/2014"
"DILANTIN (ANDA #084427)","022","PHENYTOIN","PFIZER PHARMS","Labeling Revision","02/27/2014"
"DILANTIN (ANDA #084427)","025","PHENYTOIN","PFIZER PHARMS","Labeling Revision","02/27/2014"
"DILANTIN (ANDA #084427)","030","PHENYTOIN","PFIZER PHARMS","Labeling Revision","02/27/2014"
"LUCENTIS (BLA #125156)","094","RANIBIZUMAB","GENENTECH","Efficacy Supplement with Clinical Data to Support","02/27/2014"
"PHOSPHOLINE IODIDE (NDA #011963)","047","ECHOTHIOPHATE IODIDE","WYETH PHARMS INC","Manufacturing Change or Addition","02/28/2014"
"PREGNYL (NDA #017692)","024","GONADOTROPIN, CHORIONIC","ORGANON USA INC","Manufacturing Change or Addition","02/28/2014"
"DDAVP (NDA #017922)","043","DESMOPRESSIN ACETATE","SANOFI AVENTIS US","Manufacturing Change or Addition","02/28/2014"
"DDAVP (NEEDS NO REFRIGERATION) (NDA #017922)","043","DESMOPRESSIN ACETATE","SANOFI AVENTIS US","Manufacturing Change or Addition","02/28/2014"
"MPI DMSA KIDNEY REAGENT (NDA #017944)","024","TECHNETIUM TC-99M SUCCIMER KIT","GE HEALTHCARE","Manufacturing Change or Addition","02/28/2014"
"LIDEX (NDA #018849)","020","FLUOCINONIDE","CNTY LINE PHARMS","Manufacturing Change or Addition","02/28/2014"
"DDAVP (NDA #018938)","031","DESMOPRESSIN ACETATE","SANOFI AVENTIS US","Manufacturing Change or Addition","02/28/2014"
"DDAVP (NDA #019955)","016","DESMOPRESSIN ACETATE","SANOFI AVENTIS US","Manufacturing Change or Addition","02/28/2014"
"VOLTAREN-XR (NDA #020254)","025","DICLOFENAC SODIUM","NOVARTIS","Manufacturing Change or Addition","02/28/2014"
"HYCAMTIN (NDA #020671)","020","TOPOTECAN HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","02/28/2014"
"INOMAX (NDA #020845)","015","NITRIC OXIDE","INO","Manufacturing Change or Addition","02/28/2014"
"TRILEPTAL (NDA #021285)","028","OXCARBAZEPINE","NOVARTIS","Manufacturing Change or Addition","02/28/2014"
"MEN'S ROGAINE (NDA #021812)","009","MINOXIDIL","JOHNSON AND JOHNSON","General Efficacy (MarkIV)","02/28/2014"
"WOMEN'S ROGAINE (NDA #021812)","009","MINOXIDIL","JOHNSON AND JOHNSON","General Efficacy (MarkIV)","02/28/2014"
"FLO-PRED (NDA #022067)","010","PREDNISOLONE ACETATE","TARO","Manufacturing Change or Addition","02/28/2014"
"BYDUREON (NDA #022200)","008","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling Revision","02/28/2014"
"SAMSCA (NDA #022275)","014","TOLVAPTAN","OTSUKA AMERICA PHARM","Labeling Revision","02/28/2014"
"ANDROGEL (NDA #022309)","010","TESTOSTERONE","ABBVIE","Manufacturing Change or Addition","02/28/2014"
"TOPOTECAN HYDROCHLORIDE (NDA #022453)","002","TOPOTECAN HYDROCHLORIDE","TEVA PHARMS USA","Labeling Revision","02/28/2014"
"ACANYA (NDA #050819)","010","BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","DOW PHARM","Labeling Revision","02/28/2014"
"KALBITOR (BLA #125277)","070","ECALLANTIDE","DYAX CORP.","Efficacy Supplement with Clinical Data to Support","02/28/2014"
"TOPOTECAN (NDA #200199)","003","TOPOTECAN HYDROCHLORIDE","SANDOZ INC","Labeling Revision","02/28/2014"
"TEFLARO (NDA #200327)","012","CEFTAROLINE FOSAMIL","CEREXA","Manufacturing Change or Addition","02/28/2014"
"TOPOTECAN HYDROCHLORIDE (NDA #200582)","001","TOPOTECAN HYDROCHLORIDE","HOSPIRA INC","Labeling Revision","02/28/2014"
"LATUDA (NDA #200603)","017","LURASIDONE HYDROCHLORIDE","SUNOVION PHARMS INC","Manufacturing Change or Addition","02/28/2014"
"COMETRIQ (NDA #203756)","001","CABOZANTINIB S-MALATE","EXELIXIS","Manufacturing Change or Addition","02/28/2014"
"ASTAGRAF XL (NDA #204096)","002","TACROLIMUS","ASTELLAS","Labeling Revision","02/28/2014"
"AZULFIDINE (NDA #007073)","128","SULFASALAZINE","PHARMACIA AND UPJOHN","Labeling Revision","03/04/2014"
"AZULFIDINE EN-TABS (NDA #007073)","128","SULFASALAZINE","PHARMACIA AND UPJOHN","Labeling Revision","03/04/2014"
"HUMULIN N (NDA #018781)","139","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/04/2014"
"HUMULIN 70/30 (NDA #019717)","118","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/04/2014"
"HUMULIN 70/30 PEN (NDA #019717)","118","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/04/2014"
"ADAGEN (NDA #019818)","052","PEGADEMASE BOVINE","SIGMA TAU","Manufacturing Change or Addition","03/04/2014"
"HUMALOG (NDA #020563)","144","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/04/2014"
"HUMALOG KWIKPEN (NDA #020563)","144","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/04/2014"
"HUMALOG PEN (NDA #020563)","144","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/04/2014"
"CRINONE (NDA #020701)","027","PROGESTERONE","WATSON LABS","Manufacturing Change or Addition","03/04/2014"
"NOVOLOG (NDA #020986)","074","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"NOVOLOG FLEXPEN (NDA #020986)","074","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"NOVOLOG FLEXTOUCH (NDA #020986)","074","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"NOVOLOG INNOLET (NDA #020986)","074","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"NOVOLOG PENFILL (NDA #020986)","074","INSULIN ASPART RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"PROTONIX IV (NDA #020988)","047","PANTOPRAZOLE SODIUM","WYETH PHARMS INC","Manufacturing Change or Addition","03/04/2014"
"HUMALOG MIX 75/25 (NDA #021017)","097","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/04/2014"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","097","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/04/2014"
"HUMALOG MIX 75/25 PEN (NDA #021017)","097","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/04/2014"
"COPEGUS (NDA #021511)","027","RIBAVIRIN","ROCHE","Manufacturing Change or Addition","03/04/2014"
"LEVEMIR (NDA #021536)","046","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"LEVEMIR FLEXPEN (NDA #021536)","046","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"LEVEMIR FLEXTOUCH (NDA #021536)","046","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"LEVEMIR INNOLET (NDA #021536)","046","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"LEVEMIR PENFILL (NDA #021536)","046","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","03/04/2014"
"NEXIUM IV (NDA #021689)","014","ESOMEPRAZOLE SODIUM","ASTRAZENECA","Efficacy Supplement with Clinical Data to Support","03/04/2014"
"DUEXIS (NDA #022519)","008","FAMOTIDINE; IBUPROFEN","HORIZON PHARMA","Manufacturing Change or Addition","03/04/2014"
"CLOPIDOGREL BISULFATE (ANDA #076274)","000","CLOPIDOGREL BISULFATE","APOTEX INC","Approval","03/04/2014"
"MOXIFLOXACIN HYDROCHLORIDE (ANDA #076938)","000","MOXIFLOXACIN HYDROCHLORIDE","DR REDDYS LABS LTD","Approval","03/04/2014"
"RALOXIFENE HYDROCHLORIDE (ANDA #078193)","000","RALOXIFENE HYDROCHLORIDE","TEVA PHARMS USA","Approval","03/04/2014"
"OXYBUTYNIN (ANDA #090526)","000","OXYBUTYNIN","BARR LABS DIV TEVA","Approval","03/04/2014"
"RALOXIFENE HYDROCHLORIDE (ANDA #090842)","000","RALOXIFENE HYDROCHLORIDE","INVAGEN PHARMS","Tentative Approval","03/04/2014"
"ZOLMITRIPTAN (ANDA #090861)","000","ZOLMITRIPTAN","TEVA PHARMS USA","Approval","03/04/2014"
"STELARA (BLA #125261)","114","USTEKINUMAB","CENTOCOR ORTHO BIOTECH INC","Labeling Revision","03/04/2014"
"LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (ANDA #202588)","000","AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE","SANDOZ","Approval","03/04/2014"
"MOXIFLOXACIN HYDROCHLORIDE (ANDA #202632)","000","MOXIFLOXACIN HYDROCHLORIDE","AUROBINDO PHARMA LTD","Approval","03/04/2014"
"COLAZAL (NDA #020610)","019","BALSALAZIDE DISODIUM","SALIX PHARMS","Manufacturing Change or Addition","03/05/2014"
"GLUCOPHAGE XR (NDA #021202)","020","METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","03/05/2014"
"FORTEO (NDA #021318)","037","TERIPARATIDE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/05/2014"
"MIRALAX (NDA #022015)","019","POLYETHYLENE GLYCOL 3350","SCHERING PLOUGH","Manufacturing Change or Addition","03/05/2014"
"AVEED (NDA #022219)","000","TESTOSTERONE UNDECANOATE","ENDO PHARMS INC","Approval","03/05/2014"
"RISEDRONATE SODIUM (ANDA #090877)","000","RISEDRONATE SODIUM","APOTEX INC","Tentative Approval","03/05/2014"
"CIPROFLOXACIN (ANDA #200563)","000","CIPROFLOXACIN","LUPIN LTD","Approval","03/05/2014"
"DOXYCYCLINE (ANDA #204234)","000","DOXYCYCLINE","LUPIN LTD","Approval","03/05/2014"
"ALDACTAZIDE (NDA #012616)","075","HYDROCHLOROTHIAZIDE; SPIRONOLACTONE","GD SEARLE LLC","Labeling Revision","03/06/2014"
"TYLENOL (NDA #019872)","040","ACETAMINOPHEN","MCNEIL CONS","Labeling Revision","03/06/2014"
"REVATIO (NDA #021845)","014","SILDENAFIL CITRATE","PFIZER","Labeling Revision","03/06/2014"
"XARELTO (NDA #022406)","009","RIVAROXABAN","JANSSEN PHARMS","Labeling Revision","03/06/2014"
"REVATIO (NDA #022473)","007","SILDENAFIL CITRATE","PFIZER","Labeling Revision","03/06/2014"
"AMLODIPINE BESYLATE; VALSARTAN (ANDA #091235)","000","AMLODIPINE BESYLATE; VALSARTAN","TEVA PHARMS USA","Tentative Approval","03/06/2014"
"ACYCLOVIR (ANDA #201445)","000","ACYCLOVIR","CADILA PHARMS LTD","Approval","03/06/2014"
"SPIRONOLACTONE (ANDA #202187)","000","SPIRONOLACTONE","ORION CORP ORION","Approval","03/06/2014"
"REVATIO (NDA #203109)","005","SILDENAFIL CITRATE","PFIZER","Labeling Revision","03/06/2014"
"NALOXONE HYDROCHLORIDE (ANDA #204997)","000","NALOXONE HYDROCHLORIDE","MYLAN INSTITUTIONAL","Approval","03/06/2014"
"KEPPRA (NDA #021035)","091","LEVETIRACETAM","UCB INC","Labeling Revision","03/07/2014"
"NITROSTAT (NDA #021134)","007","NITROGLYCERIN","PFIZER PHARMS","Labeling Revision","03/07/2014"
"MIRENA (NDA #021225)","029","LEVONORGESTREL","BAYER HLTHCARE","Manufacturing Change or Addition","03/07/2014"
"CLARINEX-D 12 HOUR (NDA #021313)","005","DESLORATADINE; PSEUDOEPHEDRINE SULFATE","MERCK SHARP DOHME","Labeling Revision","03/07/2014"
"KEPPRA (NDA #021505)","031","LEVETIRACETAM","UCB INC","Labeling Revision","03/07/2014"
"CLARINEX D 24 HOUR (NDA #021605)","012","DESLORATADINE; PSEUDOEPHEDRINE SULFATE","MERCK SHARP DOHME","Labeling Revision","03/07/2014"
"NEVANAC (NDA #021862)","010","NEPAFENAC","ALCON PHARMS LTD","Manufacturing Change or Addition","03/07/2014"
"KEPPRA (NDA #021872)","015","LEVETIRACETAM","UCB INC","Labeling Revision","03/07/2014"
"STAVZOR (NDA #022152)","006","VALPROIC ACID","BANNER PHARMACAPS","Labeling Revision","03/07/2014"
"KEPPRA XR (NDA #022285)","016","LEVETIRACETAM","UCB INC","Labeling Revision","03/07/2014"
"KEPPRA XR (NDA #022285)","019","LEVETIRACETAM","UCB INC","Labeling Revision","03/07/2014"
"BRILINTA (NDA #022433)","011","TICAGRELOR","ASTRAZENECA LP","Manufacturing Change or Addition","03/07/2014"
"PANCREAZE (NDA #022523)","004","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","JANSSEN PHARMS","Manufacturing Change or Addition","03/07/2014"
"GENTAMICIN SULFATE (ANDA #062366)","033","GENTAMICIN SULFATE","FRESENIUS KABI USA","Labeling Revision","03/07/2014"
"DEXTROAMPHETAMINE SULFATE (ANDA #090652)","000","DEXTROAMPHETAMINE SULFATE","COREPHARMA","Approval","03/07/2014"
"HERCEPTIN (BLA #103792)","5311","TRASTUZUMAB","GENENTECH","Efficacy Supplement with Clinical Data to Support","03/07/2014"
"ERWINAZE (BLA #125359)","070","asparaginase Erwinia chrysanthemi","EUSA PHARMA USA","Labeling Revision","03/07/2014"
"MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE (ANDA #202150)","000","HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE","HERITAGE PHARMS INC","Approval","03/07/2014"
"AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM (ANDA #203874)","000","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","DR REDDYS LABS LTD","Approval","03/07/2014"
"MONISTAT 7 (NDA #017450)","067","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","03/10/2014"
"MONISTAT 3 (NDA #020827)","025","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","03/10/2014"
"ACOVA (NDA #020883)","016","ARGATROBAN","PFIZER","Labeling Revision","03/10/2014"
"MONISTAT 3 COMBINATION PACK (NDA #021261)","018","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","03/10/2014"
"MONISTAT 3 COMBINATION PACK (PREFILLED) (NDA #021261)","018","MICONAZOLE NITRATE","INSIGHT PHARMS","Manufacturing Change or Addition","03/10/2014"
"SYNERA (NDA #021623)","015","LIDOCAINE; TETRACAINE","GALEN SPECIALTY","Labeling Revision","03/10/2014"
"SYNERA (NDA #021623)","017","LIDOCAINE; TETRACAINE","GALEN SPECIALTY","Labeling Revision","03/10/2014"
"ORABLOC (NDA #022466)","002","ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","PIERREL","Manufacturing Change or Addition","03/10/2014"
"RISPERIDONE (ANDA #078036)","000","RISPERIDONE","CARACO","Approval","03/10/2014"
"OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE (ANDA #200532)","000","OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE","TEVA PHARMS USA INC","Tentative Approval","03/10/2014"
"SITAGLIPTIN; METFORMIN HYDROCHLORIDE (ANDA #202426)","000","SITAGLIPTIN; METFORMIN HYDROCHLORIDE","APOTEX INC","Tentative Approval","03/10/2014"
"CARBIDOPA (ANDA #203261)","000","CARBIDOPA","AMERIGEN PHARMS LTD","Approval","03/10/2014"
"DANTRIUM (NDA #017443)","064","DANTROLENE SODIUM","PAR STERILE PRODUCTS","Manufacturing Change or Addition","03/11/2014"
"MIACALCIN (NDA #017808)","035","CALCITONIN SALMON","NOVARTIS","Labeling Revision","03/11/2014"
"MOTRIN IB (NDA #019012)","052","IBUPROFEN","MCNEIL","Manufacturing Change or Addition","03/11/2014"
"MOTRIN MIGRAINE PAIN (NDA #019012)","052","IBUPROFEN","MCNEIL","Manufacturing Change or Addition","03/11/2014"
"NUPRIN (NDA #019012)","052","IBUPROFEN","MCNEIL","Manufacturing Change or Addition","03/11/2014"
"PROSCAR (NDA #020180)","044","FINASTERIDE","MERCK","Labeling Revision","03/11/2014"
"MIACALCIN (NDA #020313)","034","CALCITONIN SALMON","NOVARTIS","Labeling Revision","03/11/2014"
"ULTANE (NDA #020478)","025","SEVOFLURANE","ABBVIE","Labeling Revision","03/11/2014"
"ULTANE (NDA #020478)","026","SEVOFLURANE","ABBVIE","Labeling Revision","03/11/2014"
"INFASURF PRESERVATIVE FREE (NDA #020521)","027","CALFACTANT","ONY","Manufacturing Change or Addition","03/11/2014"
"PEDIATRIC ADVIL (NDA #020812)","021","IBUPROFEN","PFIZER","Manufacturing Change or Addition","03/11/2014"
"VIAGRA (NDA #020895)","039","SILDENAFIL CITRATE","PFIZER IRELAND","Labeling Revision","03/11/2014"
"VIAGRA (NDA #020895)","042","SILDENAFIL CITRATE","PFIZER IRELAND","Efficacy Supplement with Clinical Data to Support","03/11/2014"
"REVATIO (NDA #021845)","011","SILDENAFIL CITRATE","PFIZER","Labeling Revision","03/11/2014"
"EVAMIST (NDA #022014)","006","ESTRADIOL","LUMARA HEALTH INC","Labeling Revision","03/11/2014"
"AKTEN (NDA #022221)","005","LIDOCAINE HYDROCHLORIDE","AKORN","Labeling Revision","03/11/2014"
"WELCHOL (NDA #022362)","019","COLESEVELAM HYDROCHLORIDE","DAIICHI SANKYO","Manufacturing Change or Addition","03/11/2014"
"REVATIO (NDA #022473)","004","SILDENAFIL CITRATE","PFIZER","Labeling Revision","03/11/2014"
"CEFAZOLIN AND DEXTROSE (NDA #050779)","021","CEFAZOLIN SODIUM","B BRAUN","Manufacturing Change or Addition","03/11/2014"
"ROSUVASTATIN CALCIUM (ANDA #079166)","000","ROSUVASTATIN CALCIUM","TEVA PHARMS","Tentative Approval","03/11/2014"
"ACAMPROSATE CALCIUM (ANDA #200142)","000","ACAMPROSATE CALCIUM","MYLAN PHARMS INC","Approval","03/11/2014"
"CETIRIZINE HYDROCHLORIDE ALLERGY (ANDA #202277)","000","CETIRIZINE HYDROCHLORIDE","IPCA LABS LTD","Approval","03/11/2014"
"CETIRIZINE HYDROCHLORIDE HIVES (ANDA #202277)","000","CETIRIZINE HYDROCHLORIDE","IPCA LABS LTD","Approval","03/11/2014"
"REVATIO (NDA #203109)","002","SILDENAFIL CITRATE","PFIZER","Labeling Revision","03/11/2014"
"ZOLEDRONIC ACID (NDA #203231)","004","ZOLEDRONIC ACID","ACS DOBFAR INFO SA","Manufacturing Change or Addition","03/11/2014"
"XARTEMIS XR (NDA #204031)","000","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","MALLINCKRODT INC","Approval","03/11/2014"
"QUDEXY XR (NDA #205122)","000","TOPIRAMATE","UPSHER SMITH","Approval","03/11/2014"
"FREAMINE 8.5% (NDA #016822)","072","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"FREAMINE HBC 6.9% (NDA #016822)","072","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"FREAMINE II 8.5% (NDA #016822)","072","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"FREAMINE III 10% (NDA #016822)","072","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"FREAMINE III 3% W/ ELECTROLYTES (NDA #016822)","072","AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"FREAMINE III 8.5% (NDA #016822)","072","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"FREAMINE III 8.5% W/ ELECTROLYTES (NDA #016822)","072","AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE","B BRAUN","Manufacturing Change or Addition","03/12/2014"
"EDEX (NDA #020649)","022","ALPROSTADIL","AUXILIUM PHARMS LLC","Manufacturing Change or Addition","03/12/2014"
"ZOMIG (NDA #020768)","022","ZOLMITRIPTAN","IPR","Manufacturing Change or Addition","03/12/2014"
"PLAVIX (NDA #020839)","059","CLOPIDOGREL BISULFATE","SANOFI AVENTIS US","Manufacturing Change or Addition","03/12/2014"
"ATROPINE SULFATE ANSYR PLASTIC SYRINGE (NDA #021146)","014","ATROPINE SULFATE","HOSPIRA","Manufacturing Change or Addition","03/12/2014"
"XIFAXAN (NDA #021361)","013","RIFAXIMIN","SALIX PHARMS","Labeling Revision","03/12/2014"
"ALPHAGAN P (NDA #021770)","008","BRIMONIDINE TARTRATE","ALLERGAN","Manufacturing Change or Addition","03/12/2014"
"SUBOXONE (NDA #022410)","014","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","03/12/2014"
"ZYMAXID (NDA #022548)","001","GATIFLOXACIN","ALLERGAN","Manufacturing Change or Addition","03/12/2014"
"METHYLPHENIDATE HYDROCHLORIDE (ANDA #091159)","000","METHYLPHENIDATE HYDROCHLORIDE","COREPHARMA","Approval","03/12/2014"
"PICATO (NDA #202833)","002","INGENOL MEBUTATE","LEO PHARMA AS","Labeling Revision","03/12/2014"
"LIDOCAINE HYDROCHLORIDE (ANDA #204494)","000","LIDOCAINE HYDROCHLORIDE","IGI LABS INC","Approval","03/12/2014"
"HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019339)","054","HEPARIN SODIUM","HOSPIRA","Labeling Revision","03/13/2014"
"HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019339)","054","HEPARIN SODIUM","HOSPIRA","Labeling Revision","03/13/2014"
"HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019339)","054","HEPARIN SODIUM","HOSPIRA","Labeling Revision","03/13/2014"
"HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019805)","036","HEPARIN SODIUM","HOSPIRA","Labeling Revision","03/13/2014"
"HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019805)","036","HEPARIN SODIUM","HOSPIRA","Labeling Revision","03/13/2014"
"ASTELIN (NDA #020114)","025","AZELASTINE HYDROCHLORIDE","MEDA PHARMS","Manufacturing Change or Addition","03/13/2014"
"VELCADE (NDA #021602)","037","BORTEZOMIB","MILLENNIUM PHARMS","Manufacturing Change or Addition","03/13/2014"
"TACLONEX (NDA #021852)","014","BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE","LEO PHARMA AS","Manufacturing Change or Addition","03/13/2014"
"VIBATIV (NDA #022110)","009","TELAVANCIN HYDROCHLORIDE","THERAVANCE BIOPHARMA","Manufacturing Change or Addition","03/13/2014"
"ASTEPRO (NDA #022203)","009","AZELASTINE HYDROCHLORIDE","MEDA PHARMS","Manufacturing Change or Addition","03/13/2014"
"ELIQUIS (NDA #202155)","003","APIXABAN","BRISTOL MYERS SQUIBB","Efficacy Supplement with Clinical Data to Support","03/13/2014"
"DOCETAXEL (NDA #202356)","000","DOCETAXEL","PFIZER LABS","Approval","03/13/2014"
"MYRBETRIQ (NDA #202611)","003","MIRABEGRON","APGDI","Manufacturing Change or Addition","03/13/2014"
"CLINDAMYCIN PALMITATE HYDROCHLORIDE (ANDA #203513)","000","CLINDAMYCIN PALMITATE HYDROCHLORIDE","AMNEAL PHARMS","Approval","03/13/2014"
"POMALYST (NDA #204026)","003","POMALIDOMIDE","CELGENE","Labeling Revision","03/13/2014"
"SODIUM FLUORIDE F-18 (ANDA #204437)","000","SODIUM FLUORIDE F-18","UCSF RODIOPHARM","Approval","03/13/2014"
"NOXAFIL (NDA #205596)","000","POSACONAZOLE","MERCK SHARP DOHME","Approval","03/13/2014"
"NAVELBINE (NDA #020388)","027","VINORELBINE TARTRATE","PIERRE FABRE","Labeling Revision","03/14/2014"
"TRELSTAR (NDA #020715)","031","TRIPTORELIN PAMOATE","WATSON LABS","Manufacturing Change or Addition","03/14/2014"
"GLUCAGEN (NDA #020918)","042","GLUCAGON HYDROCHLORIDE RECOMBINANT","NOVO NORDISK","Labeling Revision","03/14/2014"
"LIALDA (NDA #022000)","012","MESALAMINE","SHIRE","Labeling Revision","03/14/2014"
"DICLOFENAC SODIUM AND MISOPROSTOL (ANDA #200540)","000","DICLOFENAC SODIUM; MISOPROSTOL","EAGLE PHARMS","Approval","03/14/2014"
"JEVTANA KIT (NDA #201023)","010","CABAZITAXEL","SANOFI AVENTIS US","Labeling Revision","03/14/2014"
"JEVTANA KIT (NDA #201023)","012","CABAZITAXEL","SANOFI AVENTIS US","Labeling Revision","03/14/2014"
"AMYVID (NDA #202008)","021","FLORBETAPIR F-18","AVID RADIOPHARMS INC","Manufacturing Change or Addition","03/14/2014"
"OSELTAMIVIR PHOSPHATE (ANDA #202595)","000","OSELTAMIVIR PHOSPHATE","NATCO PHARMA","Tentative Approval","03/14/2014"
"LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE (NDA #205355)","000","LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE","HETERO LABS LTD III","Tentative Approval","03/14/2014"
"HEMANGEOL (NDA #205410)","000","PROPRANOLOL HYDROCHLORIDE","PIERRE FABRE DERMA","Approval","03/14/2014"
"MESNEX (NDA #019884)","013","MESNA","BAXTER HLTHCARE","Labeling Revision","03/17/2014"
"DIOVAN (NDA #020665)","034","VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"DIOVAN (NDA #020665)","035","VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"CREON (NDA #020725)","009","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","ABBVIE","Manufacturing Change or Addition","03/17/2014"
"DIOVAN HCT (NDA #020818)","058","HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"DIOVAN HCT (NDA #020818)","062","HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"MESNEX (NDA #020855)","002","MESNA","BAXTER HLTHCARE","Labeling Revision","03/17/2014"
"DIOVAN (NDA #021283)","041","VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"DIOVAN (NDA #021283)","042","VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"MEGACE ES (NDA #021778)","015","MEGESTROL ACETATE","PAR PHARM","Manufacturing Change or Addition","03/17/2014"
"EXFORGE (NDA #021990)","020","AMLODIPINE BESYLATE; VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"EXFORGE (NDA #021990)","021","AMLODIPINE BESYLATE; VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"EXFORGE HCT (NDA #022314)","015","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"EXFORGE HCT (NDA #022314)","016","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Labeling Revision","03/17/2014"
"ATAZANAVIR SULFATE; RITONAVIR (NDA #205508)","000","ATAZANAVIR SULFATE; RITONAVIR","EMCURE PHARMS LTD","Tentative Approval","03/17/2014"
"ROBINUL (NDA #017558)","060","GLYCOPYRROLATE","HIKMA MAPLE","Manufacturing Change or Addition","03/18/2014"
"HUMULIN R (NDA #018780)","146","INSULIN RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMULIN R PEN (NDA #018780)","146","INSULIN RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMULIN N (NDA #018781)","140","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMULIN 70/30 (NDA #019717)","119","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMULIN 70/30 PEN (NDA #019717)","119","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG (NDA #020563)","145","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG KWIKPEN (NDA #020563)","145","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG PEN (NDA #020563)","145","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG MIX 75/25 (NDA #021017)","098","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","098","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG MIX 75/25 PEN (NDA #021017)","098","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG MIX 50/50 (NDA #021018)","090","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG MIX 50/50 KWIKPEN (NDA #021018)","090","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"HUMALOG MIX 50/50 PEN (NDA #021018)","090","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","03/18/2014"
"TEKTURNA (NDA #021985)","026","ALISKIREN HEMIFUMARATE","NOVARTIS","Labeling Revision","03/18/2014"
"JANUMET (NDA #022044)","030","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","MERCK SHARP DOHME","Manufacturing Change or Addition","03/18/2014"
"TEKTURNA HCT (NDA #022107)","024","ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE","NOVARTIS","Labeling Revision","03/18/2014"
"TEKAMLO (NDA #022545)","015","ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE","NOVARTIS","Labeling Revision","03/18/2014"
"ACANYA (NDA #050819)","011","BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","DOW PHARM","Manufacturing Change or Addition","03/18/2014"
"AMTURNIDE (NDA #200045)","015","ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE","NOVARTIS","Labeling Revision","03/18/2014"
"ATOVAQUONE (ANDA #202960)","000","ATOVAQUONE","AMNEAL PHARMS","Approval","03/18/2014"
"DIAMOX (NDA #012945)","045","ACETAZOLAMIDE","DURAMED PHARMS BARR","Manufacturing Change or Addition","03/19/2014"
"GALLIUM CITRATE GA 67 (NDA #018058)","013","GALLIUM CITRATE GA-67","MALLINCKRODT","Manufacturing Change or Addition","03/19/2014"
"PERFOROMIST (NDA #022007)","009","FORMOTEROL FUMARATE","MYLAN SPECLT","Manufacturing Change or Addition","03/19/2014"
"MULTAQ (NDA #022425)","022","DRONEDARONE HYDROCHLORIDE","SANOFI AVENTIS US","Labeling Revision","03/19/2014"
"MULTAQ (NDA #022425)","024","DRONEDARONE HYDROCHLORIDE","SANOFI AVENTIS US","Labeling Revision","03/19/2014"
"MULTAQ (NDA #022425)","026","DRONEDARONE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","03/19/2014"
"PENICILLIN G POTASSIUM IN PLASTIC CONTAINER (NDA #050638)","018","PENICILLIN G POTASSIUM","BAXTER HLTHCARE","Manufacturing Change or Addition","03/19/2014"
"PROGRAF (NDA #050708)","044","TACROLIMUS","ASTELLAS","Manufacturing Change or Addition","03/19/2014"
"SODIUM POLYSTYRENE SULFONATE (ANDA #202333)","000","SODIUM POLYSTYRENE SULFONATE","EPIC PHARMA LLC","Approval","03/19/2014"
"ZELBORAF (NDA #202429)","004","VEMURAFENIB","HOFFMANN LA ROCHE","Efficacy Supplement with Clinical Data to Support","03/19/2014"
"QNASL (NDA #202813)","005","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Labeling Revision","03/19/2014"
"SIRTURO (NDA #204384)","001","BEDAQUILINE FUMARATE","JANSSEN THERAP","Manufacturing Change or Addition","03/19/2014"
"NEURACEQ (NDA #204677)","000","FLORBETABEN F-18","PIRAMAL IMAGING","Approval","03/19/2014"
"IMPAVIDO (NDA #204684)","000","MILTEFOSINE","PALADIN THERAP","Approval","03/19/2014"
"SODIUM IODIDE I 131 (NDA #016515)","012","SODIUM IODIDE I-131","MALLINCKRODT","Labeling Revision","03/20/2014"
"SODIUM IODIDE I 131 (NDA #016517)","011","SODIUM IODIDE I-131","MALLINCKRODT","Labeling Revision","03/20/2014"
"SUFENTA PRESERVATIVE FREE (NDA #019050)","032","SUFENTANIL CITRATE","AKORN","Labeling Revision","03/20/2014"
"FENTANYL CITRATE PRESERVATIVE FREE (NDA #019101)","039","FENTANYL CITRATE","HIKMA MAPLE","Manufacturing Change or Addition","03/20/2014"
"BREVIBLOC (NDA #019386)","046","ESMOLOL HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","03/20/2014"
"BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER (NDA #019386)","046","ESMOLOL HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","03/20/2014"
"BREVIBLOC IN PLASTIC CONTAINER (NDA #019386)","046","ESMOLOL HYDROCHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","03/20/2014"
"IMODIUM A-D EZ CHEWS (NDA #020448)","008","LOPERAMIDE HYDROCHLORIDE","MCNEIL","Manufacturing Change or Addition","03/20/2014"
"PEPCID AC (NDA #020801)","018","FAMOTIDINE","MCNEIL CONS","Manufacturing Change or Addition","03/20/2014"
"PEPCID COMPLETE (NDA #020958)","021","CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE","MCNEIL CONS","Manufacturing Change or Addition","03/20/2014"
"TEMODAR (NDA #021029)","024","TEMOZOLOMIDE","MERCK SHARP DOHME","Manufacturing Change or Addition","03/20/2014"
"BARACLUDE (NDA #021797)","018","ENTECAVIR","BRISTOL MYERS SQUIBB","Efficacy Supplement with Clinical Data to Support","03/20/2014"
"BARACLUDE (NDA #021798)","019","ENTECAVIR","BRISTOL MYERS SQUIBB","Efficacy Supplement with Clinical Data to Support","03/20/2014"
"VIMOVO (NDA #022511)","011","ESOMEPRAZOLE MAGNESIUM; NAPROXEN","HORIZON PHARMA","Manufacturing Change or Addition","03/20/2014"
"NIACIN (ANDA #090446)","000","NIACIN","LUPIN LTD","Approval","03/20/2014"
"NIACIN (ANDA #090860)","000","NIACIN","LUPIN LTD","Approval","03/20/2014"
"NIACIN (ANDA #090892)","000","NIACIN","LUPIN LTD","Approval","03/20/2014"
"INDOMETHACIN (ANDA #202139)","001","INDOMETHACIN","MYLAN PHARMS INC","Approval","03/20/2014"
"LARIN 1.5/30 (ANDA #202996)","000","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","NOVAST LABS LTD","Approval","03/20/2014"
"LIPIODOL (NDA #009190)","021","ETHIODIZED OIL","GUERBET","Labeling Revision","03/21/2014"
"HEPARIN SODIUM (NDA #017029)","135","HEPARIN SODIUM","FRESENIUS KABI USA","Labeling Revision","03/21/2014"
"HEPARIN SODIUM IN PLASTIC CONTAINER (NDA #017029)","135","HEPARIN SODIUM","FRESENIUS KABI USA","Labeling Revision","03/21/2014"
"HEPARIN SODIUM PRESERVATIVE FREE (NDA #017029)","135","HEPARIN SODIUM","FRESENIUS KABI USA","Labeling Revision","03/21/2014"
"HEPARIN SODIUM (NDA #017651)","059","HEPARIN SODIUM","FRESENIUS KABI USA","Labeling Revision","03/21/2014"
"TUSSIONEX PENNKINETIC (NDA #019111)","017","CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX","UCB INC","Manufacturing Change or Addition","03/21/2014"
"THYROGEN (NDA #020898)","054","THYROTROPIN ALFA","GENZYME","Efficacy Supplement with Clinical Data to Support","03/21/2014"
"STRIANT (NDA #021543)","009","TESTOSTERONE","AUXILIUM PHARMS LLC","Labeling Revision","03/21/2014"
"ADENOSINE (ANDA #078640)","000","ADENOSINE","AGILA SPECLTS","Approval","03/21/2014"
"SYNAGIS (BLA #103770)","5185","PALIVIZUMAB","MEDIMMUNE","Labeling Revision","03/21/2014"
"XOLAIR (BLA #103976)","5211","OMALIZUMAB","GENENTECH","Efficacy Supplement with Clinical Data to Support","03/21/2014"
"ZECUITY (NDA #202278)","001","SUMATRIPTAN SUCCINATE","TEVA BRANDED PHARM","Labeling Revision","03/21/2014"
"ZECUITY (NDA #202278)","002","SUMATRIPTAN SUCCINATE","TEVA BRANDED PHARM","Labeling Revision","03/21/2014"
"OTEZLA (NDA #205437)","000","APREMILAST","CELGENE CORP","Approval","03/21/2014"
"AUVI-Q (NDA #201739)","002","EPINEPHRINE","SANOFI AVENTIS US","Manufacturing Change or Addition","03/22/2014"
"BETAMETHASONE VALERATE (NDA #018866)","013","BETAMETHASONE VALERATE","FOUGERA","Manufacturing Change or Addition","03/24/2014"
"DIFLUCAN (NDA #019949)","058","FLUCONAZOLE","PFIZER","Labeling Revision","03/24/2014"
"DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #019950)","062","FLUCONAZOLE","PFIZER","Labeling Revision","03/24/2014"
"DIFLUCAN IN SODIUM CHLORIDE 0.9% (NDA #019950)","062","FLUCONAZOLE","PFIZER","Labeling Revision","03/24/2014"
"DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #019950)","062","FLUCONAZOLE","PFIZER","Labeling Revision","03/24/2014"
"DIFLUCAN (NDA #020090)","042","FLUCONAZOLE","PFIZER","Labeling Revision","03/24/2014"
"ADRENACLICK (NDA #020800)","025","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","03/24/2014"
"TWINJECT 0.15 (NDA #020800)","025","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","03/24/2014"
"TWINJECT 0.3 (NDA #020800)","025","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","03/24/2014"
"FORTESTA (NDA #021463)","012","TESTOSTERONE","ENDO PHARMS","Labeling Revision","03/24/2014"
"PREVANTICS MAXI SWABSTICK (NDA #021524)","014","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","PROF DSPLS","Labeling Revision","03/24/2014"
"PREVANTICS SWAB (NDA #021524)","014","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","PROF DSPLS","Labeling Revision","03/24/2014"
"PREVANTICS SWABSTICK (NDA #021524)","014","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","PROF DSPLS","Labeling Revision","03/24/2014"
"BYDUREON (NDA #022200)","009","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Manufacturing Change or Addition","03/24/2014"
"MEMANTINE HYDROCHLORIDE (ANDA #203175)","000","MEMANTINE HYDROCHLORIDE","AUROBINDO PHARMA LTD","Tentative Approval","03/24/2014"
"ADENOSINE (ANDA #203883)","000","ADENOSINE","HOSPIRA INC","Approval","03/24/2014"
"METRONIDAZOLE (NDA #205223)","000","METRONIDAZOLE","WATSON LABS INC","Approval","03/24/2014"
"ACEPHEN (NDA #018060)","066","ACETAMINOPHEN","G AND W LABS","Labeling Revision","03/25/2014"
"METRO I.V. IN PLASTIC CONTAINER (NDA #018900)","030","METRONIDAZOLE","B BRAUN","Manufacturing Change or Addition","03/25/2014"
"SYNAREL (NDA #019886)","031","NAFARELIN ACETATE","GD SEARLE LLC","Manufacturing Change or Addition","03/25/2014"
"ADRENACLICK (NDA #020800)","026","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","03/25/2014"
"TWINJECT 0.15 (NDA #020800)","026","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","03/25/2014"
"TWINJECT 0.3 (NDA #020800)","026","EPINEPHRINE","AMEDRA PHARMS","Manufacturing Change or Addition","03/25/2014"
"VIAGRA (NDA #020895)","041","SILDENAFIL CITRATE","PFIZER IRELAND","Manufacturing Change or Addition","03/25/2014"
"FEMHRT (NDA #021065)","023","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","03/25/2014"
"ESTROGEL (NDA #021166)","010","ESTRADIOL","ASCEND THERAPS US","Labeling Revision","03/25/2014"
"EMTRIVA (NDA #021500)","025","EMTRICITABINE","GILEAD","Manufacturing Change or Addition","03/25/2014"
"FLUDARABINE PHOSPHATE (NDA #022137)","005","FLUDARABINE PHOSPHATE","SANDOZ","Manufacturing Change or Addition","03/25/2014"
"FLUDARABINE PHOSPHATE (NDA #022137)","006","FLUDARABINE PHOSPHATE","SANDOZ","Manufacturing Change or Addition","03/25/2014"
"FLUDARABINE PHOSPHATE (NDA #022137)","007","FLUDARABINE PHOSPHATE","SANDOZ","Manufacturing Change or Addition","03/25/2014"
"FIRMAGON (NDA #022201)","004","DEGARELIX ACETATE","FERRING","Manufacturing Change or Addition","03/25/2014"
"ZENPEP (NDA #022210)","016","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","FOREST LABS INC","Manufacturing Change or Addition","03/25/2014"
"INCIVEK (NDA #201917)","013","TELAPREVIR","VERTEX PHARMS","Manufacturing Change or Addition","03/25/2014"
"VERSACLOZ (NDA #203479)","004","CLOZAPINE","JAZZ PHARMS III","Manufacturing Change or Addition","03/25/2014"
"XELJANZ (NDA #203214)","005","TOFACITINIB CITRATE","PF PRISM CV","Labeling Revision","03/26/2014"
"PRILOSEC (NDA #019810)","098","OMEPRAZOLE","ASTRAZENECA","Labeling Revision","03/27/2014"
"ZYBAN (NDA #020711)","039","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","03/27/2014"
"GLUCAGON (NDA #020928)","048","GLUCAGON RECOMBINANT","LILLY","Manufacturing Change or Addition","03/27/2014"
"NEXIUM (NDA #021153)","046","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","03/27/2014"
"NEXIUM IV (NDA #021689)","027","ESOMEPRAZOLE SODIUM","ASTRAZENECA","Labeling Revision","03/27/2014"
"NEXIUM (NDA #021957)","015","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","03/27/2014"
"PRILOSEC (NDA #022056)","014","OMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","03/27/2014"
"NEXIUM (NDA #022101)","012","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA","Labeling Revision","03/27/2014"
"SELZENTRY (NDA #022128)","012","MARAVIROC","VIIV HLTHCARE","Labeling Revision","03/27/2014"
"TREANDA (NDA #022249)","017","BENDAMUSTINE HYDROCHLORIDE","CEPHALON","Manufacturing Change or Addition","03/27/2014"
"VIMOVO (NDA #022511)","010","ESOMEPRAZOLE MAGNESIUM; NAPROXEN","HORIZON PHARMA","Labeling Revision","03/27/2014"
"PARICALCITOL (ANDA #202539)","000","PARICALCITOL","BANNER PHARMACAPS","Approval","03/27/2014"
"ICLUSIG (NDA #203469)","006","PONATINIB HYDROCHLORIDE","ARIAD","Manufacturing Change or Addition","03/27/2014"
"SOLU-CORTEF (NDA #009866)","099","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","03/28/2014"
"SOLU-MEDROL (NDA #011856)","119","METHYLPREDNISOLONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","03/28/2014"
"DTPA (NDA #018511)","024","TECHNETIUM TC-99M PENTETATE KIT","DRAXIMAGE","Manufacturing Change or Addition","03/28/2014"
"SPECTAZOLE (NDA #018751)","023","ECONAZOLE NITRATE","MERZ PHARMS LLC","Labeling Revision","03/28/2014"
"CAVERJECT (NDA #020379)","026","ALPROSTADIL","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","03/28/2014"
"TOPAMAX (NDA #020505)","052","TOPIRAMATE","JANSSEN PHARMS","Efficacy Supplement with Clinical Data to Support","03/28/2014"
"TOPAMAX (NDA #020844)","043","TOPIRAMATE","JANSSEN PHARMS","Efficacy Supplement with Clinical Data to Support","03/28/2014"
"TOPAMAX SPRINKLE (NDA #020844)","043","TOPIRAMATE","JANSSEN PHARMS","Efficacy Supplement with Clinical Data to Support","03/28/2014"
"GEODON (NDA #020919)","036","ZIPRASIDONE MESYLATE","PFIZER","Manufacturing Change or Addition","03/28/2014"
"ELIDEL (NDA #021302)","018","PIMECROLIMUS","VALEANT BERMUDA","Labeling Revision","03/28/2014"
"ERAXIS (NDA #021632)","019","ANIDULAFUNGIN","VICURON","Manufacturing Change or Addition","03/28/2014"
"DICLEGIS (NDA #021876)","003","DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE","DUCHESNAY","Manufacturing Change or Addition","03/28/2014"
"EXPAREL (NDA #022496)","006","BUPIVACAINE","PACIRA PHARMS INC","Manufacturing Change or Addition","03/28/2014"
"AUGMENTIN '875' (NDA #050720)","030","AMOXICILLIN; CLAVULANATE POTASSIUM","DR REDDYS LABS INC","Manufacturing Change or Addition","03/28/2014"
"ADENOSINE (ANDA #090212)","000","ADENOSINE","SAGENT STRIDES","Approval","03/28/2014"
"RITONAVIR (ANDA #202573)","000","RITONAVIR","ROXANE","Tentative Approval","03/28/2014"
"AMMONIA N 13 (ANDA #204496)","000","AMMONIA N-13","UCSF RODIOPHARM","Approval","03/28/2014"
"NEXIUM 24HR (NDA #204655)","000","ESOMEPRAZOLE MAGNESIUM","ASTRAZENECA LP","Approval","03/28/2014"
"LEXISCAN (NDA #022161)","005","REGADENOSON","ASTELLAS","Manufacturing Change or Addition","03/29/2014"
"DEXTROAMPHETAMINE SULFATE (ANDA #040361)","017","DEXTROAMPHETAMINE SULFATE","BARR","Labeling Revision","03/29/2014"
"XOPENEX (NDA #020837)","039","LEVALBUTEROL HYDROCHLORIDE","SUNOVION","Labeling Revision","03/31/2014"
"TRI-LUMA (NDA #021112)","009","FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN","GALDERMA LABS LP","Labeling Revision","03/31/2014"
"CHILDREN'S ELIXSURE (NDA #021604)","004","IBUPROFEN","MOBERG PHARMA NORTH","Labeling Revision","03/31/2014"
"CAPRELSA (NDA #022405)","007","VANDETANIB","IPR PHARMS INC","Labeling Revision","03/31/2014"
"MULTAQ (NDA #022425)","025","DRONEDARONE HYDROCHLORIDE","SANOFI AVENTIS US","Labeling Revision","03/31/2014"
"TRAMADOL HYDROCHLORIDE (ANDA #203494)","000","TRAMADOL HYDROCHLORIDE","AUROBINDO PHARMA LTD","Approval","03/31/2014"
"HUMALOG (NDA #020563)","147","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/01/2014"
"HUMALOG KWIKPEN (NDA #020563)","147","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/01/2014"
"HUMALOG PEN (NDA #020563)","147","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/01/2014"
"ZOVIRAX (NDA #021478)","007","ACYCLOVIR","VALEANT BERMUDA","Labeling Revision","04/01/2014"
"CEFTAZIDIME IN DEXTROSE CONTAINER (NDA #050823)","003","CEFTAZIDIME","B BRAUN","Manufacturing Change or Addition","04/01/2014"
"FEXOFENADINE; PSEUDOEPHEDRINE HYDROCHLORIDES (ANDA #090818)","000","FEXOFENADINE; PSEUDOEPHEDRINE HYDROCHLORIDES","SUN PHARMA GLOBAL","Tentative Approval","04/01/2014"
"FUROSEMIDE (ANDA #091258)","000","FUROSEMIDE","CARACO","Approval","04/01/2014"
"ZYTIGA (NDA #202379)","010","ABIRATERONE ACETATE","JANSSEN BIOTECH","Manufacturing Change or Addition","04/01/2014"
"BRISDELLE (NDA #204516)","002","PAROXETINE MESYLATE","NOVEN THERAP","Manufacturing Change or Addition","04/01/2014"
"HALOG (NDA #017556)","041","HALCINONIDE","RANBAXY","Manufacturing Change or Addition","04/02/2014"
"BUDESONIDE (ANDA #090379)","000","BUDESONIDE","BARR LABS DIV TEVA","Approval","04/02/2014"
"SOLIFENACIN SUCCINATE (ANDA #091464)","000","SOLIFENACIN SUCCINATE","TEVA PHARMS USA","Approval","04/02/2014"
"INTRON A (BLA #103132)","5183","INTERFERON ALFA-2B","SCHERING","Labeling Revision","04/02/2014"
"CLONIDINE HYDROCHLORIDE (ANDA #202983)","000","CLONIDINE HYDROCHLORIDE","ANCHEN PHARMS","Approval","04/02/2014"
"DILANTIN-125 (NDA #008762)","051","PHENYTOIN","PARKE DAVIS","Labeling Revision","04/03/2014"
"DILANTIN-30 (NDA #008762)","051","PHENYTOIN","PARKE DAVIS","Labeling Revision","04/03/2014"
"DILANTIN (NDA #010151)","039","PHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","04/03/2014"
"HUMULIN N (NDA #018781)","142","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/03/2014"
"HUMULIN 70/30 (NDA #019717)","121","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/03/2014"
"HUMULIN 70/30 PEN (NDA #019717)","121","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/03/2014"
"OMNISCAN (NDA #020123)","041","GADODIAMIDE","GE HEALTHCARE","Manufacturing Change or Addition","04/03/2014"
"SABRIL (NDA #020427)","013","VIGABATRIN","LUNDBECK LLC","Labeling Revision","04/03/2014"
"HUMALOG (NDA #020563)","148","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/03/2014"
"HUMALOG KWIKPEN (NDA #020563)","148","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/03/2014"
"HUMALOG PEN (NDA #020563)","148","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/03/2014"
"XALATAN (NDA #020597)","049","LATANOPROST","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","04/03/2014"
"HUMALOG MIX 50/50 (NDA #021018)","092","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/03/2014"
"HUMALOG MIX 50/50 KWIKPEN (NDA #021018)","092","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/03/2014"
"HUMALOG MIX 50/50 PEN (NDA #021018)","092","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/03/2014"
"SURFAXIN (NDA #021746)","004","LUCINACTANT","DISCOVERY LABS","Manufacturing Change or Addition","04/03/2014"
"SABRIL (NDA #022006)","014","VIGABATRIN","LUNDBECK LLC","Labeling Revision","04/03/2014"
"GRIFULVIN V (ANDA #062279)","022","GRISEOFULVIN, MICROCRYSTALLINE","VALEANT LUXEMBOURG","Labeling Revision","04/03/2014"
"GRIFULVIN V (ANDA #062279)","022","GRISEOFULVIN, MICROSIZE","VALEANT LUXEMBOURG","Labeling Revision","04/03/2014"
"BENLYSTA (BLA #125370)","053","BELIMUMAB","HUMAN GENOME SCIENCES INC.","Labeling Revision","04/03/2014"
"MOXIFLOXACIN HYDROCHLORIDE (ANDA #200160)","000","MOXIFLOXACIN HYDROCHLORIDE","TORRENT PHARMS LTD","Approval","04/03/2014"
"MEMANTINE HYDROCHLORIDE (ANDA #200891)","000","MEMANTINE HYDROCHLORIDE","ALEMBIC LTD","Tentative Approval","04/03/2014"
"NIFEDIPINE (ANDA #203126)","000","NIFEDIPINE","TWI PHARMS INC","Approval","04/03/2014"
"NEVIRAPINE (ANDA #203411)","000","NEVIRAPINE","SANDOZ","Approval","04/03/2014"
"NEURACEQ (NDA #204677)","001","FLORBETABEN F-18","PIRAMAL IMAGING","Labeling Revision","04/03/2014"
"NEVIRAPINE (ANDA #205258)","000","NEVIRAPINE","APOTEX INC","Approval","04/03/2014"
"EVZIO (NDA #205787)","000","NALOXONE HYDROCHLORIDE","KALEO INC","Approval","04/03/2014"
"LIPIODOL (NDA #009190)","024","ETHIODIZED OIL","GUERBET","Efficacy Supplement with Clinical Data to Support","04/04/2014"
"SOLU-CORTEF (NDA #009866)","095","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","04/04/2014"
"SOLU-MEDROL (NDA #011856)","116","METHYLPREDNISOLONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","04/04/2014"
"LUNESTA (NDA #021476)","025","ESZOPICLONE","SUNOVION PHARMS INC","Manufacturing Change or Addition","04/04/2014"
"SYMBICORT (NDA #021929)","037","BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE","ASTRAZENECA","Manufacturing Change or Addition","04/04/2014"
"PRADAXA (NDA #022512)","018","DABIGATRAN ETEXILATE MESYLATE","BOEHRINGER INGELHEIM","Efficacy Supplement with Clinical Data to Support","04/04/2014"
"CLEOCIN (NDA #050537)","035","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","04/04/2014"
"CLEOCIN T (NDA #050537)","035","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","04/04/2014"
"CLEOCIN T (NDA #050600)","013","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","04/04/2014"
"CLEOCIN T (NDA #050615)","012","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","04/04/2014"
"AUGMENTIN XR (NDA #050785)","015","AMOXICILLIN; CLAVULANATE POTASSIUM","DR REDDYS LABS INC","Labeling Revision","04/04/2014"
"VALACYCLOVIR HYDROCHLORIDE (ANDA #090500)","000","VALACYCLOVIR HYDROCHLORIDE","APOTEX INC","Approval","04/04/2014"
"LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","085","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","04/07/2014"
"LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","085","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","04/07/2014"
"LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","085","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","04/07/2014"
"ZOMETA (NDA #021223)","028","ZOLEDRONIC ACID","NOVARTIS","Labeling Revision","04/07/2014"
"VFEND (NDA #021266)","037","VORICONAZOLE","PFIZER","Labeling Revision","04/07/2014"
"VFEND (NDA #021267)","044","VORICONAZOLE","PFIZER","Labeling Revision","04/07/2014"
"VFEND (NDA #021630)","027","VORICONAZOLE","PFIZER","Labeling Revision","04/07/2014"
"APTIVUS (NDA #021814)","014","TIPRANAVIR","BOEHRINGER INGELHEIM","Labeling Revision","04/07/2014"
"PREZISTA (NDA #021976)","034","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Labeling Revision","04/07/2014"
"TORISEL (NDA #022088)","016","TEMSIROLIMUS","PF PRISM CV","Labeling Revision","04/07/2014"
"APTIVUS (NDA #022292)","007","TIPRANAVIR","BOEHRINGER INGELHEIM","Labeling Revision","04/07/2014"
"VIIBRYD (NDA #022567)","011","VILAZODONE HYDROCHLORIDE","FOREST LABS INC","Labeling Revision","04/07/2014"
"LAZANDA (NDA #022569)","018","FENTANYL CITRATE","DEPOMED INC","Manufacturing Change or Addition","04/07/2014"
"TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ANDA #078778)","000","ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE","APOTEX INC","Approval","04/07/2014"
"NIMODIPINE (ANDA #090103)","000","NIMODIPINE","THEPHARMANETWORK LLC","Approval","04/07/2014"
"HYDROCHLOROTHIAZIDE (ANDA #090651)","000","HYDROCHLOROTHIAZIDE","CARACO","Approval","04/07/2014"
"OMEGA-3-ACID ETHYL ESTERS (ANDA #091028)","000","OMEGA-3-ACID ETHYL ESTERS","TEVA PHARMS USA","Approval","04/07/2014"
"NAFCILLIN SODIUM (ANDA #200002)","000","NAFCILLIN SODIUM","AGILA SPECLTS","Approval","04/07/2014"
"AMPICILLIN AND SULBACTAM (ANDA #201024)","000","AMPICILLIN SODIUM; SULBACTAM SODIUM","AGILA SPECLTS","Approval","04/07/2014"
"AMPICILLIN AND SULBACTAM (ANDA #202197)","000","AMPICILLIN SODIUM; SULBACTAM SODIUM","AGILA SPECLTS","Approval","04/07/2014"
"AMPICILLIN SODIUM (ANDA #202198)","000","AMPICILLIN SODIUM","AGILA SPECLTS","Approval","04/07/2014"
"PREZISTA (NDA #202895)","011","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Labeling Revision","04/07/2014"
"PIOGLITAZONE HYDROCHLORIDE (ANDA #204133)","000","PIOGLITAZONE HYDROCHLORIDE","LUPIN LTD","Approval","04/07/2014"
"ORTHO-CEPT (NDA #020301)","033","DESOGESTREL; ETHINYL ESTRADIOL","JANSSEN PHARMS","Manufacturing Change or Addition","04/08/2014"
"SYNTHROID (NDA #021402)","026","LEVOTHYROXINE SODIUM","ABBVIE","Manufacturing Change or Addition","04/08/2014"
"ISENTRESS (NDA #022145)","032","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","04/08/2014"
"AUGMENTIN ES-600 (NDA #050755)","020","AMOXICILLIN; CLAVULANATE POTASSIUM","DR REDDYS LABS INC","Manufacturing Change or Addition","04/08/2014"
"OXALIPLATIN (ANDA #202922)","000","OXALIPLATIN","SUN PHARMA GLOBAL","Approval","04/08/2014"
"OXALIPLATIN (ANDA #202922)","000","OXALIPLATIN","SUN PHARMA GLOBAL","Tentative Approval","04/08/2014"
"ISENTRESS (NDA #203045)","010","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","04/08/2014"
"KALYDECO (NDA #203188)","008","IVACAFTOR","VERTEX PHARMS","Labeling Revision","04/08/2014"
"ISENTRESS (NDA #205786)","001","RALTEGRAVIR POTASSIUM","MERCK SHARP DOHME","Labeling Revision","04/08/2014"
"DIAMOX (NDA #012945)","046","ACETAZOLAMIDE","DURAMED PHARMS BARR","Manufacturing Change or Addition","04/09/2014"
"EXELON (NDA #020823)","031","RIVASTIGMINE TARTRATE","NOVARTIS","Manufacturing Change or Addition","04/09/2014"
"ORAVERSE (NDA #022159)","007","PHENTOLAMINE MESYLATE","SEPTODONT HOLDING","Manufacturing Change or Addition","04/09/2014"
"AMPICILLIN SODIUM (ANDA #201025)","000","AMPICILLIN SODIUM","STRIDES ARCOLAB LTD","Approval","04/09/2014"
"VICTRELIS (NDA #202258)","011","BOCEPREVIR","MERCK SHARP DOHME","Efficacy Supplement with Clinical Data to Support","04/09/2014"
"GATIFLOXACIN (ANDA #203190)","000","GATIFLOXACIN","HI-TECH PHARMACAL","Tentative Approval","04/09/2014"
"ZOLMITRIPTAN (ANDA #204284)","000","ZOLMITRIPTAN","INVAGEN PHARMS","Approval","04/09/2014"
"SPRYCEL (NDA #021986)","014","DASATINIB","BRISTOL MYERS SQUIBB","Labeling Revision","04/10/2014"
"PROMACTA (NDA #022291)","011","ELTROMBOPAG OLAMINE","GLAXOSMITHKLINE","Labeling Revision","04/10/2014"
"OFLOXACIN (ANDA #076182)","014","OFLOXACIN","TEVA","Labeling Revision","04/10/2014"
"PREMARIN (NDA #004782)","163","ESTROGENS, CONJUGATED","WYETH PHARMS INC","Manufacturing Change or Addition","04/11/2014"
"HUMULIN N (NDA #018781)","143","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMATROPE (NDA #019640)","095","SOMATROPIN RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMULIN 70/30 (NDA #019717)","122","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMULIN 70/30 PEN (NDA #019717)","122","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/11/2014"
"SPORANOX (NDA #020083)","054","ITRACONAZOLE","JANSSEN PHARMS","Manufacturing Change or Addition","04/11/2014"
"HUMALOG (NDA #020563)","149","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG KWIKPEN (NDA #020563)","149","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG PEN (NDA #020563)","149","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG MIX 75/25 (NDA #021017)","100","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","100","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG MIX 75/25 PEN (NDA #021017)","100","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG MIX 50/50 (NDA #021018)","093","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG MIX 50/50 KWIKPEN (NDA #021018)","093","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"HUMALOG MIX 50/50 PEN (NDA #021018)","093","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","04/11/2014"
"ORTHO EVRA (NDA #021180)","046","ETHINYL ESTRADIOL; NORELGESTROMIN","JANSSEN PHARMS","Labeling Revision","04/11/2014"
"XYREM (NDA #021196)","019","SODIUM OXYBATE","JAZZ PHARMS","Efficacy Supplement with Clinical Data to Support","04/11/2014"
"FORTEO (NDA #021318)","039","TERIPARATIDE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","04/11/2014"
"VIMPAT (NDA #022255)","015","LACOSAMIDE","UCB INC","Manufacturing Change or Addition","04/11/2014"
"FORTAZ IN PLASTIC CONTAINER (NDA #050634)","027","CEFTAZIDIME SODIUM","COVIS INJECTABLES","Manufacturing Change or Addition","04/11/2014"
"LIDOCAINE HYDROCHLORIDE (ANDA #202242)","000","LIDOCAINE HYDROCHLORIDE","AGILA SPECLTS","Approval","04/11/2014"
"CLOPIDOGREL (ANDA #203751)","000","CLOPIDOGREL","AMNEAL PHARMS","Approval","04/11/2014"
"KADIAN (NDA #020616)","052","MORPHINE SULFATE","WATSON LABS INC","Manufacturing Change or Addition","04/14/2014"
"SEREVENT (NDA #020692)","043","SALMETEROL XINAFOATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"FLOVENT DISKUS 100 (NDA #020833)","028","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"FLOVENT DISKUS 250 (NDA #020833)","028","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"FLOVENT DISKUS 50 (NDA #020833)","028","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"ADVAIR DISKUS 100/50 (NDA #021077)","051","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"ADVAIR DISKUS 250/50 (NDA #021077)","051","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"ADVAIR DISKUS 500/50 (NDA #021077)","051","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Labeling Revision","04/14/2014"
"TARCEVA (NDA #021743)","019","ERLOTINIB HYDROCHLORIDE","OSI PHARMS","Labeling Revision","04/14/2014"
"SELZENTRY (NDA #022128)","013","MARAVIROC","VIIV HLTHCARE","Manufacturing Change or Addition","04/14/2014"
"DOXIL (LIPOSOMAL) (NDA #050718)","047","DOXORUBICIN HYDROCHLORIDE","JANSSEN RES AND DEV","Manufacturing Change or Addition","04/14/2014"
"METHADONE HYDROCHLORIDE (ANDA #090707)","003","METHADONE HYDROCHLORIDE","VISTAPHARM","Labeling Revision","04/14/2014"
"NULOJIX (BLA #125288)","059","BELATACEPT","BRISTOL MYERS SQUIBB","Labeling Revision","04/14/2014"
"SUMATRIPTAN SUCCINATE (ANDA #203322)","000","SUMATRIPTAN SUCCINATE","AGILA SPECLTS","Approval","04/14/2014"
"MINASTRIN 24 FE (NDA #203667)","003","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT LLC","Manufacturing Change or Addition","04/14/2014"
"DIAZEPAM (ANDA #204433)","000","DIAZEPAM","LANNETT HOLDINGS INC","Approval","04/14/2014"
"ZORVOLEX (NDA #204592)","001","DICLOFENAC","IROKO PHARMS LLC","Manufacturing Change or Addition","04/14/2014"
"ESMOLOL HYDROCHLORIDE (NDA #205703)","000","ESMOLOL HYDROCHLORIDE","HQ SPECIALITY PHARMA","Tentative Approval","04/14/2014"
"EXCEDRIN (MIGRAINE) (NDA #020802)","022","ACETAMINOPHEN; ASPIRIN; CAFFEINE","NOVARTIS","Labeling Revision","04/15/2014"
"NEURONTIN (NDA #021129)","041","GABAPENTIN","PARKE DAVIS","Manufacturing Change or Addition","04/15/2014"
"ELIGARD (NDA #021379)","028","LEUPROLIDE ACETATE","TOLMAR THERAP","Manufacturing Change or Addition","04/15/2014"
"ESZOPICLONE (ANDA #091024)","000","ESZOPICLONE","DR REDDYS LABS LTD","Approval","04/15/2014"
"ESZOPICLONE (ANDA #091153)","000","ESZOPICLONE","ROXANE","Approval","04/15/2014"
"ESZOPICLONE (ANDA #091166)","000","ESZOPICLONE","GLENMARK GENERICS","Approval","04/15/2014"
"TANZEUM (BLA #125431)","000","ALBIGLUTIDE","GLAXOSMITHKLINE LLC","Approval","04/15/2014"
"SITAGLIPTIN PHOSPHATE (ANDA #202327)","000","SITAGLIPTIN PHOSPHATE","WATSON LABS INC","Tentative Approval","04/15/2014"
"RAMIPRIL (ANDA #202392)","000","RAMIPRIL","ACCORD HLTHCARE INC","Approval","04/15/2014"
"DOLOPHINE HYDROCHLORIDE (NDA #006134)","035","METHADONE HYDROCHLORIDE","ROXANE","Labeling Revision","04/16/2014"
"MS CONTIN (NDA #019516)","042","MORPHINE SULFATE","PURDUE PHARMA LP","Labeling Revision","04/16/2014"
"DURAGESIC-100 (NDA #019813)","063","FENTANYL","JANSSEN PHARMS","Labeling Revision","04/16/2014"
"DURAGESIC-12 (NDA #019813)","063","FENTANYL","JANSSEN PHARMS","Labeling Revision","04/16/2014"
"DURAGESIC-25 (NDA #019813)","063","FENTANYL","JANSSEN PHARMS","Labeling Revision","04/16/2014"
"DURAGESIC-50 (NDA #019813)","063","FENTANYL","JANSSEN PHARMS","Labeling Revision","04/16/2014"
"DURAGESIC-75 (NDA #019813)","063","FENTANYL","JANSSEN PHARMS","Labeling Revision","04/16/2014"
"KADIAN (NDA #020616)","051","MORPHINE SULFATE","WATSON LABS INC","Labeling Revision","04/16/2014"
"CELEXA (NDA #020822)","045","CITALOPRAM HYDROBROMIDE","FOREST LABS","Labeling Revision","04/16/2014"
"ALLEGRA ALLERGY (NDA #020872)","031","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","04/16/2014"
"ALLEGRA HIVES (NDA #020872)","031","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","04/16/2014"
"CHILDREN'S ALLEGRA ALLERGY (NDA #020872)","031","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","04/16/2014"
"CHILDREN'S ALLEGRA HIVES (NDA #020872)","031","FEXOFENADINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","04/16/2014"
"PALLADONE (NDA #021044)","013","HYDROMORPHONE HYDROCHLORIDE","PURDUE PHARMA LP","Labeling Revision","04/16/2014"
"EXALGO (NDA #021217)","013","HYDROMORPHONE HYDROCHLORIDE","MALLINCKRODT INC","Labeling Revision","04/16/2014"
"AVINZA (NDA #021260)","022","MORPHINE SULFATE","KING PHARMS LLC","Labeling Revision","04/16/2014"
"BUTRANS (NDA #021306)","018","BUPRENORPHINE","PURDUE PHARMA LP","Labeling Revision","04/16/2014"
"OPANA ER (NDA #021610)","018","OXYMORPHONE HYDROCHLORIDE","ENDO PHARMS","Labeling Revision","04/16/2014"
"OXYCONTIN (NDA #022272)","022","OXYCODONE HYDROCHLORIDE","PURDUE PHARMA LP","Labeling Revision","04/16/2014"
"EMBEDA (NDA #022321)","017","MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE","ALPHARMA PHARMS","Labeling Revision","04/16/2014"
"PRADAXA (NDA #022512)","020","DABIGATRAN ETEXILATE MESYLATE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","04/16/2014"
"OXYMORPHONE HYDROCHLORIDE (ANDA #079046)","013","OXYMORPHONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Labeling Revision","04/16/2014"
"METHADONE HYDROCHLORIDE (ANDA #087393)","033","METHADONE HYDROCHLORIDE","ROXANE","Labeling Revision","04/16/2014"
"METHADONE HYDROCHLORIDE INTENSOL (ANDA #089897)","028","METHADONE HYDROCHLORIDE","ROXANE","Labeling Revision","04/16/2014"
"NUCYNTA ER (NDA #200533)","010","TAPENTADOL HYDROCHLORIDE","JANSSEN PHARMS","Labeling Revision","04/16/2014"
"XULANE (ANDA #200910)","000","ETHINYL ESTRADIOL; NORELGESTROMIN","MYLAN TECHNOLOGIES","Approval","04/16/2014"
"OPANA ER (NDA #201655)","012","OXYMORPHONE HYDROCHLORIDE","ENDO PHARMS","Labeling Revision","04/16/2014"
"LO MINASTRIN FE (NDA #204654)","002","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT","Manufacturing Change or Addition","04/16/2014"
"NICORETTE (NDA #018612)","070","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","04/17/2014"
"NICORETTE (MINT) (NDA #018612)","070","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","04/17/2014"
"TRENTAL (NDA #018631)","036","PENTOXIFYLLINE","SANOFI AVENTIS US","Labeling Revision","04/17/2014"
"NICORETTE (NDA #020066)","051","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","04/17/2014"
"NICORETTE (MINT) (NDA #020066)","051","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Manufacturing Change or Addition","04/17/2014"
"VIVITROL (NDA #021897)","026","NALTREXONE","ALKERMES","Manufacturing Change or Addition","04/17/2014"
"COARTEM (NDA #022268)","008","ARTEMETHER; LUMEFANTRINE","NOVARTIS","Manufacturing Change or Addition","04/17/2014"
"DULERA (NDA #022518)","014","FORMOTEROL FUMARATE; MOMETASONE FUROATE","MERCK SHARP DOHME","Labeling Revision","04/17/2014"
"VIIBRYD (NDA #022567)","010","VILAZODONE HYDROCHLORIDE","FOREST LABS INC","Manufacturing Change or Addition","04/17/2014"
"ARZERRA (BLA #125326)","060","OFATUMUMAB","GLAXO GRP LTD","Efficacy Supplement with Clinical Data to Support","04/17/2014"
"PHENYTOIN (ANDA #200565)","000","PHENYTOIN","TARO","Approval","04/17/2014"
"ZYTIGA (NDA #202379)","011","ABIRATERONE ACETATE","JANSSEN BIOTECH","Manufacturing Change or Addition","04/17/2014"
"VASOSTRICT (NDA #204485)","000","VASOPRESSIN","PAR STERILE PRODUCTS","Approval","04/17/2014"
"ZINECARD (NDA #020212)","017","DEXRAZOXANE HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","04/18/2014"
"NASONEX (NDA #020762)","049","MOMETASONE FUROATE MONOHYDRATE","MERCK SHARP DOHME","Manufacturing Change or Addition","04/18/2014"
"PRECEDEX (NDA #021038)","016","DEXMEDETOMIDINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","04/18/2014"
"MORPHINE SULFATE (NDA #022195)","008","MORPHINE SULFATE","ROXANE","Manufacturing Change or Addition","04/18/2014"
"CEFADROXIL (ANDA #065396)","012","CEFADROXIL/CEFADROXIL HEMIHYDRATE","LUPIN","Labeling Revision","04/18/2014"
"EDARBI (NDA #200796)","005","AZILSARTAN KAMEDOXOMIL","ARBOR PHARMS IRELAND","Labeling Revision","04/18/2014"
"TROKENDI XR (NDA #201635)","001","TOPIRAMATE","SUPERNUS PHARMS","Manufacturing Change or Addition","04/18/2014"
"TROKENDI XR (NDA #201635)","004","TOPIRAMATE","SUPERNUS PHARMS","Manufacturing Change or Addition","04/18/2014"
"EDARBYCLOR (NDA #202331)","005","AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE","ARBOR PHARMS IRELAND","Labeling Revision","04/18/2014"
"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (ANDA #203136)","003","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","AMNEAL PHARMS","Manufacturing Change or Addition","04/18/2014"
"MINIVELLE (NDA #203752)","005","ESTRADIOL","NOVEN","Manufacturing Change or Addition","04/18/2014"
"SSD (NDA #018578)","016","SILVER SULFADIAZINE","DR REDDYS LA","Manufacturing Change or Addition","04/21/2014"
"SSD AF (NDA #018578)","016","SILVER SULFADIAZINE","DR REDDYS LA","Manufacturing Change or Addition","04/21/2014"
"LOTRISONE (NDA #018827)","046","BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE","MERCK SHARP DOHME","Labeling Revision","04/21/2014"
"UROXATRAL (NDA #021287)","018","ALFUZOSIN HYDROCHLORIDE","COVIS PHARMA SARL","Labeling Revision","04/21/2014"
"CADUET (NDA #021540)","033","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","PFIZER","Manufacturing Change or Addition","04/21/2014"
"ENDOMETRIN (NDA #022057)","007","PROGESTERONE","FERRING","Manufacturing Change or Addition","04/21/2014"
"FANAPT (NDA #022192)","013","ILOPERIDONE","NOVARTIS","Labeling Revision","04/21/2014"
"SPRIX (NDA #022382)","009","KETOROLAC TROMETHAMINE","LUITPOLD","Labeling Revision","04/21/2014"
"CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #050596)","041","CEFOTAXIME SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","04/21/2014"
"CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #050596)","041","CEFOTAXIME SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","04/21/2014"
"ATRIDOX (NDA #050751)","019","DOXYCYCLINE HYCLATE","TOLMAR","Manufacturing Change or Addition","04/21/2014"
"CYRAMZA (BLA #125477)","000","RAMUCIRUMAB","ELI LILLY AND CO","Approval","04/21/2014"
"PROCYSBI (NDA #203389)","005","CYSTEAMINE BITARTRATE","RAPTOR PHARMS","Manufacturing Change or Addition","04/21/2014"
"ALVESCO (NDA #021658)","008","CICLESONIDE","TAKEDA GMBH","Manufacturing Change or Addition","04/22/2014"
"ATAZANAVIR SULFATE (ANDA #091673)","000","ATAZANAVIR SULFATE","TEVA PHARMS USA","Approval","04/22/2014"
"ONCASPAR (BLA #103411)","5180","PEGASPARGASE","SIGMA TAU","Labeling Revision","04/22/2014"
"SYLVANT (BLA #125496)","000","SILTUXIMAB","JANSSEN BIOTECH","Approval","04/22/2014"
"HEPARIN SODIUM (NDA #201370)","004","HEPARIN SODIUM","PFIZER","Labeling Revision","04/22/2014"
"HEPARIN SODIUM (NDA #201370)","005","HEPARIN SODIUM","PFIZER","Labeling Revision","04/22/2014"
"HEPARIN SODIUM PRESERVATIVE FREE (NDA #201370)","004","HEPARIN SODIUM","PFIZER","Labeling Revision","04/22/2014"
"HEPARIN SODIUM PRESERVATIVE FREE (NDA #201370)","005","HEPARIN SODIUM","PFIZER","Labeling Revision","04/22/2014"
"ZETONNA (NDA #202129)","003","CICLESONIDE","TAKEDA GMBH","Manufacturing Change or Addition","04/22/2014"
"DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (NDA #018883)","054","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","054","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (NDA #018883)","054","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","054","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (NDA #018883)","054","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","054","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","036","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","036","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","036","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Manufacturing Change or Addition","04/23/2014"
"ADRENACLICK (NDA #020800)","024","EPINEPHRINE","AMEDRA PHARMS","Labeling Revision","04/23/2014"
"TWINJECT 0.15 (NDA #020800)","024","EPINEPHRINE","AMEDRA PHARMS","Labeling Revision","04/23/2014"
"TWINJECT 0.3 (NDA #020800)","024","EPINEPHRINE","AMEDRA PHARMS","Labeling Revision","04/23/2014"
"DIOVAN HCT (NDA #020818)","059","HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Manufacturing Change or Addition","04/23/2014"
"DEPOCYT (NDA #021041)","027","CYTARABINE","PACIRA PHARMS INC","Manufacturing Change or Addition","04/23/2014"
"DEPOCYT (NDA #021041)","028","CYTARABINE","PACIRA PHARMS INC","Manufacturing Change or Addition","04/23/2014"
"OLUX (NDA #021142)","019","CLOBETASOL PROPIONATE","DELCOR ASSET","Labeling Revision","04/23/2014"
"CLARINEX (NDA #021165)","017","DESLORATADINE","MERCK SHARP DOHME","Labeling Revision","04/23/2014"
"CLARINEX (NDA #021300)","014","DESLORATADINE","MERCK SHARP DOHME","Labeling Revision","04/23/2014"
"CLARINEX (NDA #021312)","015","DESLORATADINE","MERCK SHARP DOHME","Labeling Revision","04/23/2014"
"CLARINEX (NDA #021563)","003","DESLORATADINE","SCHERING","Labeling Revision","04/23/2014"
"BYETTA (NDA #021773)","035","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Manufacturing Change or Addition","04/23/2014"
"KUVAN (NDA #022181)","013","SAPROPTERIN DIHYDROCHLORIDE","BIOMARIN PHARM","Efficacy Supplement with Clinical Data to Support","04/23/2014"
"MEMANTINE HYDROCHLORIDE (ANDA #091585)","000","MEMANTINE HYDROCHLORIDE","JUBILANT LIFE","Tentative Approval","04/23/2014"
"NIACIN (ANDA #200484)","000","NIACIN","SUN PHARMA GLOBAL","Approval","04/23/2014"
"NIACIN (ANDA #201273)","000","NIACIN","SUN PHARMA GLOBAL","Approval","04/23/2014"
"DOCETAXEL (NDA #201525)","003","DOCETAXEL","SANDOZ","Labeling Revision","04/23/2014"
"SPIRONOLACTONE (ANDA #203253)","000","SPIRONOLACTONE","JUBILANT LIFE","Approval","04/23/2014"
"NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ANDA #203371)","000","ETHINYL ESTRADIOL; NORETHINDRONE","FAMY CARE LTD","Approval","04/23/2014"
"JUXTAPID (NDA #203858)","005","LOMITAPIDE MESYLATE","AEGERION","Manufacturing Change or Addition","04/23/2014"
"OMTRYG (NDA #204977)","000","OMEGA-3-ACID ETHYL ESTERS","TRYGG","Approval","04/23/2014"
"DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (NDA #018883)","051","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","051","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (NDA #018883)","051","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","051","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (NDA #018883)","051","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER (NDA #018883)","051","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"CHEMET (NDA #019998)","018","SUCCIMER","RECORDATI RARE","Manufacturing Change or Addition","04/24/2014"
"DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","033","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","033","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER (NDA #020171)","033","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE","FRESENIUS MEDCL","Labeling Revision","04/24/2014"
"PROVIGIL (NDA #020717)","042","MODAFINIL","CEPHALON","Manufacturing Change or Addition","04/24/2014"
"REBIF (BLA #103780)","5178","INTERFERON BETA-1A","SERONO INC","Labeling Revision","04/24/2014"
"REBIF (BLA #103780)","5179","INTERFERON BETA-1A","SERONO INC","Labeling Revision","04/24/2014"
"DESOXIMETASONE (ANDA #201005)","000","DESOXIMETASONE","VERSAPHARM INC","Approval","04/24/2014"
"BICILLIN C-R (NDA #050138)","235","PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE","KING PHARMS","Labeling Revision","04/25/2014"
"BICILLIN C-R 900/300 (NDA #050138)","235","PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE","KING PHARMS","Labeling Revision","04/25/2014"
"BICILLIN L-A (NDA #050141)","232","PENICILLIN G BENZATHINE","KING PHARMS","Labeling Revision","04/25/2014"
"TOBI (NDA #050753)","016","TOBRAMYCIN","NOVARTIS PHARMS","Labeling Revision","04/25/2014"
"TOBI PODHALER (NDA #201688)","002","TOBRAMYCIN","NOVARTIS","Labeling Revision","04/25/2014"
"ASMANEX HFA (NDA #205641)","000","MOMETASONE FUROATE","MERCK SHARP DOHME","Approval","04/25/2014"
"RISPERDAL (NDA #020272)","073","RISPERIDONE","JANSSEN PHARMS","Labeling Revision","04/28/2014"
"RISPERDAL (NDA #020588)","062","RISPERIDONE","JANSSEN PHARMS","Labeling Revision","04/28/2014"
"RISPERDAL CONSTA (NDA #021346)","051","RISPERIDONE","JANSSEN PHARMS","Labeling Revision","04/28/2014"
"RISPERDAL (NDA #021444)","048","RISPERIDONE","JANSSEN PHARMS","Labeling Revision","04/28/2014"
"ABRAXANE (NDA #021660)","039","PACLITAXEL","ABRAXIS BIOSCIENCE","Manufacturing Change or Addition","04/28/2014"
"SUBOXONE (NDA #022410)","004","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Efficacy Supplement with Clinical Data to Support","04/28/2014"
"SUBOXONE (NDA #022410)","017","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Labeling Revision","04/28/2014"
"SUBOXONE (NDA #022410)","018","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Efficacy Supplement with Clinical Data to Support","04/28/2014"
"GLYDO (ANDA #201094)","000","LIDOCAINE HYDROCHLORIDE","SAGENT PHARMS","Approval","04/28/2014"
"DELZICOL (NDA #204412)","003","MESALAMINE","WARNER CHILCOTT LLC","Efficacy Supplement with Clinical Data to Support","04/28/2014"
"PURIXAN (NDA #205919)","000","MERCAPTOPURINE","NOVA LABS LTD","Approval","04/28/2014"
"ROBAXIN (NDA #011790)","050","METHOCARBAMOL","HIKMA MAPLE","Manufacturing Change or Addition","04/29/2014"
"TRECATOR (NDA #013026)","028","ETHIONAMIDE","WYETH PHARMS INC","Manufacturing Change or Addition","04/29/2014"
"CIALIS (NDA #021368)","023","TADALAFIL","LILLY","Labeling Revision","04/29/2014"
"LEVITRA (NDA #021400)","017","VARDENAFIL HYDROCHLORIDE","BAYER HLTHCARE","Labeling Revision","04/29/2014"
"INVEGA (NDA #021999)","029","PALIPERIDONE","JANSSEN PHARMS","Labeling Revision","04/29/2014"
"ZIRGAN (NDA #022211)","005","GANCICLOVIR","BAUSCH AND LOMB","Manufacturing Change or Addition","04/29/2014"
"INVEGA SUSTENNA (NDA #022264)","010","PALIPERIDONE PALMITATE","JANSSEN PHARMS","Labeling Revision","04/29/2014"
"ADCIRCA (NDA #022332)","006","TADALAFIL","ELI LILLY CO","Labeling Revision","04/29/2014"
"STAXYN (NDA #200179)","002","VARDENAFIL HYDROCHLORIDE","BAYER HLTHCARE","Labeling Revision","04/29/2014"
"STENDRA (NDA #202276)","006","AVANAFIL","VIVUS","Labeling Revision","04/29/2014"
"LUPANETA PACK (NDA #203696)","003","LEUPROLIDE ACETATE; NORETHINDRONE ACETATE","ABBVIE ENDOCRINE","Manufacturing Change or Addition","04/29/2014"
"HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE (ANDA #204627)","000","CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE","PADDOCK LLC","Approval","04/29/2014"
"HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE (ANDA #204658)","000","HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE","PADDOCK LLC","Approval","04/29/2014"
"ZYKADIA (NDA #205755)","000","CERITINIB","NOVARTIS PHARMS CORP","Approval","04/29/2014"
"EPI E Z PEN JR (NDA #019430)","059","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","04/30/2014"
"EPIPEN (NDA #019430)","059","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","04/30/2014"
"EPIPEN E Z PEN (NDA #019430)","059","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","04/30/2014"
"EPIPEN JR. (NDA #019430)","059","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","04/30/2014"
"CARDENE (NDA #019734)","022","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","04/30/2014"
"CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #019734)","022","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","04/30/2014"
"CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #019734)","022","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","04/30/2014"
"CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NDA #019734)","022","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","04/30/2014"
"CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER (NDA #019734)","022","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Manufacturing Change or Addition","04/30/2014"
"NICODERM CQ (NDA #020165)","029","NICOTINE","SANOFI AVENTIS US","Labeling Revision","04/30/2014"
"ACTIQ (NDA #020747)","040","FENTANYL CITRATE","CEPHALON","Manufacturing Change or Addition","04/30/2014"
"XENICAL (NDA #020766)","034","ORLISTAT","HOFFMANN LA ROCHE","Manufacturing Change or Addition","04/30/2014"
"ALTOPREV (NDA #021316)","031","LOVASTATIN","ANDRX LABS LLC","Labeling Revision","04/30/2014"
"BESIVANCE (NDA #022308)","008","BESIFLOXACIN HYDROCHLORIDE","BAUSCH AND LOMB","Manufacturing Change or Addition","04/30/2014"
"GILENYA (NDA #022527)","009","FINGOLIMOD","NOVARTIS","Labeling Revision","04/30/2014"
"SOLIRIS (BLA #125166)","368","ECULIZUMAB","ALEXION PHARM","Efficacy Supplement with Clinical Data to Support","04/30/2014"
"SOLIRIS (BLA #125166)","380","ECULIZUMAB","ALEXION PHARM","Labeling Revision","04/30/2014"
"ELIQUIS (NDA #202155)","007","APIXABAN","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","04/30/2014"
"INCRUSE ELLIPTA (NDA #205382)","000","UMECLIDINIUM BROMIDE","GLAXO GRP ENGLAND","Approval","04/30/2014"
"TESTIM (NDA #021454)","020","TESTOSTERONE","AUXILIUM PHARMS","Supplement","05/01/2014"
"MAXIPIME (NDA #050679)","031","CEFEPIME HYDROCHLORIDE","HOSPIRA INC","Labeling Revision","05/01/2014"
"EDURANT (NDA #202022)","007","RILPIVIRINE HYDROCHLORIDE","JANSSEN PRODS","Labeling Revision","05/01/2014"
"SYNRIBO (NDA #203585)","003","OMACETAXINE MEPESUCCINATE","IVAX INTL","Labeling Revision","05/01/2014"
"CHORIONIC GONADOTROPIN (NDA #017016)","158","GONADOTROPIN, CHORIONIC","FERRING","Manufacturing Change or Addition","05/02/2014"
"ACCUPRIL (NDA #019885)","040","QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","05/02/2014"
"ALTACE (NDA #019901)","064","RAMIPRIL","KING PHARMS","Labeling Revision","05/02/2014"
"ACCURETIC (NDA #020125)","018","HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling Revision","05/02/2014"
"ARIMIDEX (NDA #020541)","029","ANASTROZOLE","ASTRAZENECA","Labeling Revision","05/02/2014"
"AROMASIN (NDA #020753)","015","EXEMESTANE","PHARMACIA AND UPJOHN","Labeling Revision","05/02/2014"
"AROMASIN (NDA #020753)","016","EXEMESTANE","PHARMACIA AND UPJOHN","Labeling Revision","05/02/2014"
"ZOLEDRONIC ACID (NDA #203231)","002","ZOLEDRONIC ACID","ACS DOBFAR INFO SA","Labeling Revision","05/02/2014"
"OSPHENA (NDA #203505)","004","OSPEMIFENE","SHIONOGI INC","Manufacturing Change or Addition","05/02/2014"
"DIPRIVAN (NDA #019627)","058","PROPOFOL","FRESENIUS KABI USA","Manufacturing Change or Addition","05/05/2014"
"TEMODAR (NDA #021029)","026","TEMOZOLOMIDE","MERCK SHARP DOHME","Labeling Revision","05/05/2014"
"LETAIRIS (NDA #022081)","029","AMBRISENTAN","GILEAD","Labeling Revision","05/05/2014"
"TEMODAR (NDA #022277)","007","TEMOZOLOMIDE","MERCK SHARP DOHME","Labeling Revision","05/05/2014"
"DOXERCALCIFEROL (ANDA #091333)","000","DOXERCALCIFEROL","SANDOZ","Approval","05/05/2014"
"PHENTERMINE HYDROCHLORIDE (ANDA #204414)","000","PHENTERMINE HYDROCHLORIDE","INVAGEN PHARMS","Approval","05/05/2014"
"EPANOVA (NDA #205060)","000","OMEGA-3-CARBOXYLIC ACIDS","ASTRAZENECA PHARMS","Approval","05/05/2014"
"BUPIVACAINE HYDROCHLORIDE (NDA #018053)","056","BUPIVACAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","05/06/2014"
"PROCARDIA XL (NDA #019684)","027","NIFEDIPINE","PFIZER","Labeling Revision","05/06/2014"
"TOPROL-XL (NDA #019962)","044","METOPROLOL SUCCINATE","ASTRAZENECA","Labeling Revision","05/06/2014"
"VISUDYNE (NDA #021119)","026","VERTEPORFIN","VALEANT PHARMS INC","Manufacturing Change or Addition","05/06/2014"
"LEVOXYL (NDA #021301)","035","LEVOTHYROXINE SODIUM","KING PHARMS R AND D","Manufacturing Change or Addition","05/06/2014"
"HYLENEX RECOMBINANT (NDA #021859)","020","HYALURONIDASE RECOMBINANT HUMAN","HALOZYME THERAP","Manufacturing Change or Addition","05/06/2014"
"COARTEM (NDA #022268)","009","ARTEMETHER; LUMEFANTRINE","NOVARTIS","Manufacturing Change or Addition","05/06/2014"
"CLONIDINE (ANDA #090873)","000","CLONIDINE","WATSON LABS INC","Approval","05/06/2014"
"DICLOFENAC SODIUM (ANDA #202769)","000","DICLOFENAC SODIUM","IGI LABS INC","Tentative Approval","05/06/2014"
"ADEMPAS (NDA #204819)","002","RIOCIGUAT","BAYER HLTHCARE","Labeling Revision","05/06/2014"
"AVANDIA (NDA #021071)","047","ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDIA (NDA #021071)","048","ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDIA (NDA #021071)","049","ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDAMET (NDA #021410)","036","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDAMET (NDA #021410)","037","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDAMET (NDA #021410)","038","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"BENICAR HCT (NDA #021532)","023","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Manufacturing Change or Addition","05/07/2014"
"AVANDARYL (NDA #021700)","018","GLIMEPIRIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDARYL (NDA #021700)","019","GLIMEPIRIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"AVANDARYL (NDA #021700)","020","GLIMEPIRIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling Revision","05/07/2014"
"ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE (ANDA #077337)","000","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","TEVA","Approval","05/07/2014"
"ROSIGLITAZONE MALEATE; METFORMIN HYDROCHLORIDE (ANDA #077337)","000","ROSIGLITAZONE MALEATE; METFORMIN HYDROCHLORIDE","TEVA","Approval","05/07/2014"
"BOTOX (BLA #103000)","5280","OnabotulinumtoxinA","ALLERGAN","Labeling Revision","05/07/2014"
"BOTOX COSMETIC (BLA #103000)","5280","OnabotulinumtoxinA","ALLERGAN","Labeling Revision","05/07/2014"
"PANTOPRAZOLE SODIUM (ANDA #203024)","000","PANTOPRAZOLE SODIUM","PERRIGO R AND D","Approval","05/07/2014"
"XELJANZ (NDA #203214)","007","TOFACITINIB CITRATE","PF PRISM CV","Labeling Revision","05/07/2014"
"KYNAMRO (NDA #203568)","002","MIPOMERSEN SODIUM","GENZYME CORP","Supplement","05/07/2014"
"PERSANTINE (NDA #012836)","059","DIPYRIDAMOLE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","05/08/2014"
"HEPATAMINE 8% (NDA #018676)","032","AMINO ACIDS","B BRAUN","Manufacturing Change or Addition","05/08/2014"
"GEMZAR (NDA #020509)","077","GEMCITABINE HYDROCHLORIDE","LILLY","Labeling Revision","05/08/2014"
"TRILEPTAL (NDA #021014)","034","OXCARBAZEPINE","NOVARTIS","Manufacturing Change or Addition","05/08/2014"
"LOTRONEX (NDA #021107)","024","ALOSETRON HYDROCHLORIDE","PROMETHEUS LABS","Labeling Revision","05/08/2014"
"MIRENA (NDA #021225)","034","LEVONORGESTREL","BAYER HLTHCARE","Manufacturing Change or Addition","05/08/2014"
"TRILEPTAL (NDA #021285)","029","OXCARBAZEPINE","NOVARTIS","Manufacturing Change or Addition","05/08/2014"
"PREZISTA (NDA #021976)","035","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Manufacturing Change or Addition","05/08/2014"
"MIRAPEX ER (NDA #022421)","003","PRAMIPEXOLE DIHYDROCHLORIDE","BOEHRINGER INGELHEIM","Labeling Revision","05/08/2014"
"GEMCITABINE HYDROCHLORIDE (NDA #200795)","005","GEMCITABINE HYDROCHLORIDE","HOSPIRA INC","Labeling Revision","05/08/2014"
"AZELASTINE HYDROCHLORIDE (ANDA #202743)","000","AZELASTINE HYDROCHLORIDE","PERRIGO ISRAEL","Approval","05/08/2014"
"PREZISTA (NDA #202895)","012","DARUNAVIR ETHANOLATE","JANSSEN PRODS","Manufacturing Change or Addition","05/08/2014"
"SKYLA (NDA #203159)","003","LEVONORGESTREL","BAYER HLTHCARE","Manufacturing Change or Addition","05/08/2014"
"ZONTIVITY (NDA #204886)","000","VORAPAXAR SULFATE","MERCK SHARP DOHME","Approval","05/08/2014"
"OXYTOCIN (NDA #018243)","016","OXYTOCIN","HIKMA MAPLE","Manufacturing Change or Addition","05/09/2014"
"LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","086","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","05/09/2014"
"LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","086","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","05/09/2014"
"LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018388)","086","LIDOCAINE HYDROCHLORIDE","HOSPIRA","Manufacturing Change or Addition","05/09/2014"
"DIFFERIN (NDA #020380)","008","ADAPALENE","GALDERMA LABS LP","Manufacturing Change or Addition","05/09/2014"
"ATROVENT HFA (NDA #021527)","023","IPRATROPIUM BROMIDE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","05/09/2014"
"CLEOCIN (NDA #050680)","010","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","05/09/2014"
"CLEOCIN (NDA #050767)","011","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","05/09/2014"
"ZYTIGA (NDA #202379)","009","ABIRATERONE ACETATE","JANSSEN BIOTECH","Labeling Revision","05/09/2014"
"IRBESARTAN AND HYDROCHLOROTHIAZIDE (ANDA #203072)","000","HYDROCHLOROTHIAZIDE; IRBESARTAN","PRINSTON INC","Approval","05/09/2014"
"FLUDEOXYGLUCOSE F18 (ANDA #203902)","000","FLUDEOXYGLUCOSE F-18","UCSF RODIOPHARM","Approval","05/09/2014"
"TOPICORT (NDA #018594)","009","DESOXIMETASONE","TARO PHARMS NORTH","Manufacturing Change or Addition","05/12/2014"
"TOPROL-XL (NDA #019962)","045","METOPROLOL SUCCINATE","ASTRAZENECA","Manufacturing Change or Addition","05/12/2014"
"ZIRGAN (NDA #022211)","006","GANCICLOVIR","BAUSCH AND LOMB","Manufacturing Change or Addition","05/12/2014"
"BUDESONIDE (ANDA #078949)","000","BUDESONIDE","APOTEX INC","Approval","05/12/2014"
"RAYOS (NDA #202020)","005","PREDNISONE","HORIZON PHARMA","Manufacturing Change or Addition","05/12/2014"
"HYDROMORPHONE HYDROCHLORIDE (ANDA #202144)","000","HYDROMORPHONE HYDROCHLORIDE","ACTAVIS LABS FL INC","Approval","05/12/2014"
"OLANZAPINE (ANDA #202285)","000","OLANZAPINE","MYLAN PHARMS INC","Approval","05/12/2014"
"LO-BLISOVI FE (ANDA #203113)","000","NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE","LUPIN LTD","Tentative Approval","05/12/2014"
"TIVICAY (NDA #204790)","001","DOLUTEGRAVIR SODIUM","VIIV HLTHCARE","Labeling Revision","05/12/2014"
"SORIATANE (NDA #019821)","024","ACITRETIN","STIEFEL LABS INC","Labeling Revision","05/13/2014"
"RECLAST (NDA #021817)","018","ZOLEDRONIC ACID","NOVARTIS","Manufacturing Change or Addition","05/13/2014"
"TREXIMET (NDA #021926)","010","NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE","SMITHKLINE BEECHAM","Manufacturing Change or Addition","05/13/2014"
"DOPAMINE HYDROCHLORIDE (NDA #018132)","067","DOPAMINE HYDROCHLORIDE","HOSPIRA","Labeling Revision","05/14/2014"
"DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #018826)","045","DOPAMINE HYDROCHLORIDE","HOSPIRA","Labeling Revision","05/14/2014"
"OMNISCAN (NDA #020123)","040","GADODIAMIDE","GE HEALTHCARE","Manufacturing Change or Addition","05/14/2014"
"ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION (NDA #020786)","032","FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","05/14/2014"
"PLAVIX (NDA #020839)","060","CLOPIDOGREL BISULFATE","SANOFI AVENTIS US","Manufacturing Change or Addition","05/14/2014"
"APIDRA (NDA #021629)","029","INSULIN GLULISINE RECOMBINANT","SANOFI AVENTIS US","Labeling Revision","05/14/2014"
"APIDRA SOLOSTAR (NDA #021629)","029","INSULIN GLULISINE RECOMBINANT","SANOFI AVENTIS US","Labeling Revision","05/14/2014"
"LOVAZA (NDA #021654)","041","OMEGA-3-ACID ETHYL ESTERS","SMITHKLINE BEECHAM","Labeling Revision","05/14/2014"
"VYVANSE (NDA #021977)","029","LISDEXAMFETAMINE DIMESYLATE","SHIRE DEVELOPMENT","Manufacturing Change or Addition","05/14/2014"
"OMNISCAN (NDA #022066)","005","GADODIAMIDE","GE HEALTHCARE","Manufacturing Change or Addition","05/14/2014"
"AZOR (NDA #022100)","023","AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Manufacturing Change or Addition","05/14/2014"
"ELELYSO (NDA #022458)","002","TALIGLUCERASE ALFA","PFIZER","Labeling Revision","05/14/2014"
"VIMOVO (NDA #022511)","013","ESOMEPRAZOLE MAGNESIUM; NAPROXEN","HORIZON PHARMA","Manufacturing Change or Addition","05/14/2014"
"TIMENTIN IN PLASTIC CONTAINER (NDA #050658)","030","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Manufacturing Change or Addition","05/14/2014"
"HUMIRA (BLA #125057)","368","ADALIMUMAB","ABBVIE INC","Labeling Revision","05/14/2014"
"DESONIDE (NDA #017010)","022","DESONIDE","PERRIGO NEW YORK","Manufacturing Change or Addition","05/15/2014"
"TAXOTERE (NDA #020449)","072","DOCETAXEL","SANOFI AVENTIS US","Manufacturing Change or Addition","05/15/2014"
"NUTROPIN AQ (NDA #020522)","052","SOMATROPIN RECOMBINANT","GENENTECH","Manufacturing Change or Addition","05/15/2014"
"NUTROPIN AQ PEN (NDA #020522)","052","SOMATROPIN RECOMBINANT","GENENTECH","Manufacturing Change or Addition","05/15/2014"
"CLARITIN (NDA #020641)","035","LORATADINE","SCHERING PLOUGH","Manufacturing Change or Addition","05/15/2014"
"CLARITIN HIVES RELIEF (NDA #020641)","035","LORATADINE","SCHERING PLOUGH","Manufacturing Change or Addition","05/15/2014"
"TRIVAGIZOLE 3 (NDA #021143)","011","CLOTRIMAZOLE","TARO","Manufacturing Change or Addition","05/15/2014"
"ATNAA (NDA #021175)","024","ATROPINE; PRALIDOXIME CHLORIDE","US ARMY","Manufacturing Change or Addition","05/15/2014"
"PRILOSEC OTC (NDA #021229)","027","OMEPRAZOLE MAGNESIUM","ASTRAZENECA","Manufacturing Change or Addition","05/15/2014"
"LUNESTA (NDA #021476)","030","ESZOPICLONE","SUNOVION PHARMS INC","Labeling Revision","05/15/2014"
"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (ANDA #091422)","006","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ACTAVIS ELIZABETH","Manufacturing Change or Addition","05/15/2014"
"OPANA ER (NDA #201655)","013","OXYMORPHONE HYDROCHLORIDE","ENDO PHARMS","Manufacturing Change or Addition","05/15/2014"
"OXYTROL FOR WOMEN (NDA #202211)","003","OXYBUTYNIN","MSD CONSUMER","Manufacturing Change or Addition","05/15/2014"
"XARELTO (NDA #202439)","011","RIVAROXABAN","JANSSEN PHARMS","Manufacturing Change or Addition","05/15/2014"
"OLANZAPINE (ANDA #203708)","000","OLANZAPINE","AUROBINDO PHARMA LTD","Approval","05/15/2014"
"INVOKANA (NDA #204042)","002","CANAGLIFLOZIN","JANSSEN PHARMS","Labeling Revision","05/15/2014"
"IZBA (NDA #204822)","000","TRAVOPROST","ALCON LABS INC","Approval","05/15/2014"
"MESTINON (NDA #009829)","017","PYRIDOSTIGMINE BROMIDE","VALEANT PHARMS LLC","Manufacturing Change or Addition","05/16/2014"
"ESTRING (NDA #020472)","010","ESTRADIOL","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","05/16/2014"
"OXYTROL (NDA #021351)","014","OXYBUTYNIN","WATSON LABS (UTAH)","Manufacturing Change or Addition","05/16/2014"
"CHILDREN'S ZYRTEC ALLERGY (NDA #022155)","009","CETIRIZINE HYDROCHLORIDE","MCNEIL CONSUMER","Labeling Revision","05/16/2014"
"CHILDREN'S ZYRTEC HIVES RELIEF (NDA #022155)","009","CETIRIZINE HYDROCHLORIDE","MCNEIL CONSUMER","Labeling Revision","05/16/2014"
"PHOSLYRA (NDA #022581)","002","CALCIUM ACETATE","FRESENIUS MEDCL","Manufacturing Change or Addition","05/16/2014"
"LIPTRUZET (NDA #200153)","003","ATORVASTATIN CALCIUM; EZETIMIBE","MERCK SHARP DOHME","Manufacturing Change or Addition","05/16/2014"
"EXELDERM (NDA #018738)","014","SULCONAZOLE NITRATE","RANBAXY","Manufacturing Change or Addition","05/19/2014"
"SANDOSTATIN LAR (NDA #021008)","028","OCTREOTIDE ACETATE","NOVARTIS","Labeling Revision","05/19/2014"
"ALPHAGAN P (NDA #021262)","024","BRIMONIDINE TARTRATE","ALLERGAN","Manufacturing Change or Addition","05/19/2014"
"DUAC (NDA #050741)","022","BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","STIEFEL","Manufacturing Change or Addition","05/19/2014"
"CAYSTON (NDA #050814)","013","AZTREONAM","GILEAD","Manufacturing Change or Addition","05/19/2014"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #078908)","002","DEXMETHYLPHENIDATE HYDROCHLORIDE","TEVA PHARMS USA","Approval","05/19/2014"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #079108)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","WATSON LABS INC","Approval","05/19/2014"
"DEXMETHYLPHENIDATE HYDROCHLORIDE (ANDA #202731)","000","DEXMETHYLPHENIDATE HYDROCHLORIDE","TEVA PHARMS USA","Approval","05/19/2014"
"CEENU (NDA #017588)","040","LOMUSTINE","CORDEN PHARMA","Labeling Revision","05/20/2014"
"WELCHOL (NDA #021176)","039","COLESEVELAM HYDROCHLORIDE","DAIICHI SANKYO","Manufacturing Change or Addition","05/20/2014"
"TYVASO (NDA #022387)","009","TREPROSTINIL","UNITED THERAP","Efficacy Supplement with Clinical Data to Support","05/20/2014"
"MYOZYME (BLA #125141)","219","ALGLUCOSIDASE ALFA","GENZYME","Labeling Revision","05/20/2014"
"ENTYVIO (BLA #125476)","000","VEDOLIZUMAB","TAKEDA PHARMS USA","Approval","05/20/2014"
"OPSUMIT (NDA #204410)","001","MACITENTAN","ACTELION PHARMS LTD","Manufacturing Change or Addition","05/20/2014"
"LO MINASTRIN FE (NDA #204654)","003","ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","WARNER CHILCOTT","Manufacturing Change or Addition","05/20/2014"
"CELESTONE SOLUSPAN (NDA #014602)","057","BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE","MERCK SHARP DOHME","Manufacturing Change or Addition","05/21/2014"
"IMURAN (NDA #016324)","036","AZATHIOPRINE","PROMETHEUS LABS","Manufacturing Change or Addition","05/21/2014"
"FENTANYL CITRATE PRESERVATIVE FREE (NDA #019101)","040","FENTANYL CITRATE","HIKMA MAPLE","Manufacturing Change or Addition","05/21/2014"
"LIPITOR (NDA #020702)","064","ATORVASTATIN CALCIUM","PFIZER","Labeling Revision","05/21/2014"
"VUSION (NDA #021026)","011","MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE","DELCOR ASSET","Manufacturing Change or Addition","05/21/2014"
"ORFADIN (NDA #021232)","013","NITISINONE","SWEDISH ORPHAN","Labeling Revision","05/21/2014"
"GEODON (NDA #021483)","012","ZIPRASIDONE HYDROCHLORIDE","PFIZER INC","Manufacturing Change or Addition","05/21/2014"
"LATUDA (NDA #200603)","014","LURASIDONE HYDROCHLORIDE","SUNOVION PHARMS INC","Manufacturing Change or Addition","05/21/2014"
"MINIVELLE (NDA #203752)","002","ESTRADIOL","NOVEN","Manufacturing Change or Addition","05/21/2014"
"COLESTID (NDA #017563)","023","COLESTIPOL HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","05/22/2014"
"FLAVORED COLESTID (NDA #017563)","023","COLESTIPOL HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","05/22/2014"
"COLESTID (NDA #020222)","005","COLESTIPOL HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","05/22/2014"
"IMODIUM A-D EZ CHEWS (NDA #020448)","009","LOPERAMIDE HYDROCHLORIDE","MCNEIL","Manufacturing Change or Addition","05/22/2014"
"QVAR 40 (NDA #020911)","026","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Manufacturing Change or Addition","05/22/2014"
"QVAR 80 (NDA #020911)","026","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Manufacturing Change or Addition","05/22/2014"
"MUCINEX (NDA #021282)","043","GUAIFENESIN","RECKITT BENCKISER","Manufacturing Change or Addition","05/22/2014"
"CADUET (NDA #021540)","034","AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM","PFIZER","Labeling Revision","05/22/2014"
"GLEEVEC (NDA #021588)","040","IMATINIB MESYLATE","NOVARTIS","Labeling Revision","05/22/2014"
"BYDUREON (NDA #022200)","012","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling Revision","05/22/2014"
"BYDUREON (NDA #022200)","013","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Labeling Revision","05/22/2014"
"BACTROBAN (NDA #050591)","032","MUPIROCIN","GLAXOSMITHKLINE","Labeling Revision","05/22/2014"
"BACTROBAN (NDA #050703)","015","MUPIROCIN CALCIUM","GLAXOSMITHKLINE","Labeling Revision","05/22/2014"
"BACTROBAN (NDA #050746)","018","MUPIROCIN CALCIUM","GLAXOSMITHKLINE","Labeling Revision","05/22/2014"
"LUMIZYME (BLA #125291)","133","ALGLUCOSIDASE ALFA","GENZYME","Labeling Revision","05/22/2014"
"TRADJENTA (NDA #201280)","009","LINAGLIPTIN","BOEHRINGER INGELHEIM","Labeling Revision","05/22/2014"
"JENTADUETO (NDA #201281)","007","LINAGLIPTIN; METFORMIN HYDROCHLORIDE","BOEHRINGER INGELHEIM","Labeling Revision","05/22/2014"
"ZOLEDRONIC ACID (ANDA #202548)","000","ZOLEDRONIC ACID","AKORN INC","Approval","05/22/2014"
"DEXTROSE 5% IN PLASTIC CONTAINER (NDA #016673)","148","DEXTROSE","BAXTER HLTHCARE","Manufacturing Change or Addition","05/23/2014"
"DEXTROSE 10% IN PLASTIC CONTAINER (NDA #016694)","120","DEXTROSE","BAXTER HLTHCARE","Manufacturing Change or Addition","05/23/2014"
"SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #016733)","055","SODIUM CHLORIDE","B BRAUN","Manufacturing Change or Addition","05/23/2014"
"NAVELBINE (NDA #020388)","029","VINORELBINE TARTRATE","PIERRE FABRE","Manufacturing Change or Addition","05/23/2014"
"LEVAQUIN (NDA #020634)","066","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","05/23/2014"
"LEVAQUIN (NDA #020635)","072","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","05/23/2014"
"LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #020635)","072","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","05/23/2014"
"SUSTIVA (NDA #020972)","046","EFAVIRENZ","BRISTOL MYERS SQUIBB","Labeling Revision","05/23/2014"
"SUSTIVA (NDA #021360)","035","EFAVIRENZ","BRISTOL MYERS SQUIBB","Labeling Revision","05/23/2014"
"LEVAQUIN (NDA #021721)","033","LEVOFLOXACIN","JANSSEN PHARMS","Labeling Revision","05/23/2014"
"DALVANCE (NDA #021883)","000","DALBAVANCIN HYDROCHLORIDE","DURATA THERAPS INTL","Approval","05/23/2014"
"VECTIBIX (BLA #125147)","108","PANITUMUMAB","AMGEN","Efficacy Supplement with Clinical Data to Support","05/23/2014"
"VECTIBIX (BLA #125147)","186","PANITUMUMAB","AMGEN","Efficacy Supplement with Clinical Data to Support","05/23/2014"
"XTANDI (NDA #203415)","002","ENZALUTAMIDE","ASTELLAS","Manufacturing Change or Addition","05/23/2014"
"FETZIMA (NDA #204168)","001","LEVOMILNACIPRAN HYDROCHLORIDE","FOREST LABS INC","Labeling Revision","05/23/2014"
"PHOSLO (NDA #021160)","028","CALCIUM ACETATE","FRESENIUS MEDCL","Manufacturing Change or Addition","05/27/2014"
"PHOSLO GELCAPS (NDA #021160)","028","CALCIUM ACETATE","FRESENIUS MEDCL","Manufacturing Change or Addition","05/27/2014"
"ALOXI (NDA #021372)","018","PALONOSETRON HYDROCHLORIDE","HELSINN HLTHCARE","Efficacy Supplement with Clinical Data to Support","05/27/2014"
"ALOXI (NDA #021372)","019","PALONOSETRON HYDROCHLORIDE","HELSINN HLTHCARE","Efficacy Supplement with Clinical Data to Support","05/27/2014"
"SYNTHROID (NDA #021402)","025","LEVOTHYROXINE SODIUM","ABBVIE","Manufacturing Change or Addition","05/27/2014"
"PANCREAZE (NDA #022523)","005","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","JANSSEN PHARMS","Manufacturing Change or Addition","05/27/2014"
"NIKKI (ANDA #201661)","000","DROSPIRENONE; ETHINYL ESTRADIOL","LUPIN LTD","Approval","05/27/2014"
"DICLOFENAC SODIUM (ANDA #202027)","000","DICLOFENAC SODIUM","APOTEX INC","Approval","05/27/2014"
"ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (ANDA #202362)","000","ATOVAQUONE; PROGUANIL HYDROCHLORIDE","MYLAN PHARMS INC","Approval","05/27/2014"
"VALGANCICLOVIR (ANDA #203511)","000","VALGANCICLOVIR","DR REDDYS LABS LTD","Tentative Approval","05/27/2014"
"AVAPRO (NDA #020757)","064","IRBESARTAN","SANOFI AVENTIS US","Labeling Revision","05/28/2014"
"AVALIDE (NDA #020758)","067","HYDROCHLOROTHIAZIDE; IRBESARTAN","SANOFI AVENTIS US","Labeling Revision","05/28/2014"
"IMPLANON (NDA #021529)","008","ETONOGESTREL","ORGANON USA INC","Labeling Revision","05/28/2014"
"NEXPLANON (NDA #021529)","008","ETONOGESTREL","ORGANON USA INC","Labeling Revision","05/28/2014"
"PYLERA (NDA #050786)","010","BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE","FOREST LABS INC","Manufacturing Change or Addition","05/28/2014"
"TOBRAMYCIN (ANDA #201422)","000","TOBRAMYCIN","AKORN INC","Approval","05/28/2014"
"XALKORI (NDA #202570)","011","CRIZOTINIB","PF PRISM CV","Labeling Revision","05/28/2014"
"NATESTO (NDA #205488)","000","TESTOSTERONE","TRIMEL BIOPHARMA SRL","Approval","05/28/2014"
"LOVENOX (NDA #020164)","105","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","05/29/2014"
"LOVENOX (PRESERVATIVE FREE) (NDA #020164)","105","ENOXAPARIN SODIUM","SANOFI AVENTIS US","Manufacturing Change or Addition","05/29/2014"
"MAXALT (NDA #020864)","020","RIZATRIPTAN BENZOATE","MERCK","Manufacturing Change or Addition","05/29/2014"
"MAXALT-MLT (NDA #020865)","022","RIZATRIPTAN BENZOATE","MERCK","Manufacturing Change or Addition","05/29/2014"
"MIRENA (NDA #021225)","033","LEVONORGESTREL","BAYER HLTHCARE","Manufacturing Change or Addition","05/29/2014"
"FEMRING (NDA #021367)","013","ESTRADIOL ACETATE","WARNER IRELAND","Labeling Revision","05/29/2014"
"LUNESTA (NDA #021476)","029","ESZOPICLONE","SUNOVION PHARMS INC","Manufacturing Change or Addition","05/29/2014"
"AZILECT (NDA #021641)","016","RASAGILINE MESYLATE","TEVA","Labeling Revision","05/29/2014"
"AZILECT (NDA #021641)","017","RASAGILINE MESYLATE","TEVA","Efficacy Supplement with Clinical Data to Support","05/29/2014"
"ENTEREG (NDA #021775)","012","ALVIMOPAN","CUBIST PHARMS","Manufacturing Change or Addition","05/29/2014"
"DIFFERIN (NDA #022502)","004","ADAPALENE","GALDERMA LABS LP","Manufacturing Change or Addition","05/29/2014"
"MINOCIN (NDA #050649)","024","MINOCYCLINE HYDROCHLORIDE","PRECISION DERMAT","Manufacturing Change or Addition","05/29/2014"
"AMOXIL (NDA #050760)","017","AMOXICILLIN","DR REDDYS LABS INC","Manufacturing Change or Addition","05/29/2014"
"ZOLEDRONIC ACID (ANDA #078475)","000","ZOLEDRONIC ACID","CIPLA LTD","Tentative Approval","05/29/2014"
"SUPRAX (NDA #202091)","002","CEFIXIME","LUPIN LTD","Labeling Revision","05/29/2014"
"DOSTINEX (NDA #020664)","014","CABERGOLINE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","05/30/2014"
"DIOVAN HCT (NDA #020818)","060","HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Manufacturing Change or Addition","05/30/2014"
"AGGRENOX (NDA #020884)","033","ASPIRIN; DIPYRIDAMOLE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","05/30/2014"
"TAMIFLU (NDA #021087)","064","OSELTAMIVIR PHOSPHATE","ROCHE","Labeling Revision","05/30/2014"
"TAMIFLU (NDA #021246)","047","OSELTAMIVIR PHOSPHATE","ROCHE","Labeling Revision","05/30/2014"
"ELIGARD (NDA #021343)","029","LEUPROLIDE ACETATE","TOLMAR THERAP","Manufacturing Change or Addition","05/30/2014"
"CELECOXIB (ANDA #076898)","000","CELECOXIB","TEVA","Approval","05/30/2014"
"CELECOXIB (ANDA #078857)","000","CELECOXIB","MYLAN PHARMS INC","Approval","05/30/2014"
"CELECOXIB (ANDA #078857)","000","CELECOXIB","MYLAN PHARMS INC","Tentative Approval","05/30/2014"
"HUMIRA (BLA #125057)","366","ADALIMUMAB","ABBVIE INC","Labeling Revision","05/30/2014"
"LINEZOLID (ANDA #200904)","000","LINEZOLID","SANDOZ","Tentative Approval","05/30/2014"
"FAMOTIDINE (ANDA #201995)","000","FAMOTIDINE","HI-TECH PHARMA CO","Approval","05/30/2014"
"JAKAFI (NDA #202192)","007","RUXOLITINIB PHOSPHATE","INCYTE CORP","Manufacturing Change or Addition","05/30/2014"
"ABILIFY MAINTENA KIT (NDA #202971)","002","ARIPIPRAZOLE","OTSUKA PHARM CO LTD","Manufacturing Change or Addition","05/30/2014"
"OMIDRIA (NDA #205388)","000","KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE","OMEROS","Approval","05/30/2014"
"METHADOSE (NDA #017116)","026","METHADONE HYDROCHLORIDE","MALLINCKRODT","Manufacturing Change or Addition","06/02/2014"
"MS CONTIN (NDA #019516)","040","MORPHINE SULFATE","PURDUE PHARMA LP","Manufacturing Change or Addition","06/02/2014"
"REYATAZ (NDA #021567)","035","ATAZANAVIR SULFATE","BRISTOL MYERS SQUIBB","Efficacy Supplement with Clinical Data to Support","06/02/2014"
"CEFPODOXIME PROXETIL (ANDA #090031)","005","CEFPODOXIME PROXETIL","SANDOZ","Labeling Revision","06/02/2014"
"MEFENAMIC ACID (ANDA #091608)","000","MEFENAMIC ACID","VINTAGE PHARMS LLC","Approval","06/02/2014"
"OXYCODONE HYDROCHLORIDE (NDA #200534)","004","OXYCODONE HYDROCHLORIDE","LEHIGH VALLEY","Manufacturing Change or Addition","06/02/2014"
"OXYCODONE HYDROCHLORIDE (NDA #201194)","001","OXYCODONE HYDROCHLORIDE","VISTAPHARM","Manufacturing Change or Addition","06/02/2014"
"DYMISTA (NDA #202236)","005","AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE","MEDA PHARMS","Manufacturing Change or Addition","06/02/2014"
"DIVALPROEX SODIUM (ANDA #202419)","000","DIVALPROEX SODIUM","AUROBINDO PHARMA LTD","Approval","06/02/2014"
"KYPROLIS (NDA #202714)","004","CARFILZOMIB","ONYX PHARMS","Manufacturing Change or Addition","06/02/2014"
"REYATAZ (NDA #206352)","000","ATAZANAVIR SULFATE","BRISTOL MYERS SQUIBB","Approval","06/02/2014"
"VISTARIL (NDA #011459)","048","HYDROXYZINE PAMOATE","PFIZER","Labeling Revision","06/03/2014"
"VISTARIL (NDA #011795)","025","HYDROXYZINE PAMOATE","PFIZER","Labeling Revision","06/03/2014"
"CORTENEMA (NDA #016199)","036","HYDROCORTISONE","ANI PHARMS","Manufacturing Change or Addition","06/03/2014"
"K-TAB (NDA #018279)","032","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","06/03/2014"
"POTASSIUM CHLORIDE (NDA #018279)","032","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","06/03/2014"
"INCRELEX (NDA #021839)","016","MECASERMIN RECOMBINANT","IPSEN INC","Labeling Revision","06/03/2014"
"VOTRIENT (NDA #022465)","018","PAZOPANIB HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","06/03/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #040010)","008","HYDROXYZINE HYDROCHLORIDE","HI TECH PHARMA","Labeling Revision","06/03/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #040391)","007","HYDROXYZINE HYDROCHLORIDE","VINTAGE PHARMS","Labeling Revision","06/03/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #087294)","026","HYDROXYZINE HYDROCHLORIDE","WOCKHARDT","Labeling Revision","06/03/2014"
"NITHIODOTE (NDA #201444)","012","SODIUM NITRITE; SODIUM THIOSULFATE","HOPE PHARMS","Manufacturing Change or Addition","06/03/2014"
"PRAMIPEXOLE DIHYDROCHLORIDE (ANDA #202702)","000","PRAMIPEXOLE DIHYDROCHLORIDE","STRIDES ARCOLAB LTD","Approval","06/03/2014"
"OXYCODONE HYDROCHLORIDE (ANDA #203638)","000","OXYCODONE HYDROCHLORIDE","AMNEAL PHARMS","Approval","06/03/2014"
"HUMULIN N (NDA #018781)","147","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMULIN 70/30 (NDA #019717)","126","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMULIN 70/30 PEN (NDA #019717)","126","INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG (NDA #020563)","150","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG KWIKPEN (NDA #020563)","150","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG PEN (NDA #020563)","150","INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG MIX 75/25 (NDA #021017)","102","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG MIX 75/25 KWIKPEN (NDA #021017)","102","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG MIX 75/25 PEN (NDA #021017)","102","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG MIX 50/50 (NDA #021018)","095","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG MIX 50/50 KWIKPEN (NDA #021018)","095","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"HUMALOG MIX 50/50 PEN (NDA #021018)","095","INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT","LILLY","Manufacturing Change or Addition","06/04/2014"
"ELIDEL (NDA #021302)","019","PIMECROLIMUS","VALEANT BERMUDA","Manufacturing Change or Addition","06/04/2014"
"FORTESTA (NDA #021463)","013","TESTOSTERONE","ENDO PHARMS","Manufacturing Change or Addition","06/04/2014"
"BYETTA (NDA #021773)","037","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Manufacturing Change or Addition","06/04/2014"
"BYETTA (NDA #021773)","038","EXENATIDE SYNTHETIC","ASTRAZENECA AB","Manufacturing Change or Addition","06/04/2014"
"VIMPAT (NDA #022253)","029","LACOSAMIDE","UCB INC","Manufacturing Change or Addition","06/04/2014"
"PRANDIMET (NDA #022386)","014","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Manufacturing Change or Addition","06/04/2014"
"PRANDIMET (NDA #022386)","015","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Manufacturing Change or Addition","06/04/2014"
"CEFEPIME IN PLASTIC CONTAINER (NDA #050817)","003","CEFEPIME HYDROCHLORIDE","BAXTER HLTHCARE","Labeling Revision","06/04/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #087329)","019","HYDROXYZINE HYDROCHLORIDE","FRESENIUS KABI USA","Labeling Revision","06/04/2014"
"PROLIA (BLA #125320)","155","DENOSUMAB","AMGEN","Labeling Revision","06/04/2014"
"XGEVA (BLA #125320)","155","DENOSUMAB","AMGEN","Labeling Revision","06/04/2014"
"LEVOTHYROXINE SODIUM (NDA #202231)","006","LEVOTHYROXINE SODIUM","FRESENIUS KABI USA","Manufacturing Change or Addition","06/04/2014"
"AMITRIPTYLINE HYDROCHORIDE (ANDA #202446)","000","AMITRIPTYLINE HYDROCHLORIDE","ACCORD HLTHCARE","Approval","06/04/2014"
"CEVIMELINE HYDROCHLORIDE (ANDA #203775)","000","CEVIMELINE HYDROCHLORIDE","PACK PHARMS LLC","Approval","06/04/2014"
"VOGELXO (NDA #204399)","000","TESTOSTERONE","UPSHER SMITH","Approval","06/04/2014"
"SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #016677)","149","SODIUM CHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","06/05/2014"
"SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (NDA #018016)","053","SODIUM CHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","06/05/2014"
"VOLTAREN (NDA #019201)","045","DICLOFENAC SODIUM","NOVARTIS","Manufacturing Change or Addition","06/05/2014"
"PROCARDIA XL (NDA #019684)","028","NIFEDIPINE","PFIZER","Manufacturing Change or Addition","06/05/2014"
"ADAGEN (NDA #019818)","053","PEGADEMASE BOVINE","SIGMA TAU","Labeling Revision","06/05/2014"
"LIORESAL (NDA #020075)","030","BACLOFEN","MEDTRONIC NEURO","Manufacturing Change or Addition","06/05/2014"
"FIORICET W/ CODEINE (NDA #020232)","037","ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE","WATSON LABS INC","Manufacturing Change or Addition","06/05/2014"
"VOLTAREN-XR (NDA #020254)","026","DICLOFENAC SODIUM","NOVARTIS","Manufacturing Change or Addition","06/05/2014"
"SEPTOCAINE (NDA #020971)","032","ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","DEPROCO","Manufacturing Change or Addition","06/05/2014"
"SEPTOCAINE (NDA #020971)","033","ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","DEPROCO","Manufacturing Change or Addition","06/05/2014"
"RISPERDAL CONSTA (NDA #021346)","052","RISPERIDONE","JANSSEN PHARMS","Manufacturing Change or Addition","06/05/2014"
"LOVAZA (NDA #021654)","040","OMEGA-3-ACID ETHYL ESTERS","SMITHKLINE BEECHAM","Manufacturing Change or Addition","06/05/2014"
"ALSUMA (NDA #022377)","002","SUMATRIPTAN SUCCINATE","MERIDIAN MEDCL","Labeling Revision","06/05/2014"
"ALSUMA (NDA #022377)","004","SUMATRIPTAN SUCCINATE","MERIDIAN MEDCL","Labeling Revision","06/05/2014"
"SUBOXONE (NDA #022410)","016","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","RECKITT BENCKISER","Manufacturing Change or Addition","06/05/2014"
"EXPAREL (NDA #022496)","007","BUPIVACAINE","PACIRA PHARMS INC","Manufacturing Change or Addition","06/05/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #088617)","043","HYDROXYZINE HYDROCHLORIDE","PLIVA","Labeling Revision","06/05/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #088618)","043","HYDROXYZINE HYDROCHLORIDE","PLIVA","Labeling Revision","06/05/2014"
"HYDROXYZINE HYDROCHLORIDE (ANDA #088619)","044","HYDROXYZINE HYDROCHLORIDE","PLIVA","Labeling Revision","06/05/2014"
"COMPLERA (NDA #202123)","016","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling Revision","06/05/2014"
"METHOXSALEN (ANDA #202687)","000","METHOXSALEN","STRIDES ARCOLAB LTD","Approval","06/05/2014"
"INVOKANA (NDA #204042)","003","CANAGLIFLOZIN","JANSSEN PHARMS","Manufacturing Change or Addition","06/05/2014"
"OXYCODONE HYDROCHLORIDE (ANDA #204092)","000","OXYCODONE HYDROCHLORIDE","COASTAL PHARMS","Approval","06/05/2014"
"SODIUM CHLORIDE 3% IN PLASTIC CONTAINER (NDA #019022)","027","SODIUM CHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","06/06/2014"
"SODIUM CHLORIDE 5% IN PLASTIC CONTAINER (NDA #019022)","027","SODIUM CHLORIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","06/06/2014"
"TRILEPTAL (NDA #021014)","035","OXCARBAZEPINE","NOVARTIS","Labeling Revision","06/06/2014"
"TRILEPTAL (NDA #021285)","030","OXCARBAZEPINE","NOVARTIS","Labeling Revision","06/06/2014"
"NASCOBAL (NDA #021642)","020","CYANOCOBALAMIN","PAR PHARM","Labeling Revision","06/06/2014"
"ZITHROMAX (NDA #050693)","021","AZITHROMYCIN","PFIZER","Labeling Revision","06/06/2014"
"ZITHROMAX (NDA #050710)","037","AZITHROMYCIN","PFIZER","Labeling Revision","06/06/2014"
"ZITHROMAX (NDA #050711)","034","AZITHROMYCIN","PFIZER","Labeling Revision","06/06/2014"
"ZITHROMAX (NDA #050730)","029","AZITHROMYCIN","PFIZER","Labeling Revision","06/06/2014"
"ZITHROMAX (NDA #050733)","031","AZITHROMYCIN","PFIZER","Labeling Revision","06/06/2014"
"ZITHROMAX (NDA #050784)","021","AZITHROMYCIN","PFIZER","Labeling Revision","06/06/2014"
"CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (NDA #050821)","002","CEFEPIME HYDROCHLORIDE","B BRAUN","Labeling Revision","06/06/2014"
"ROSUVASTATIN CALCIUM (ANDA #079145)","000","ROSUVASTATIN CALCIUM","APOTEX CORP","Tentative Approval","06/06/2014"
"JUBLIA (NDA #203567)","000","EFINACONAZOLE","DOW PHARM","Approval","06/06/2014"
"CLINOLIPID 20% (NDA #204508)","001","OLIVE OIL; SOYBEAN OIL","BAXTER HLTHCARE","Manufacturing Change or Addition","06/06/2014"
"BUNAVAIL (NDA #205637)","000","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","BIODELIVERY SCI INTL","Approval","06/06/2014"
"DIPRIVAN (NDA #019627)","062","PROPOFOL","FRESENIUS KABI USA","Manufacturing Change or Addition","06/08/2014"
"DURAGESIC-100 (NDA #019813)","064","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","06/08/2014"
"DURAGESIC-12 (NDA #019813)","064","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","06/08/2014"
"DURAGESIC-25 (NDA #019813)","064","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","06/08/2014"
"DURAGESIC-50 (NDA #019813)","064","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","06/08/2014"
"DURAGESIC-75 (NDA #019813)","064","FENTANYL","JANSSEN PHARMS","Manufacturing Change or Addition","06/08/2014"
"SOLU-CORTEF (NDA #009866)","102","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"DEPO-MEDROL (NDA #011757)","102","METHYLPREDNISOLONE ACETATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"SOLU-MEDROL (NDA #011856)","122","METHYLPREDNISOLONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"DEPO-PROVERA (NDA #012541)","082","MEDROXYPROGESTERONE ACETATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"HEMABATE (NDA #017989)","022","CARBOPROST TROMETHAMINE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"DEPAKENE (NDA #018081)","060","VALPROIC ACID","ABBVIE","Labeling Revision","06/09/2014"
"DEPAKENE (NDA #018082)","043","VALPROIC ACID","ABBVIE","Labeling Revision","06/09/2014"
"PROSTIN VR PEDIATRIC (NDA #018484)","026","ALPROSTADIL","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"DEPAKOTE (NDA #018723)","052","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/09/2014"
"DEPAKOTE (NDA #019680)","039","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/09/2014"
"SPORANOX (NDA #020083)","053","ITRACONAZOLE","JANSSEN PHARMS","Labeling Revision","06/09/2014"
"DEPO-PROVERA (NDA #020246)","052","MEDROXYPROGESTERONE ACETATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"CAVERJECT (NDA #020379)","027","ALPROSTADIL","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"CEREBYX (NDA #020450)","026","FOSPHENYTOIN SODIUM","PARKE DAVIS","Manufacturing Change or Addition","06/09/2014"
"CORVERT (NDA #020491)","009","IBUTILIDE FUMARATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/09/2014"
"CAMPTOSAR (NDA #020571)","047","IRINOTECAN HYDROCHLORIDE","PFIZER INC","Manufacturing Change or Addition","06/09/2014"
"DEPACON (NDA #020593)","030","VALPROATE SODIUM","ABBVIE","Labeling Revision","06/09/2014"
"SPORANOX (NDA #020657)","032","ITRACONAZOLE","JANSSEN PHARMS","Labeling Revision","06/09/2014"
"GEODON (NDA #020919)","039","ZIPRASIDONE MESYLATE","PFIZER","Manufacturing Change or Addition","06/09/2014"
"DEPAKOTE ER (NDA #021168)","028","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/09/2014"
"VFEND (NDA #021267)","045","VORICONAZOLE","PFIZER","Manufacturing Change or Addition","06/09/2014"
"ABILIFY (NDA #021436)","036","ARIPIPRAZOLE","OTSUKA","Labeling Revision","06/09/2014"
"ERAXIS (NDA #021632)","020","ANIDULAFUNGIN","VICURON","Manufacturing Change or Addition","06/09/2014"
"ABILIFY (NDA #021713)","028","ARIPIPRAZOLE","OTSUKA","Labeling Revision","06/09/2014"
"ABILIFY (NDA #021729)","020","ARIPIPRAZOLE","OTSUKA","Labeling Revision","06/09/2014"
"ABILIFY (NDA #021866)","021","ARIPIPRAZOLE","OTSUKA","Labeling Revision","06/09/2014"
"EXFORGE (NDA #021990)","022","AMLODIPINE BESYLATE; VALSARTAN","NOVARTIS","Manufacturing Change or Addition","06/09/2014"
"EXFORGE HCT (NDA #022314)","017","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","Manufacturing Change or Addition","06/09/2014"
"DULOXETINE HYDROCHLORIDE (ANDA #202949)","000","DULOXETINE HYDROCHLORIDE","ALEMBIC PHARMS LTD","Approval","06/09/2014"
"FEXOFENADINE HYDROCHLORIDE (ANDA #203330)","000","FEXOFENADINE HYDROCHLORIDE","ACTAVIS MID ATLANTIC","Tentative Approval","06/09/2014"
"HUMULIN N (NDA #018781)","146","INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","06/10/2014"
"DDAVP (NDA #018938)","032","DESMOPRESSIN ACETATE","SANOFI AVENTIS US","Manufacturing Change or Addition","06/10/2014"
"FOSCAVIR (NDA #020068)","019","FOSCARNET SODIUM","CLINIGEN HLTHCARE","Manufacturing Change or Addition","06/10/2014"
"LAMICTAL (NDA #020241)","052","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","06/10/2014"
"GEMZAR (NDA #020509)","075","GEMCITABINE HYDROCHLORIDE","LILLY","Labeling Revision","06/10/2014"
"LAMICTAL CD (NDA #020764)","045","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","06/10/2014"
"LEVEMIR (NDA #021536)","047","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","06/10/2014"
"LEVEMIR FLEXPEN (NDA #021536)","047","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","06/10/2014"
"LEVEMIR FLEXTOUCH (NDA #021536)","047","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","06/10/2014"
"LEVEMIR INNOLET (NDA #021536)","047","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","06/10/2014"
"LEVEMIR PENFILL (NDA #021536)","047","INSULIN DETEMIR RECOMBINANT","NOVO NORDISK INC","Manufacturing Change or Addition","06/10/2014"
"LAMICTAL XR (NDA #022115)","019","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","06/10/2014"
"LAMICTAL ODT (NDA #022251)","016","LAMOTRIGINE","GLAXOSMITHKLINE LLC","Labeling Revision","06/10/2014"
"CLEOCIN PHOSPHATE (NDA #050441)","066","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","06/10/2014"
"CLEOCIN PHOSPHATE (NDA #050441)","067","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","06/10/2014"
"CLEOCIN PHOSPHATE (NDA #050441)","068","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","06/10/2014"
"RISEDRONATE SODIUM (ANDA #090877)","000","RISEDRONATE SODIUM","APOTEX INC","Approval","06/10/2014"
"RISEDRONATE SODIUM (ANDA #090886)","000","RISEDRONATE SODIUM","SUN PHARMA GLOBAL","Approval","06/10/2014"
"RISEDRONATE SODIUM (ANDA #090886)","000","RISEDRONATE SODIUM","SUN PHARMA GLOBAL","Tentative Approval","06/10/2014"
"ESZOPICLONE (ANDA #091113)","000","ESZOPICLONE","ORCHID HLTHCARE","Approval","06/10/2014"
"RISEDRONATE SODIUM (ANDA #200477)","000","RISEDRONATE SODIUM","MYLAN PHARMS INC","Approval","06/10/2014"
"NICORETTE (NDA #018612)","072","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"NICORETTE (NDA #018612)","073","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"NICORETTE (MINT) (NDA #018612)","072","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"NICORETTE (MINT) (NDA #018612)","073","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"MAGNEVIST (NDA #019596)","057","GADOPENTETATE DIMEGLUMINE","BAYER HLTHCARE","Labeling Revision","06/11/2014"
"NICORETTE (NDA #020066)","053","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"NICORETTE (NDA #020066)","054","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"NICORETTE (MINT) (NDA #020066)","053","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"NICORETTE (MINT) (NDA #020066)","054","NICOTINE POLACRILEX","GLAXOSMITHKLINE","Labeling Revision","06/11/2014"
"COLGATE TOTAL (NDA #020231)","072","SODIUM FLUORIDE; TRICLOSAN","COLGATE PALMOLIVE","Labeling Revision","06/11/2014"
"COLGATE TOTAL (NDA #020231)","073","SODIUM FLUORIDE; TRICLOSAN","COLGATE PALMOLIVE","Labeling Revision","06/11/2014"
"MAGNEVIST (NDA #021037)","030","GADOPENTETATE DIMEGLUMINE","BAYER HLTHCARE","Labeling Revision","06/11/2014"
"CAVERJECT IMPULSE (NDA #021212)","010","ALPROSTADIL","PHARMACIA AND UPJOHN","Labeling Revision","06/11/2014"
"NASCOBAL (NDA #021642)","011","CYANOCOBALAMIN","PAR PHARM","Labeling Revision","06/11/2014"
"SUTENT (NDA #021938)","026","SUNITINIB MALATE","CPPI CV","Labeling Revision","06/11/2014"
"PRANDIMET (NDA #022386)","012","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Manufacturing Change or Addition","06/11/2014"
"ERLOTINIB HYDROCHLORIDE (ANDA #091002)","000","ERLOTINIB HYDROCHLORIDE","MYLAN PHARMS INC","Approval","06/11/2014"
"GADAVIST (NDA #201277)","007","GADOBUTROL","BAYER HLTHCARE","Efficacy Supplement with Clinical Data to Support","06/11/2014"
"DULOXETINE HYDROCHLORIDE (ANDA #202045)","000","DULOXETINE HYDROCHLORIDE","APOTEX INC","Approval","06/11/2014"
"DOXAZOSIN MESYLATE (ANDA #202824)","000","DOXAZOSIN MESYLATE","ACCORD HLTHCARE","Approval","06/11/2014"
"DULOXETINE HYDROCHLORIDE (ANDA #203088)","000","DULOXETINE HYDROCHLORIDE","BRECKENRIDGE PHARM","Approval","06/11/2014"
"ADEMPAS (NDA #204819)","001","RIOCIGUAT","BAYER HLTHCARE","Supplement","06/11/2014"
"NOXAFIL (NDA #205053)","001","POSACONAZOLE","MERCK SHARP DOHME","Labeling Revision","06/11/2014"
"SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #017514)","069","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"RINGER'S IN PLASTIC CONTAINER (NDA #017635)","057","CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"PHYSIOSOL IN PLASTIC CONTAINER (NDA #017637)","061","MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"ACETIC ACID 0.25% IN PLASTIC CONTAINER (NDA #017656)","051","ACETIC ACID, GLACIAL","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"MICRO-K (NDA #018238)","042","POTASSIUM CHLORIDE","NESHER PHARMS","Manufacturing Change or Addition","06/12/2014"
"MICRO-K 10 (NDA #018238)","042","POTASSIUM CHLORIDE","NESHER PHARMS","Manufacturing Change or Addition","06/12/2014"
"BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018800)","027","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"STERILE WATER FOR INJECTION IN PLASTIC CONTAINER (NDA #018801)","038","STERILE WATER FOR INJECTION","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER (NDA #018802)","025","STERILE WATER FOR INJECTION","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (NDA #018803)","028","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"SODIUM PHOSPHATES IN PLASTIC CONTAINER (NDA #018892)","030","SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"SODIUM ACETATE IN PLASTIC CONTAINER (NDA #018893)","028","SODIUM ACETATE ANHYDROUS","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"TPN ELECTROLYTES IN PLASTIC CONTAINER (NDA #018895)","024","CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"POTASSIUM ACETATE IN PLASTIC CONTAINER (NDA #018896)","022","POTASSIUM ACETATE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #018897)","028","SODIUM CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"SODIUM LACTATE IN PLASTIC CONTAINER (NDA #018947)","023","SODIUM LACTATE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"ZINC CHLORIDE IN PLASTIC CONTAINER (NDA #018959)","022","ZINC CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"CUPRIC CHLORIDE IN PLASTIC CONTAINER (NDA #018960)","021","CUPRIC CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"CHROMIC CHLORIDE IN PLASTIC CONTAINER (NDA #018961)","023","CHROMIC CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"MANGANESE CHLORIDE IN PLASTIC CONTAINER (NDA #018962)","023","MANGANESE CHLORIDE","HOSPIRA","Manufacturing Change or Addition","06/12/2014"
"ZEBETA (NDA #019982)","018","BISOPROLOL FUMARATE","TEVA WOMENS","Manufacturing Change or Addition","06/12/2014"
"ZIAC (NDA #020186)","031","BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE","TEVA WOMENS","Manufacturing Change or Addition","06/12/2014"
"CAVERJECT (NDA #020379)","028","ALPROSTADIL","PHARMACIA AND UPJOHN","Labeling Revision","06/12/2014"
"CEREBYX (NDA #020450)","025","FOSPHENYTOIN SODIUM","PARKE DAVIS","Labeling Revision","06/12/2014"
"NASACORT ALLERGY 24 HOUR (NDA #020468)","038","TRIAMCINOLONE ACETONIDE","SANOFI AVENTIS US","Manufacturing Change or Addition","06/12/2014"
"DOVONEX (NDA #020554)","009","CALCIPOTRIENE","LEO PHARMA AS","Manufacturing Change or Addition","06/12/2014"
"TACLONEX (NDA #021852)","010","BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE","LEO PHARMA AS","Manufacturing Change or Addition","06/12/2014"
"ELLA (NDA #022474)","004","ULIPRISTAL ACETATE","LAB HRA PHARMA","Labeling Revision","06/12/2014"
"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ANDA #040422)","036","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","BARR","Labeling Revision","06/12/2014"
"TIMENTIN (NDA #050590)","069","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Labeling Revision","06/12/2014"
"TIMENTIN IN PLASTIC CONTAINER (NDA #050658)","031","CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM","GLAXOSMITHKLINE","Labeling Revision","06/12/2014"
"MAXIPIME (NDA #050679)","038","CEFEPIME HYDROCHLORIDE","HOSPIRA INC","Manufacturing Change or Addition","06/12/2014"
"LAMOTRIGINE (ANDA #201168)","000","LAMOTRIGINE","ALEMBIC PHARMS LTD","Approval","06/12/2014"
"HEPARIN SODIUM PRESERVATIVE FREE (ANDA #202732)","000","HEPARIN SODIUM","SHENZHEN TECHDOW","Approval","06/12/2014"
"HEPARIN SODIUM (ANDA #202733)","000","HEPARIN SODIUM","SHENZHEN TECHDOW","Approval","06/12/2014"
"HEPARIN SODIUM (ANDA #202957)","000","HEPARIN SODIUM","SHENZHEN TECHDOW","Approval","06/12/2014"
"HEPARIN SODIUM (ANDA #203198)","000","HEPARIN SODIUM","SHENZHEN TECHDOW","Approval","06/12/2014"
"BICNU (NDA #017422)","047","CARMUSTINE","EMCURE PHARMS LTD","Manufacturing Change or Addition","06/13/2014"
"SPORANOX (NDA #020083)","055","ITRACONAZOLE","JANSSEN PHARMS","Manufacturing Change or Addition","06/13/2014"
"COMTAN (NDA #020796)","016","ENTACAPONE","ORION PHARMA","Labeling Revision","06/13/2014"
"RENOVA (NDA #021108)","015","TRETINOIN","VALEANT INTL","Manufacturing Change or Addition","06/13/2014"
"VENOFER (NDA #021135)","027","IRON SUCROSE","LUITPOLD","Manufacturing Change or Addition","06/13/2014"
"BENICAR (NDA #021286)","030","OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/13/2014"
"TALC (NDA #021388)","002","TALC","BRYAN","Labeling Revision","06/13/2014"
"BENICAR HCT (NDA #021532)","024","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/13/2014"
"DIFFERIN (NDA #021753)","007","ADAPALENE","GALDERMA LABS LP","Manufacturing Change or Addition","06/13/2014"
"ALLI (NDA #021887)","006","ORLISTAT","GLAXOSMITHKLINE CONS","Labeling Revision","06/13/2014"
"AZOR (NDA #022100)","024","AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/13/2014"
"RISEDRONATE SODIUM (ANDA #079215)","000","RISEDRONATE SODIUM","TEVA PHARMS USA","Approval","06/13/2014"
"JETREA (BLA #125422)","025","OCRIPLASMIN","THROMBOGENICS, INC","Efficacy Supplement with Clinical Data to Support","06/13/2014"
"TRIBENZOR (NDA #200175)","018","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/13/2014"
"LYMPHOSEEK KIT (NDA #202207)","001","TECHNETIUM TC-99M TILMANOCEPT","NAVIDEA BIOPHARMS","Efficacy Supplement with Clinical Data to Support","06/13/2014"
"CODEINE SULFATE (ANDA #203046)","000","CODEINE SULFATE","LANNETT HOLDINGS INC","Approval","06/13/2014"
"KALYDECO (NDA #203188)","007","IVACAFTOR","VERTEX PHARMS","Labeling Revision","06/13/2014"
"SAIZEN (NDA #019764)","072","SOMATROPIN RECOMBINANT","EMD SERONO","Labeling Revision","06/16/2014"
"BIO-TROPIN (NDA #019774)","027","SOMATROPIN RECOMBINANT","FERRING","Labeling Revision","06/16/2014"
"TEV-TROPIN (NDA #019774)","027","SOMATROPIN RECOMBINANT","FERRING","Labeling Revision","06/16/2014"
"NUTROPIN AQ (NDA #020522)","051","SOMATROPIN RECOMBINANT","GENENTECH","Labeling Revision","06/16/2014"
"NUTROPIN AQ PEN (NDA #020522)","051","SOMATROPIN RECOMBINANT","GENENTECH","Labeling Revision","06/16/2014"
"SEROSTIM (NDA #020604)","078","SOMATROPIN RECOMBINANT","EMD SERONO","Labeling Revision","06/16/2014"
"SEROSTIM LQ (NDA #020604)","078","SOMATROPIN RECOMBINANT","EMD SERONO","Labeling Revision","06/16/2014"
"NOXAFIL (NDA #022003)","014","POSACONAZOLE","SCHERING","Manufacturing Change or Addition","06/16/2014"
"PROLIA (BLA #125320)","150","DENOSUMAB","AMGEN","Supplement","06/16/2014"
"XGEVA (BLA #125320)","150","DENOSUMAB","AMGEN","Supplement","06/16/2014"
"DAPTOMYCIN (ANDA #202857)","000","DAPTOMYCIN","HOSPIRA INC","Tentative Approval","06/16/2014"
"TECHNESCAN (NDA #018321)","021","TECHNETIUM TC-99M OXIDRONATE KIT","MALLINCKRODT","Manufacturing Change or Addition","06/17/2014"
"BECONASE AQ (NDA #019389)","033","BECLOMETHASONE DIPROPIONATE MONOHYDRATE","GLAXOSMITHKLINE","Manufacturing Change or Addition","06/17/2014"
"FLONASE (NDA #020121)","042","FLUTICASONE PROPIONATE","GLAXOSMITHKLINE","Manufacturing Change or Addition","06/17/2014"
"FLONASE (NDA #020121)","043","FLUTICASONE PROPIONATE","GLAXOSMITHKLINE","Manufacturing Change or Addition","06/17/2014"
"FLOVENT DISKUS 100 (NDA #020833)","029","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"FLOVENT DISKUS 250 (NDA #020833)","029","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"FLOVENT DISKUS 50 (NDA #020833)","029","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"VENTOLIN HFA (NDA #020983)","031","ALBUTEROL SULFATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"ADVAIR DISKUS 100/50 (NDA #021077)","052","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"ADVAIR DISKUS 250/50 (NDA #021077)","052","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"ADVAIR DISKUS 500/50 (NDA #021077)","052","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"EXALGO (NDA #021217)","012","HYDROMORPHONE HYDROCHLORIDE","MALLINCKRODT INC","Labeling Revision","06/17/2014"
"ZOMETA (NDA #021223)","030","ZOLEDRONIC ACID","NOVARTIS","Manufacturing Change or Addition","06/17/2014"
"ADVAIR HFA (NDA #021254)","021","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"ADVAIR HFA (NDA #021254)","022","FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"FLOVENT HFA (NDA #021433)","023","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"FLOVENT HFA (NDA #021433)","024","FLUTICASONE PROPIONATE","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"RECLAST (NDA #021817)","019","ZOLEDRONIC ACID","NOVARTIS","Manufacturing Change or Addition","06/17/2014"
"VERAMYST (NDA #022051)","010","FLUTICASONE FUROATE","GLAXOSMITHKLINE","Manufacturing Change or Addition","06/17/2014"
"ALTABAX (NDA #022055)","006","RETAPAMULIN","GLAXO GRP LTD","Manufacturing Change or Addition","06/17/2014"
"MICRONOR (NDA #016954)","106","NORETHINDRONE","JANSSEN PHARMS","Labeling Revision","06/18/2014"
"PITOCIN (NDA #018261)","032","OXYTOCIN","PAR STERILE PRODUCTS","Manufacturing Change or Addition","06/18/2014"
"HYCAMTIN (NDA #020981)","006","TOPOTECAN HYDROCHLORIDE","GLAXO WELLCOME","Labeling Revision","06/18/2014"
"NUVARING (NDA #021187)","024","ETHINYL ESTRADIOL; ETONOGESTREL","ORGANON USA INC","Labeling Revision","06/18/2014"
"BONIVA (NDA #021455)","017","IBANDRONATE SODIUM","HOFFMANN LA ROCHE","Manufacturing Change or Addition","06/18/2014"
"TRUVADA (NDA #021752)","044","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Labeling Revision","06/18/2014"
"BONIVA (NDA #021858)","015","IBANDRONATE SODIUM","ROCHE","Manufacturing Change or Addition","06/18/2014"
"VPRIV (NDA #022575)","014","VELAGLUCERASE ALFA","SHIRE HUMAN GENETIC","Manufacturing Change or Addition","06/18/2014"
"MERREM (NDA #050706)","033","MEROPENEM","ASTRAZENECA","Manufacturing Change or Addition","06/18/2014"
"CHLOROTHIAZIDE SODIUM (ANDA #202493)","000","CHLOROTHIAZIDE SODIUM","MYLAN INSTITUTIONAL","Approval","06/18/2014"
"OXALIPLATIN (ANDA #203869)","000","OXALIPLATIN","JIANGSU HENGRUI MED","Approval","06/18/2014"
"BLOXIVERZ (NDA #204078)","001","NEOSTIGMINE METHYLSULFATE","ECLAT PHARMS LLC","Manufacturing Change or Addition","06/18/2014"
"ACYCLOVIR (ANDA #204605)","000","ACYCLOVIR","AMNEAL PHARMS","Approval","06/18/2014"
"DELATESTRYL (NDA #009165)","032","TESTOSTERONE ENANTHATE","ENDO PHARMS","Labeling Revision","06/19/2014"
"DEPAKENE (NDA #018081)","049","VALPROIC ACID","ABBVIE","Labeling Revision","06/19/2014"
"DEPAKENE (NDA #018082)","034","VALPROIC ACID","ABBVIE","Labeling Revision","06/19/2014"
"DELSYM (NDA #018658)","030","DEXTROMETHORPHAN POLISTIREX","RECKITT BENCKISER","Labeling Revision","06/19/2014"
"DEPAKOTE (NDA #018723)","041","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/19/2014"
"OMNIPAQUE 140 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"OMNIPAQUE 180 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"OMNIPAQUE 210 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"OMNIPAQUE 240 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"OMNIPAQUE 300 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"OMNIPAQUE 350 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"OMNIPAQUE 70 (NDA #018956)","093","IOHEXOL","GE HEALTHCARE","Manufacturing Change or Addition","06/19/2014"
"DEPAKOTE (NDA #019680)","028","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/19/2014"
"ANDRODERM (NDA #020489)","031","TESTOSTERONE","WATSON LABS","Labeling Revision","06/19/2014"
"DEPACON (NDA #020593)","019","VALPROATE SODIUM","ABBVIE","Labeling Revision","06/19/2014"
"THALOMID (NDA #020785)","055","THALIDOMIDE","CELGENE","Labeling Revision","06/19/2014"
"ANDROGEL (NDA #021015)","039","TESTOSTERONE","ABBVIE","Labeling Revision","06/19/2014"
"DEPAKOTE ER (NDA #021168)","019","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/19/2014"
"TESTIM (NDA #021454)","021","TESTOSTERONE","AUXILIUM PHARMS","Labeling Revision","06/19/2014"
"FORTESTA (NDA #021463)","014","TESTOSTERONE","ENDO PHARMS","Labeling Revision","06/19/2014"
"STRIANT (NDA #021543)","010","TESTOSTERONE","AUXILIUM PHARMS LLC","Labeling Revision","06/19/2014"
"COMBIVENT RESPIMAT (NDA #021747)","004","ALBUTEROL SULFATE; IPRATROPIUM BROMIDE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","06/19/2014"
"AVEED (NDA #022219)","001","TESTOSTERONE UNDECANOATE","ENDO PHARMS INC","Labeling Revision","06/19/2014"
"ANDROGEL (NDA #022309)","012","TESTOSTERONE","ABBVIE","Labeling Revision","06/19/2014"
"AXIRON (NDA #022504)","011","TESTOSTERONE","ELI LILLY AND CO","Labeling Revision","06/19/2014"
"TESTRED (ANDA #083976)","031","METHYLTESTOSTERONE","VALEANT PHARM INTL","Labeling Revision","06/19/2014"
"DEPO-TESTOSTERONE (ANDA #085635)","029","TESTOSTERONE CYPIONATE","PHARMACIA AND UPJOHN","Labeling Revision","06/19/2014"
"FALLBACK SOLO (ANDA #201446)","000","LEVONORGESTREL","LUPIN LTD","Approval","06/19/2014"
"BROMFENAC SODIUM (ANDA #202435)","000","BROMFENAC SODIUM","APOTEX INC","Approval","06/19/2014"
"TESTOSTERONE (NDA #202763)","002","TESTOSTERONE","TEVA PHARMS","Labeling Revision","06/19/2014"
"TESTOSTERONE (NDA #203098)","002","TESTOSTERONE","PERRIGO ISRAEL","Labeling Revision","06/19/2014"
"HUMULIN R (NDA #018780)","147","INSULIN RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","06/20/2014"
"HUMULIN R PEN (NDA #018780)","147","INSULIN RECOMBINANT HUMAN","LILLY","Manufacturing Change or Addition","06/20/2014"
"DEPAKOTE (NDA #019680)","033","DIVALPROEX SODIUM","ABBVIE","Labeling Revision","06/20/2014"
"INDICLOR (NDA #019862)","021","INDIUM IN-111 CHLORIDE","GE HEALTHCARE","Manufacturing Change or Addition","06/20/2014"
"ISOVUE-200 (NDA #020327)","008","IOPAMIDOL","BRACCO","Labeling Revision","06/20/2014"
"ISOVUE-250 (NDA #020327)","008","IOPAMIDOL","BRACCO","Labeling Revision","06/20/2014"
"ISOVUE-300 (NDA #020327)","008","IOPAMIDOL","BRACCO","Labeling Revision","06/20/2014"
"ISOVUE-370 (NDA #020327)","008","IOPAMIDOL","BRACCO","Labeling Revision","06/20/2014"
"RETISERT (NDA #021737)","021","FLUOCINOLONE ACETONIDE","BAUSCH AND LOMB","Manufacturing Change or Addition","06/20/2014"
"DRONABINOL (ANDA #079217)","000","DRONABINOL","AKORN INC","Approval","06/20/2014"
"TRIBENZOR (NDA #200175)","017","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Manufacturing Change or Addition","06/20/2014"
"OXYCODONE HYDROCHLORIDE (NDA #200535)","009","OXYCODONE HYDROCHLORIDE","LEHIGH VALLEY","Manufacturing Change or Addition","06/20/2014"
"TROKENDI XR (NDA #201635)","002","TOPIRAMATE","SUPERNUS PHARMS","Manufacturing Change or Addition","06/20/2014"
"SIVEXTRO (NDA #205435)","000","TEDIZOLID PHOSPHATE","CUBIST PHARMS INC","Approval","06/20/2014"
"SIVEXTRO (NDA #205436)","000","TEDIZOLID PHOSPHATE","CUBIST PHARMS INC","Approval","06/20/2014"
"METRO I.V. IN PLASTIC CONTAINER (NDA #018900)","028","METRONIDAZOLE","B BRAUN","Manufacturing Change or Addition","06/23/2014"
"OMNISCAN (NDA #020123)","042","GADODIAMIDE","GE HEALTHCARE","Manufacturing Change or Addition","06/23/2014"
"NAPHCON-A (NDA #020226)","022","NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE","ALCON","Manufacturing Change or Addition","06/23/2014"
"TRIESENCE (NDA #022048)","003","TRIAMCINOLONE ACETONIDE","ALCON","Manufacturing Change or Addition","06/23/2014"
"PANCREAZE (NDA #022523)","006","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","JANSSEN PHARMS","Manufacturing Change or Addition","06/23/2014"
"ENOXAPARIN SODIUM (PRESERVATIVE FREE) (ANDA #076726)","000","ENOXAPARIN SODIUM","TEVA","Approval","06/23/2014"
"BROMFENAC SODIUM (ANDA #202620)","000","BROMFENAC SODIUM","APOTEX INC","Approval","06/23/2014"
"LISDEXAMFETAMINE DIMESYLATE (ANDA #202827)","000","LISDEXAMFETAMINE DIMESYLATE","ROXANE","Tentative Approval","06/23/2014"
"MORPHINE SULFATE (NDA #204223)","001","MORPHINE SULFATE","BD RX","Manufacturing Change or Addition","06/23/2014"
"SOLU-CORTEF (NDA #009866)","103","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","06/24/2014"
"CARDIZEM (NDA #018602)","064","DILTIAZEM HYDROCHLORIDE","VALEANT INTL","Manufacturing Change or Addition","06/24/2014"
"FUSILEV (NDA #020140)","018","LEVOLEUCOVORIN CALCIUM","SPECTRUM PHARMS","Manufacturing Change or Addition","06/24/2014"
"VFEND (NDA #021267)","046","VORICONAZOLE","PFIZER","Manufacturing Change or Addition","06/24/2014"
"CHLORHEXIDINE GLUCONATE (NDA #021669)","019","CHLORHEXIDINE GLUCONATE","SAGE PRODS","Labeling Revision","06/24/2014"
"ELELYSO (NDA #022458)","004","TALIGLUCERASE ALFA","PFIZER","Manufacturing Change or Addition","06/24/2014"
"ZITHROMAX (NDA #050733)","038","AZITHROMYCIN","PFIZER","Manufacturing Change or Addition","06/24/2014"
"ZOSYN IN PLASTIC CONTAINER (NDA #050750)","032","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Manufacturing Change or Addition","06/24/2014"
"OMEGA-3-ACID ETHYL ESTERS (ANDA #091018)","000","OMEGA-3-ACID ETHYL ESTERS","PAR PHARM INC","Approval","06/24/2014"
"PARICALCITOL (ANDA #091412)","000","PARICALCITOL","DR REDDYS LABS LTD","Approval","06/24/2014"
"IMIQUIMOD (ANDA #202002)","000","IMIQUIMOD","STRIDES ARCOLAB LTD","Approval","06/24/2014"
"PARICALCITOL (ANDA #202124)","000","PARICALCITOL","ANCHEN PHARMS","Approval","06/24/2014"
"RAVICTI (NDA #203284)","001","GLYCEROL PHENYLBUTYRATE","HYPERION THERAP INC","Labeling Revision","06/24/2014"
"FAMVIR (NDA #020363)","041","FAMCICLOVIR","NOVARTIS","Manufacturing Change or Addition","06/25/2014"
"CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #050639)","027","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","06/25/2014"
"CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #050639)","028","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","06/25/2014"
"CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (NDA #050639)","029","CLINDAMYCIN PHOSPHATE","PHARMACIA AND UPJOHN","Labeling Revision","06/25/2014"
"DOXYCYCLINE HYCLATE (ANDA #065095)","014","DOXYCYCLINE HYCLATE","HIKMA PHARMS","Labeling Revision","06/25/2014"
"LISDEXAMFETAMINE DIMESYLATE (ANDA #202830)","000","LISDEXAMFETAMINE DIMESYLATE","AMNEAL PHARMS","Tentative Approval","06/25/2014"
"LISDEXAMFETAMINE DIMESYLATE (ANDA #202835)","000","LISDEXAMFETAMINE DIMESYLATE","MYLAN PHARMS INC","Tentative Approval","06/25/2014"
"K-TAB (NDA #018279)","034","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","06/26/2014"
"POTASSIUM CHLORIDE (NDA #018279)","034","POTASSIUM CHLORIDE","ABBVIE","Manufacturing Change or Addition","06/26/2014"
"ZESTRIL (NDA #019777)","057","LISINOPRIL","ASTRAZENECA","Labeling Revision","06/26/2014"
"CLEOCIN HYDROCHLORIDE (NDA #050162)","092","CLINDAMYCIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","06/26/2014"
"CLEOCIN HYDROCHLORIDE (NDA #050162)","093","CLINDAMYCIN HYDROCHLORIDE","PHARMACIA AND UPJOHN","Labeling Revision","06/26/2014"
"VALSARTAN (ANDA #077492)","000","VALSARTAN","OHM LABS INC","Approval","06/26/2014"
"GATTEX KIT (NDA #203441)","002","TEDUGLUTIDE RECOMBINANT","NPS PHARMS INC","Efficacy Supplement with Clinical Data to Support","06/26/2014"
"VARITHENA (NDA #205098)","001","POLIDOCANOL","PROVENSIS","Manufacturing Change or Addition","06/26/2014"
"FUROSEMIDE (NDA #018579)","030","FUROSEMIDE","LUITPOLD","Manufacturing Change or Addition","06/27/2014"
"VIRAZOLE (NDA #018859)","031","RIBAVIRIN","VALEANT PHARM INTL","Manufacturing Change or Addition","06/27/2014"
"LUPRON DEPOT (NDA #019732)","041","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","06/27/2014"
"CERETEC (NDA #019829)","027","TECHNETIUM TC-99M EXAMETAZIME KIT","GE HEALTHCARE","Manufacturing Change or Addition","06/27/2014"
"TAXOL (NDA #020262)","050","PACLITAXEL","HQ SPCLT PHARMA","Manufacturing Change or Addition","06/27/2014"
"LUPRON DEPOT (NDA #020517)","036","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","06/27/2014"
"BENICAR (NDA #021286)","031","OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/27/2014"
"SYMLIN (NDA #021332)","007","PRAMLINTIDE ACETATE","ASTRAZENECA AB","Efficacy Supplement with Clinical Data to Support","06/27/2014"
"SYMLIN (NDA #021332)","016","PRAMLINTIDE ACETATE","ASTRAZENECA AB","Labeling Revision","06/27/2014"
"BENICAR HCT (NDA #021532)","025","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/27/2014"
"AFREZZA (NDA #022472)","000","INSULIN RECOMBINANT HUMAN","MANNKIND","Approval","06/27/2014"
"ELLA (NDA #022474)","003","ULIPRISTAL ACETATE","LAB HRA PHARMA","Manufacturing Change or Addition","06/27/2014"
"GAZYVA (BLA #125486)","008","OBINUTUZUMAB","GENENTECH","Labeling Revision","06/27/2014"
"TRIBENZOR (NDA #200175)","019","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","06/27/2014"
"DESMOPRESSIN ACETATE (ANDA #200653)","000","DESMOPRESSIN ACETATE","MYLAN PHARMS INC","Approval","06/27/2014"
"ELETRIPTAN HYDROBROMIDE (ANDA #202040)","000","ELETRIPTAN HYDROBROMIDE","TEVA PHARMS USA","Tentative Approval","06/27/2014"
"OXYMORPHONE HYDROCHLORIDE (ANDA #202946)","000","OXYMORPHONE HYDROCHLORIDE","MALLINCKRODT INC","Approval","06/27/2014"
"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (ANDA #203326)","000","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ROXANE","Approval","06/27/2014"
"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDRODHCLORIDE (ANDA #203326)","000","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","ROXANE","Approval","06/27/2014"
"DOXORUBICIN HYDROCHLORIDE (ANDA #203622)","000","DOXORUBICIN HYDROCHLORIDE","ACTAVIS INC","Approval","06/27/2014"
"AMMONIA N 13 (ANDA #203933)","000","AMMONIA N-13","UNIV TX MD ANDERSON","Approval","06/27/2014"
"VAZCULEP (NDA #204300)","000","PHENYLEPHRINE HYDROCHLORIDE","ECLAT PHARMS LLC","Approval","06/27/2014"
"SYMBICORT (NDA #021929)","039","BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE","ASTRAZENECA","Manufacturing Change or Addition","06/28/2014"
"OZURDEX (NDA #022315)","009","DEXAMETHASONE","ALLERGAN","New or Modified Indication","06/28/2014"
"HIBICLENS (NDA #017768)","041","CHLORHEXIDINE GLUCONATE","MOLNLYCKE HLTH","Labeling Revision","06/30/2014"
"CHLORAPREP ONE-STEP (NDA #020832)","034","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","06/30/2014"
"CHLORAPREP ONE-STEP FREPP (NDA #020832)","034","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","06/30/2014"
"CHLORAPREP WITH TINT (NDA #020832)","034","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","06/30/2014"
"BUTRANS (NDA #021306)","015","BUPRENORPHINE","PURDUE PHARMA LP","Labeling Revision","06/30/2014"
"BUTRANS (NDA #021306)","019","BUPRENORPHINE","PURDUE PHARMA LP","Manufacturing Change or Addition","06/30/2014"
"FASLODEX (NDA #021344)","030","FULVESTRANT","ASTRAZENECA","Manufacturing Change or Addition","06/30/2014"
"CHLORAPREP ONE-STEP SEPP (NDA #021555)","019","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","06/30/2014"
"CHLORAPREP SINGLE SWABSTICK (NDA #021555)","019","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","06/30/2014"
"CHLORAPREP TRIPLE SWABSTICK (NDA #021555)","019","CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL","CAREFUSION","Labeling Revision","06/30/2014"
"ARGATROBAN (ANDA #091665)","000","ARGATROBAN","PAR STERILE PRODUCTS","Approval","06/30/2014"
"HERCEPTIN (BLA #103792)","5313","TRASTUZUMAB","GENENTECH","Labeling Revision","06/30/2014"
"HERCEPTIN (BLA #103792)","5318","TRASTUZUMAB","GENENTECH","Labeling Revision","06/30/2014"
"MYALEPT (BLA #125390)","004","METRELEPTIN","AMYLIN PHARMS LLC","Labeling Revision","06/30/2014"
"ARGATROBAN (ANDA #202626)","000","ARGATROBAN","MYLAN INSTITUTIONAL","Approval","06/30/2014"
"LITHIUM CITRATE (NDA #018421)","028","LITHIUM CITRATE","ROXANE","Manufacturing Change or Addition","07/01/2014"
"PREMPHASE 14/14 (NDA #020527)","059","ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE","WYETH PHARMS INC","Manufacturing Change or Addition","07/01/2014"
"PREMPRO (NDA #020527)","059","ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE","WYETH PHARMS INC","Manufacturing Change or Addition","07/01/2014"
"IPRIVASK (NDA #021271)","005","DESIRUDIN RECOMBINANT","MARATHON PHARMS LLC","Manufacturing Change or Addition","07/01/2014"
"M.V.I. ADULT (NDA #021625)","017","ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K","HOSPIRA","Manufacturing Change or Addition","07/01/2014"
"EPIDUO (NDA #022320)","007","ADAPALENE; BENZOYL PEROXIDE","GALDERMA LABS LP","Manufacturing Change or Addition","07/01/2014"
"AFINITOR (NDA #022334)","025","EVEROLIMUS","NOVARTIS","Labeling Revision","07/01/2014"
"LINZESS (NDA #202811)","005","LINACLOTIDE","FOREST LABS INC","Manufacturing Change or Addition","07/01/2014"
"AFINITOR DISPERZ (NDA #203985)","007","EVEROLIMUS","NOVARTIS PHARM","Labeling Revision","07/01/2014"
"NORPRAMIN (NDA #014399)","069","DESIPRAMINE HYDROCHLORIDE","SANOFI AVENTIS US","Labeling Revision","07/02/2014"
"QUALAQUIN (NDA #021799)","024","QUININE SULFATE","MUTUAL PHARM CO INC","Labeling Revision","07/02/2014"
"LETAIRIS (NDA #022081)","026","AMBRISENTAN","GILEAD","Manufacturing Change or Addition","07/02/2014"
"AZOR (NDA #022100)","025","AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Labeling Revision","07/02/2014"
"BENDAMUSTINE HYDROCHLORIDE (NDA #205580)","000","BENDAMUSTINE HYDROCHLORIDE","EAGLE PHARMS","Tentative Approval","07/02/2014"
"SOLU-CORTEF (NDA #009866)","104","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Labeling Revision","07/03/2014"
"ARISTOCORT (NDA #011685)","026","TRIAMCINOLONE DIACETATE","SANDOZ","Labeling Revision","07/03/2014"
"DEPO-MEDROL (NDA #011757)","103","METHYLPREDNISOLONE ACETATE","PHARMACIA AND UPJOHN","Labeling Revision","07/03/2014"
"SOLU-MEDROL (NDA #011856)","123","METHYLPREDNISOLONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Labeling Revision","07/03/2014"
"KENALOG-10 (NDA #012041)","042","TRIAMCINOLONE ACETONIDE","APOTHECON","Labeling Revision","07/03/2014"
"ARISTOCORT (NDA #012802)","033","TRIAMCINOLONE DIACETATE","SANDOZ","Labeling Revision","07/03/2014"
"CELESTONE SOLUSPAN (NDA #014602)","058","BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE","MERCK SHARP DOHME","Labeling Revision","07/03/2014"
"KENALOG-40 (NDA #014901)","042","TRIAMCINOLONE ACETONIDE","APOTHECON","Labeling Revision","07/03/2014"
"ARISTOSPAN (NDA #016466)","046","TRIAMCINOLONE HEXACETONIDE","SANDOZ","Labeling Revision","07/03/2014"
"ZOLOFT (NDA #019839)","080","SERTRALINE HYDROCHLORIDE","PFIZER","Labeling Revision","07/03/2014"
"ZOLOFT (NDA #019839)","083","SERTRALINE HYDROCHLORIDE","PFIZER","Labeling Revision","07/03/2014"
"DOVONEX (NDA #020273)","012","CALCIPOTRIENE","LEO PHARMA AS","Manufacturing Change or Addition","07/03/2014"
"ZOLOFT (NDA #020990)","039","SERTRALINE HYDROCHLORIDE","PFIZER","Labeling Revision","07/03/2014"
"ZOLOFT (NDA #020990)","041","SERTRALINE HYDROCHLORIDE","PFIZER","Labeling Revision","07/03/2014"
"TRILEPTAL (NDA #021014)","033","OXCARBAZEPINE","NOVARTIS","Labeling Revision","07/03/2014"
"RAPAMUNE (NDA #021110)","071","SIROLIMUS","PF PRISM CV","Manufacturing Change or Addition","07/03/2014"
"TRILEPTAL (NDA #021285)","027","OXCARBAZEPINE","NOVARTIS","Labeling Revision","07/03/2014"
"BENICAR (NDA #021286)","029","OLMESARTAN MEDOXOMIL","DAIICHI SANKYO","Manufacturing Change or Addition","07/03/2014"
"IMPLANON (NDA #021529)","008","ETONOGESTREL","ORGANON USA INC","Labeling Revision","07/03/2014"
"NEXPLANON (NDA #021529)","008","ETONOGESTREL","ORGANON USA INC","Labeling Revision","07/03/2014"
"DIGOXIN (NDA #021648)","007","DIGOXIN","ROXANE","Manufacturing Change or Addition","07/03/2014"
"CYANOKIT (NDA #022041)","015","HYDROXOCOBALAMIN","MERCK SANTE SAS","Manufacturing Change or Addition","07/03/2014"
"TRELSTAR (NDA #022437)","009","TRIPTORELIN PAMOATE","WATSON LABS","Manufacturing Change or Addition","07/03/2014"
"NAMENDA XR (NDA #022525)","005","MEMANTINE HYDROCHLORIDE","FOREST LABS","Efficacy Supplement with Clinical Data to Support","07/03/2014"
"CLONIDINE HYDROCHLORIDE (ANDA #090329)","000","CLONIDINE HYDROCHLORIDE","CARACO","Approval","07/03/2014"
"DOCETAXEL (NDA #201195)","006","DOCETAXEL","ACCORD HLTHCARE","Labeling Revision","07/03/2014"
"IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE (ANDA #203200)","000","IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE","PERRIGO R AND D","Approval","07/03/2014"
"ILEVRO (NDA #203491)","006","NEPAFENAC","ALCON RES LTD","Manufacturing Change or Addition","07/03/2014"
"FLUPHENAZINE DECANOATE (ANDA #203732)","000","FLUPHENAZINE DECANOATE","PAR STERILE PRODUCTS","Approval","07/03/2014"
"ZOLEDRONIC ACID (ANDA #204051)","000","ZOLEDRONIC ACID","SUN PHARMA GLOBAL","Tentative Approval","07/03/2014"
"BELEODAQ (NDA #206256)","000","BELINOSTAT","SPECTRUM PHARMS","Approval","07/03/2014"
"INDIUM IN-111 OXYQUINOLINE (NDA #019044)","023","INDIUM IN-111 OXYQUINOLINE","GE HEALTHCARE","Manufacturing Change or Addition","07/07/2014"
"EFFEXOR XR (NDA #020699)","103","VENLAFAXINE HYDROCHLORIDE","WYETH PHARMS INC","Labeling Revision","07/07/2014"
"EFFEXOR XR (NDA #020699)","105","VENLAFAXINE HYDROCHLORIDE","WYETH PHARMS INC","Labeling Revision","07/07/2014"
"TELMISARTAN (ANDA #090032)","000","TELMISARTAN","GLENMARK GENERICS","Approval","07/07/2014"
"TELMISARTAN (ANDA #202130)","000","TELMISARTAN","ALEMBIC PHARMS LTD","Approval","07/07/2014"
"TELMISARTAN (ANDA #202397)","000","TELMISARTAN","MYLAN PHARMS INC","Approval","07/07/2014"
"MARQIBO KIT (NDA #202497)","001","VINCRISTINE SULFATE","TALON THERAP","Manufacturing Change or Addition","07/07/2014"
"TELMISARTAN (ANDA #203171)","000","TELMISARTAN","TORRENT PHARMS LTD","Approval","07/07/2014"
"DESVENLAFAXINE (NDA #204150)","001","DESVENLAFAXINE","ALEMBIC PHARMS LTD","Labeling Revision","07/07/2014"
"DESVENLAFAXINE (NDA #204150)","002","DESVENLAFAXINE","ALEMBIC PHARMS LTD","Labeling Revision","07/07/2014"
"KERYDIN (NDA #204427)","000","TAVABOROLE","ANACOR PHARMS INC","Approval","07/07/2014"
"CONRAY (NDA #013295)","066","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Labeling Revision","07/08/2014"
"CONRAY 43 (NDA #013295)","066","IOTHALAMATE MEGLUMINE","MALLINCKRODT","Labeling Revision","07/08/2014"
"CELEXA (NDA #020822)","046","CITALOPRAM HYDROBROMIDE","FOREST LABS","Labeling Revision","07/08/2014"
"LEXAPRO (NDA #021323)","045","ESCITALOPRAM OXALATE","FOREST LABS","Labeling Revision","07/08/2014"
"LEXAPRO (NDA #021365)","033","ESCITALOPRAM OXALATE","FOREST LABS","Labeling Revision","07/08/2014"
"CRESTOR (NDA #021366)","030","ROSUVASTATIN CALCIUM","IPR","Labeling Revision","07/08/2014"
"VANTAS (NDA #021732)","019","HISTRELIN ACETATE","ENDO PHARM","Labeling Revision","07/08/2014"
"QUETIAPINE FUMARATE (ANDA #202228)","000","QUETIAPINE FUMARATE","MYLAN PHARMS INC","Tentative Approval","07/08/2014"
"VALCHLOR (NDA #202317)","001","MECHLORETHAMINE HYDROCHLORIDE","ACTELION PHARMS LTD","Labeling Revision","07/08/2014"
"VALCHLOR (NDA #202317)","002","MECHLORETHAMINE HYDROCHLORIDE","ACTELION PHARMS LTD","Manufacturing Change or Addition","07/08/2014"
"FROVATRIPTAN SUCCINATE (ANDA #202931)","000","FROVATRIPTAN SUCCINATE","MYLAN PHARMS INC","Tentative Approval","07/08/2014"
"FORTICAL (NDA #021406)","017","CALCITONIN SALMON RECOMBINANT","UPSHER SMITH","Labeling Revision","07/09/2014"
"FORTICAL (NDA #021406)","022","CALCITONIN SALMON RECOMBINANT","UPSHER SMITH","Labeling Revision","07/09/2014"
"APLENZIN (NDA #022108)","011","BUPROPION HYDROBROMIDE","VALEANT BERMUDA","Labeling Revision","07/09/2014"
"CAYSTON (NDA #050814)","012","AZTREONAM","GILEAD","Manufacturing Change or Addition","07/09/2014"
"LINZESS (NDA #202811)","004","LINACLOTIDE","FOREST LABS INC","Labeling Revision","07/09/2014"
"TOFRANIL-PM (NDA #017090)","077","IMIPRAMINE PAMOATE","MALLINCKRODT INC","Labeling Revision","07/10/2014"
"PAMELOR (NDA #018012)","030","NORTRIPTYLINE HYDROCHLORIDE","MALLINCKRODT INC","Labeling Revision","07/10/2014"
"PAMELOR (NDA #018013)","062","NORTRIPTYLINE HYDROCHLORIDE","MALLINCKRODT LLC","Labeling Revision","07/10/2014"
"LUPRON (NDA #019010)","037","LEUPROLIDE ACETATE","ABBVIE ENDOCRINE INC","Labeling Revision","07/10/2014"
"ANAFRANIL (NDA #019906)","038","CLOMIPRAMINE HYDROCHLORIDE","MALLINCKRODT LLC","Labeling Revision","07/10/2014"
"RESCULA (NDA #021214)","008","UNOPROSTONE ISOPROPYL","SUCAMPO PHARMS","Manufacturing Change or Addition","07/10/2014"
"NAMENDA (NDA #021627)","011","MEMANTINE HYDROCHLORIDE","FOREST LABS","Manufacturing Change or Addition","07/10/2014"
"DOCETAXEL (NDA #022234)","003","DOCETAXEL","HOSPIRA INC","Efficacy Supplement with Clinical Data to Support","07/10/2014"
"DOXYCYCLINE (ANDA #065055)","013","DOXYCYCLINE","PAR PHARM","Labeling Revision","07/10/2014"
"QNASL (NDA #202813)","006","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Labeling Revision","07/10/2014"
"PENNSAID (NDA #204623)","002","DICLOFENAC SODIUM","MALLINCKRODT INC","Manufacturing Change or Addition","07/10/2014"
"RASUVO (NDA #205776)","000","METHOTREXATE","MEDAC PHARMA INC","Approval","07/10/2014"
"RYTHMOL (NDA #019151)","013","PROPAFENONE HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Manufacturing Change or Addition","07/11/2014"
"TRELSTAR (NDA #020715)","032","TRIPTORELIN PAMOATE","WATSON LABS","Labeling Revision","07/11/2014"
"TRELSTAR (NDA #021288)","028","TRIPTORELIN PAMOATE","WATSON LABS","Labeling Revision","07/11/2014"
"BRAVELLE (NDA #021289)","021","UROFOLLITROPIN","FERRING","Manufacturing Change or Addition","07/11/2014"
"RYTHMOL SR (NDA #021416)","013","PROPAFENONE HYDROCHLORIDE","GLAXOSMITHKLINE LLC","Manufacturing Change or Addition","07/11/2014"
"WELLBUTRIN XL (NDA #021515)","032","BUPROPION HYDROCHLORIDE","VALEANT INTL","Labeling Revision","07/11/2014"
"MENOPUR (NDA #021663)","019","MENOTROPINS (FSH;LH)","FERRING","Manufacturing Change or Addition","07/11/2014"
"TRUVADA (NDA #021752)","045","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","07/11/2014"
"ATRIPLA (NDA #021937)","032","EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Manufacturing Change or Addition","07/11/2014"
"TRELSTAR (NDA #022437)","008","TRIPTORELIN PAMOATE","WATSON LABS","Labeling Revision","07/11/2014"
"VPRIV (NDA #022575)","010","VELAGLUCERASE ALFA","SHIRE HUMAN GENETIC","Manufacturing Change or Addition","07/11/2014"
"KADCYLA (BLA #125427)","033","ADO-TRASTUZUMAB EMTANSINE","GENENTECH","Labeling Revision","07/11/2014"
"COMPLERA (NDA #202123)","017","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Manufacturing Change or Addition","07/11/2014"
"RITALIN (NDA #010187)","078","METHYLPHENIDATE HYDROCHLORIDE","NOVARTIS","Manufacturing Change or Addition","07/14/2014"
"SINEQUAN (NDA #016798)","056","DOXEPIN HYDROCHLORIDE","PFIZER","Labeling Revision","07/14/2014"
"SINEQUAN (NDA #017516)","025","DOXEPIN HYDROCHLORIDE","PFIZER","Labeling Revision","07/14/2014"
"OMNITROPE (NDA #021426)","029","SOMATROPIN RECOMBINANT","SANDOZ","Manufacturing Change or Addition","07/14/2014"
"INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) (NDA #021646)","014","ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K","SANDOZ","Labeling Revision","07/14/2014"
"FLUOCINONIDE (ANDA #091282)","000","FLUOCINONIDE","GLENMARK GENERICS","Approval","07/14/2014"
"FLUOCINONIDE (ANDA #200734)","000","FLUOCINONIDE","TARO","Approval","07/14/2014"
"FLUOCINONIDE (ANDA #200735)","000","FLUOCINONIDE","FOUGERA PHARMS INC","Approval","07/14/2014"
"DEMSER (NDA #017871)","019","METYROSINE","ATON PHARMA VPNA","Manufacturing Change or Addition","07/15/2014"
"SODIUM LACTATE IN PLASTIC CONTAINER (NDA #018947)","024","SODIUM LACTATE","HOSPIRA","Manufacturing Change or Addition","07/15/2014"
"TRELSTAR (NDA #020715)","033","TRIPTORELIN PAMOATE","WATSON LABS","Manufacturing Change or Addition","07/15/2014"
"EXCEDRIN (MIGRAINE) (NDA #020802)","024","ACETAMINOPHEN; ASPIRIN; CAFFEINE","NOVARTIS","Labeling Revision","07/15/2014"
"TRELSTAR (NDA #021288)","029","TRIPTORELIN PAMOATE","WATSON LABS","Manufacturing Change or Addition","07/15/2014"
"ARIXTRA (NDA #021345)","032","FONDAPARINUX SODIUM","AGI","Labeling Revision","07/15/2014"
"SANCUSO (NDA #022198)","011","GRANISETRON","PROSTRAKAN INC","Manufacturing Change or Addition","07/15/2014"
"SOLODYN (NDA #050808)","021","MINOCYCLINE HYDROCHLORIDE","MEDICIS","Manufacturing Change or Addition","07/15/2014"
"BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (ANDA #205292)","000","BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","PADDOCK LLC","Approval","07/15/2014"
"HEXADROL (NDA #014694)","030","DEXAMETHASONE SODIUM PHOSPHATE","ORGANON USA INC","Labeling Revision","07/16/2014"
"BACTRIM (NDA #017377)","074","SULFAMETHOXAZOLE; TRIMETHOPRIM","MUTUAL PHARM","Labeling Revision","07/16/2014"
"BACTRIM DS (NDA #017377)","074","SULFAMETHOXAZOLE; TRIMETHOPRIM","MUTUAL PHARM","Labeling Revision","07/16/2014"
"PROMACTA (NDA #022291)","013","ELTROMBOPAG OLAMINE","GLAXOSMITHKLINE","Labeling Revision","07/16/2014"
"VIIBRYD (NDA #022567)","013","VILAZODONE HYDROCHLORIDE","FOREST LABS INC","Labeling Revision","07/16/2014"
"KHEDEZLA (NDA #204683)","002","DESVENLAFAXINE","OSMOTICA PHARM CORP","Labeling Revision","07/16/2014"
"VIVACTIL (NDA #016012)","053","PROTRIPTYLINE HYDROCHLORIDE","TEVA WOMENS","Labeling Revision","07/17/2014"
"SURMONTIL (NDA #016792)","037","TRIMIPRAMINE MALEATE","ODYSSEY PHARMS","Labeling Revision","07/17/2014"
"SINEMET (NDA #017555)","056","CARBIDOPA; LEVODOPA","MERCK SHARP DOHME","Labeling Revision","07/17/2014"
"SINEMET (NDA #017555)","068","CARBIDOPA; LEVODOPA","MERCK SHARP DOHME","Labeling Revision","07/17/2014"
"SINEMET (NDA #017555)","071","CARBIDOPA; LEVODOPA","MERCK SHARP DOHME","Labeling Revision","07/17/2014"
"DESYREL (NDA #018207)","031","TRAZODONE HYDROCHLORIDE","APOTHECON","Labeling Revision","07/17/2014"
"WELLBUTRIN (NDA #018644)","049","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","07/17/2014"
"EPI E Z PEN JR (NDA #019430)","058","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","07/17/2014"
"EPIPEN (NDA #019430)","058","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","07/17/2014"
"EPIPEN E Z PEN (NDA #019430)","058","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","07/17/2014"
"EPIPEN JR. (NDA #019430)","058","EPINEPHRINE","MYLAN SPECLT","Labeling Revision","07/17/2014"
"ADAGEN (NDA #019818)","055","PEGADEMASE BOVINE","SIGMA TAU","Manufacturing Change or Addition","07/17/2014"
"SINEMET CR (NDA #019856)","016","CARBIDOPA; LEVODOPA","MERCK SHARP DOHME","Labeling Revision","07/17/2014"
"SINEMET CR (NDA #019856)","024","CARBIDOPA; LEVODOPA","MERCK SHARP DOHME","Labeling Revision","07/17/2014"
"SINEMET CR (NDA #019856)","028","CARBIDOPA; LEVODOPA","MERCK SHARP DOHME","Labeling Revision","07/17/2014"
"WELLBUTRIN SR (NDA #020358)","056","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","Labeling Revision","07/17/2014"
"SANDOSTATIN LAR (NDA #021008)","030","OCTREOTIDE ACETATE","NOVARTIS","Manufacturing Change or Addition","07/17/2014"
"CYMBALTA (NDA #021427)","045","DULOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","07/17/2014"
"PRISTIQ (NDA #021992)","040","DESVENLAFAXINE SUCCINATE","WYETH PHARMS INC","Labeling Revision","07/17/2014"
"OLEPTRO (NDA #022411)","008","TRAZODONE HYDROCHLORIDE","ANGELINI PHARMA","Labeling Revision","07/17/2014"
"FORFIVO XL (NDA #022497)","002","BUPROPION HYDROCHLORIDE","EDGEMONT PHARMS LLC","Labeling Revision","07/17/2014"
"ZOSYN IN PLASTIC CONTAINER (NDA #050750)","031","PIPERACILLIN SODIUM; TAZOBACTAM SODIUM","WYETH PHARMS INC","Manufacturing Change or Addition","07/17/2014"
"ROPIVACAINE HYDROCHLORIDE (ANDA #078601)","000","ROPIVACAINE HYDROCHLORIDE","NAVINTA LLC","Approval","07/17/2014"
"ABACAVIR SULFATE; LAMIVUDINE (ANDA #079246)","000","ABACAVIR SULFATE; LAMIVUDINE","TEVA PHARMS","Tentative Approval","07/17/2014"
"TUDORZA PRESSAIR (NDA #202450)","002","ACLIDINIUM BROMIDE","FOREST LABS INC","Labeling Revision","07/17/2014"
"BRINTELLIX (NDA #204447)","005","VORTIOXETINE HYDROBROMIDE","TAKEDA PHARMS USA","Labeling Revision","07/17/2014"
"KINEVAC (NDA #017697)","023","SINCALIDE","BRACCO","Manufacturing Change or Addition","07/18/2014"
"PROZAC (NDA #018936)","105","FLUOXETINE HYDROCHLORIDE","ELI LILLY AND CO","Labeling Revision","07/18/2014"
"SARAFEM (NDA #018936)","105","FLUOXETINE HYDROCHLORIDE","ELI LILLY AND CO","Labeling Revision","07/18/2014"
"PAXIL (NDA #020031)","071","PAROXETINE HYDROCHLORIDE","APOTEX TECHNOLOGIES","Labeling Revision","07/18/2014"
"REMERON (NDA #020415)","031","MIRTAZAPINE","ORGANON USA INC","Labeling Revision","07/18/2014"
"ELLIOTTS B SOLUTION (NDA #020577)","008","CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE","LUKARE MEDICAL LLC","Manufacturing Change or Addition","07/18/2014"
"PAXIL (NDA #020710)","035","PAROXETINE HYDROCHLORIDE","APOTEX TECHNOLOGIES","Labeling Revision","07/18/2014"
"PAXIL CR (NDA #020936)","049","PAROXETINE HYDROCHLORIDE","APOTEX TECHNOLOGIES","Labeling Revision","07/18/2014"
"REMERON SOLTAB (NDA #021208)","021","MIRTAZAPINE","ORGANON USA INC","Labeling Revision","07/18/2014"
"PROZAC WEEKLY (NDA #021235)","024","FLUOXETINE HYDROCHLORIDE","LILLY","Labeling Revision","07/18/2014"
"BRAVELLE (NDA #021289)","022","UROFOLLITROPIN","FERRING","Manufacturing Change or Addition","07/18/2014"
"PEXEVA (NDA #021299)","032","PAROXETINE MESYLATE","NOVEN THERAP","Labeling Revision","07/18/2014"
"ELIGARD (NDA #021343)","028","LEUPROLIDE ACETATE","TOLMAR THERAP","Manufacturing Change or Addition","07/18/2014"
"OXYTROL (NDA #021351)","015","OXYBUTYNIN","WATSON LABS (UTAH)","Manufacturing Change or Addition","07/18/2014"
"ELIGARD (NDA #021379)","026","LEUPROLIDE ACETATE","TOLMAR THERAP","Manufacturing Change or Addition","07/18/2014"
"STALEVO 100 (NDA #021485)","028","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 100 (NDA #021485)","029","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 125 (NDA #021485)","028","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 125 (NDA #021485)","029","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 150 (NDA #021485)","028","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 150 (NDA #021485)","029","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 200 (NDA #021485)","028","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 200 (NDA #021485)","029","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 50 (NDA #021485)","028","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 50 (NDA #021485)","029","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 75 (NDA #021485)","028","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"STALEVO 75 (NDA #021485)","029","CARBIDOPA; ENTACAPONE; LEVODOPA","ORION PHARMA","Labeling Revision","07/18/2014"
"LUVOX (NDA #021519)","008","FLUVOXAMINE MALEATE","ANI PHARMS","Labeling Revision","07/18/2014"
"SYMBYAX (NDA #021520)","045","FLUOXETINE HYDROCHLORIDE; OLANZAPINE","LILLY","Labeling Revision","07/18/2014"
"ELIGARD (NDA #021731)","024","LEUPROLIDE ACETATE","TOLMAR THERAP","Manufacturing Change or Addition","07/18/2014"
"VYVANSE (NDA #021977)","031","LISDEXAMFETAMINE DIMESYLATE","SHIRE DEVELOPMENT","Labeling Revision","07/18/2014"
"VYVANSE (NDA #021977)","032","LISDEXAMFETAMINE DIMESYLATE","SHIRE DEVELOPMENT","Labeling Revision","07/18/2014"
"LUVOX CR (NDA #022033)","010","FLUVOXAMINE MALEATE","JAZZ PHARMS","Labeling Revision","07/18/2014"
"VENLAFAXINE HYDROCHLORIDE (NDA #022104)","010","VENLAFAXINE HYDROCHLORIDE","OSMOTICA PHARM","Labeling Revision","07/18/2014"
"BRILINTA (NDA #022433)","012","TICAGRELOR","ASTRAZENECA LP","Manufacturing Change or Addition","07/18/2014"
"FLUOXETINE HYDROCHLORIDE (NDA #202133)","003","FLUOXETINE HYDROCHLORIDE","EDGEMONT PHARMS LLC","Labeling Revision","07/18/2014"
"ETOMIDATE (ANDA #202360)","000","ETOMIDATE","ZYDUS PHARMS USA INC","Approval","07/18/2014"
"MESNA (ANDA #203364)","000","MESNA","AGILA SPECLTS","Approval","07/18/2014"
"TOPICORT (NDA #204141)","001","DESOXIMETASONE","TARO","Manufacturing Change or Addition","07/18/2014"
"FETZIMA (NDA #204168)","002","LEVOMILNACIPRAN HYDROCHLORIDE","FOREST LABS INC","Labeling Revision","07/18/2014"
"DESVENLAFAXINE (NDA #205208)","001","DESVENLAFAXINE FUMARATE","TEVA PHARMS USA","Labeling Revision","07/18/2014"
"DESVENLAFAXINE (NDA #205583)","001","DESVENLAFAXINE FUMARATE","SUN PHARMA GLOBAL","Labeling Revision","07/18/2014"
"DESVENLAFAXINE (NDA #205583)","003","DESVENLAFAXINE FUMARATE","SUN PHARMA GLOBAL","Labeling Revision","07/18/2014"
"ATROPINE SULFATE (NDA #206289)","000","ATROPINE SULFATE","AKORN INC","Approval","07/18/2014"
"FLOMAX (NDA #020579)","028","TAMSULOSIN HYDROCHLORIDE","BOEHRINGER INGELHEIM","Labeling Revision","07/20/2014"
"FIORINAL (NDA #017534)","072","ASPIRIN; BUTALBITAL; CAFFEINE","WATSON LABS INC","Manufacturing Change or Addition","07/21/2014"
"QVAR 40 (NDA #020911)","025","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Labeling Revision","07/21/2014"
"QVAR 80 (NDA #020911)","025","BECLOMETHASONE DIPROPIONATE","TEVA BRANDED PHARM","Labeling Revision","07/21/2014"
"BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (ANDA #202940)","000","BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","VINTAGE PHARMS","Approval","07/21/2014"
"PENNSAID (NDA #204623)","001","DICLOFENAC SODIUM","MALLINCKRODT INC","Manufacturing Change or Addition","07/21/2014"
"SOLU-CORTEF (NDA #009866)","101","HYDROCORTISONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","07/22/2014"
"SOLU-MEDROL (NDA #011856)","121","METHYLPREDNISOLONE SODIUM SUCCINATE","PHARMACIA AND UPJOHN","Manufacturing Change or Addition","07/22/2014"
"CYTOXAN (NDA #012142)","114","CYCLOPHOSPHAMIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","07/22/2014"
"CYTOXAN (LYOPHILIZED) (NDA #012142)","114","CYCLOPHOSPHAMIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","07/22/2014"
"LYOPHILIZED CYTOXAN (NDA #012142)","114","CYCLOPHOSPHAMIDE","BAXTER HLTHCARE","Manufacturing Change or Addition","07/22/2014"
"LOTENSIN HCT (NDA #020033)","048","BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE","US PHARMS HOLDINGS I","Manufacturing Change or Addition","07/22/2014"
"CLARITIN HIVES RELIEF REDITAB (NDA #020704)","027","LORATADINE","SCHERING PLOUGH","Labeling Revision","07/22/2014"
"CLARITIN REDITABS (NDA #020704)","027","LORATADINE","SCHERING PLOUGH","Labeling Revision","07/22/2014"
"TEVETEN (NDA #020738)","029","EPROSARTAN MESYLATE","ABBVIE","Labeling Revision","07/22/2014"
"XELODA (NDA #020896)","033","CAPECITABINE","HOFFMANN LA ROCHE","Manufacturing Change or Addition","07/22/2014"
"TEVETEN HCT (NDA #021268)","019","EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE","ABBVIE","Labeling Revision","07/22/2014"
"PROHANCE MULTIPACK (NDA #021489)","004","GADOTERIDOL","BRACCO","Labeling Revision","07/22/2014"
"DESONATE (NDA #021844)","008","DESONIDE","BAYER HLTHCARE","Labeling Revision","07/22/2014"
"CLARITIN REDITABS (NDA #021993)","012","LORATADINE","SCHERING PLOUGH","Labeling Revision","07/22/2014"
"TACROLIMUS (ANDA #090687)","000","TACROLIMUS","STRIDES ARCOLAB LTD","Approval","07/22/2014"
"ZOLEDRONIC ACID (ANDA #204138)","000","ZOLEDRONIC ACID","SUN PHARMA GLOBAL","Tentative Approval","07/22/2014"
"OTEZLA (NDA #205437)","001","APREMILAST","CELGENE CORP","Manufacturing Change or Addition","07/22/2014"
"RYANODEX (NDA #205579)","000","DANTROLENE SODIUM","EAGLE PHARMS","Approval","07/22/2014"
"TERAZOL 7 (NDA #019579)","037","TERCONAZOLE","JANSSEN PHARMS","Labeling Revision","07/23/2014"
"TERAZOL 3 (NDA #019641)","030","TERCONAZOLE","JANSSEN PHARMS","Labeling Revision","07/23/2014"
"CARDENE (NDA #019734)","023","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Labeling Revision","07/23/2014"
"CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #019734)","023","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Labeling Revision","07/23/2014"
"CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER (NDA #019734)","023","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Labeling Revision","07/23/2014"
"CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NDA #019734)","023","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Labeling Revision","07/23/2014"
"CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER (NDA #019734)","023","NICARDIPINE HYDROCHLORIDE","CHIESI USA INC","Labeling Revision","07/23/2014"
"TERAZOL 3 (NDA #019964)","032","TERCONAZOLE","JANSSEN PHARMS","Labeling Revision","07/23/2014"
"EDARBI (NDA #200796)","006","AZILSARTAN KAMEDOXOMIL","ARBOR PHARMS IRELAND","Labeling Revision","07/23/2014"
"EDARBYCLOR (NDA #202331)","006","AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE","ARBOR PHARMS IRELAND","Labeling Revision","07/23/2014"
"TESTOSTERONE (NDA #202763)","001","TESTOSTERONE","TEVA PHARMS","Labeling Revision","07/23/2014"
"HYDROCHLOROTHIAZIDE (ANDA #203018)","000","HYDROCHLOROTHIAZIDE","SCIEGEN PHARMS INC","Approval","07/23/2014"
"FLONASE ALLERGY RELIEF (NDA #205434)","000","FLUTICASONE PROPIONATE","GLAXOSMITHKLINE CONS","Approval","07/23/2014"
"TARGINIQ ER (NDA #205777)","000","OXYCODONE HYDROCHLORIDE;NALOXONE HYDROCHLORIDE","PURDUE FREDERICK","Approval","07/23/2014"
"ZYDELIG (NDA #205858)","000","IDELALISIB","GILEAD SCIENCES INC","Approval","07/23/2014"
"ZYDELIG (NDA #206545)","000","IDELALISIB","GILEAD SCIENCES INC","Approval","07/23/2014"
"CRIXIVAN (NDA #020685)","076","INDINAVIR SULFATE","MERCK SHARP DOHME","Labeling Revision","07/24/2014"
"ADDERALL XR 10 (NDA #021303)","027","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","07/24/2014"
"ADDERALL XR 15 (NDA #021303)","027","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","07/24/2014"
"ADDERALL XR 20 (NDA #021303)","027","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","07/24/2014"
"ADDERALL XR 25 (NDA #021303)","027","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","07/24/2014"
"ADDERALL XR 30 (NDA #021303)","027","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","07/24/2014"
"ADDERALL XR 5 (NDA #021303)","027","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","SHIRE","Labeling Revision","07/24/2014"
"FORTICAL (NDA #021406)","023","CALCITONIN SALMON RECOMBINANT","UPSHER SMITH","Manufacturing Change or Addition","07/24/2014"
"MESTINON (NDA #011665)","020","PYRIDOSTIGMINE BROMIDE","VALEANT PHARMS LLC","Manufacturing Change or Addition","07/25/2014"
"ALINIA (NDA #021498)","006","NITAZOXANIDE","ROMARK","Manufacturing Change or Addition","07/25/2014"
"LASTACAFT (NDA #022134)","003","ALCAFTADINE","ALLERGAN","Manufacturing Change or Addition","07/25/2014"
"PRADAXA (NDA #022512)","022","DABIGATRAN ETEXILATE MESYLATE","BOEHRINGER INGELHEIM","Manufacturing Change or Addition","07/25/2014"
"AZACTAM IN PLASTIC CONTAINER (NDA #050632)","017","AZTREONAM","BRISTOL MYERS SQUIBB","Manufacturing Change or Addition","07/25/2014"
"BIAXIN (NDA #050662)","055","CLARITHROMYCIN","ABBVIE","Labeling Revision","07/25/2014"
"BIAXIN (NDA #050698)","035","CLARITHROMYCIN","ABBVIE","Labeling Revision","07/25/2014"
"BIAXIN XL (NDA #050775)","023","CLARITHROMYCIN","ABBVIE","Labeling Revision","07/25/2014"

		
		
